Sentence,class,file
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d0/4b/dddt-9-5727.PMC4621195.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 5727–5736Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  5727Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S9235 54-hydroxyisoleucine ameliorates an insulin  resistant-like state in 3T3-l1 adipocytes by  regulating TACE/TIMP3  expression Feng gao1 Wen Du1,4 Mohammad ishraq Zafar1 raja adeel shafqat2 liumeng Jian1 Qin cai1 Furong lu3 1Department of endocrinology, Union  hospital, 2Department of Medicine,   T ongji hospital, 3Department of  integrated Traditional chinese and  Western Medicine, Union hospital,   Tongji Medical college, huazhong  University of science and T echnology,   Wuhan, hubei, 4chengdu First  People’s hospital, sichuan, People’s  republic of chinaBackground:  Obesity-associated insulin resistance (IR) is highly correlated with soluble tumor  necrosis factor- α (sTNF- α), which is released from transmembranous TNF- α by TNF- α convert - ing enzyme ( TACE ).",Non-OADS,/arxiv_data1/oa_pdf/d0/4b/dddt-9-5727.PMC4621195.pdf
"It is synthesized as  a transmembrane 26-kDa precursor transmembrane tumor necrosis factor- α (mTNF- α),  which is cleaved into the secreted 17-kDa form (sTNF- α) by TNF- α converting correspondence: Furong lu Department of integrated Traditional  chinese and Western Medicine, Union  hospital, Tongji Medical college,  huazhong University of science and  Technology, 1277 Jiefang avenue, Wuhan,  hubei 430022, People’s republic of china email furonglulove@163.co m Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Gao et al Running head recto: 4-HIL improves insulin resistant-like state in 3T3-L1 adipocytes DOI: http://dx.doi.org/10.2147/DDDT.S92355",Non-OADS,/arxiv_data1/oa_pdf/d0/4b/dddt-9-5727.PMC4621195.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/d0/4b/dddt-9-5727.PMC4621195.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/d0/4b/dddt-9-5727.PMC4621195.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/bf/a3/jir-8-201.PMC4621196.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pJournal of Inflammation Research 2015:8 201–209Journal of Inflammation Research Dove press submit your manuscript | www.dovepress.co m Dove press  201ORIg Inal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/JIR.S8909 7exploring the translational disconnect between  the murine and human inflammatory response:  analysis of lPs dose–response relationship in  murine versus human cell lines and implications  for translation into murine models of sepsis eamon P Mccarron1 Dominic P Williams1 Daniel J antoine1 anja Kipar2 Jana lemm3 sebastian stehr3 Ingeborg D Welters4 1Department of clinical and  Molecular Pharmacology, centre  for Drug safety science, Institute of  Translational Medicine,  2Department  of Veterinary Pathology, University of  liverpool, liverpool, UK;  3Department  of anaesthesiology and Intensive care  Medicine, Jena University hospital,   Jena, germany;  4Department of  Obesity and endocrinology, Institute  of ageing and chronic Disease,   University of liverpool, liverpool, UK correspondence: eamon P Mccarron   Department of clinical and Molecular  Pharmacology, centre for Drug safety  science, Institute of Translational  Medicine, University of liverpool, ashton  street, liverpool, l69 3ge, UK   email e.p.mccarron@doctors.org.u kBackground:  Inflammation forms an important part of the human innate immune system  and is largely dependent on the activation of the “classical” NF- κB pathway through Toll-like  receptors (TLRs).",Non-OADS,/arxiv_data1/oa_pdf/bf/a3/jir-8-201.PMC4621196.pdf
"Journal of Inflammation Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-inflammation-research-journa lThe Journal of Inflammation Research is an international, peer-reviewed  open-access journal that welcomes laboratory and clinical findings on the  molecular basis, cell biology and pharmacology of inflammation including  original research, reviews, symposium reports, hypothesis formation and  commentaries on: acute/chronic inflammation; mediators of inflamma -tion; cellular processes; molecular mechanisms; pharmacology and novel  anti-inflammatory drugs; clinical conditions involving inflammation.",Non-OADS,/arxiv_data1/oa_pdf/bf/a3/jir-8-201.PMC4621196.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/bf/a3/jir-8-201.PMC4621196.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ad/a3/ott-8-2959.PMC4621197.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 2959–2965OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2959Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S8550 4Differential regulation of human eag1 channel  expression by serum and epidermal growth factor  in lung and breast cancer cells isabel acuña-Macías1 eunice Vera1 alma Y olanda Vázquez- sánchez1 María eugenia Mendoza- garrido2 Javier camacho1 1Department of Pharmacology,   2Department of Physiology, Biophysics  and neurosciences, centro de  investigación y de estudios avanzados  del instituto Politécnico nacional,   Mexico city, MexicoAbstract:  Oncogenic ether à-go-go-1  (Eag1) potassium channels are overexpressed in most  primary human solid tumors.",Non-OADS,/arxiv_data1/oa_pdf/ad/a3/ott-8-2959.PMC4621197.pdf
"Here, we investigated the effect of  serum deprivation, epidermal and vascular endothelial growth factors (EGF and VEGF, correspondence: Javier camacho Department of Pharmacology,  centro de investigación y de estudios  avanzados del instituto Politécnico  nacional, avenida instituto Politécnico  nacional 2508, Mexico city,  cP 07360, Mexico Tel +52 55 5747 3800 ext 5416 Fax +52 55 5747 7002 email fcamacho@cinvestav.m x Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2015 Volume: 8 Running head verso: Acuña-Macías et al Running head recto: Potassium channel regulation by serum and EGF DOI: http://dx.doi.org/10.2147/OTT.S85504",Non-OADS,/arxiv_data1/oa_pdf/ad/a3/ott-8-2959.PMC4621197.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/ad/a3/ott-8-2959.PMC4621197.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/ad/a3/ott-8-2959.PMC4621197.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/63/ca/tcrm-11-1597.PMC4621198.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpTherapeutics and Clinical Risk Management 2015:11 1597–1602Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  1597ORiginal ReseaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S9064 9Symptomatic flexible flatfoot in adults: subtalar  arthroereisis Fırat Ozan1 Fatih Do ğar1 Kürşat Gençer1 Şemmi Koyuncu2 Fatih Vatansever1 Fuat Duygulu1 Taşkın Altay3 1Department of Orthopedics and  Traumatology, Kayseri Training  and Research hospital, Kayseri,   2Department of Orthopedics and  Traumatology, Bayburt State Hospital,   Bayburt, 3Department of Orthopedics  and Traumatology, İzmir Bozyaka  Training and Research hospital, İzmir,   T urkeyAbstract:  Flexible flatfoot is a common deformity in pediatric and adult populations.",Non-OADS,/arxiv_data1/oa_pdf/63/ca/tcrm-11-1597.PMC4621198.pdf
"Keywords:  arthroereisis, flatfoot, sinus tarsi implant, pes planus Introduction Flexible flatfoot is a common deformity in children and adults.1,2 It is characterized by  medial rotation and plantar flexion of the talus, eversion of the calcaneus, collapsed  medial arch, and abduction of the forefoot.3–5 In general, infants are born with a flexible  flatfoot, with the arch of the foot typically developing during the first decade of life.1,6  Most flexible flatfoot cases resolve spontaneously or remain asymptomatic, whereas  symptomatic and pathological conditions require treatment.1,7 Various conservative and surgical procedures have been defined in the treatment of  symptomatic flexible flatfoot.5,8,9 Conservative interventions include shoe modification,  brace, physical therapy, and exercise modifications.10 Surgery is indicated in patients  in whom conservative interventions fail,11,12 and encompasses both soft-tissue and  bone procedures.4,13 Surgery mainly includes muscle and tendon lengthening, tendon  transfer, osteotomy, arthrodesis, and arthroereisis.4,5,10,13 It has been well documented  that subtalar arthroereisis is an effective surgical procedure in the treatment of flexible  flatfoot in adults, minimizing pain, deformity, and instability.2,8,14 Despite controversial  opinions on the optimal technique and implant, the principle of reducing overpronation  has been widely accepted.2,4,15 Subtalar joint implants previously consisted of a bone  graft; however, various specifically designed implants are currently used.2,8,10,14Correspondence: Fırat Ozan Department of Orthopedics and  Traumatology, Kayseri Training and  Research hospital, sanayi Mahallesi,  atatürk Bulvari hastane Caddesi,  Kocasinan, 38010 Kayseri, Turkey email firatozan9@gmail.co m Journal name: Therapeutics and Clinical Risk Management Article Designation: Original Research Y ear: 2015 Volume: 11 Running head verso: Ozan et al Running head recto: Symptomatic flexible flatfoot in adults DOI: http://dx.doi.org/10.2147/TCRM.S90649",Non-OADS,/arxiv_data1/oa_pdf/63/ca/tcrm-11-1597.PMC4621198.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/63/ca/tcrm-11-1597.PMC4621198.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/63/ca/tcrm-11-1597.PMC4621198.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/3d/eb/ott-8-2989.PMC4621199.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 2989–3001OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2989Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9151 1luteolin decreases invasiveness, deactivates  sTaT3 signaling, and reverses interleukin-6  induced epithelial–mesenchymal transition and  matrix metalloproteinase secretion of pancreatic  cancer cells Xince huang1 shengjie Dai1 Juji Dai1 Yuwu Xiao1 Y ongyu Bai1 Bicheng chen1,2 Mengtao Zhou1 1Department of surgery, The First  affiliated hospital, Wenzhou Medical  University, Wenzhou, Zhejiang  Province, People’s republic of  china; 2Zhejiang Provincial Top Key  Discipline in surgery, Wenzhou Key  laboratory of surgery, Wenzhou,   Zhejiang Province, People’s republic  of chinaAbstract:  Luteolin, a flavone, has been shown to exhibit anticancer properties.",Non-OADS,/arxiv_data1/oa_pdf/3d/eb/ott-8-2989.PMC4621199.pdf
"Keywords:  epithelial–mesenchymal transition, matrix metalloproteinase, luteolin, STAT3 Introduction Flavonoids are polyphenolic compounds that are extensively found in food plants.1,2  They have been proven to be the effective constituents of many plants and herbs used  in traditional Chinese medicine and have preventive and therapeutic effects against  some diseases.3 Luteolin, a flavone widely found in many food plants and herbs, has  been identified as one of the most potent flavonoids in vitro and in vivo.4,5 With many  biological activities and therapeutic effects, including anti-inflammatory, proapopto - sis, and reverse antineoplastic drug resistance, luteolin demonstrates a potential for  treatment of inflammatory and neoplastic diseases.6–10 A variety of effects, such as  proapoptosis and cell cycle arrest, matrix metalloproteinase (MMP) suppression, and  angiogenesis inhibition, have been uncovered as means of luteolin anticancer activi - ties in vivo and in vitro.9,11–13 In our study, we aimed at revealing luteolin’s effect on  inhibiting epithelial–mesenchymal transition (EMT) and on the invasiveness of pan - creatic cancer, and their relationships with dephosphorylation of signal transducer and correspondence: Mengtao Zhou;   Bicheng chen Department of surgery, The First  Affiliated Hospital, Wenzhou Medical  University, 2 Fuxue lane, Wenzhou  325000, Zhejiang Province, People’s  republic of china email zmt0417 @hotmail.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2015 Volume: 8 Running head verso: Huang et al Running head recto: Luteolin inhibits EMT and invasiveness of pancreatic cancer DOI: http://dx.doi.org/10.2147/OTT.S91511",Non-OADS,/arxiv_data1/oa_pdf/3d/eb/ott-8-2989.PMC4621199.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/3d/eb/ott-8-2989.PMC4621199.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/3d/eb/ott-8-2989.PMC4621199.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/79/53/ott-8-3003.PMC4621200.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 3003–3007OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3003Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S8975 4association between pre-mir-27a functional  polymorphism and risk of colorectal cancer  in north chinese han population Quan Bian1,* Jian-Jun chen2,* Jun-Ping gu1 Jing Xu3 1Department of general surgery,   Tianjin hospital, Tianjin, 2Department  of general surgery, Beijing chaoyang  hospital, Beijing, 3Department of  gastrointestinal surgery, Union  Medical center of Tianjin, nankai  University affiliated hospital, Tianjin,   People’s republic of china *These authors contributed equally  to the studyAbstract:  MicroRNA-27a (miR-27a) is deemed as an oncogene in malignancies including  colorectal cancer (CRC), and rs895819 within pre-miR-27a  may affect its secondary struc - ture, leading to its aberrant expression and dysfunction of its targeted gene.",Non-OADS,/arxiv_data1/oa_pdf/79/53/ott-8-3003.PMC4621200.pdf
"Overexpression of hsa-miR-27a was examined in laryngeal carcinoma,  osteosarcoma, hepatocellular carcinoma, CRC, and many kinds of cell lines, such correspondence: Quan Bian Department of general surgery, Tianjin  hospital, 406 south road of Jiefang,  Tianjin, People’s republic of china Tel/fax +86 022 6091 0608 email bianquantjyy@163.co m  Jing Xu Department of gastrointestinal surgery,  Union Medical central of Tianjin, nankai  University Affiliated Hospital, 130 West  Jieyuan road, Tianjin, People’s republic  of china Tel/fax +86 022 8772 9595 email jingxutj@yeah.ne t Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2015 Volume: 8 Running head verso: Bian et al Running head recto: pre-miR-27a polymorphism and CRC DOI: http://dx.doi.org/10.2147/OTT.S89754",Non-OADS,/arxiv_data1/oa_pdf/79/53/ott-8-3003.PMC4621200.pdf
Hardy–Weinberg equilibrium  (HWE) software ( http://www.oege.org/software/hwe-mr- calc.shtm l) was used to evaluate whether the genotypes of  the locus fit for HWE in controls.,OADS,/arxiv_data1/oa_pdf/79/53/ott-8-3003.PMC4621200.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/79/53/ott-8-3003.PMC4621200.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/79/53/ott-8-3003.PMC4621200.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/27/16/vhrm-11-549.PMC4621201.pdf
"Information on how to request permission may be found at: http://www.dovepress.com/permissions.ph pVascular Health and Risk Management 2015:11 549–553Vascular Health and Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  549ORiginal ReseaRcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/VHRM.S7907 9Progression of carotid-artery disease in type 2  diabetic patients: a cohort prospective study Marijan Bosevski1 lily stojanovska2 1Faculty of Medicine, University  cardiology clinic, skopje, Macedonia;   2centre for chronic Disease, college  of Health and Biomedicine, Victoria  University, Melbourne, Vic , australia  correspondence: Marijan Bosevski   Faculty of Medicine, University cardiology  clinic, skopje 1000, Macedonia   email marijanbosevski@yahoo.co mAbstract:  In order to assess the progression of carotid-artery disease in type 2 diabetic cohort  (n=207 patients), the dynamic change in carotid intima-media thickness (CIMT) and the occur - rence of plaques were followed for a period of 31.35 ±10.59 months.",Non-OADS,/arxiv_data1/oa_pdf/27/16/vhrm-11-549.PMC4621201.pdf
"Vascular Health and Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/vascular-health-and-risk-management-journa lVascular Health and Risk Management is an international, peer- reviewed journal of therapeutics and risk management, focusing on  concise rapid reporting of clinical studies on the processes involved  in the maintenance of vascular health; the monitoring, prevention and  treatment of vascular disease and its sequelae; and the involvement of metabolic disorders, particularly diabetes.",Non-OADS,/arxiv_data1/oa_pdf/27/16/vhrm-11-549.PMC4621201.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/27/16/vhrm-11-549.PMC4621201.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/fd/5e/tacg-8-235.PMC4621202.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pThe Application of Clinical Genetics 2015:8 235–243The Application of Clinical Genetics Dove press submit your manuscript | www.dovepress.co m Dove press  235Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TACG.S6996 9The genetics of Charcot–Marie–T ooth disease:  current trends and future implications for  diagnosis and management J Chad Hoyle1 Michael C isfort1 Jennifer Roggenbuck1,2 w David Arnold1,3,4 1Department of Neurology, Division  of Neuromuscular Disorders,   2Department of internal Medicine,   Division of Human Genetics,   3Department of Physical Medicine  and Rehabilitation, 4Department  of Neuroscience, The Ohio State  University wexner Medical Center,   Columbus, OH, USA Correspondence: J Chad Hoyle   Department of Neurology, Division of  Neuromuscular Disorders, The Ohio  State University wexner Medical Center,  7th Floor, 395 west 12th Avenue,  Columbus, OH 43210, USA   Phone +1 614 293 4969   Fax +1 614 293 6111   email c had.hoyle@osumc.ed uAbstract:  Charcot–Marie–Tooth (CMT) disease is the most common hereditary polyneuropathy  and is classically associated with an insidious onset of distal predominant motor and sensory  loss, muscle wasting, and pes cavus.",Non-OADS,/arxiv_data1/oa_pdf/fd/5e/tacg-8-235.PMC4621202.pdf
"The Application of Clinical Genetics Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/the-application-of-clinical-genetics-journa lThe Application of Clinical Genetics is an international, peer-reviewed  open access journal that welcomes laboratory and clinical findings in  the field of human genetics.",Non-OADS,/arxiv_data1/oa_pdf/fd/5e/tacg-8-235.PMC4621202.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/fd/5e/tacg-8-235.PMC4621202.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/63/3e/ijnrd-8-145.PMC4621203.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Journal of Nephrology and Renovascular Disease 2015:8 145–150International Journal of Nephrology and Renovascular Disease Dove press submit your manuscript | www.dovepress.co m Dove press  145ORIg INal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJNRD.S9386 6Performance of the estimated glomerular  filtration rate creatinine and cystatin C  based equations in Thai patients with chronic  glomerulonephritis Bancha satirapoj Ketkan Jirawatsiwaporn Theerasak Tangwonglert Panbubpa choovichian Division of Nephrology, Department  of Medicine, Phramongkutklao  hospital and college of Medicine,   Bangkok, Thailand correspondence: Bancha satirapoj   315 Rajavithee Road, Division of  Nephrology, Department of Medicine,  Phramongkutklao hospital and college of  Medicine, Bangkok   10400, Thailand   Tel +66 2 644 4676  Fax +66 2 644 4676  email satirapoj@yahoo.co mBackground:  Glomerular filtration rate (GFR) is considered the indicator of overall kidney  function, and therefore, its assessment has become an important clinical tool in the daily care  of chronic glomerulonephritis (CGN) patients.",Non-OADS,/arxiv_data1/oa_pdf/63/3e/ijnrd-8-145.PMC4621203.pdf
"International Journal of Nephrology and Renovascular Disease Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nephrology-and-renovascular-disease-journa lThe International Journal of Nephrology and Renovascular Disease is  an international, peer-reviewed open-access journal focusing on the  pathophysiology of the kidney and vascular supply.",Non-OADS,/arxiv_data1/oa_pdf/63/3e/ijnrd-8-145.PMC4621203.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/63/3e/ijnrd-8-145.PMC4621203.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/4f/dc/copd-10-2257.PMC4621204.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2015:10 2257–2263International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  2257OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S9216 0respiratory infectious phenotypes in acute  exacerbation of COPD: an aid to length of stay  and COPD assessment T est Meng-Yuan Dai1 Jin-Ping Qiao2 Yuan-hong Xu2 guang-he Fei1 1Pulmonary Department, 2Department  of Clinical laboratory, First affiliated  hospital of anhui Medical University,   hefei, anhui, People’s republic  of ChinaPurpose:  To investigate the respiratory infectious phenotypes and their impact on length  of stay (LOS) and the COPD Assessment Test (CAT) Scale in acute exacerbation of COPD  (AECOPD).",Non-OADS,/arxiv_data1/oa_pdf/4f/dc/copd-10-2257.PMC4621204.pdf
"The prolonged length of stay (LOS) indicates more fragile patients who need more  attention from healthy subjects.7 However, there is a lack of identified predictors of Correspondence: guang-he Fei Pulmonary Department, First Affiliated  hospital of anhui Medical University,  hefei 230022, anhui, People’s republic  of China Tel +86 551 6292 2013 Fax +86 551 6363 5578 email guanghefei@126.co m Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Dai et al Running head recto: Respiratory infectious phenotypes in AECOPD DOI: http://dx.doi.org/10.2147/COPD.S92160",Non-OADS,/arxiv_data1/oa_pdf/4f/dc/copd-10-2257.PMC4621204.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/4f/dc/copd-10-2257.PMC4621204.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/4f/dc/copd-10-2257.PMC4621204.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/04/e0/opth-9-1945.PMC4621205.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2015:9 1945–1951Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  1945Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OPTH.S8011 1A review of the efficacy of mitomycin C in  glaucoma filtration surgery Ahmed Al Habash1,2 Leyla Ali Aljasim1 Ohoud Owaidhah1 Deepak P edward1,3 1King Khaled eye Specialist Hospital,   Riyadh, Kingdom of Saudi Arabia;   2Department of Ophthalmology,   University of Dammam, Dammam,   Saudi Arabia; 3wilmer eye institute,   Johns Hopkins University School of  Medicine, Baltimore, MD, USAAbstract:  The success of trabeculectomy, which is considered the gold standard in the surgical  treatment of glaucoma, depends on the wound healing response.",Non-OADS,/arxiv_data1/oa_pdf/04/e0/opth-9-1945.PMC4621205.pdf
"Role of filtration surgery in glaucoma Cairns introduced trabeculectomy in 1968.6 Over time, trabeculectomy has become  the most common surgical procedure for glaucoma and is considered the gold standard Correspondence: Deepak P edward King Khaled eye Specialist Hospital,  PO Box 7191, Riyadh 11462, Saudi Arabia Tel +966 11 482 1234 ext 2055 Fax +966 11 482 1908 email dedward@kkesh.med.s a Journal name: Clinical Ophthalmology Article Designation: Review Y ear: 2015 Volume: 9 Running head verso: Al Habash et al Running head recto: Mitomycin for glaucoma surgery DOI: http://dx.doi.org/10.2147/OPTH.S80111",Non-OADS,/arxiv_data1/oa_pdf/04/e0/opth-9-1945.PMC4621205.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/04/e0/opth-9-1945.PMC4621205.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/04/e0/opth-9-1945.PMC4621205.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/1a/c7/ndt-11-2711.PMC4621206.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2015:11 2711–2719Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  2711OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S8636 6Neuropsychological and neuroimaging markers in  prediction of cognitive impairment after ischemic  stroke: a prospective follow-up study shima Mehrabian1 Margarita raycheva1 Neli Petrova2 armina Janyan3,4 Mariya Petrova1 latchezar Traykov1 1clinic of Neurology, University  hospital alexandrovska, sofia, 2clinic  of Neurology, M haT “ruse”, ruse,   3research center for cognitive  science, Department of cognitive  science and Psychology, New  Bulgarian University, sofia, Bulgaria;   4laboratory for cognitive studies in  language, National research T omsk  state University, T omsk, russiaBackground:  There are few longitudinal studies with controversial results examining delayed  changes in cognition after ischemic stroke and predictive values of neuropsychological and  neuroimaging markers.",Non-OADS,/arxiv_data1/oa_pdf/1a/c7/ndt-11-2711.PMC4621206.pdf
"There are, however, few longitudinal  studies examining delayed changes in cognition, and predictive values of neuropsycho - logical and neuroradiological markers.1–5 In community-based studies, the prevalence  of poststroke dementia (PSD) is approximately 30% and the incidence of new-onset  dementia after stroke increases from 7% after 1 year to 48% after 25 years.6 Some  studies indicate that PSD may be reversible in a substantial proportion of patients.5 In  contrast, other studies found that not only is the risk of PSD high immediately after  stroke but it also remains higher in nondemented patients 3 months after the stroke.1  There is a need to identify individuals at particular risk of poststroke cognitive decline, correspondence: latchezar Traykov clinic of Neurology, University hospital  Alexandrovska, 1 Georgi Sofiiski Street,  1431 Sofia, Bulgaria Tel +359 2 923 0752 Fax +359 2 952 0427 email traykov_l@yahoo.f r Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2015 Volume: 11 Running head verso: Mehrabian et al Running head recto: Neuropsychological and neuroimaging markers and poststroke dementia DOI: http://dx.doi.org/10.2147/NDT.S86366",Non-OADS,/arxiv_data1/oa_pdf/1a/c7/ndt-11-2711.PMC4621206.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/1a/c7/ndt-11-2711.PMC4621206.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/1a/c7/ndt-11-2711.PMC4621206.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/2f/08/copd-10-2207.PMC4621207.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2015:10 2207–2217International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  2207OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S9169 4The inevitable drift to triple therapy in COPD: an  analysis of prescribing pathways in the UK guy Brusselle1–3 David Price4,5 Kevin gruffydd-Jones6 Marc Miravitlles7 Dorothy l Keininger8 rebecca stewart5 Michael Baldwin9 rupert C Jones10 1Department of respiratory Medicine,  University hospital ghent, ghent,  Belgium; 2Department of epidemiology,  3Department of respiratory Medicine,  erasmus Medical Center, rotterdam,  netherlands; 4Centre of academic  Primary Care, University of aberdeen,  aberdeen, UK; 5research in real  life (rirl), singapore; 6Box surgery,  Wiltshire, UK; 7Pneumology  Department, hospital Universitari Vall  d’hebron, CIBer de enfermedades  respiratorias (CIBeres), Barcelona,  spain; 8novartis Pharma ag, Basel,  switzerland; 9novartis Pharmaceuticals  limited, horsham, UK; 10Plymouth  University Peninsula schools of  Medicine and Dentistry, Plymouth, UKBackground:  Real-world prescription pathways leading to triple therapy (TT) (inhaled  corticosteroid [ICS] plus long-acting β2-agonist bronchodilator [LABA] plus long-acting mus - carinic antagonist) differ from Global initiative for chronic Obstructive Lung Disease [GOLD]  and National Institute for Health and Care Excellence treatment recommendations.",Non-OADS,/arxiv_data1/oa_pdf/2f/08/copd-10-2207.PMC4621207.pdf
"Keywords:  chronic obstructive pulmonary disease, GOLD guidelines, observational study,  prescribing patterns, primary care Introduction Chronic obstructive pulmonary disease (COPD) contributes significantly to health care  costs worldwide.1 While there is no cure for COPD, it is preventable and treatable  by reducing and relieving the impact of symptoms, such as chronic cough, chronic  sputum production, and dyspnea while also reducing the risk of exacerbations.2 The  current Global initiative for chronic Obstructive Lung Disease (GOLD) strategy  classifies COPD patients, according to an assessment of lung function (spirometry),  current symptoms, and future exacerbation risks, into one of four groups: GOLD A,  B, C, and D.2 The GOLD 2015 strategy document also proposes suitable first and secondary  choice pharmacologic therapies for each of these groups.2 Specifically, the prescribing  of triple therapy (TT), designated as long-acting β2-agonist bronchodilator (LABA)  with a long-acting muscarinic antagonist (LAMA) and an inhaled corticosteroid Correspondence: David Price research in real life, 2 Changi Business  Park avenue 1, level 2, singapore 486015 email david@respiratoryresearch.or g Journal name: International Journal of COPD Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Brusselle et al Running head recto: Pathways to triple therapy DOI: http://dx.doi.org/10.2147/COPD.S91694",Non-OADS,/arxiv_data1/oa_pdf/2f/08/copd-10-2207.PMC4621207.pdf
"Available from: http://www.goldcopd.org/uploads/ users/files/GOLD_Report_2015.pd f. Accessed July 2, 2015.",OADS,/arxiv_data1/oa_pdf/2f/08/copd-10-2207.PMC4621207.pdf
"Available from: http://www.goldcopd.org/uploads/ users/files/GOLD_Report_2013_Feb20.pd f. Accessed July 2, 2015.",OADS,/arxiv_data1/oa_pdf/2f/08/copd-10-2207.PMC4621207.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/2f/08/copd-10-2207.PMC4621207.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/2f/08/copd-10-2207.PMC4621207.pdf
"Available  from: http://www.optimumpatientcare.org/Html_Docs/OPCRD.htm l.  Accessed July 2, 2015.",Non-OADS,/arxiv_data1/oa_pdf/2f/08/copd-10-2207.PMC4621207.pdf
Available from: http://bma.org.,Non-OADS,/arxiv_data1/oa_pdf/2f/08/copd-10-2207.PMC4621207.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/14/b2/ijgm-8-345.PMC4621214.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Journal of General Medicine 2015:8 345–347International Journal of General Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  345Case reportopen access to scientific and medical research open access Full text article http: //dx.doi.org/10.2147/IJGM.S9243 5a case of polymyalgia rheumatica following  influenza B infection Kentaro Iwata1 Yasushi Mizuno2 1Division of Infectious Diseases, Kobe  University Hospital, 2Department of  General Medicine, Kobe City Medical  Center General Hospital, Kobe, Japan Correspondence: Kentaro Iwata   Division of Infectious Diseases,   Kobe University Hospital,   Kusunokicho 7-5-2, Chuo-ku,   Kobe, Hyogo 650-0017, Japan   tel +81 78 382 6296   Fax +81 78 382 6298   email kentaroiwata1969@gmail.co mAbstract:  Polymyalgia rheumatica (PMR) is relatively common among the elderly, and is  characterized by multiple body aches with an elevated erythrocyte sedimentation rate.",Non-OADS,/arxiv_data1/oa_pdf/14/b2/ijgm-8-345.PMC4621214.pdf
"International Journal of General Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-general-medicine-journa lThe International Journal of General Medicine is an international,  peer-reviewed open-access journal that focuses on general and internal  medicine, pathogenesis, epidemiology, diagnosis, monitoring and treat - ment protocols.",Non-OADS,/arxiv_data1/oa_pdf/14/b2/ijgm-8-345.PMC4621214.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/14/b2/ijgm-8-345.PMC4621214.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/61/04/ppa-9-1481.PMC4621215.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2015:9 1481–1490Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  1481OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S8987 0health-related quality of life in patients with  depression treated with duloxetine or a selective  serotonin reuptake inhibitor in a naturalistic  outpatient setting Jihyung hong1 Diego novick1 William Montgomery2 Maria Victoria Moneta3 héctor Dueñas4 Xiaomei Peng5 Josep Maria haro3 1eli lilly and company, Windlesham,   surrey, UK; 2eli lilly Australia Pty ltd,   sydney, nsW, Australia; 3Parc sanitari  sant Joan de Déu, Fundació sant Joan  de Déu, ciBersAM, Universitat de  Barcelona, Barcelona, spain; 4eli lilly  de Mexico, Mexico city, Mexico; 5eli  lilly and company, indianapolis, in,   UsAPurpose:  To assess the levels of quality of life (QoL) in major depressive disorder (MDD)  patients treated with either duloxetine or a selective serotonin reuptake inhibitor (SSRI) as  monotherapy for up to 6 months in a naturalistic clinical setting mostly in the Middle East,  East Asia, and Mexico.",Non-OADS,/arxiv_data1/oa_pdf/61/04/ppa-9-1481.PMC4621215.pdf
"For example, a previous study by Rapaport et al3  correspondence: Jihyung hong Department of healthcare Management,  college of social science, gachon  University, seongnam, 13120, south  Korea Tel +82 31 750 5205 Fax +82 31 750 5372 email jihyung.hong.kr@gmail.co m Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Hong et al Running head recto: Quality of life and treatment of depression DOI: http://dx.doi.org/10.2147/PPA.S89870",Non-OADS,/arxiv_data1/oa_pdf/61/04/ppa-9-1481.PMC4621215.pdf
Available from: http://www.who.int/mediacentre/ factsheets/fs369/en /.,Non-OADS,/arxiv_data1/oa_pdf/61/04/ppa-9-1481.PMC4621215.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/61/04/ppa-9-1481.PMC4621215.pdf
"Available  from: http://www.who.int/mental_health/media/68.pd f. Accessed  August 24, 2014.",Non-OADS,/arxiv_data1/oa_pdf/61/04/ppa-9-1481.PMC4621215.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e8/06/ott-8-3017.PMC4621216.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 3017–3020OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3017Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S8714 6EGFR gene-mutation status correlated with   therapeutic decision making in lung  adenocarcinoma Yaoyao ren Yibing Yao Qing Ma Diansheng Zhong Oncology Department, Tianjin Medical  University general hospital, Tianjin,   People’s republic of chinaAbstract:  The purpose of this study was to investigate the correlation between EGFR -mutation  status and treatment efficacy for advanced lung adenocarcinoma patients.",Non-OADS,/arxiv_data1/oa_pdf/e8/06/ott-8-3017.PMC4621216.pdf
"Compared with traditional chemotherapy, it has better tolerability and  less toxicity.5 EGFR-sensitive mutations have been proved to be strongly predictive  of response to EGFR TKIs in NSCLC.6,7 Recently, a number of research results have shown that the effects of first-line TKI  treatment are obviously better than traditional platinum-based double-agent chemotherapy correspondence: Yaoyao ren Oncology Department, Tianjin Medical  University general hospital, 154  anshan road, heping, Tianjin 300052,  People’s republic of china email prettyrenyaoyao@sina.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2015 Volume: 8 Running head verso: Ren et al Running head recto: EGFR mutation and lung adenocarcinoma DOI: http://dx.doi.org/10.2147/OTT.S87146",Non-OADS,/arxiv_data1/oa_pdf/e8/06/ott-8-3017.PMC4621216.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/e8/06/ott-8-3017.PMC4621216.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/e8/06/ott-8-3017.PMC4621216.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/91/50/jpr-8-719.PMC4621217.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pJournal of Pain Research 2015:8 719–728Journal of Pain Research Dove press submit your manuscript | www.dovepress.co m Dove press  719Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/JPR.S7356 7Profile of extended-release oxycodone/ acetaminophen for acute pain Mary Hanna Bekhit1–5 1David Geffen School of Medicine,   2Ronald Reagan UCLA Medical  Center,  3UCLA Ambulatory Surgery  Center,  4UCLA Wasserman Eye  institute,  5UCLA Martin Luther King  Community Hospital, University of  California Los Angeles, Los Angeles,   CA, USA Correspondence: Mary Hanna Bekhit   Department of Anesthesiology   David Geffen School of Medicine   University of California, Los Angeles   757 westwood Plaza, Suite 2331   Los Angeles, CA 90095, USA   Tel +1 310 825 6301  email mbekhit@mednet.ucla.ed uAbstract:  This article provides a historical and pharmacological overview of a new opioid  analgesic that boasts an extended-release (ER) formulation designed to provide both immediate  and prolonged analgesia for up to 12 hours in patients who are experiencing acute pain.",Non-OADS,/arxiv_data1/oa_pdf/91/50/jpr-8-719.PMC4621217.pdf
"Journal of Pain Research 2015:8submit your manuscript | www.dovepress.co m Dove press Dove press 721ER oxycodone/acetaminophen for acute pain administration of the medication will delay peak serum levels  by 1 hour.7 The oral bioavailability of oxycodone is increased  by approximately  15%, and the peak plasma level increases  by 12%–25% when the medication is administered with a  meal.7 Acetaminophen’ s peak serum levels are reduced by  approximately  23% by co-administration with a meal.7 When administered intravenously, oxycodone has a volume  of distribution of  2.6 L/kg.7 At normal body temperature (37 °C)  and pH (7.4), it exists in plasma in a  45% protein-bound state.7  Acetaminophen’ s volume of distribution is approximately   0.9 L/kg, and it exists in plasma in a  20% protein-bound state.7 It  distributes through most tissues with the exception of lipids.7 Both the oxycodone and acetaminophen components  undergo extensive hepatic metabolism prior to primarily  renal elimination.7 The two major metabolites of oxy - codone are noroxycodone and oxymorphone, as well as  their glucuronides.7 Noroxycodone is an active metabolite,  possessing approximately  60% the potency of its parent  compound, and oxymorphone circulates in very low levels  in the plasma.7 Acetaminophen undergoes three separate  metabolic pathways in the liver: glucuronidation, conjugation  with sulfate, or cytochrome P450-dependent oxidation.7 The  metabolites of acetaminophen are inert.7 Pharmacodynamics The oxycodone component of ER oxycodone/acetaminophen  contributes to the majority of the medication’ s pharmacody - namic effects on the various organ systems listed in Table  1 (summarized from http://www.rxlist.com/xartemis-xr-drug.",Non-OADS,/arxiv_data1/oa_pdf/91/50/jpr-8-719.PMC4621217.pdf
Available from: http://www.pharmacytimes.com/ publications/issue/2008/2008-09/2008-09-8687#sthash.4OTK1ba4.dpu f.20Table  4 Genetics affecting ethnic differences in CYP2D6 metabolic  activity CYP2D6   metabolic activityGenetic   differencesEthnic group affected None Poor Asian  1% African American  2%–5% Mexican American  3%–6% Caucasian  6%–10% Low intermediate Undetermined Normal extensive Majority of population High Ultrarapid Finnish and Danish  1% North American (Caucasian)  4% Greek  10% Portuguese  10% Saudi Arabian  20% ethiopian  30% Note:  Copyright © PharmacyTimes 2008.,Non-OADS,/arxiv_data1/oa_pdf/91/50/jpr-8-719.PMC4621217.pdf
Available from: http://www.pharmacytimes.com/ publications/issue/2008/2008-07/2008-07-862 4.19,Non-OADS,/arxiv_data1/oa_pdf/91/50/jpr-8-719.PMC4621217.pdf
Available  from: http://www.cdc.gov/nchs/data/ahcd/namcs_summary/2010_ namcs_web_ table s.pdf.,OADS,/arxiv_data1/oa_pdf/91/50/jpr-8-719.PMC4621217.pdf
"Available from: http://www.cdc.gov/nchs/fastats/ insurg.ht m. Accessed March  30, 2015.",OADS,/arxiv_data1/oa_pdf/91/50/jpr-8-719.PMC4621217.pdf
"Available from: http://www.drugs.com/newdrugs/fda-approves-  xartemis-xr-oxycodone-hydrochloride-acetaminophen-extended- release-cii-4015.htm l. Accessed on February 13, 2015.",Non-OADS,/arxiv_data1/oa_pdf/91/50/jpr-8-719.PMC4621217.pdf
"Available from: http://www.rxlist.com/xartemis-xr-drug.ht m. Accessed  on February 13, 2015.",Non-OADS,/arxiv_data1/oa_pdf/91/50/jpr-8-719.PMC4621217.pdf
"Available from: http://www.drugs.com/pro/xartemis-xr.htm l. Accessed  on February 13, 2015.",Non-OADS,/arxiv_data1/oa_pdf/91/50/jpr-8-719.PMC4621217.pdf
Available  from: http://www.pharmacytimes.com/publications/issue/2008/2008- 07/2008-07-862 4.,Non-OADS,/arxiv_data1/oa_pdf/91/50/jpr-8-719.PMC4621217.pdf
"Available  from: http://www.pharmacytimes.com/publications/issue/2008/2008- 09/2008-09-8687#sthash.4OTK1ba4.dpu f. Accessed on February 13,  2015.",Non-OADS,/arxiv_data1/oa_pdf/91/50/jpr-8-719.PMC4621217.pdf
"Journal of Pain Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-pain-research-journa lThe Journal of Pain Research is an international, peer-reviewed, open  access, online journal that welcomes laboratory and clinical findings  in the fields of pain research and the prevention and management  of pain.",Non-OADS,/arxiv_data1/oa_pdf/91/50/jpr-8-719.PMC4621217.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/91/50/jpr-8-719.PMC4621217.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/83/44/dmso-8-505.PMC4621218.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy 2015:8 505–512Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  505Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DMSO.S6935 4emerging utility of once-weekly exenatide in  patients with type 2 diabetes Aditya Goud Jixin Zhong Sanjay Rajagopalan Division of Cardiovascular Medicine,   Department of Medicine, University  of Maryland, Baltimore, MD, USA Correspondence: Sanjay Rajagopalan   Division of Cardiovascular Medicine,  University of Maryland, Health Science  Facility ii, 20 Penn Street, Baltimore,   MD 21201, USA   Tel +1 410 328 4716   Fax +1 410 328 8527   email srajagopalan@medicine.umaryland.",Non-OADS,/arxiv_data1/oa_pdf/83/44/dmso-8-505.PMC4621218.pdf
Available  from: http://www.cdc.gov/diabetes/data/statistics/2014StatisticsReport.,OADS,/arxiv_data1/oa_pdf/83/44/dmso-8-505.PMC4621218.pdf
"Available  from: http://www.cdc.gov/nchs/data/factsheets/factsheet_obesity.ht m.  Accessed October 5, 2015.",Non-OADS,/arxiv_data1/oa_pdf/83/44/dmso-8-505.PMC4621218.pdf
"Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/diabetes-metabolic-syndrome-and-obesity-targets-and-therapy-journa lDiabetes, Metabolic Syndrome and Obesity: Targets and Therapy is  an international, peer-reviewed open-access journal committed to  the rapid publication of the latest laboratory and clinical findings  in the fields of diabetes, metabolic syndrome and obesity research.",Non-OADS,/arxiv_data1/oa_pdf/83/44/dmso-8-505.PMC4621218.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/83/44/dmso-8-505.PMC4621218.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b9/6a/ijgm-8-333.PMC4621219.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Journal of General Medicine 2015:8 333–344International Journal of General Medicine Video abstract Point your Smar tPhone at the code abo ve.,Non-OADS,/arxiv_data1/oa_pdf/b9/6a/ijgm-8-333.PMC4621219.pdf
"Or use: http://youtu.be/H2M1sOYdWn EDove press submit your manuscript | www.dovepress.co m Dove press  333RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJGM.S7324 9Managing neurocysticercosis: challenges   and solutions Yannick Fogoum Fogang Abdoul Aziz Savadogo Massaman Camara Dènahin Hinnoutondji T offa Anna Basse Adjaratou Djeynabou Sow Mouhamadou Mansour  Ndiaye Neurology Department, Fann Teaching  Hospital, Cheikh Anta Diop University,   Dakar, Senegal Correspondence: Yannick Fogoum Fogang   Neurology Department, Fann Teaching  Hospital, Cheikh Anta Diop University,  PO Box 5035, Dakar, Senegal   Tel +221 77 739 0619   email yanfogang@yahoo.f rAbstract:  Taenia solium  neurocysticercosis (NCC) is a major cause of neurological morbidity  in the world.",Non-OADS,/arxiv_data1/oa_pdf/b9/6a/ijgm-8-333.PMC4621219.pdf
"Creative Commons license and disclaimer available from: http://creativecommons.org/licenses/by/4.0/legalcod e.40 Abbreviation:  CT, computed tomography.",Non-OADS,/arxiv_data1/oa_pdf/b9/6a/ijgm-8-333.PMC4621219.pdf
"2012;6:e1851.94 Creative Commons license and  disclaimer available from: http://creativecommons.org/licenses/by/4.0/legalcod e.  Abbreviations:  CSF, cerebrospinal fluid; ELISA, enzyme-linked immunosorbent  assay; CNS, central nervous system.",Non-OADS,/arxiv_data1/oa_pdf/b9/6a/ijgm-8-333.PMC4621219.pdf
Available from: http://apps.who.int/iris/ bitstream/10665/152896/1/WHO_HTM_NTD_NZD_2015.05_eng.,OADS,/arxiv_data1/oa_pdf/b9/6a/ijgm-8-333.PMC4621219.pdf
Available from: http://www.oie.int/doc/ged/d11245.,Non-OADS,/arxiv_data1/oa_pdf/b9/6a/ijgm-8-333.PMC4621219.pdf
"International Journal of General Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-general-medicine-journa lThe International Journal of General Medicine is an international,  peer-reviewed open-access journal that focuses on general and internal  medicine, pathogenesis, epidemiology, diagnosis, monitoring and treat - ment protocols.",Non-OADS,/arxiv_data1/oa_pdf/b9/6a/ijgm-8-333.PMC4621219.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/b9/6a/ijgm-8-333.PMC4621219.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/7a/f0/ott-8-3029.PMC4621220.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 3029–3039OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3029Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9103 5Forkhead box protein a1 is a prognostic predictor  and promotes tumor growth of gastric cancer hongyu ren1,* Pei Zhang2,* Y ong Tang3 Mengping Wu4 Weikang Zhang2 1Department of gastroenterology,   Union hospital, 2Department  of gastrointestinal surgery,   Union hospital, 3Department of  hepatobiliary surgery, Union hospital,   4Department of internal Medicine,   Tongji hospital, Tongji Medical  college, huazhong University of  science and T echnology, Wuhan,   People’s republic of china *These authors contributed equally to  this workAbstract:  Previous studies have demonstrated the cancer-type specific role of forkhead box  protein A1 (FOXA1) in human malignancies.",Non-OADS,/arxiv_data1/oa_pdf/7a/f0/ott-8-3029.PMC4621220.pdf
"Forkhead box protein A1 (FOXA1), a member of forkhead box gene superfamily,  is a pioneer transcription factor5 and plays pleiotropic roles in the development and  differentiation.6–10 It induces the rearrangement of nucleosomal and alters the chromatin  accessibility for other collaborating transcriptional regulators.5,11 In this way, FOXA1  regulates tissue-specific transcriptional programs and plays critical roles in cell growth,  proliferation, apoptosis, and differentiation.11 Recently, emerging studies have focused  on investigating the role of FOXA1 in human malignancies.5,7 Notably, FOXA1 was  found to be overexpressed in anaplastic thyroid cancer,12 lung cancer,13,14 and esophageal correspondence: Weikang Zhang Department of gastrointestinal  surgery, Union hospital, Tongji  Medical college, huazhong University  of science and Technology, no 1277  Jiefang road, Wuhan 430022,  People’s republic of china Tel +86 27 8572 6560 Fax +86 27 8572 6560 email wkz_tongji@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2015 Volume: 8 Running head verso: Ren et al Running head recto: The role of FOXA1 in gastric cancer DOI: http://dx.doi.org/10.2147/OTT.S91035",Non-OADS,/arxiv_data1/oa_pdf/7a/f0/ott-8-3029.PMC4621220.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/7a/f0/ott-8-3029.PMC4621220.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/7a/f0/ott-8-3029.PMC4621220.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ea/db/ijn-10-6571.PMC4621221.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 6571–6585International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  6571OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S8838 4a new method of wound treatment: targeted  therapy of skin wounds with reactive oxygen  species-responsive nanoparticles containing sDF-1 α Tao Tang1,* hao Jiang1,* Yuan Yu2,* Fang he1 shi-zhao Ji1 Ying-ying liu1 Zhong-shan Wang1 shi-chu Xiao1 cui Tang3 guang-Yi Wang1 Zhao-Fan Xia1 1Department of Burn surgery, The  second Military Medical University  affiliated changhai hospital,   2Department of Pharmaceutics,   school of Pharmacy, The second  Military Medical University, 3state Key  laboratory of genetic engineering,   Department of Pharmaceutical  sciences, school of life sciences,   Fudan University, shanghai,   People’s  republic of china *These authors contributed equally  to this workObjective:  To accelerate wound healing through promoting vascularization by using reactive  oxygen species (ROS)-responsive nanoparticles loaded with stromal cell-derived factor-1 α  (SDF-1 α).",Non-OADS,/arxiv_data1/oa_pdf/ea/db/ijn-10-6571.PMC4621221.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/ea/db/ijn-10-6571.PMC4621221.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ea/db/ijn-10-6571.PMC4621221.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/9b/e4/ott-8-3021.PMC4621222.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 3021–3028OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3021Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9071 0mir-195 is a key regulator of raf1 in thyroid  cancer Fangzheng Wang1,2,* chuner Jiang3,* Quanquan sun1,2 Fenqin Yan1,2 lei Wang1,2 Zhenfu Fu1,2 T ongxin liu1,2 Fujun hu1,2 1Department of radiation Oncology,   Zhejiang cancer hospital, 2Zhejiang  Key laboratory of radiation  Oncology, Zhejiang cancer hospital,   3Department of Breast surgery,   Zhejiang cancer hospital, Zhejiang,   hangzhou, People’s republic of china *These authors contributed equally  to this workAbstract:  Proto-oncogene Raf1 serves as a part of the mitogen-activated protein  kinases/extracellular signal-regulated kinase signal transduction pathway and regulates cell  migration, apoptosis, and differentiation.",Non-OADS,/arxiv_data1/oa_pdf/9b/e4/ott-8-3021.PMC4621222.pdf
"A study  by Calin et al found that miR-15 and miR-16 are downregulated or deleted in 68% of  chronic lymphocytic leukemia.16 Besides, miR-15a/16-1 deletion can accelerate the pro - liferation of B-cells by regulating the expression of genes associated with cell cycle.17  miR-15a/16-1 can also repress the expression of oncogene BCL-2 .18 Recent studies correspondence: Fangzheng Wang Department of radiation Oncology,  Zhejiang cancer hospital, Zhejiang,  hangzhou 310022, People’s republic  of china Tel +86 571 8812 8192 Fax +86 571 8812 8192 email wangfz77@126.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2015 Volume: 8 Running head verso: Wang et al Running head recto: miR-195 is a key regulator of Raf1 in thyroid cancer DOI: http://dx.doi.org/10.2147/OTT.S90710",Non-OADS,/arxiv_data1/oa_pdf/9b/e4/ott-8-3021.PMC4621222.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/9b/e4/ott-8-3021.PMC4621222.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/9b/e4/ott-8-3021.PMC4621222.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/9d/c1/ijn-10-6555.PMC4621223.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 6555–6569International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  6555RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJN.S9190 8Diagnosis of prostate cancer via nanotechnological  approach Benedict J Kang1,2,* Minhong Jeun1,2,* Gun Hyuk Jang1,2 Sang Hoon Song3 In Gab Jeong3 Choung-Soo Kim3 Peter C Searson4 Kwan Hyi Lee1,2 1KIST Biomedical Research Institute,   2Department of Biomedical  engineering, Korea University of  Science and T echnology (UST),   3Department of Urology, Asan Medical  Center, University of Ulsan College  of Medicine, Seoul, Republic of Korea;  4Institute for Nanobiotechnology,   Johns Hopkins University, Baltimore,   MD, USA *These authors contributed equally  to this workAbstract:  Prostate cancer is one of the leading causes of cancer-related deaths among the  Caucasian adult males in Europe and the USA.",Non-OADS,/arxiv_data1/oa_pdf/9d/c1/ijn-10-6555.PMC4621223.pdf
"Correspondence: Kwan Hyi Lee Biomedical Research Institute, Korea  Institute of Science and Technology  (KIST), Seoul 02792, Republic of Korea email kwanhyi@kist.re.k r Journal name: International Journal of Nanomedicine Article Designation: Review Y ear: 2015 Volume: 10 Running head verso: Kang et al Running head recto: Diagnosis of prostate cancer with nanotechnology DOI: http://dx.doi.org/10.2147/IJN.S91908",Non-OADS,/arxiv_data1/oa_pdf/9d/c1/ijn-10-6555.PMC4621223.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/9d/c1/ijn-10-6555.PMC4621223.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/9d/c1/ijn-10-6555.PMC4621223.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ae/d0/idr-8-353.PMC4621224.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInfection and Drug Resistance 2015:8 353–357Infection and Drug Resistance Dove press submit your manuscript | www.dovepress.co m Dove press  353ORIg Inal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IDR.S9072 6clinical ineffectiveness of latamoxef   for Stenotrophomonas maltophilia  infection hideharu hagiya1 Ken Tasaka2 T oshiaki sendo2 Fumio Otsuka1 1Department of general Medicine,   Okayama University graduate  school of Medicine, Dentistry and  Pharmaceutical sciences,  2Department  of Pharmacy, Okayama University  hospital, Okayama, Japan correspondence: hideharu hagiya   Department of general Medicine,  Okayama University graduate school of  Medicine, Dentistry and Pharmaceutical  sciences,  2-5-1 shikata-cho, Kitaku,   Okayama  700-8558, Japan   Tel +81 86 235 7342  Fax +81 86 235 7345  email e_dai_for_all@hotmail.co mObjectives:  Stenotrophomonas maltophilia  shows wide-spectrum resistance to antimicrobials  and causes various infections in immunocompromised or critically ill patients with high mortality.",Non-OADS,/arxiv_data1/oa_pdf/ae/d0/idr-8-353.PMC4621224.pdf
"Infection and Drug Resistance Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/infection-and-drug-resistance-journa lInfection and Drug Resistance is an international, peer-reviewed open- access journal that focuses on the optimal treatment of infection (bacte - rial, fungal and viral) and the development and institution of preventive  strategies to minimize the development and spread of resistance.",Non-OADS,/arxiv_data1/oa_pdf/ae/d0/idr-8-353.PMC4621224.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ae/d0/idr-8-353.PMC4621224.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/62/8d/tcrm-11-1619.PMC4621225.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpTherapeutics and Clinical Risk Management 2015:11 1619–1625Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  1619ORiginal ReseaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S9129 6Effect of fluid loading on left ventricular volume  and stroke volume variability in patients with   end-stage renal disease: a pilot study hirotsugu Kanda1 Yuji hirasaki2 Takafumi iida1 Megumi Kanao-Kanda1 Yuki T oyama1 Takayuki Kunisawa1 hiroshi iwasaki1 1Department of anesthesiology and  Critical Care Medicine, asahikawa  Medical University, asahikawa,   hokkaido, Japan; 2Department  of anatomy, The Jikei University  graduate school of Medicine,   Minato-ku, T okyo, JapanPurpose:  The aim of this study was to investigate fluid loading-induced changes in left  ventricular end-diastolic volume (LVEDV) and stroke volume variability (SVV) in patients with  end-stage renal disease (ESRD) using real-time three-dimensional transesophageal echocar - diography and the Vigileo-FloTrac system.",Non-OADS,/arxiv_data1/oa_pdf/62/8d/tcrm-11-1619.PMC4621225.pdf
"Hence, these patients are at higher  risk for perioperative cardiovascular morbidity and mortality, and perioperative man - agement requires special attention.4,5Correspondence: hirotsugu Kanda Department of anesthesiology and  Critical Care Medicine, asahikawa  Medical University, Midorigaoka-higashi  2-1-1-1, asahikawa, hokkaido 078-8510,  Japan Tel +81 166 682 583 Fax +81 166 682 589 email h.kanda0629@nifty.co m Journal name: Therapeutics and Clinical Risk Management Article Designation: Original Research Y ear: 2015 Volume: 11 Running head verso: Kanda et al Running head recto: Stroke volume variability and left ventricular volume in patients with ESRD DOI: http://dx.doi.org/10.2147/TCRM.S91296",Non-OADS,/arxiv_data1/oa_pdf/62/8d/tcrm-11-1619.PMC4621225.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/62/8d/tcrm-11-1619.PMC4621225.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/62/8d/tcrm-11-1619.PMC4621225.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/66/35/ijwh-7-841.PMC4621228.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Women’s Health 2015:7 841–850International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  841RevIeWopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJWH.S5462 3epidemiology and treatment of osteoporosis  in women: an Indian perspective Anuradha v Khadilkar Rubina M Mandlik Growth and endocrine Unit, Hirabai  Cowasji Jehangir Medical Research  Institute, Jehangir Hospital, Pune,   Maharashtra, IndiaAbstract:  The number of women with osteoporosis, ie, with reduced bone mass and the  disruption of bone architecture, is increasing in India.",Non-OADS,/arxiv_data1/oa_pdf/66/35/ijwh-7-841.PMC4621228.pdf
"Avail - able from: http://ninindia.org/DietaryGuidelinesforNINwebsite.pd f.  Accessed May 3, 2015.",Non-OADS,/arxiv_data1/oa_pdf/66/35/ijwh-7-841.PMC4621228.pdf
"Available from: http://wcd.nic.in/fnb/fnb/ guidelines/univ_icds5.pd f. Accessed May 3, 2015.",Non-OADS,/arxiv_data1/oa_pdf/66/35/ijwh-7-841.PMC4621228.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/66/35/ijwh-7-841.PMC4621228.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/66/35/ijwh-7-841.PMC4621228.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non- commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/70/a5/afv119.PMC4621229.pdf
The protocol was approved by the NHS Research Ethics Committee and was registered at http://clinicaltrials.gov (NCT01703715).,Non-OADS,/arxiv_data1/oa_pdf/70/a5/afv119.PMC4621229.pdf
"http://www.cqc.org.uk/provider/RX1/ inspection-summary#overall (20 October 2014, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/70/a5/afv119.PMC4621229.pdf
"Southampton: James Lind Alliance, 2012. http://www.lindalliance.org/pdfs/ Dementia/Dementia_PSP_protocol.pdf .",Non-OADS,/arxiv_data1/oa_pdf/22/ed/afv131.PMC4621233.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org /licenses/by-nc/4.0/), which permits unrestricted reuse, distribution, and reproduction in any mediu m, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/22/ed/afv131.PMC4621233.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non- commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/35/9d/afv133.PMC4621234.pdf
EORTS quality of life group : guidelines for developing questionnaire modules.Eur Organ Res Treat Cancer 2011. http://groups.eortc.be/ qol/sites/default/ ﬁles/archives/guideli nes_for_developing_ questionnaire-_ ﬁnal.pdf .,Non-OADS,/arxiv_data1/oa_pdf/35/9d/afv133.PMC4621234.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/40/e4/afv143.PMC4621237.pdf
"Alzheimer COoperative Valuation in Europe(ALCOVE), 2013. http://www.alcove-project.eu/ .",Non-OADS,/arxiv_data1/oa_pdf/40/e4/afv143.PMC4621237.pdf
"Southampton: James Lind Alliance, 2012. http://www.lindalliance.org/pdfs/ Dementia/Dementia_PSP_protocol.pdf .",Non-OADS,/arxiv_data1/oa_pdf/40/e4/afv143.PMC4621237.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org /licenses/by-nc/4.0/), which permits unrestricted reuse, distribution, and reproduction in any mediu m, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/40/e4/afv143.PMC4621237.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/47/5f/afv145.PMC4621239.pdf
"http://www8.cao.go.jp/kourei/whitepaper/ w-2014/zenbun/ (3 March 2015, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/47/5f/afv145.PMC4621239.pdf
"Society at a Glance 2009 OECD Social Indicators, Special focus: Measuring Leisure in OECD Countries, 2009.http://www.oecd.org/berlin/42675407.pdf (3 March 2015, date last accessed).",Non-OADS,/arxiv_data1/oa_pdf/47/5f/afv145.PMC4621239.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/31/57/ijn-10-6541.PMC4621240.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 6541–6553International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  6541OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S9084 9lipid nanoparticles for cyclosporine a  administration: development, characterization, and  in vitro evaluation of their immunosuppression  activity Melissa guada1,2 Victor sebastián3,4 silvia Irusta3,4 esperanza Feijoó1 María del carmen  Dios-Viéitez1 María José Blanco-Prieto1,2 1Department of Pharmacy and  Pharmaceutical T echnology,   school of Pharmacy, University of  Navarra, Pamplona, 2Instituto de  Investigación sanitaria de Navarra,   IdisN a, Pamplona, 3chemical  and environmental engineering  Department and Nanoscience  Institute of aragon, University of  Zaragoza, Zaragoza, 4Networking  research center on Bioengineering,   Biomaterials and Nanomedicine,   cIBer-BBN, Madrid, spainAbstract:  Cyclosporine A (CsA) is an immunosuppressant commonly used in transplantation  for prevention of organ rejection as well as in the treatment of several autoimmune disorders.",Non-OADS,/arxiv_data1/oa_pdf/31/57/ijn-10-6541.PMC4621240.pdf
"As a result of this peculiar structure correspondence:  María José Blanco-Prieto Department of Pharmacy and  Pharmaceutical Technology, school  of Pharmacy, University of Navarra,  c/Irunlarrea 1, e-31008 Pamplona, spain Tel +34 948 425 600 ext 6519 Fax +34 948 425 649 email mjblanco@unav.e sJournal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Guada et al Running head recto: Development of CsA lipid nanoparticles and in vitro immunosuppression DOI: http://dx.doi.org/10.2147/IJN.S90849",Non-OADS,/arxiv_data1/oa_pdf/31/57/ijn-10-6541.PMC4621240.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/31/57/ijn-10-6541.PMC4621240.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/31/57/ijn-10-6541.PMC4621240.pdf
"This isan Open Access article distributed under the terms of theCreative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution ofthework, in any medium, provided the original work is not alteredor transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ea/61/jiv275.PMC4621252.pdf
2012 .http://www.who.int/hiv/pub/ guidelines/9789241501972/en/ .,Non-OADS,/arxiv_data1/oa_pdf/ea/61/jiv275.PMC4621252.pdf
"INC Research, 2015 .http://www.apregistry.",Non-OADS,/arxiv_data1/oa_pdf/ea/61/jiv275.PMC4621252.pdf
"In: 2014 Conference onRetroviruses and Opportunistic Infections,B o s t o n ,M a s s a c h u s e t t s ,3 –6 March 2014. http://www.croiwebcasts.org/console/player/ 22145?mediaType=slideVideo& .",Non-OADS,/arxiv_data1/oa_pdf/ea/61/jiv275.PMC4621252.pdf
An online age calculator can be found at our website (available at:http://labs.genetics.ucla.edu/horvath/dnamage/ ).,Non-OADS,/arxiv_data1/oa_pdf/86/b3/jiv277.PMC4621253.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercialreproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b2/41/jiv291.PMC4621255.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/97/c3/ijwh-6-833.PMC4621276.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Women’s Health 2015:7 833–839International Journal of Women’s Health Dove press submit your manuscript | www.dovepress.co m Dove press  833OrIg Inal researcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJWH.S5010 1randomized comparative trial of cervical  block protocols for pain management during  hysteroscopic removal of polyps and myomas andrea s lukes1 Kelly H roy2 James B Presthus3 Michael P Diamond4 Jay M Berman4 Kenneth a Konsker5 1carolina Women’s research and  Wellness center, Durham, nc, Usa;   2Phoenix gynecology consultants,   Phoenix, aZ, Usa; 3Minnesota  gynecology and surgery, edina, M n,   Usa; 4Wayne state University, Detroit,   MI, Usa; 5Florida Woman care, Boca  raton, Fl, Usa correspondence: andrea s lukes   carolina Women’s research and  Wellness center, 249 e nc Highway 54,  suite 330, Durham, nc 27713, Usa   Tel +1 919 251 9223   Fax +1 919 251 9343   email andrealukes@cwrwc.co mPurpose:  To evaluate the efficacy of two cervical block protocols for pain management during  hysteroscopic removal of intrauterine polyps and myomas using the MyoSure® device.",Non-OADS,/arxiv_data1/oa_pdf/97/c3/ijwh-6-833.PMC4621276.pdf
Available from: http://www.clinical - trials.gov/ct2/show/NCT00979342?term=myosure&rank=2.,Non-OADS,/arxiv_data1/oa_pdf/97/c3/ijwh-6-833.PMC4621276.pdf
"International Journal of Women’s Health Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-womens-health-journa lThe International Journal of Women’ s Health is an international, peer- reviewed open-access journal publishing original research, reports,  editorials, reviews and commentaries on all aspects of women’s  healthcare including gynecology, obstetrics, and breast cancer.",Non-OADS,/arxiv_data1/oa_pdf/97/c3/ijwh-6-833.PMC4621276.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/97/c3/ijwh-6-833.PMC4621276.pdf
"2015; 27(4): 200-202. doi: http://dx.doi.org/10.11919/j.issn.1002-0829.215102]Shanghai Archives of Psychiatry, 2015, Vol.",Non-OADS,/arxiv_data1/oa_pdf/61/e5/sap-27-04-200.PMC4621283.pdf
2015;  27(4): 203-205. doi:http://dx.doi.org/10.11919/j.issn.1002-0829.215068 2.,Non-OADS,/arxiv_data1/oa_pdf/61/e5/sap-27-04-200.PMC4621283.pdf
2015; 27(2): 70-81. doi:http://dx.doi.org/10.11919/ j.issn.1002-0829.215027 3.,Non-OADS,/arxiv_data1/oa_pdf/61/e5/sap-27-04-200.PMC4621283.pdf
2015;  27(4): 206-219. doi: http://dx.doi.org/10.11919/ j.issn.1002-0829.2150934.,Non-OADS,/arxiv_data1/oa_pdf/61/e5/sap-27-04-200.PMC4621283.pdf
2015; 27(4): 220-227. doi: http://dx.doi.org/10.11919/ j.issn.1002-0829.215055 5.,Non-OADS,/arxiv_data1/oa_pdf/61/e5/sap-27-04-200.PMC4621283.pdf
2015; 27(4): 228-236. doi: http://dx.doi.org/10.11919/ j.issn.1002-0829.215064 6.,Non-OADS,/arxiv_data1/oa_pdf/61/e5/sap-27-04-200.PMC4621283.pdf
2015; 27(4): 237-245. doi: http://dx.doi.org/10.11919/ j.issn.1002-0829.215080,Non-OADS,/arxiv_data1/oa_pdf/61/e5/sap-27-04-200.PMC4621283.pdf
2010; 125(1-3): 165-168. doi:  http://dx.doi.org/10.1016/j.jad.,OADS,/arxiv_data1/oa_pdf/61/e5/sap-27-04-200.PMC4621283.pdf
2008; 23: 647-651. doi:http://dx.doi.org/10.1002/hup.969 9.,Non-OADS,/arxiv_data1/oa_pdf/61/e5/sap-27-04-200.PMC4621283.pdf
2015; 27(4): 246-248. doi:http://dx.doi.org/10.11919/ j.issn.1002-0829.21500911.,Non-OADS,/arxiv_data1/oa_pdf/61/e5/sap-27-04-200.PMC4621283.pdf
2015; 27(4): 249-251  doi: http://dx.doi.org/10.11919/j.issn.1002-0829.215091 12.,Non-OADS,/arxiv_data1/oa_pdf/61/e5/sap-27-04-200.PMC4621283.pdf
2015; 27 (4): 252-255. doi: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/61/e5/sap-27-04-200.PMC4621283.pdf
"2015;  27(4): 256-259.  doi: http://dx.doi.org/10.11919/j.issn.1002-0829.215089 •Errata • There is an error in the print version of the article: Zhou Y , Zhou RS, Li WJ, Lin YQ, Yao J, Chen J, et al.",Non-OADS,/arxiv_data1/oa_pdf/61/e5/sap-27-04-200.PMC4621283.pdf
2015; 27(3): 167-174. doi: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/61/e5/sap-27-04-200.PMC4621283.pdf
2010; 125(1-3): 165-168. doi:  http://dx.doi.org/10.1016/j.jad.,OADS,/arxiv_data1/oa_pdf/f0/ff/sap-27-04-202.PMC4621284.pdf
2008; 23: 647-651. doi:http://dx.doi.org/10.1002/hup.969 9.,Non-OADS,/arxiv_data1/oa_pdf/f0/ff/sap-27-04-202.PMC4621284.pdf
2015; 27(4): 246-248. doi:http://dx.doi.org/10.11919/ j.issn.1002-0829.21500911.,Non-OADS,/arxiv_data1/oa_pdf/f0/ff/sap-27-04-202.PMC4621284.pdf
2015; 27(4): 249-251  doi: http://dx.doi.org/10.11919/j.issn.1002-0829.215091 12.,Non-OADS,/arxiv_data1/oa_pdf/f0/ff/sap-27-04-202.PMC4621284.pdf
2015; 27 (4): 252-255. doi: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f0/ff/sap-27-04-202.PMC4621284.pdf
"2015;  27(4): 256-259.  doi: http://dx.doi.org/10.11919/j.issn.1002-0829.215089 •Errata • There is an error in the print version of the article: Zhou Y , Zhou RS, Li WJ, Lin YQ, Yao J, Chen J, et al.",Non-OADS,/arxiv_data1/oa_pdf/f0/ff/sap-27-04-202.PMC4621284.pdf
2015; 27(3): 167-174. doi: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f0/ff/sap-27-04-202.PMC4621284.pdf
"Department of Psychiatry, Chinese University of Hong Kong, Hong Kong, China correspondence: cwlam@cuhk.edu.hk A full-text Chinese translation of this article will be available at http://dx.doi.org/10.11919/j.issn.1002-0829.215068  on October 26, 2015.Linda CW LAMChallenges to the uniqueness of psychotic experience in  psychosis: insights on research methodology and intervention•Commentary • Summary:  Paul Bebbington’s recent Special Article on the value of psychosocial epidemiology as a tool for  understanding the symptomatology of psychosis provides a fresh perspective on understanding the etiology  of schizophrenia and related psychotic conditions.",Non-OADS,/arxiv_data1/oa_pdf/ae/60/sap-27-04-203.PMC4621285.pdf
"2015; 27(4): 203-205.  doi: http://dx.doi.org/10.11919/j.issn.1002-0829.215068] In his narrative review on the presentations and  mechanisms of psychosis, Paul Bebbington highlighted the new method of ‘analytical psychosocial epidemio-logy’ and the fresh perspective on symptomatology of this method.",Non-OADS,/arxiv_data1/oa_pdf/ae/60/sap-27-04-203.PMC4621285.pdf
"概述： Paul Bebbington 最近发表了一篇专题文章， 关于将社会心理流行病学作为一种理解精神病的症 状学的工具的价值，该文章为理解精神分裂症的病 因学和相关精神病性状态提供了一个全新的视角。对非临床人群精神病样经验的评估可以有助于弄清非精神病性症状的角色，比如精神病性障碍发病和发展过程中的焦虑和抑郁。这种方法还可以扩大干预的范围，预防精神病发病或使精神病性状态好转。然而，为达到在脑病理、心理症状、环境压力和临床诊断之间找到足够详细的映射关系以创造一种新的精神病学疾病分类，我们还有一段漫长的道路需 要走。 关键词： 社会心理流行病学 ； 精神病 ； 非精神病性症状 ； 社会心理应激源；前驱精神病 本文全文中文版从 2015 年10月26日起在 http://dx.doi.org/10.11919/j.issn.1002-08 29.215068 可供免费阅览下载对精神病中精神病性体验的独特性的挑战：关于研究方法和干预的深入见解 Lam LCW• 204 • Shanghai Archives of Psychiatry, 2015, Vol.",Non-OADS,/arxiv_data1/oa_pdf/ae/60/sap-27-04-203.PMC4621285.pdf
2015; 27(2): 70-81. doi: http://dx.chinadoi.cn/  10.11919/j.issn.1002-0829.215027 2.,Non-OADS,/arxiv_data1/oa_pdf/ae/60/sap-27-04-203.PMC4621285.pdf
2004; 185: 298-305. doi: http://dx.doi.org/10.1192/ bjp.185.4.298 4.,Non-OADS,/arxiv_data1/oa_pdf/ae/60/sap-27-04-203.PMC4621285.pdf
2007; 89: 101-109.  doi: http://dx.doi.org/10.1016/j.schres.2006.09.014 5.,Non-OADS,/arxiv_data1/oa_pdf/ae/60/sap-27-04-203.PMC4621285.pdf
2015; 45: 1483-1493. doi: http://dx.doi.org/10.1017/ S003329171400261X 6.,Non-OADS,/arxiv_data1/oa_pdf/ae/60/sap-27-04-203.PMC4621285.pdf
2013; 144: 99-104. doi: http://dx.doi.org/10.1016/ j.schres.2012.12.0097.,OADS,/arxiv_data1/oa_pdf/ae/60/sap-27-04-203.PMC4621285.pdf
2015; 27(1): 48-51. doi: http://dx.doi.org/10.11919/ j.issn.1002-0829.215015 8.,Non-OADS,/arxiv_data1/oa_pdf/ae/60/sap-27-04-203.PMC4621285.pdf
2013; 14: 214. doi: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ae/60/sap-27-04-203.PMC4621285.pdf
2014; 53: 422-432. doi:  http://dx.doi.org/10.1111/bjc.12054 10.,Non-OADS,/arxiv_data1/oa_pdf/ae/60/sap-27-04-203.PMC4621285.pdf
doi: http://dx.doi.org/10.1038/ mp.2015.27 11.,Non-OADS,/arxiv_data1/oa_pdf/ae/60/sap-27-04-203.PMC4621285.pdf
2015; 50: 339-350. doi: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ae/60/sap-27-04-203.PMC4621285.pdf
"1 Shanghai Key Laboratory of Psychotic Disorders, Shanghai Research Institute of Mental Health, Shanghai Mental Health Center, Shanghai Jiao Tong  University School of Medicine, Shanghai, China 2 Peking University Sixth Hospital Institute of Mental Health, Mental Health Institute of Peking University, Key Laboratory of Mental Health, Ministry of  Health, Peking University, Beijing, China # joint first authors *correspondence: chunbo_li@163.com A full-text Chinese translation of this article will be available at http://dx.doi.org/10.11919/j.issn.1002-0829.215093  on October 26, 2015.Wenzheng WANG1,#, Chengcheng PU2,#, Jiangling JIANG1, Xinyi CAO1, Jijun WANG1, Min ZHAO1,  Chunbo LI1,*Efficacy and safety of treating patients with refractory  schizophrenia with antipsychotic medication and adjunctive  electroconvulsive therapy: a systematic review and meta-analysis•Systematic review and meta-analysis • Background: The efficacy and safety of the combined treatment of refractory schizophrenia with  antipsychotic medications and electroconvulsive therapy (ECT) remain uncertain.",Non-OADS,/arxiv_data1/oa_pdf/d8/eb/sap-27-04-206.PMC4621286.pdf
"2015, 27(4): 206-219. doi: http://dx.doi.org/10.11919/j.issn.1002-0829.215093]Shanghai Archives of Psychiatry, 2015, Vol.",Non-OADS,/arxiv_data1/oa_pdf/d8/eb/sap-27-04-206.PMC4621286.pdf
"背景：抗精神病药物合并电抽搐治疗 (electroconvulsive  therapy, ECT) 对难治性精神分裂症患者的疗效和安全性 还不确定。 目的： 对电抽搐治疗在难治性精神分裂症中的应用的 相关中英文文献进行系统综述和 meta 分析。 方法： 在中英文数据库中检索 2015 年5月20日前发 表的关于抗精神病药物合并 ECT治疗难治性精神分裂 症疗效和安全性的研究。由两名研究人员根据预先设 定的标准独立筛选和评估文献。采用 Review Manager  5.1软件进行数据分析。 结果：共纳入 22项随机对照研究，其中在中国大陆 开展的研究有 18项。本研究对 22项研究中的 18 项 研究共 1394 例样本进行 meta 分析后发现，相比于 单独使用抗精神病药物，抗精神病药物合并 ECT治 疗达到各研究特定的 “临床改善 ”标准的比例要显著 高 (RR=1.31, 95 %CI=1.22 -1.41) 。根据推荐 GRADE 分级 的评估、制定和评价标准  (Grades of Recommendation,  Assessment, Development, and Evaluation, GRADE) ，该 疗效评估的证据质量是“中等”。但是，在治疗过程中出现头痛的参与者比例在合并治疗组中显著更高（RR=9.10 , 95%CI=3.97-20.86 ，基于 8项研究 517例样 本）。合并治疗组中出现记忆受损的患者的比例也高（RR=6.48 ，95% CI=3.54-11.87 ，基于 7项研究 577例 样本） 。 这些不良反应的证据质量被评定为 “非常低” 。 结论： 有关抗精神病药物合并 ECT治疗难治性精神分 裂症的高质量随机对照临床试验很少。该 meta 分析 发现，抗精神病药物合并 ECT可以改善难治性精神分 裂症患者的精神症状，但大多数研究提供的方法学信息不全，存在发表偏倚（更偏向于合并治疗组结果相对好的研究），有关不良反应、认知受损和整体功能的证据质量较低，这使我们需要对结果的效度有所质疑。 关键词： 电抽搐治疗；抗精神病药物；难治性精神分 裂症；系统综述； meta 分析 本文全文中文版从 2015 年10月26日起在 http://dx.doi.org/10.11919/j.issn.1002-0829.215093 可供免费阅览下载抗精神病药物合并电抽搐治疗对难治性精神分裂症患者的疗效和安全性：一项系统综述和 meta 分析 王文政，蒲城城，蒋江灵， 曹歆轶，王继军，赵敏，李春波 References 1.",Non-OADS,/arxiv_data1/oa_pdf/d8/eb/sap-27-04-206.PMC4621286.pdf
2011; 12: 411-434. doi: http://dx.doi.org/   10.1517/14656566.2011.528200 2.,Non-OADS,/arxiv_data1/oa_pdf/d8/eb/sap-27-04-206.PMC4621286.pdf
doi: http://dx.chinadoi.cn/10.3969/ j.issn.1005-3220.2000.02.040 5.,Non-OADS,/arxiv_data1/oa_pdf/d8/eb/sap-27-04-206.PMC4621286.pdf
2008; 336: 924-926. doi: http://dx.doi.org/10.1136/ bmj.39489.470347.AD 7.,Non-OADS,/arxiv_data1/oa_pdf/d8/eb/sap-27-04-206.PMC4621286.pdf
doi: http://dx.chinadoi.cn/10.3969/ j.issn.1002-0829.2000.04.016 8.,Non-OADS,/arxiv_data1/oa_pdf/d8/eb/sap-27-04-206.PMC4621286.pdf
doi: http://dx.chinadoi.cn/10.3969/ j.issn.1672-187X.2013.03.007-0204-03 13.,Non-OADS,/arxiv_data1/oa_pdf/d8/eb/sap-27-04-206.PMC4621286.pdf
doi: http://dx.chinadoi.,Non-OADS,/arxiv_data1/oa_pdf/d8/eb/sap-27-04-206.PMC4621286.pdf
doi: http://dx.chinadoi.cn/10.3969/ j.issn.1672-0369.2011.24.035 16.,Non-OADS,/arxiv_data1/oa_pdf/d8/eb/sap-27-04-206.PMC4621286.pdf
doi: http://dx.chinadoi.cn/10.3969/ j.issn.1006-1959.2011.05.377 17.,Non-OADS,/arxiv_data1/oa_pdf/d8/eb/sap-27-04-206.PMC4621286.pdf
doi: http://dx.chinadoi.,Non-OADS,/arxiv_data1/oa_pdf/d8/eb/sap-27-04-206.PMC4621286.pdf
doi: http://dx.chinadoi.,Non-OADS,/arxiv_data1/oa_pdf/d8/eb/sap-27-04-206.PMC4621286.pdf
doi: http://dx.chinadoi.cn/10.3969/j.issn.1672- 187X.2010.01.005.0008-03 23.,Non-OADS,/arxiv_data1/oa_pdf/d8/eb/sap-27-04-206.PMC4621286.pdf
2015; 172(1): 52-58. doi:  http://dx.doi.org/10.1176/appi.ajp.2014.1306078724.,Non-OADS,/arxiv_data1/oa_pdf/d8/eb/sap-27-04-206.PMC4621286.pdf
2014; 14: 253. doi: http://dx.doi.org/10.1186/ s12888-014-0253-4 25.,Non-OADS,/arxiv_data1/oa_pdf/d8/eb/sap-27-04-206.PMC4621286.pdf
2013; 66(9): 973- 981. doi: http://dx.doi.org/10.1016/ j.jclinepi.2012.07.005 26.,OADS,/arxiv_data1/oa_pdf/d8/eb/sap-27-04-206.PMC4621286.pdf
doi: http://dx.chinadoi.cn/10.3969/ j.issn.1674-3296.2013.24.082 27.,Non-OADS,/arxiv_data1/oa_pdf/d8/eb/sap-27-04-206.PMC4621286.pdf
doi: http://dx.chinadoi.cn/10.3969/ j.issn.1006-2785.2011.11.012 29.,Non-OADS,/arxiv_data1/oa_pdf/d8/eb/sap-27-04-206.PMC4621286.pdf
doi: http://dx.chinadoi.cn/10.3969/ j.issn.1001-5183.2012.09.016 30.,Non-OADS,/arxiv_data1/oa_pdf/d8/eb/sap-27-04-206.PMC4621286.pdf
doi: http://dx.chinadoi.,Non-OADS,/arxiv_data1/oa_pdf/d8/eb/sap-27-04-206.PMC4621286.pdf
"Shanghai Xuhui District Mental Health Center, Shanghai, China *correspondence: li_chenhu@163.com A full-text Chinese translation of this article will be available at http://dx.doi.org/10.11919/j.issn.1002-0829.215055  on Oct 26, 2015.Hong ZHANG, Chenhu LI*, Liyu ZHAO, Guilai ZHAN Single-blind, randomized controlled trial of effectiveness of  Naikan therapy as an adjunctive treatment for schizophrenia  over a one-year follow-up period•Original research article • Background: Current treatments for schizophrenia are often only partially effective.",Non-OADS,/arxiv_data1/oa_pdf/9c/91/sap-27-04-220.PMC4621287.pdf
"2015, 27(4): 220-227. doi: http://dx.doi.org/10.11919/j.issn.1002-0829.215055]Shanghai Archives of Psychiatry, 2015, Vol.",Non-OADS,/arxiv_data1/oa_pdf/9c/91/sap-27-04-220.PMC4621287.pdf
doi: http://dx.chinadoi.cn/10.3321/ j.issn:1000-6729.2004.04.019 2.,Non-OADS,/arxiv_data1/oa_pdf/9c/91/sap-27-04-220.PMC4621287.pdf
2010; 10: 2. doi: http://dx.doi.org/10.1186/1471-244X-10-2 3.,Non-OADS,/arxiv_data1/oa_pdf/9c/91/sap-27-04-220.PMC4621287.pdf
2008; 34(6): 1021-1023. doi: http://dx.doi.org/10.1093/ schbul/sbn1244.,Non-OADS,/arxiv_data1/oa_pdf/9c/91/sap-27-04-220.PMC4621287.pdf
"Chinese背景：目前的精神分裂症治疗常常只是部分有效。 目的：评估在精神分裂症的治疗中使用辅助性内观 疗法可能带来的益处，该疗法是一种源于日本、基 于内省的认知方法。   方法：在急性精神病性症状缓解后， 235例具有初 中以上学历的精神分裂症住院患者被随机分为对照组 (n=112) 或干预组  (n=123)。前者接受常规药物治 疗和住院康复治疗，后者在此基础上接受辅助性内观疗法，每天 2 小时，每周 5天，为期 4周。对所 有患者在出院后进行 12个月的随访。在基线、干预 1个月后以及随访 12个月后，采用阳性和阴性症状 量表  (Positive and Negative Syndrome Scale, PANSS) 、 个人和社会功能量表  (Personal and Social Performance  scale, PSP) 以及自知力与治疗态度问卷  (Insight and  Attitude Questionnaire, ITAQ) 分别对患者进行评估。 对评估者使用盲法，隐瞒患者的分组情况。 结果：在12个月的随访中干预组只有 13例 (10.6%)  复发，但是对照组有 23例 (20.5%) 复发  (X 2=4.50, p=0.034)。使用修正的意向治疗分析和重复测量方 差分析，内观疗法组的 PANSS、PSP和ITAQ总分均 在12个月的随访中比对照组有更显著的改善。尽管 两组之间药物剂量（氯丙嗪等效剂量）随时间变化 趋势的差异并无统计学意义，但从入组到随访终点，干预组的平均剂量显著减少而对照组的减少在统计 学上并不显著。 结论：本研究有力支持了内观疗法作为辅助治疗在 精神分裂症康复期是有效的。相比于常规治疗，辅 以内观疗法可以维持急性治疗期间所取得的精神病 性症状改善的疗效、提高对疾病的自知力、提高社 会功能，并在一年的随访期内减少复发。这值得我们在更大、更多样化的精神分裂症患者样本中进一步研究这种治疗方法。 关键词： 内观疗法；精神分裂症；复发；社会功能； 随机对照试验；中国 本文全文中文版从 2015年10月26日起在 http://dx.doi.org/10.11919/j.issn.1002-0829.215055 可供免费阅览下载对内观疗法辅助治疗精神分裂症疗效的 1年随访：一项单盲、随机对照研究 张红，李晨虎，赵立宇，占归来rehabilitative treatment of Chinese patients who have  recovered from an acute episode of schizophrenia.",Non-OADS,/arxiv_data1/oa_pdf/9c/91/sap-27-04-220.PMC4621287.pdf
doi: http://dx.chinadoi.cn/10.1097/ MCD.0b013e32832e38a6 9.,Non-OADS,/arxiv_data1/oa_pdf/9c/91/sap-27-04-220.PMC4621287.pdf
doi: http://dx.chinadoi.cn/10.3969/ j.issn.1005-3611.2000.02.001 11.,Non-OADS,/arxiv_data1/oa_pdf/9c/91/sap-27-04-220.PMC4621287.pdf
doi: http://dx.chinadoi.cn/10.3969/ j.issn.1000-6729.2009.11.008 12.,Non-OADS,/arxiv_data1/oa_pdf/9c/91/sap-27-04-220.PMC4621287.pdf
2002; 346: 16-22.  doi: http://dx.doi.org/10.1056/NEJMoa002028 14.,Non-OADS,/arxiv_data1/oa_pdf/9c/91/sap-27-04-220.PMC4621287.pdf
2013; 17: 2-9. doi: http://dx.doi.org/10.3109/136 51501.2012.687452 17.,Non-OADS,/arxiv_data1/oa_pdf/9c/91/sap-27-04-220.PMC4621287.pdf
2013;  12(1):  32. doi: http://dx.doi.org/10.1186/1744-859X-12-32 18.,Non-OADS,/arxiv_data1/oa_pdf/9c/91/sap-27-04-220.PMC4621287.pdf
doi: http://dx.chinadoi.cn/10.3760/cma.,Non-OADS,/arxiv_data1/oa_pdf/9c/91/sap-27-04-220.PMC4621287.pdf
"1 Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China  2 Department of Psychiatry, Huashan Hospital, Fudan University, Shanghai, China  3 Department of Psychiatry, First Affiliated Hospital, Kunming Medical College, Kunming, Yunnan Province, China 4 Xijing Hospital, Fourth Military Medical University, Xi’an, Shaanxi Province, China  5 Hebei Mental Health Center, Baoding, Hebei Province, China 6 Guangzhou Brain Hospital, Guangzhou, Guangdong Province, China  7 Affiliated Brain Hospital of Nanjing Medical University, Nanjing, Jiangsu Province, China  8 First Affiliated Hospital of Xi’an, Jiao Tong University Medical College, Xi’an, Shaanxi Province, China 9 Beijing Anding Hospital, Capital Medical University, Beijing, China *correspondence: lhlh_5@163.com A full-text Chinese translation of this article will be available at http://dx.doi.org/10.11919/j.issn.1002-0829.215064  on Oct 26, 2015.Zhiyang WANG1,2, Xiufeng XU3, Qingrong TAN4, Keqing LI5, Cui MA6, Shiping XIE7, Chengge GAO8,  Gang WANG9, Huafang LI1,*Treatment of major depressive disorders with generic  duloxetine and paroxetine: a multi-centered, double-blind,  double-dummy, randomized controlled clinical trial•Original research article • Background: This study is a pre-registration trial of generic duloxetine that was approved by the China Food  and Drug Administration (approval number: 2006L01603).",Non-OADS,/arxiv_data1/oa_pdf/70/a6/sap-27-04-228.PMC4621288.pdf
"2015, 27(4): 228-236. doi: http://dx.doi.org/10.11919/j.issn.1002-0829.215064 ]Shanghai Archives of Psychiatry, 2015, Vol.",Non-OADS,/arxiv_data1/oa_pdf/70/a6/sap-27-04-228.PMC4621288.pdf
"背景： 本研究是经国家食品药品监督管理总局批准的 仿制度洛西汀注册前试验（批准号： 2006L01603 ）。 目的： 比较仿制度洛西汀和帕罗西汀治疗抑郁症患者 的疗效和安全性。 方法： 这是一项双盲双安慰剂  (double dummy) 、多中 心、有效药物（帕罗西汀）平行随机对照临床试验。 将纳入的 299 例抑郁症患者随机分组，使用度洛西汀   (n=149; 40-60 mg/d) 或帕罗西汀  (n=150; 20 mg/d) 连续 治疗 8周。在基线和开始治疗后的第 1、2、4、6和 8周使用汉密尔顿抑郁量表 (Hamilton Depression rating  scale, HAMD-17) 评估。缓解的定义为研究终点 HAMD- 17评分低于 8分，治疗有效的定义为研究终点 HAMD- 17得分较基线至少降低了 50%。根据报告的不良反应 的发生率、严重程度以及实验室检查结果、心电图结果的变化来评估安全性。度洛西汀组中有三例患者在开始用药前退出，采用修正的意向治疗分析  (intention-to-treat, ITT) 方法以比较研究组 146例患者和对照组 150例患者的研究结果。 结果： 在8周的研究期间两组有均 29例患者脱落。与 基线比，两组 HAMD-17 评分在整个试验过程中均显著 降低。根据 ITT分析，研究终点时度洛西汀组和帕罗 西汀组在疗效方面差异无统计学意义  (67.1% v. 71.3%,  X 2=0.62, p=0.433) ，缓解率  (41.1% v. 51.3%, X2=3.12,  p=0.077) 及不良作用发生率 56.8% v. 54.7%, X2=0.14,  p=0.705) 等方面的差异也无统计学意义。 结论： 对于在国内精神科门诊就医的抑郁症患者而言， 急性期使用仿制度洛西汀与使用帕罗西汀同样安全有 效。 关键词： 度洛西汀；帕罗西汀；疗效；安全性；抑郁症； 随机对照试验；中国 本文全文中文版从 2015 年10月26日起在 http://dx.doi.org/10.11919/j.issn.1002-0829.215064 可供免费阅览下载使用仿制度洛西汀或帕罗西汀治疗抑郁症：一项多中心、双盲、双安慰剂、随机对照临床试验 王志阳，许秀峰， 谭庆荣，栗克清， 马崔， 谢世平，高成阁，王刚，李华芳 References 1.",Non-OADS,/arxiv_data1/oa_pdf/70/a6/sap-27-04-228.PMC4621288.pdf
2012; 73(Suppl 1):  5-9. doi: http://dx.doi.org/10.4088/JCP .11096su1c.01 2.,Non-OADS,/arxiv_data1/oa_pdf/70/a6/sap-27-04-228.PMC4621288.pdf
2007; 6: 23.  doi: http://dx.doi.org/10.1186/1744-859X-6-23 3.,Non-OADS,/arxiv_data1/oa_pdf/70/a6/sap-27-04-228.PMC4621288.pdf
2013; 382(9904):  1575-1586. doi: http://dx.doi.org/10.1016/S0140- 6736(13)61611-6 4.,Non-OADS,/arxiv_data1/oa_pdf/70/a6/sap-27-04-228.PMC4621288.pdf
2009; 373(9680):  2041-2053. doi: http://dx.doi.org/10.1016/S0140- 6736(09)60660-7 6.,Non-OADS,/arxiv_data1/oa_pdf/70/a6/sap-27-04-228.PMC4621288.pdf
2005; 25(3): 396- 410. doi: http://dx.doi.org/10.1592/phco.25.3.396.61600 8.,Non-OADS,/arxiv_data1/oa_pdf/70/a6/sap-27-04-228.PMC4621288.pdf
2013; 2013: 212245. doi: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/70/a6/sap-27-04-228.PMC4621288.pdf
2007; 27(6): 672-676. doi: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/70/a6/sap-27-04-228.PMC4621288.pdf
2009; 23(6): 523-541. doi: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/70/a6/sap-27-04-228.PMC4621288.pdf
2012; 28(9): 775-781.doi: http://dx.doi.org/10.1097/ AJP .0b013e3182510295 14.,Non-OADS,/arxiv_data1/oa_pdf/70/a6/sap-27-04-228.PMC4621288.pdf
2012; 27(1): 17-26. doi: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/70/a6/sap-27-04-228.PMC4621288.pdf
2011; 27(10): 1849-1858. doi: http://dx.doi.org/10.1185/0 3007995.2011.609539 21.,Non-OADS,/arxiv_data1/oa_pdf/70/a6/sap-27-04-228.PMC4621288.pdf
2010; 33(5): 393-407. doi: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/70/a6/sap-27-04-228.PMC4621288.pdf
"1 Department of Psychiatry, Zhejiang University School of Medicine affiliated Sir Run Run Shaw Hospital and the Collaborative Innovation Center for Brain  Science, Hangzhou, Zhejiang Province, China 2 Huzhou Third People’s  Hospital, Huzhou, Zhejiang Province, China 3 Zhejiang Provincial Tongde Hospital, Hangzhou, Zhejiang Province, China *correspondence: srrcw@zju.edu.cn A full-text Chinese translation of this article will be available at http://dx.doi.org/10.11919/j.issn.1002-0829.215080  on Oct 26, 2015.Shiliang WANG1,2, Mincai QIAN2, Hua ZHONG2, Guohua SONG2, Meijuan LU2, Rui FENG1, Lei ZHANG1, Jianliang NI3,  Wei CHEN1,*Comparison of the effectiveness of duloxetine in depressed  patients with and without a family history of affective  disorders in first-degree relatives•Original research article • Background: It remains unclear whether or not a positive family history of affective disorders predicts the  effectiveness of antidepressant treatment of depression.",Non-OADS,/arxiv_data1/oa_pdf/db/52/sap-27-04-237.PMC4621289.pdf
"2015, 27(4): 237-245. doi: http://dx.doi.org/10.11919/j.issn.1002-0829.215080]Shanghai Archives of Psychiatry, 2015, Vol.",Non-OADS,/arxiv_data1/oa_pdf/db/52/sap-27-04-237.PMC4621289.pdf
"背景：阳性情感障碍家族史能否预测抗抑郁药疗效尚 不清楚。 目的：评估情感障碍家族史与度洛西汀治疗抑郁症的 疗效之间的相关性。方法：研究纳入符合国际疾病分类第 10版中抑郁症定 义的 77例患者，采用标准剂量的度洛西汀治疗 12周。 其中 37例患者有情感障碍家族史（一级亲属中），另 外40例家族史阴性。采用汉密尔顿抑郁量表  (Hamilton  Depression rating scale, HAMD-17) 、汉密尔顿焦虑量表   (Hamilton Anxiety rating scale, HAMA) 、抗抑郁药副反应 量表  (Side Effects Rating Scale, SERS) 、斯奈思 -汉密尔顿 快感量表  (Snaith-Hamilton Pleasure Scale, SHAPS) 和贝克 抑郁自评量表  (Beck Depression Inventory, BDI) 在基线与 纳入研究后第 2、4、6、8、12周末对患者进行评估。采用重复测量方差分析和 logistic回归分析情感障碍家 族史与度洛西汀疗效之间的相关性。结果：情感障碍阳性家族史的患者发病较早，病程较 长，精神性焦虑水平更高，而且快感缺乏更加突出。 重复测量方差分析显示经过 12周治疗抑郁症严重程度 显著改善，但两组之间的改善幅度或速度没有显著差异。情感障碍家族史阳性的患者中有 75.7％治疗有效 （即 HAMD-17 总分较基线下降 >50%），而家族史阴 性的患者有 77.5％有效  (X 2=0.04, p=0.850)。 结论：情感障碍家族史与度洛西汀对抑郁症的急性期 治疗的疗效不相关。 关键词： 家族史；抑郁症；度洛西汀；中国 本文全文中文版从 2015年10月26日起在 http://dx.doi.org/10.11919/j.issn.1002-0829.215080 可供免费阅览下载比较度洛西汀治疗一级亲属情感障碍家族史阳性或阴性的抑郁症患者的疗效 王士良，钱敏才，钟华，宋国华，陆梅娟，冯锐，张磊，倪建良，陈炜 References 1.",Non-OADS,/arxiv_data1/oa_pdf/db/52/sap-27-04-237.PMC4621289.pdf
2010; 31: 69-87.doi: http://dx.doi.org/10.1146/annurev.,Non-OADS,/arxiv_data1/oa_pdf/db/52/sap-27-04-237.PMC4621289.pdf
Philos Trans R Soc Lond B Biol Sci .2013; 368 (1615):  20120129. doi: http://dx.doi.org/10.1098/rstb.2012.0129 6.,Non-OADS,/arxiv_data1/oa_pdf/db/52/sap-27-04-237.PMC4621289.pdf
2010; 125(1-3): 165-168. doi:  http://dx.doi.org/10.1016/j.jad.,OADS,/arxiv_data1/oa_pdf/db/52/sap-27-04-237.PMC4621289.pdf
2008; 23: 647-651. doi:http://dx.doi.org/10.1002/hup.969 8.,Non-OADS,/arxiv_data1/oa_pdf/db/52/sap-27-04-237.PMC4621289.pdf
2012; 12: 184. doi: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/db/52/sap-27-04-237.PMC4621289.pdf
doi: http://dx.chinadoi.cn/10.3760/ cma.j.issn.1006-7884.2009.01.006 13.,Non-OADS,/arxiv_data1/oa_pdf/db/52/sap-27-04-237.PMC4621289.pdf
2007; 41(3-4): 214-221.  doi: http://dx.doi.org/10.1016/j.jpsychires.2006.02.00514.,Non-OADS,/arxiv_data1/oa_pdf/db/52/sap-27-04-237.PMC4621289.pdf
2011; 131(1-3): 251-259. doi: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/db/52/sap-27-04-237.PMC4621289.pdf
2003;  18(3): 197-200. doi: http://dx.doi.org/10.1002/hup.469 17.,Non-OADS,/arxiv_data1/oa_pdf/db/52/sap-27-04-237.PMC4621289.pdf
2009; 48(1): 71-78. doi:  http://dx.doi.org/10.1097/CHI.,Non-OADS,/arxiv_data1/oa_pdf/db/52/sap-27-04-237.PMC4621289.pdf
"•Forum• Comorbid bipolar disorder and obsessive-compulsive disorder Daihui PENG, Kaida JIANG* Division of Affective Disorders, Shanghai Mental Health Center, Shanghai Jiao Tong University School of Medicine, Shanghai, China *correspondence: jiangkaida@aliyun.com A full-text Chinese translation of this article will be available at http://dx.doi.org/10.11919/j.issn.1002-0829.215009  on October 26, 2015.Summary: Obsessive-compulsive symptoms are common in patients with bipolar disorders.",Non-OADS,/arxiv_data1/oa_pdf/b6/4e/sap-27-04-246.PMC4621290.pdf
"2015, 27(4): 246-248. doi: http://dx.doi.org/10.11919/j.issn.1002-0829.215009] Previous studies have documented high rates of  comorbidity of other psychiatric conditions among individuals with bipolar disorders (BD).",Non-OADS,/arxiv_data1/oa_pdf/b6/4e/sap-27-04-246.PMC4621290.pdf
概述： 在双相障碍患者中强迫症状是常见的。因为双 相障碍和强迫症的共病状态会令这两种障碍的临床治 疗复杂化，所以确定这些共病的患者是很重要的。我们讨论了强迫症和双相障碍的共病，介绍了可能导致这种常见共病状态的发病机制，也讨论了该领域最新的研究进展，并提出一些管理这些患者的临床原则。关键词： 强迫症；双相障碍；共病 本文全文中文版从 2015 年10月26日起在 http://dx.doi.org/10.11919/ j.issn.1002-0829.215009 可供免费阅览下载双相障碍与强迫症的共病 彭代辉，江开达 References 1.,Non-OADS,/arxiv_data1/oa_pdf/b6/4e/sap-27-04-246.PMC4621290.pdf
doi: http://dx.doi.org/10.1111/j.1600- 0447.2004.00502.x 4.,Non-OADS,/arxiv_data1/oa_pdf/b6/4e/sap-27-04-246.PMC4621290.pdf
Epub 2012 Nov 2. doi: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b6/4e/sap-27-04-246.PMC4621290.pdf
Epub 2009 Dec 2. doi: http://dx.doi.org/10.1111/j.1600- 0447.2009.01514.x7.,Non-OADS,/arxiv_data1/oa_pdf/b6/4e/sap-27-04-246.PMC4621290.pdf
doi: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b6/4e/sap-27-04-246.PMC4621290.pdf
doi: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b6/4e/sap-27-04-246.PMC4621290.pdf
"doi: http://dx.do.org/10.1007/s00406-005- 0576-8Shanghai Archives of Psychiatry, 2015, Vol.",Non-OADS,/arxiv_data1/oa_pdf/b6/4e/sap-27-04-246.PMC4621290.pdf
2007; 9: 722-729. doi: http://dx.doi.org/10.1111/ j.1399-5618.2007.00508.x 14.,Non-OADS,/arxiv_data1/oa_pdf/b6/4e/sap-27-04-246.PMC4621290.pdf
doi:  http://dx.doi.org/10.1016/j.comppsych.2009.07.006 16.,OADS,/arxiv_data1/oa_pdf/b6/4e/sap-27-04-246.PMC4621290.pdf
2010; 22: 81-86. doi: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b6/4e/sap-27-04-246.PMC4621290.pdf
2007; 24: 251-255. doi: http://dx.doi.org/10.1002/da.20234 19.,Non-OADS,/arxiv_data1/oa_pdf/b6/4e/sap-27-04-246.PMC4621290.pdf
doi: http://dx.doi.org/10.1016/ j.psychres.2005.03.003 20.,OADS,/arxiv_data1/oa_pdf/b6/4e/sap-27-04-246.PMC4621290.pdf
2005; 27: 139-142. doi: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b6/4e/sap-27-04-246.PMC4621290.pdf
2006;  256: 240-245. doi: http://dx.doi.org/10.1007/s00406-006- 0632-z 22.,Non-OADS,/arxiv_data1/oa_pdf/b6/4e/sap-27-04-246.PMC4621290.pdf
doi: http://dx.doi.org/10.1007/ s004060050044 23.,Non-OADS,/arxiv_data1/oa_pdf/b6/4e/sap-27-04-246.PMC4621290.pdf
2010; 43:  69-78. doi: http://dx.doi.org/10.1159/000274175 25.,Non-OADS,/arxiv_data1/oa_pdf/b6/4e/sap-27-04-246.PMC4621290.pdf
doi: http://dx.doi.org/10.1002/ da.20908 27.,Non-OADS,/arxiv_data1/oa_pdf/b6/4e/sap-27-04-246.PMC4621290.pdf
doi: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/b6/4e/sap-27-04-246.PMC4621290.pdf
doi: http://dx.doi.org/10.1176/appi.ajp.161.12.2222 30.,Non-OADS,/arxiv_data1/oa_pdf/b6/4e/sap-27-04-246.PMC4621290.pdf
Epub 2011 Nov 21. doi: http://dx.doi.org/10.1017/ S0033291711002637 31.,Non-OADS,/arxiv_data1/oa_pdf/b6/4e/sap-27-04-246.PMC4621290.pdf
2013; 15(1): 1-44. doi:  http://dx.doi.org/10.1111/bdi.12025 34.,Non-OADS,/arxiv_data1/oa_pdf/b6/4e/sap-27-04-246.PMC4621290.pdf
2010; 32(5): 556-558.  doi: http://dx.doi.org/10.1016/j.genhosppsych.2010.07.004 35.,Non-OADS,/arxiv_data1/oa_pdf/b6/4e/sap-27-04-246.PMC4621290.pdf
"Huashan Hospital, Fudan University, Shanghai, China  correspondence: shishenxun@163.com A full-text Chinese translation of this article will be available at http://dx.doi.org/10.11919/j.issn.1002-0829.215091  on October 26, 2015.Shenxun SHIObsessive compulsive symptoms in bipolar disorder patients:  a comorbid disorder or a subtype of bipolar disorder?•Forum • Comorbid bipolar disorder and OCD Summary: Over the last decade increasing attention has been focused on individuals that simultaneously  meet the criteria of two or more mental disorders.",Non-OADS,/arxiv_data1/oa_pdf/c5/f4/sap-27-04-249.PMC4621291.pdf
"2015, 27(4): 249-251. doi: http://dx.doi.org/10.11919/j.issn.1002-0829.215091]Shanghai Archives of Psychiatry, 2015, Vol.",Non-OADS,/arxiv_data1/oa_pdf/c5/f4/sap-27-04-249.PMC4621291.pdf
概述： 在过去十年中，人们越来越关注同时符合两 种或两种以上精神障碍诊断标准的患者。上述共病情况之一就是双相障碍合并强迫症，这在以双相障碍为主要诊断的患者中比较常见。但是，关于这种共病的诊断和治疗的研究很少，在中国尤为如此。现有的研究主要集中在小样本的横断面研究，因此它们在对理解这种共病情况的病因和病程作用有 限。对有限的文献进行回顾发现这是双相障碍中一 种相对严重的、难治性的亚型，只有少数情况可以被认为是一种共病障碍。要阐明这种共病的病因、预后以及合适的治疗方法，则需要大样本的前瞻性 研究。 关键词： 双相障碍；强迫症；共病精神障碍 本文全文中文版从 2015 年10月26日起在 http://dx.doi.org/10.11919/j.issn.1002-0829.215091 可供免费阅览下载双相障碍患者的强迫症状：是一种共病障碍还是双相障碍的一种亚型？ 施慎逊,Non-OADS,/arxiv_data1/oa_pdf/c5/f4/sap-27-04-249.PMC4621291.pdf
2015; 27(4): 246-248. doi: http://dx.doi.org/10.11919/ j.issn.1002-0829.215009 2.,Non-OADS,/arxiv_data1/oa_pdf/c5/f4/sap-27-04-249.PMC4621291.pdf
1995; 34(2): 117-120. doi: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c5/f4/sap-27-04-249.PMC4621291.pdf
Epub 2014 Feb 7. doi: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c5/f4/sap-27-04-249.PMC4621291.pdf
2005; 255(1): 65-71. doi: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c5/f4/sap-27-04-249.PMC4621291.pdf
2010; 22(2): 81-86. doi: http://dx.doi.org/10.1111/j.1601- 5215.2010.00457.x 9.,Non-OADS,/arxiv_data1/oa_pdf/c5/f4/sap-27-04-249.PMC4621291.pdf
Epub 2009 Aug 28. doi: http://dx.doi.org/10.1016/ j.comppsych.2009.07.006 10.,OADS,/arxiv_data1/oa_pdf/c5/f4/sap-27-04-249.PMC4621291.pdf
2006; 21(3): 189-193. doi: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c5/f4/sap-27-04-249.PMC4621291.pdf
"Epub 2014 May 28. doi: http://dx.doi.org/10.1016/ j.jad.2014.05.026 (received, 2015-08-12; accepted, 2015-08-20) Dr. Shi obtained his Master’s Degree from Fudan University School of Medicine in 1989.",OADS,/arxiv_data1/oa_pdf/c5/f4/sap-27-04-249.PMC4621291.pdf
"2 Department of Psychiatry and Drug De-addiction, Post Graduate Institute of Medical Education and Research, Dr. Ram Manohar Lohia Hospital, Park  Street, New Delhi, India *correspondence: drankur.rml@gmail.com A full-text Chinese translation of this article will be available at http://dx.doi.org/10.11919/j.issn.1002-0829.215013  on October 26, 2015.Ankur SACHDEVA1,*, Mina CHANDRA2, Ankit SAXENA2, RP BENIWAL2, Manish KANDPAL2,  Arvind KUMAR2Case rep ort of comorbid schizophrenia and obsessive- compulsive disorder in a patient who was tube-fed for four  years by family members because of his refusal to eat•Case report • Summary: Refusal to eat is a common presentation in many psychiatric disorders including obsessive  compulsive disorder and schizophrenia.",Non-OADS,/arxiv_data1/oa_pdf/eb/a0/sap-27-04-252.PMC4621292.pdf
"2015; 27(4): 252-255. doi: http://dx.doi.org/10.11919/j.issn.1002-0829.215013]Shanghai Archives of Psychiatry, 2015, Vol.",Non-OADS,/arxiv_data1/oa_pdf/eb/a0/sap-27-04-252.PMC4621292.pdf
"概述： 在许多精神障碍中（包括强迫症和精神分裂 症），拒食是常见的表现。当突然出现拒食时，这 可能需要急诊处理；一旦变成慢性，它就成为一种难以改变的根深蒂固的行为。对拒食患者的诊断可能有难度，尤其是对有共病问题、智力受损或对自 身状况缺乏自知力的患者。鼻饲是一种有效的短期 干预方法，当患者重新进食时即可中止这一干预。然而，在某些情况下，患者可能变得依赖于鼻饲。我们介绍一个病例，报告一名患有精神分裂症、强 迫症、边缘智力以及癫痫的患者由于拒绝进食而由 其家庭成员用鼻饲管喂食超过三年。 关键词： 拒食；共病精神障碍；精神分裂症；强迫症； 边缘智力；癫痫；病例报告；印度 本文全文中文版从 2015 年10月26日起在 http://dx.doi.org/10.11919/j.issn.1002-0829.215013 可供免费阅览下载因拒食而由家庭成员对其鼻饲四年的精神分裂症和强迫症共病患者一例 Sachdeva A, Chandra M, Saxena A, Beniwal R, Kandpal M, Kumar AShanghai Archives of Psychiatry, 2015, Vol.",Non-OADS,/arxiv_data1/oa_pdf/eb/a0/sap-27-04-252.PMC4621292.pdf
1999;  100: 369-399. doi: http://dx.doi.org/ 10.1111/j.1600- 0447.1999.tb10884.x 5.,Non-OADS,/arxiv_data1/oa_pdf/eb/a0/sap-27-04-252.PMC4621292.pdf
doi: http://dx.doi.org/10.1111/ j.1753-4887.1998.tb06130.x 6.,Non-OADS,/arxiv_data1/oa_pdf/eb/a0/sap-27-04-252.PMC4621292.pdf
doi:  http://dx.doi.org/10.1901/jeab.1962.5-343 7.,Non-OADS,/arxiv_data1/oa_pdf/eb/a0/sap-27-04-252.PMC4621292.pdf
2000; 176: 281-284. doi:  http://dx.doi.org/ 10.1192/bjp.176.3.281 12.,Non-OADS,/arxiv_data1/oa_pdf/eb/a0/sap-27-04-252.PMC4621292.pdf
2003; 44(4): 311-316. doi: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/eb/a0/sap-27-04-252.PMC4621292.pdf
doi: http://dx.doi.org/10.1093/ schbul/sbp059 16.,Non-OADS,/arxiv_data1/oa_pdf/eb/a0/sap-27-04-252.PMC4621292.pdf
doi:  http://dx.doi.org/10.1046/j.1528-1157.2002.22402.x 19.,Non-OADS,/arxiv_data1/oa_pdf/eb/a0/sap-27-04-252.PMC4621292.pdf
"doi: http://dx.doi.org/10.1136/ jnnp.2005.069245  (received, 2015-04-27; accepted, 2015-06-06)",Non-OADS,/arxiv_data1/oa_pdf/eb/a0/sap-27-04-252.PMC4621292.pdf
"•Biostatistics in psychiatry (28) • Introduction to longitudinal data analysis in psychiatric research Xian LIU1,2 1 DoD Deployment Health Clinical Center, Defense Center of Excellence for Psychological Health and Traumatic Brain Injury, Walter Reed National Military  Medical Center, Bethesda, Maryland, United States 2 Department of Psychiatry, F. Edward Hebert School of Medicine, Uniformed Services University of the Health Sciences, Bethesda, Maryland, United States correspondence: xian.liu@usuhs.edu The views expressed in this article are those of the author and do not necessarily represent the official position of the government of the United States  of America A full-text Chinese translation of this article will be available at http://dx.doi.org/10.11919/j.issn.1002-0829.215089 on October 26, 2015.Summary: The onset, course, and management of mental health problems typically occur over relatively  long periods of time, so a substantial proportion of psychiatric research – particularly the research that  can provide clear answers about the complex interaction of biological, psychological, and social factors – requires multiple assessments of individuals and the environments in which they live over time.",Non-OADS,/arxiv_data1/oa_pdf/49/e2/sap-27-04-256.PMC4621293.pdf
"2015; 27(4): 256-259. doi: http://dx.doi.org/10.11919/j.issn.1002-0829.215089]Shanghai Archives of Psychiatry, 2015, Vol.",Non-OADS,/arxiv_data1/oa_pdf/49/e2/sap-27-04-256.PMC4621293.pdf
1993; 88(421): 9-25.  doi: http://dx.doi.org/10.2307/2290687 9.,Non-OADS,/arxiv_data1/oa_pdf/49/e2/sap-27-04-256.PMC4621293.pdf
"Cary, NC: SAS  Institute Inc; 2012 (received, 2015-07-22; accepted, 2015-07-25)概述： 精神卫生问题的发生、发展及对其管理都需 要相对较长的时间，所以相当一部分精神病学研 究—— 特别是能够明确回答有关生物、心理和社会因素复杂的相互作用的研究——要求对患者及其生活环境进行跨时长久的多种评估。然而，许多精神病学的研究人员使用不正确的统计方法来分析这一 类型的纵向数据，这一问题会导致分析结果中出现 无法识别的偏倚而由此得出不正确的结论。本文就纵向数据分析的话题做了介绍。文章探讨了纵向数据分析中使用的不同数据集结构、缺失数据的分类和处理以及使用纵向数据建立多元回归模型时对个体内相关性校正的方法。 关键词： 个体内相关性；纵向数据；缺失数据；多 元与一元数据结构；重复测量 本文全文中文版从 2015 年10月26日起在 http://dx.doi.org/10.11919/j.issn.1002-0829.215089 可供免费阅览下载精神病学研究中纵向数据分析的介绍 Liu X Dr. Xian Liu is Professor of Research at the Department of Psychiatry and Senior Scientist at the  Center for the Study of Traumatic Stress, F. Edward Hebert School of Medicine at the Uniformed Services University of the Health Sciences in Bethesda, Maryland, USA.",Non-OADS,/arxiv_data1/oa_pdf/49/e2/sap-27-04-256.PMC4621293.pdf
(AmoebaDB; http://amoebadb.org/amoeba/ ).,Non-OADS,/arxiv_data1/oa_pdf/23/87/zek1144.PMC4621310.pdf
"The recombinant EhMCF (rEhMCF) protein that is encoded in the E. histolytica genome (EHI_095150 in AmoebaDB; http://amoebadb.org/amoeba/ ) was pro- duced using a wheat germ cell-free translation system in the presence ofasolectin liposomes, which were freshly prepared just prior to use, asdescribed previously ( 12).",Non-OADS,/arxiv_data1/oa_pdf/23/87/zek1144.PMC4621310.pdf
"In the E. histolytica genome, three genes encoding putative PAPase1 to -3 (EHI_193350, EHI_179820, and EHI_175410, re-spectively) (AmoebaDB; http://amoebadb.org/amoeba/ ) are pres- ent.",Non-OADS,/arxiv_data1/oa_pdf/23/87/zek1144.PMC4621310.pdf
http://dx.doi.org/10 .1016/j.pt.2011.02.006 .,OADS,/arxiv_data1/oa_pdf/23/87/zek1144.PMC4621310.pdf
http://dx.doi.org/10 .1371/journal.pntd.0001263 .,Non-OADS,/arxiv_data1/oa_pdf/23/87/zek1144.PMC4621310.pdf
http://dx.doi .org/10.1016/j.cub.2005.02.068 .,OADS,/arxiv_data1/oa_pdf/23/87/zek1144.PMC4621310.pdf
MicrobiolMol Biol Rev 76:444 – 495. http://dx.doi.org/10.1128/MMBR.05024-11 .,OADS,/arxiv_data1/oa_pdf/23/87/zek1144.PMC4621310.pdf
http://dx.doi.org/10.1016/B978-0 -12-800223-0.00008-6 .,OADS,/arxiv_data1/oa_pdf/23/87/zek1144.PMC4621310.pdf
http://dx.doi.org/10.1111/j.1365-313X .2011.04516.x .,Non-OADS,/arxiv_data1/oa_pdf/23/87/zek1144.PMC4621310.pdf
"Cell-free synthesis, reconstitution, and characterization of a mitochon-drial dicarboxylate-tricarboxylate carrier of Plasmodium falciparum.Biochem Biophys Res Commun 414:612– 617. http://dx.doi.org/10.1016 /j.bbrc.2011.09.130 .",OADS,/arxiv_data1/oa_pdf/23/87/zek1144.PMC4621310.pdf
http://dx.doi.org/10.1371/journal .ppat.1000812 .,Non-OADS,/arxiv_data1/oa_pdf/23/87/zek1144.PMC4621310.pdf
J Biol Chem 282:8848 – 8859. http://dx.doi.org/10.1074/jbc.M609130200 .,OADS,/arxiv_data1/oa_pdf/23/87/zek1144.PMC4621310.pdf
Plant Cell 24:4187– 4204. http://dx.doi.org/10.1105/tpc.112.101964 .,OADS,/arxiv_data1/oa_pdf/23/87/zek1144.PMC4621310.pdf
http://dx.doi .org/10.1098/rstb.2009.0224 .,Non-OADS,/arxiv_data1/oa_pdf/23/87/zek1144.PMC4621310.pdf
http://dx.doi.org/10.1007/978-1-62703-631-3_19 .,Non-OADS,/arxiv_data1/oa_pdf/23/87/zek1144.PMC4621310.pdf
http://dx.doi.org/10.1016/j.sbi.2013.03.012 .,OADS,/arxiv_data1/oa_pdf/23/87/zek1144.PMC4621310.pdf
Science 267:232– 234. http://dx.doi.org/10.1126/science.7809627 .,Non-OADS,/arxiv_data1/oa_pdf/23/87/zek1144.PMC4621310.pdf
http://dx.doi.org/10.1107/S1399004714010268 .,Non-OADS,/arxiv_data1/oa_pdf/23/87/zek1144.PMC4621310.pdf
Acta Crystallogr D Biol Crystallogr 70:3023– 3033. http://dx.doi.org/10.1107/S1399004714021245 .,OADS,/arxiv_data1/oa_pdf/23/87/zek1144.PMC4621310.pdf
3 =-5= phosphoadenosine phosphate is an inhibitor of PARP-1 and a potentialmediator of the lithium-dependent inhibition of PARP-1 in vivo.Biochem J 443:485– 490. http://dx.doi.org/10.1042/BJ20111057 .Mi-ichi et al.,Non-OADS,/arxiv_data1/oa_pdf/23/87/zek1144.PMC4621310.pdf
To view please visit the journal online(http://dx.doi.org/10.1136/injuryprev-2014-041241).,Non-OADS,/arxiv_data1/oa_pdf/ee/8f/injuryprev-2014-041241.PMC4621367.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ 346 Brussoni M, et al.Inj Prev 2015; 21:344–347.",Non-OADS,/arxiv_data1/oa_pdf/ee/8f/injuryprev-2014-041241.PMC4621367.pdf
Helsinki: 2010. http://www.thl.,Non-OADS,/arxiv_data1/oa_pdf/ee/8f/injuryprev-2014-041241.PMC4621367.pdf
2013. http://www.cbc.ca/player/Radio/Local +Shows/British+Columbia/On+The+Island/ID/2362092477/?page=4 (accessed 30 Sep 2013).,Non-OADS,/arxiv_data1/oa_pdf/ee/8f/injuryprev-2014-041241.PMC4621367.pdf
http://www.cpsionline.ca/UserFiles/File/EN/sitePdfs/trainingCPSI/StandardsComparisonChart-2007-03-29.pdf (accessed 11 Oct 2013).,OADS,/arxiv_data1/oa_pdf/ee/8f/injuryprev-2014-041241.PMC4621367.pdf
See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 Hansen PR.,Non-OADS,/arxiv_data1/oa_pdf/90/21/heartjnl-2015-307745.PMC4621368.pdf
To view please visit the journal online(http://dx.doi.org/10.1136/jmedgenet-2015-103001).,Non-OADS,/arxiv_data1/oa_pdf/0a/05/jmedgenet-2015-103001.PMC4621369.pdf
W e checked the quality of the sequence reads using the FastQC 0.1 software (http://www.bioinformatics.babraham.ac.uk/projects/fastqc) and trimmed thelast 41 bp sequences from reads using the NGSQCT oolkit 2.2.3software.,OADS,/arxiv_data1/oa_pdf/0a/05/jmedgenet-2015-103001.PMC4621369.pdf
"W e excluded variants with minor allele frequency >0.5%in all populations and East populations from the 1000 Genomesand ExAC data (Exome Aggregation Consortium, http://exac.broadinstitute.org (April 2015 accessed)).",Non-OADS,/arxiv_data1/oa_pdf/0a/05/jmedgenet-2015-103001.PMC4621369.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ REFERENCES 1 Cohen MM, MacLean RE.",Non-OADS,/arxiv_data1/oa_pdf/0a/05/jmedgenet-2015-103001.PMC4621369.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Pang T. Genomics for public health improvement: relevant international ethical and policy issues around genome-wide association studies and biobanks.,Non-OADS,/arxiv_data1/oa_pdf/b7/cf/medethics-2014-102126.PMC4621370.pdf
"ISBN3-900051-07-0, URL http://www.R-project.org/).",Non-OADS,/arxiv_data1/oa_pdf/b4/81/bjophthalmol-2015-306636.PMC4621373.pdf
"See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Rosenfeld PJ, Brown DM, Heier JS, et al .",Non-OADS,/arxiv_data1/oa_pdf/b4/81/bjophthalmol-2015-306636.PMC4621373.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 Kopelman LM.,Non-OADS,/arxiv_data1/oa_pdf/dd/b9/medethics-2014-102231.PMC4621374.pdf
http://www.mrc.ac.za/ethics/ethics.htm 3 Council of Europe.,Non-OADS,/arxiv_data1/oa_pdf/dd/b9/medethics-2014-102231.PMC4621374.pdf
http://www.coe.int/t/dg3/healthbioethic/Activities/02_Biomedical_research_en/195%20Protocole%20recherche%20biomedicale%20e.pdf 4 Wendler D. Protecting subjects who cannot give consent: toward a better standard for“minimal ”risks.,Non-OADS,/arxiv_data1/oa_pdf/dd/b9/medethics-2014-102231.PMC4621374.pdf
"US Department of Health & Human Services, 2009. http://www.hhs.gov/ohrp/humansubjects/guidance/45cfr46.",Non-OADS,/arxiv_data1/oa_pdf/dd/b9/medethics-2014-102231.PMC4621374.pdf
"CIOMS, 2002. http://www.cioms.ch/publications/layout_guide2002.pdf 7 Canadian Institutes of Health Research, Natural Sciences and Engineering Research Council of Canada, Social Sciences and Humanities Research Council of Canada.Tri-council policy statement: ethical conduct for research involving humans .",Non-OADS,/arxiv_data1/oa_pdf/dd/b9/medethics-2014-102231.PMC4621374.pdf
"Government of Canada, 2010. http://www.pre.ethics.gc.ca Wada K, Nisker J. J Med Ethics 2015; 41:804 –808.",Non-OADS,/arxiv_data1/oa_pdf/dd/b9/medethics-2014-102231.PMC4621374.pdf
http://www.gmc-uk.org/guidance/ethical_guidance/consent_guidance_index.asp 31 American Hospital Association.,Non-OADS,/arxiv_data1/oa_pdf/dd/b9/medethics-2014-102231.PMC4621374.pdf
"http://www.aha.org/advocacy-issues/communicatingpts/pt-care-partnership.shtml 32 Oliveira GHM, Nesbitt GC, Murphy JG.",Non-OADS,/arxiv_data1/oa_pdf/dd/b9/medethics-2014-102231.PMC4621374.pdf
http://www.wma.net/en/30publications/30ethicsmanual/index.html 34 CMA.,Non-OADS,/arxiv_data1/oa_pdf/dd/b9/medethics-2014-102231.PMC4621374.pdf
http://www.acponline.org/running_practice/ethics/ manual/manual6th.htm#informed 38 British Medical Association.,Non-OADS,/arxiv_data1/oa_pdf/dd/b9/medethics-2014-102231.PMC4621374.pdf
"http://www.bma.org.uk/ethics/consent_and_capacity/ consenttoolkit.jsp 39 Jackson E. Medical law: text, cases, and materials .",Non-OADS,/arxiv_data1/oa_pdf/dd/b9/medethics-2014-102231.PMC4621374.pdf
"http://www.ama-assn.org/ama/pub/physician-resources/medical-ethics/code-medical-ethics.page 42 Bowman D, Spicer J, Iqbal R. Informed consent: a primer for clinical practice .",Non-OADS,/arxiv_data1/oa_pdf/dd/b9/medethics-2014-102231.PMC4621374.pdf
To viewplease visit the journal online (http://dx.doi.org/10.1136/ postgradmedj-2015-133353).,Non-OADS,/arxiv_data1/oa_pdf/3c/d7/postgradmedj-2015-133353.PMC4621375.pdf
"1Queen ’s University, Kingston, Ontario, Canada 2Cardiff University School of Medicine, Cardiff, UK 3University of Ottawa, Ottawa, Ontario, Canada 4McMaster University, Hamilton, Ontario, Canada Correspondence to Dr Alireza Jalali, TeachingChair, Faculty of Medicine, University of Ottawa, uOttawa, 451 Smyth Rd, Ottawa,Ontario, Canada K1H 8M5;ajalali@uottawa.ca Received 3 March 2015 Revised 9 June 2015Accepted 23 July 2015Published Online First 20 August 2015 ▸http://dx.doi.org/10.1136/ postgradmedj-2014-133230▸http://dx.doi.org/10.1136/ postgradmedj-2015-133300 ▸http://dx.doi.org/10.1136/ postgradmedj-2015-133358▸http://dx.doi.org/10.1136/ postgradmedj-2015-133612 ▸http://dx.doi.org/10.1136/ postgradmedj-2015-133686 To cite: Pereira I, Cunningham AM, Moreau K, et al.Postgrad Med J 2015; 91:561 –564.ABSTRACT Background Social media may blur the line between socialisation and professional use.",Non-OADS,/arxiv_data1/oa_pdf/3c/d7/postgradmedj-2015-133353.PMC4621375.pdf
"See: http://creativecommons.org/ licenses/by-nc/4.0/ Pereira I, et al.Postgrad Med J 2015; 91:561 –564.",Non-OADS,/arxiv_data1/oa_pdf/3c/d7/postgradmedj-2015-133353.PMC4621375.pdf
2013. http://www.rcgp.org.uk/~/media/Files/Policy/A-Z-policy/RCGP-Social-Media-Highway-Code.ashx 24 Canadian Medical Protective Association .,Non-OADS,/arxiv_data1/oa_pdf/3c/d7/postgradmedj-2015-133353.PMC4621375.pdf
To viewplease visit the journal online (http://dx.doi.org/10.1136/ bjsports-2014-094148).,Non-OADS,/arxiv_data1/oa_pdf/c0/6e/bjsports-2014-094148.PMC4621376.pdf
Statistical analyses Data were analysed with V .3.0.2 of the R statistical software (http://www.r-project.org/).,OADS,/arxiv_data1/oa_pdf/c0/6e/bjsports-2014-094148.PMC4621376.pdf
See: http://creativecommons.org/licenses/by-nc/4.0/ REFERENCES 1 van der Heijden GJ.,Non-OADS,/arxiv_data1/oa_pdf/c0/6e/bjsports-2014-094148.PMC4621376.pdf
Most public and pri- vate insurance covers PrEP ( http://myprepexperience.blogspot.,Non-OADS,/arxiv_data1/oa_pdf/4d/53/ofv126.PMC4621406.pdf
"com/p/truvada-track.html ), and the drug manufacturer has a medication assistance program for uninsured people with low in- come and a copayment assistance program that applies regardless of income ( http://start.truvada.com/individual/truvadaprep- copay ).",Non-OADS,/arxiv_data1/oa_pdf/4d/53/ofv126.PMC4621406.pdf
Avail- able at: http://www.cdc.gov/hiv/pdf/statistics_hssr_vol_17_no_4.pdf .,Non-OADS,/arxiv_data1/oa_pdf/4d/53/ofv126.PMC4621406.pdf
Available at: http://www.hivguidelines.,Non-OADS,/arxiv_data1/oa_pdf/4d/53/ofv126.PMC4621406.pdf
Avail- able at: http://www.cdc.gov/hiv/pdf/g uidelines/PrEPguidelines2014.,Non-OADS,/arxiv_data1/oa_pdf/4d/53/ofv126.PMC4621406.pdf
Available at http://www.who.int/hiv/pub/guidelines/ earlyrelease-arv/en/ .,Non-OADS,/arxiv_data1/oa_pdf/4d/53/ofv126.PMC4621406.pdf
Available at: http://stacks.cdc.,Non-OADS,/arxiv_data1/oa_pdf/4d/53/ofv126.PMC4621406.pdf
Available at: http://aidsinfo.nih.go v/guidelines/html/1/ adult-and-adolescent-treatment-guidelines/0 .,Non-OADS,/arxiv_data1/oa_pdf/4d/53/ofv126.PMC4621406.pdf
Supplementary Material Supplementary material is available online at Open Forum In- fectious Diseases ( http://OpenForumInfectiousDiseases.oxford- journals.org/ ).,Non-OADS,/arxiv_data1/oa_pdf/62/29/ofv135.PMC4621456.pdf
"This is an Open Access article distributed under the terms of the CreativeCommons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/03/e5/ofv137.PMC4621457.pdf
Available at:http://www.afro.who.int/en/clusters-a-programmes/dpc/integrated- disease-surveillance/features/2775-technical-guidelines-for-integrated- disease-surveillance-and-response-in-the-african-region.html .,Non-OADS,/arxiv_data1/oa_pdf/03/e5/ofv137.PMC4621457.pdf
Available at: http://www.fda.gov/MedicalDevices/ Safety/EmergencySituations/ucm161496.htm#ebola .,Non-OADS,/arxiv_data1/oa_pdf/03/e5/ofv137.PMC4621457.pdf
Available at: http://apps.who.int/iris/bitstream/10665/ 134009/1/WHO_EVD_GUIDANCE_LA .,OADS,/arxiv_data1/oa_pdf/03/e5/ofv137.PMC4621457.pdf
Available at: http://apps.who.,Non-OADS,/arxiv_data1/oa_pdf/03/e5/ofv137.PMC4621457.pdf
Available at: http://www.ammi.,Non-OADS,/arxiv_data1/oa_pdf/03/e5/ofv137.PMC4621457.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/Spinal cord injury-induced bone damage T Lin et al 9 /C2232015 Sichuan University Bone Research (2015) 15028",Non-OADS,/arxiv_data1/oa_pdf/32/7c/boneres201528.PMC4621491.pdf
"Brie ﬂy, 1mg RNA was reverse transcribed in a total volume of 40 (Super- Script II) or 50 mL (SuperScript III).Contents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/lrrLeukemia Research Reports http://dx.doi.org/10.1016/j.lrr.2015.07.001 2213-0489/ &2015 Published by Elsevier Ltd. nCorresponding author.",OADS,/arxiv_data1/oa_pdf/a5/8e/main.PMC4621498.pdf
KW/1294/LBK/003/001) (Klinisch Onderzoeksfonds).Appendix A. Suplementary information Supplementary data associated with this article can be found in the online version at http://dx.doi.org/10.1016/j.lrr.2015.07.001 .,OADS,/arxiv_data1/oa_pdf/a5/8e/main.PMC4621498.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/30/a9/rjv124.PMC4621524.pdf
"Logistic and Cox regression models were used to evaluate theContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/lrrLeukemia Research Reports http://dx.doi.org/10.1016/j.lrr.2015.05.005 2213-0489/ &2015 Published by Elsevier Ltd. nCorrespondence to: 4200 Colket Translational Research Building, Children's Hospital of Philadelphia, 3501 Civic Center Boulevard, Philadelphia, PA 19104, USA.",OADS,/arxiv_data1/oa_pdf/69/ec/main.PMC4621538.pdf
Editor: Rong Li./C2112015 The Authors 0006-3495/15/07/0407/8 $2.00 http://dx.doi.org/10.1016/j.bpj.2015.04.029 Biophysical Journal Volume 109 July 2015 407–414 407,Non-OADS,/arxiv_data1/oa_pdf/7b/ac/main.PMC4621544.pdf
SCS screening in T2DM patients 1–7 4:242 http://www.endocrineconnections.org DOI: 10.1530/EC-15-0078/C2092015 The authors Published by Bioscientiﬁca Ltd.,Non-OADS,/arxiv_data1/oa_pdf/2a/18/ec-04-242.PMC4621608.pdf
SCS screening in T2DM patients 2–7 4:243 http://www.endocrineconnections.org DOI: 10.1530/EC-15-0078/C2092015 The authors Published by Bioscientiﬁca Ltd.,Non-OADS,/arxiv_data1/oa_pdf/2a/18/ec-04-242.PMC4621608.pdf
SCS screening in T2DM patients 3–7 4:244 http://www.endocrineconnections.org DOI: 10.1530/EC-15-0078/C2092015 The authors Published by Bioscientiﬁca Ltd.,Non-OADS,/arxiv_data1/oa_pdf/2a/18/ec-04-242.PMC4621608.pdf
SCS screening in T2DM patients 4–7 4:245 http://www.endocrineconnections.org DOI: 10.1530/EC-15-0078/C2092015 The authors Published by Bioscientiﬁca Ltd.,Non-OADS,/arxiv_data1/oa_pdf/2a/18/ec-04-242.PMC4621608.pdf
SCS screening in T2DM patients 5–7 4:246 http://www.endocrineconnections.org DOI: 10.1530/EC-15-0078/C2092015 The authors Published by Bioscientiﬁca Ltd.,Non-OADS,/arxiv_data1/oa_pdf/2a/18/ec-04-242.PMC4621608.pdf
SCS screening in T2DM patients 6–7 4:247 http://www.endocrineconnections.org DOI: 10.1530/EC-15-0078/C2092015 The authors Published by Bioscientiﬁca Ltd.,Non-OADS,/arxiv_data1/oa_pdf/2a/18/ec-04-242.PMC4621608.pdf
SCS screening in T2DM patients 7–7 4:248 http://www.endocrineconnections.org DOI: 10.1530/EC-15-0078/C2092015 The authors Published by Bioscientiﬁca Ltd.,Non-OADS,/arxiv_data1/oa_pdf/2a/18/ec-04-242.PMC4621608.pdf
Available from:  http://epe.lac-bac.gc.ca/100/200/301/pwgsc-tpsgc/por-ef/health/2011/135-09/report.pdf  22.,Non-OADS,/arxiv_data1/oa_pdf/ba/32/RPS-10-182.PMC4621624.pdf
Available from;  http://www.oecdbookshop.org/oecd/index.,OADS,/arxiv_data1/oa_pdf/6a/dc/RPS-10-206.PMC4621627.pdf
Available from: http://www.journals.lww.com/ academicmedicine/Documents/00001888-200604001-00001.pdf.,Non-OADS,/arxiv_data1/oa_pdf/52/54/JRMS-20-563.PMC4621650.pdf
Available from: http://www.aamc.org/members/msmr/ mbmbooklet.pdf.,Non-OADS,/arxiv_data1/oa_pdf/52/54/JRMS-20-563.PMC4621650.pdf
Available from: http://www.ecs.,Non-OADS,/arxiv_data1/oa_pdf/0f/0f/JRMS-20-627.PMC4621661.pdf
"Guidelines for the use of antiretroviral agents in HIV-1-infected adults and adolescents, 2014 ; Available at: http://aidsinfo.nih.gov/guidelines .",Non-OADS,/arxiv_data1/oa_pdf/f9/90/ofv138.PMC4621663.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense (http://creativecommons.org/licenses/by-nc/4.0/), which per-mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commonslicense, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/17/37/10549_2015_Article_3584.PMC4621693.pdf
http://stlouis-mo.gov/government/depart ments/health/documents/public-health-understanding-our-needs-report.cfm .,Non-OADS,/arxiv_data1/oa_pdf/17/37/10549_2015_Article_3584.PMC4621693.pdf
119. http://www.gpo.gov/fdsys/pkg/PLAW-111publ148/pdf/ PLAW-111publ148.pdf .,Non-OADS,/arxiv_data1/oa_pdf/17/37/10549_2015_Article_3584.PMC4621693.pdf
"License (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commonslicense, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/fc/48/10549_2015_Article_3597.PMC4621694.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense ( http://creativecommons.org/licenses/by-nc/4.0/ ), which per- mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the originalauthor(s) and the source, provide a link to the Creative Commonslicense, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/64/f9/10549_2015_Article_3587.PMC4621695.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/54/0f/10549_2015_Article_3586.PMC4621696.pdf
"Table 1 Complete list of websites hosting or linking to breast cancer risk assessment tools, sorted by rating Superior rating Your disease risk http://yourdiseaserisk.wustl.edu/YDRDefault.aspx?ScreenControl=YDRGeneral&ScreenName=YDRbreastHarvard School of Public Healthhttp://www.diseaseriskindex.harvard.edu/update/hccpquiz.pl?lang=english&func=home&quiz=breastSt.",Non-OADS,/arxiv_data1/oa_pdf/c1/f3/10549_2015_Article_3601.PMC4621697.pdf
"Peter’s Healthcare Systemhttp://www.saintpetershcs.com/BreastCenter/Assessment/Bright Pinkhttp://www.assessyourrisk.org/#/introBlueCrossBlueShieldhttp://wellness.bcbsla.com/InteractiveTools/RiskAssessments/42,BreastCancerRisk#sthash.DqCj45oE.dpbsMary Washington Healthcarehttp://marywashington.staywellsolutionsonline.com/InteractiveTools/RiskAssessments/42,BreastCancerRiskBrigham and Women’s Hospitalhttp://healthlibrary.brighamandwomens.org/Search/42,BreastCancerRiskBanner Health http://healthlibrary.bannerhealth.com/InteractiveTools/RiskAssessments/42,BreastCancerRisk?rd=breastcancerrisk Worldwide Breast Cancerhttp://www.worldwidebreastcancer.com/ Adequate rating Breastcancerprevention.com http://www.breastcancerprevention.org/breastcancerrisks.htmlBREVAGenhttp://brevagen.com/c/brca-testing-overviewMD Anderson Cancer Centerhttps://www3.mdanderson.org/publicedu/prevention/Myriad Geneticshttps://www.hereditarycancerquiz.com/Breast Cancer Genetics Referral Screening Toolhttps://www.breastcancergenescreen.org/WebMDhttp://www.webmd.com/cancer/health-check-cancer-risk/University of Virginia Health System http://uvahealth.com/services/high-risk-breast-ovarian-cancer/detection-treatment/gail-model Adequate rating Dr. Holmes MD http://drholmesmd.com/resources/risk-assessment/Seattle Cancer Care Alliancehttp://www.seattlecca.org/breast-cancer-risk-assessment.cfmbreastcancer.orghttp://www.breastcancer.org/symptoms/understand_bc/risk/understandingSheKnowshttp://www.sheknows.com/health-and-wellness/articles/805910/breast-cancer-measuring-your-riskBRACAnalysishttp://www.bracnow.com/considering-testing/check-inherited-cancer-risk.phpNational Cancer Institutehttp://www.cancer.gov/bcrisktool/Lauren Greenberg MDhttp://www.laurengreenbergmd.com/breast/breast-cancer-are-you-at-risk-how-much-risk-calculator/ Centers for Disease Control and Prevention http://www.cdc.gov/cancer/breast/basic_info/risk_factors.htmMidstate Medical Centerhttp://www.midstatemedical.org/cancer_breast_risk.aspxBreast Cancer Res Treat (2015) 154:191–199 195 123",Non-OADS,/arxiv_data1/oa_pdf/c1/f3/10549_2015_Article_3601.PMC4621697.pdf
"We recommend developers ofhealth information materials use common wording (i.e., doctor instead of physician), words with fewer syllables and shorter sentences.Table 1 continued Raleigh Radiology https://www.raleighrad.com/expertise/womens-imaging/breast-risk-calculator/Cancer.nethttp://www.cancer.net/cancer-types/breast-cancer/risk-factorsBreast Cancer Surveillance Consortiumhttps://tools.bcsc-scc.org/BC5yearRisk/intro.htmHalls MDhttp://www.halls.md/breast/risk.htmSan Luis Diagnostic Centerhttp://sldcinfo.com/PR/HighRiskCalc.htmMemorial Care Health Systemhttp://www.memorialcare.org/services/breast-care/breast-cancer-risk-assessmentMedicineNethttp://www.medicinenet.com/estimating_breast_cancer_risk/article.htmSusan G. Komen http://ww5.komen.org/BreastCancer/GailAssessmentModel.html Adequate rating HealthyInfo.com http://www.healthyinfo.com/clinical/breastcancerrisk/eHowhttp://www.ehow.com/how_5944004_calculate-gail-score.htmlComprehensive Breast Care Surgeonshttp://www.comprehensivebreastcare.com/resources/risk-reduction/ Not suitable rating MedCalc3000 http://medcalc3000.com/Gail99.htmRoswell Park Cancer Institutehttps://www.roswellpark.org/cancer/breast/prevention-detection/risk-assessment-formArticlesBasehttp://www.articlesbase.com/womens-health-articles/how-to-calculate-your-risk-for-breast-cancer-795965.htmlDr.",Non-OADS,/arxiv_data1/oa_pdf/c1/f3/10549_2015_Article_3601.PMC4621697.pdf
Susan Love Research Foundationhttp://www.dslrf.org/breastcancer/content.asp?L2=2&L3=1&SID=139aboutcancer.com http://www.aboutcancer.com/breast_risk_calculation.htm Emory Healthcarehttp://www.emoryhealthcare.org/breast-health/treatment-services/high-risk-breast-cancer-clinic.html196 Breast Cancer Res Treat (2015) 154:191–199 123,Non-OADS,/arxiv_data1/oa_pdf/c1/f3/10549_2015_Article_3601.PMC4621697.pdf
"Ac- quisition, analysis, or interpretation of data : Cortez, Milbrandt,Table 4 Areas of suggested improvement for all sites SAM factor Description Example Summary Retell the key messages at the conclusion ‘‘Based on the information provided (see below), the woman’s estimated risk for developing invasive breast cancer over the next5 years is 4.6 % compared to a risk of 1.8 % for a woman of the same age and race/ethnicity from the general U.S. population ’’ National Cancer Institutehttp://www.cancer.gov/bcrisktool/ Reading grade 5th grade level or lowerVocabulary Common words Technical words are explained with examples Imagery words are used‘‘If you ﬁnd new changes like this that stay around, show your doctor’’ Worldwide Breast Cancerhttp://www.worldwidebreastcancer.com/ Cover graphic Friendly Attracts attentionPortrays purposeFollow the link below for an example of a superior cover graphic Midstate Medical Centerhttp://www.midstatemedical.org/cancer_breast_risk.aspx Relevance of illustrationsIllustrations present key messages visually Follow the link below for an example of a superior illustrations: Worldwide Breast Cancerhttp://www.worldwidebreastcancer.com/ Interaction Problems or questions were provided for reader responses‘‘You have 3things you can do to lower your risk.",Non-OADS,/arxiv_data1/oa_pdf/c1/f3/10549_2015_Article_3601.PMC4621697.pdf
"To see what your risk could be, click on a box and watch your risk drop’’ Your Disease Riskhttp://yourdiseaserisk.wustl.edu/YDRDefault.aspx?ScreenControl= YDRGeneral&ScreenName=YDRbreast The above are categories that fewer than 50 % of overall superior SAM-rated sites featured198 Breast Cancer Res Treat (2015) 154:191–199 123",Non-OADS,/arxiv_data1/oa_pdf/c1/f3/10549_2015_Article_3601.PMC4621697.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per-mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/c1/f3/10549_2015_Article_3601.PMC4621697.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per-mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, andindicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/0a/4e/10620_2015_Article_3726.PMC4621698.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the originalauthor(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/64/97/10620_2015_Article_3759.PMC4621700.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense (http://creativecommons.org/licenses/by-nc/4.0/), which per-mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, andindicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/41/ec/10620_2015_Article_3733.PMC4621704.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in anymedium, provided you give appropriate credit to the originalauthor(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.References 1.",Non-OADS,/arxiv_data1/oa_pdf/4e/82/40261_2015_Article_333.PMC4621710.pdf
http://globocan.iarc.fr .,Non-OADS,/arxiv_data1/oa_pdf/4e/82/40261_2015_Article_333.PMC4621710.pdf
http://evs.nci.nih.gov/ftp1/CTCAE/ About.html .,OADS,/arxiv_data1/oa_pdf/4e/82/40261_2015_Article_333.PMC4621710.pdf
"Open Access This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 InternationalLicense (http://creativecommons.org/licenses/by-nc/4.0/), which per- mits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s)and the source, provide a link to the Creative Commons license, and indicate if changes were made.",Non-OADS,/arxiv_data1/oa_pdf/26/d1/40262_2015_Article_290.PMC4621714.pdf
Updated Dec 2013.Available at: http://packageinserts.bms.com/pi/pi_plavix.pdf .,Non-OADS,/arxiv_data1/oa_pdf/26/d1/40262_2015_Article_290.PMC4621714.pdf
Available at: https://www.medicines.org.uk/emc/medicine/30245 .,Non-OADS,/arxiv_data1/oa_pdf/26/d1/40262_2015_Article_290.PMC4621714.pdf
Available from: http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/9c/e6/SaudiMedJ-36-1149.PMC4621717.pdf
Available from: https://www.shef.ac.uk/FRAX/index.aspx   4.,Non-OADS,/arxiv_data1/oa_pdf/9c/e6/SaudiMedJ-36-1149.PMC4621717.pdf
Available  from: http://www.capture-the-fracture.org/ fracture-liaison-services   1150 Saudi Med J 2015; Vol.,Non-OADS,/arxiv_data1/oa_pdf/9c/e6/SaudiMedJ-36-1149.PMC4621717.pdf
"“Anesthesia, cerebral, oximetry, mannitol,  laparoscope, cholecystectomy” as keywords was entered  into Google® search engine ( http://www.google.com/ )  to identify related information in the public domain.",OADS,/arxiv_data1/oa_pdf/95/cd/SaudiMedJ-36-1199.PMC4621726.pdf
[Updated 2015 January] Available from: http://www.who.int/ mediacentre/factsheets/fs312/en   16.,Non-OADS,/arxiv_data1/oa_pdf/06/9c/SaudiMedJ-36-1210.PMC4621728.pdf
Available from: http://diabetes.darmanyab.,Non-OADS,/arxiv_data1/oa_pdf/06/9c/SaudiMedJ-36-1210.PMC4621728.pdf
Available from: http://www.alpencapital.com/ downloads/GCC_Healthcare_Sector_22_April_2014_Final.,Non-OADS,/arxiv_data1/oa_pdf/de/9d/SaudiMedJ-36-1216.PMC4621729.pdf
Available  from: http://www.colliers.com/-/media/961B1B350CF146FE 910AFDBECDCC605A.ashx   6.,Non-OADS,/arxiv_data1/oa_pdf/de/9d/SaudiMedJ-36-1216.PMC4621729.pdf
Available from: http://www.who.,Non-OADS,/arxiv_data1/oa_pdf/de/9d/SaudiMedJ-36-1216.PMC4621729.pdf
Available from: http://www.who.int/ whosis/whostat/EN_WHS09_ Table6.pdf   8.,OADS,/arxiv_data1/oa_pdf/de/9d/SaudiMedJ-36-1216.PMC4621729.pdf
Available from:  http://www.idf.org/sites/default/files/EN_6E_Atlas_Full_0.pdf 13.,Non-OADS,/arxiv_data1/oa_pdf/de/9d/SaudiMedJ-36-1216.PMC4621729.pdf
"Available from: http://www.med-ed-online.org  Research methods concepts....  Al-Zahrani & Aba Al-Khail Related Articles Abu-Dawas RB, Mallick MA, Hamadah RE, Kharraz RH, Chamseddin RA, Khan TA,   et al.",Non-OADS,/arxiv_data1/oa_pdf/66/59/SaudiMedJ-36-1236.PMC4621733.pdf
This article is distributed under the terms of an Attribution–Non- commercial–Share Alike–No Mirror Sites license for the first six months after the publication  date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/95/bc/JGP_201511444.PMC4621747.pdf
"After six months it is available under a Creative  Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as de- scribed at http://creativecommons.org/licenses/by-nc-sa/3.0/).The Journal of General Physiology",Non-OADS,/arxiv_data1/oa_pdf/95/bc/JGP_201511444.PMC4621747.pdf
"http://dx.doi.org/10.1016/ S0306-4522(01)00476-6 Balijepalli, S.Y., C.L.",OADS,/arxiv_data1/oa_pdf/95/bc/JGP_201511444.PMC4621747.pdf
"http://dx.doi .org/10.1097/FJC.0b013e3181dab014 Bell, C.J., D.L.",OADS,/arxiv_data1/oa_pdf/95/bc/JGP_201511444.PMC4621747.pdf
"http://dx.doi .org/10.1126/scitranslmed.3001756 Berg, A.T., S.F.",Non-OADS,/arxiv_data1/oa_pdf/95/bc/JGP_201511444.PMC4621747.pdf
"http://dx.doi.org/10.1111/j.1528-1167.2010.02522.x Cai, Z.W., J. Liu, H.Y.",OADS,/arxiv_data1/oa_pdf/95/bc/JGP_201511444.PMC4621747.pdf
"http://dx.doi.org/10.1038/ aps.2011.71 Cavaretta, J.P., K.R.",Non-OADS,/arxiv_data1/oa_pdf/95/bc/JGP_201511444.PMC4621747.pdf
"http://dx.doi .org/10.1371/journal.pone.0103655 Covanis, A.",Non-OADS,/arxiv_data1/oa_pdf/95/bc/JGP_201511444.PMC4621747.pdf
"http://dx.doi.org/10.1016/S0920- 1211(03)00037-8 Devaux, J.J., K.A.",OADS,/arxiv_data1/oa_pdf/95/bc/JGP_201511444.PMC4621747.pdf
"http://dx.doi.org/10.1111/j.1469-7793.2000.t01-2-00019.xm Dyment, D.A., M. Tétreault, C.L.",OADS,/arxiv_data1/oa_pdf/95/bc/JGP_201511444.PMC4621747.pdf
http://dx.doi.org/10.1111/cge.12464 EuroEPINOMICS-RES.,Non-OADS,/arxiv_data1/oa_pdf/95/bc/JGP_201511444.PMC4621747.pdf
"http://dx.doi.org/10.1016/j.ajhg .2014.08.013 Fox, P.D., R.J. Loftus, and M.M.",OADS,/arxiv_data1/oa_pdf/95/bc/JGP_201511444.PMC4621747.pdf
"http://dx.doi.org/10.1523/JNEUROSCI.3008-12.2013 Fox, P.D., C.J.",Non-OADS,/arxiv_data1/oa_pdf/95/bc/JGP_201511444.PMC4621747.pdf
"http://dx.doi.org/10.1242/jcs.166009 Gagnier, J.J., G. Kienle, D.G.",Non-OADS,/arxiv_data1/oa_pdf/95/bc/JGP_201511444.PMC4621747.pdf
"http://dx.doi.org/10.7453/gahmj.2013.008neuronal subpopulations (Mandikian et al., 2014).",OADS,/arxiv_data1/oa_pdf/95/bc/JGP_201511444.PMC4621747.pdf
"http://dx.doi.org/10.1016/ 0896-6273(95)90022-5 Adzhubei, I.A., S. Schmidt, L. Peshkin, V.E.",OADS,/arxiv_data1/oa_pdf/95/bc/JGP_201511444.PMC4621747.pdf
http://dx.doi.org/10.1038/nmeth0410-248,Non-OADS,/arxiv_data1/oa_pdf/95/bc/JGP_201511444.PMC4621747.pdf
"522:3555– 3574. http://dx.doi.org/10.1002/cne.23641 Manganas, L.N., and J.S.",OADS,/arxiv_data1/oa_pdf/95/bc/JGP_201511444.PMC4621747.pdf
"http://dx.doi.org/10.1074/jbc.M005010200 Manganas, L.N., S. Akhtar, D.E.",OADS,/arxiv_data1/oa_pdf/95/bc/JGP_201511444.PMC4621747.pdf
"http://dx.doi.org/10.1074/jbc.M109325200 Manganas, L.N., Q. Wang, R.H. Scannevin, D.E.",OADS,/arxiv_data1/oa_pdf/95/bc/JGP_201511444.PMC4621747.pdf
"http://dx.doi.org/10.1073/ pnas.241403898 Milescu, M., F. Bosmans, S. Lee, A.A. Alabi, J.I.",OADS,/arxiv_data1/oa_pdf/95/bc/JGP_201511444.PMC4621747.pdf
"http://dx.doi.org/10.1038/nsmb.1679 Misonou, H., D.P.",Non-OADS,/arxiv_data1/oa_pdf/95/bc/JGP_201511444.PMC4621747.pdf
"http://dx.doi.org/10.1038/ nn1260 Misonou, H., S.M.",Non-OADS,/arxiv_data1/oa_pdf/95/bc/JGP_201511444.PMC4621747.pdf
"28:8529– 8538. http://dx.doi.org/10.1523/JNEUROSCI.1417-08.2008 Mohapatra, D.P., and J.S.",OADS,/arxiv_data1/oa_pdf/95/bc/JGP_201511444.PMC4621747.pdf
"http://dx.doi .org/10.1523/JNEUROSCI.4620-05.2006 Murakoshi, H., and J.S.",OADS,/arxiv_data1/oa_pdf/95/bc/JGP_201511444.PMC4621747.pdf
"http://dx.doi.org/10.1038/nrneurol.2012.12 O’Connell, K.M., R. Loftus, and M.M.",OADS,/arxiv_data1/oa_pdf/95/bc/JGP_201511444.PMC4621747.pdf
"http://dx.doi.org/10.1073/ pnas.1003028107 Parcej, D.N., and J.O.",OADS,/arxiv_data1/oa_pdf/95/bc/JGP_201511444.PMC4621747.pdf
"http://dx.doi .org/10.1074/jbc.M109.071266 Richards, C.S., S. Bale, D.B.",Non-OADS,/arxiv_data1/oa_pdf/95/bc/JGP_201511444.PMC4621747.pdf
"http://dx.doi .org/10.1097/GIM.0b013e31816b5cae Ridgway, N.D., P.A.",Non-OADS,/arxiv_data1/oa_pdf/95/bc/JGP_201511444.PMC4621747.pdf
"116:307– 319. http://dx.doi.org/10.1083/jcb.116.2.307Guan, D., T. Tkatch, D.J.",Non-OADS,/arxiv_data1/oa_pdf/95/bc/JGP_201511444.PMC4621747.pdf
"581:941– 960. http://dx.doi.org/10.1113/jphysiol.2007.128454 Gupta, K., M. Zamanian, C. Bae, M. Milescu, D. Krepkiy, D.C. Tilley,  J.T.",OADS,/arxiv_data1/oa_pdf/95/bc/JGP_201511444.PMC4621747.pdf
"http://dx.doi.org/10.7554/eLife.06774 Heginbotham, L., Z. Lu, T. Abramson, and R. MacKinnon.",Non-OADS,/arxiv_data1/oa_pdf/95/bc/JGP_201511444.PMC4621747.pdf
"66:1061– 1067. http://dx.doi.org/10.1016/S0006-3495(94)80887-2 Herrington, J., Y.P.",OADS,/arxiv_data1/oa_pdf/95/bc/JGP_201511444.PMC4621747.pdf
"http://dx.doi.org/10.2337/diabetes.55 .04.06.db05-0788 Hsu, V.W., N. Shah, and R.D.",Non-OADS,/arxiv_data1/oa_pdf/95/bc/JGP_201511444.PMC4621747.pdf
"http://dx.doi.org/10.1016/ 0092-8674(92)90226-3 Ikeda, S.R., F. Soler, R.D.",OADS,/arxiv_data1/oa_pdf/95/bc/JGP_201511444.PMC4621747.pdf
"http://dx.doi.org/10.1007/ BF00370422 King, A.N., C.F.",Non-OADS,/arxiv_data1/oa_pdf/95/bc/JGP_201511444.PMC4621747.pdf
"http://dx.doi .org/10.1002/cne.23551 Kullmann, D.M.",OADS,/arxiv_data1/oa_pdf/95/bc/JGP_201511444.PMC4621747.pdf
"http://dx.doi.org/10.1093/brain/awf130 Kumar, P., S. Henikoff, and P.C.",OADS,/arxiv_data1/oa_pdf/95/bc/JGP_201511444.PMC4621747.pdf
"http://dx.doi.org/ 10.1038/nprot.2009.86 Lalik, P.H., D.S.",OADS,/arxiv_data1/oa_pdf/95/bc/JGP_201511444.PMC4621747.pdf
"http://dx.doi.org/10.1016/j.phrs.2014.01.005 Li, X.N., J. Herrington, A. Petrov, L. Ge, G. Eiermann, Y. Xiong,  M.V.",OADS,/arxiv_data1/oa_pdf/95/bc/JGP_201511444.PMC4621747.pdf
"http://dx.doi.org/10.1523/JNEUROSCI.1925-13.2014 MacKinnon, R. 1991.",Non-OADS,/arxiv_data1/oa_pdf/95/bc/JGP_201511444.PMC4621747.pdf
"http://dx.doi.org/10.1038/350232a0 Malin, S.A., and J.M.",OADS,/arxiv_data1/oa_pdf/95/bc/JGP_201511444.PMC4621747.pdf
http://dx.doi.org/10.1016/B978-0-444-63326-2.00002-8,OADS,/arxiv_data1/oa_pdf/95/bc/JGP_201511444.PMC4621747.pdf
"http://dx.doi.org/10.1038/345535a0 Sack, J.T., R.W.",Non-OADS,/arxiv_data1/oa_pdf/95/bc/JGP_201511444.PMC4621747.pdf
"http://dx.doi.org/ 10.1085/jgp.200409047 Sack, J.T., O. Shamotienko, and J.O.",OADS,/arxiv_data1/oa_pdf/95/bc/JGP_201511444.PMC4621747.pdf
"http://dx.doi.org/10.1085/jgp.200709939 Sarmiere, P.D., C.M.",OADS,/arxiv_data1/oa_pdf/95/bc/JGP_201511444.PMC4621747.pdf
"9:112.  http://dx.doi.org/10.1186/1471-2202-9-112 Saunders, C.J., N.A.",Non-OADS,/arxiv_data1/oa_pdf/95/bc/JGP_201511444.PMC4621747.pdf
"http://dx.doi.org/10.1126/scitranslmed.3004041 Scannevin, R.H., H. Murakoshi, K.J.",OADS,/arxiv_data1/oa_pdf/95/bc/JGP_201511444.PMC4621747.pdf
"http://dx.doi.org/10.1083/ jcb.135.6.1619 Shi, G., A.K.",Non-OADS,/arxiv_data1/oa_pdf/95/bc/JGP_201511444.PMC4621747.pdf
"http://dx.doi.org/10.1111/gbb.12120 Srivastava, S., J.S.",Non-OADS,/arxiv_data1/oa_pdf/95/bc/JGP_201511444.PMC4621747.pdf
"http://dx.doi.org/10.1002/ana.24251 Tanaka, M., and W. Herr.",OADS,/arxiv_data1/oa_pdf/95/bc/JGP_201511444.PMC4621747.pdf
"http://dx.doi .org/10.1016/0092-8674(90)90589-7 Tilley, D.C., K.S.",OADS,/arxiv_data1/oa_pdf/95/bc/JGP_201511444.PMC4621747.pdf
"http://dx.doi.org/10.1002/ana.24263 Trimmer, J.S.",OADS,/arxiv_data1/oa_pdf/95/bc/JGP_201511444.PMC4621747.pdf
"http://dx.doi .org/10.1016/j.neuron.2014.12.042 Vacher, H., D.P.",OADS,/arxiv_data1/oa_pdf/95/bc/JGP_201511444.PMC4621747.pdf
"http://dx.doi.org/ 10.1096/fj.06-7229com Weckhuysen, S., S. Mandelstam, A. Suls, D. Audenaert, T. Deconinck,  L.R.",OADS,/arxiv_data1/oa_pdf/95/bc/JGP_201511444.PMC4621747.pdf
"http://dx.doi.org/10.1212/ 01.wnl.0000435296.72400.a1 Wimmer, V.C., C.A.",OADS,/arxiv_data1/oa_pdf/95/bc/JGP_201511444.PMC4621747.pdf
"588:1829– 1840. http://dx.doi.org/10.1113/jphysiol.2010.188417 Zhang, Z.H., Y.T.",Non-OADS,/arxiv_data1/oa_pdf/95/bc/JGP_201511444.PMC4621747.pdf
"http://dx.doi.org/10.1016/S0169-328X(03)00175-X Zhou, Y., J.H.",OADS,/arxiv_data1/oa_pdf/95/bc/JGP_201511444.PMC4621747.pdf
http://dx.doi.org/10.1038/35102009,Non-OADS,/arxiv_data1/oa_pdf/95/bc/JGP_201511444.PMC4621747.pdf
This article is distributed under the terms of an Attribution–Non- commercial–Share Alike–No Mirror Sites license for the first six months after the publication  date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/2e/8f/JGP_201511475.PMC4621748.pdf
"After six months it is available under a Creative  Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as de- scribed at http://creativecommons.org/licenses/by-nc-sa/3.0/).The Journal of General Physiology",Non-OADS,/arxiv_data1/oa_pdf/2e/8f/JGP_201511475.PMC4621748.pdf
"http://dx.doi.org/10.1016/j.ab.2006.06.004 Beblo, D.A., H.Z.",OADS,/arxiv_data1/oa_pdf/2e/8f/JGP_201511475.PMC4621748.pdf
"http://dx.doi.org/10.1161/01.RES.77.4.813 Bedner, P., H. Niessen, B. Odermatt, M. Kretz, K. Willecke, and  H. Harz.",OADS,/arxiv_data1/oa_pdf/2e/8f/JGP_201511475.PMC4621748.pdf
"281:6673– 6681. http://dx.doi.org/10.1074/jbc.M511235200 Beltramello, M., V. Piazza, F.F.",Non-OADS,/arxiv_data1/oa_pdf/2e/8f/JGP_201511475.PMC4621748.pdf
"http://dx.doi.org/10.1038/ncb1205 Bevans, C.G., M. Kordel, S.K.",Non-OADS,/arxiv_data1/oa_pdf/2e/8f/JGP_201511475.PMC4621748.pdf
"http://dx.doi.org/10.1074/jbc.273.5.2808 Bukauskas, F.F., C. Kempf, and R. Weingart.",OADS,/arxiv_data1/oa_pdf/2e/8f/JGP_201511475.PMC4621748.pdf
"http://dx.doi.org/10.1113/expphysiol .1992.sp003657 Bukauskas, F.F., C. Elfgang, K. Willecke, and R. Weingart.",OADS,/arxiv_data1/oa_pdf/2e/8f/JGP_201511475.PMC4621748.pdf
"http://dx.doi.org/10.1016/S0006- 3495(95)80411-X Cabo, C., J. Yao, P.A.",OADS,/arxiv_data1/oa_pdf/2e/8f/JGP_201511475.PMC4621748.pdf
"http://dx.doi.org/10.1016/j.cardiores.2006.07.005 Christophersen, I.E., H.N.",OADS,/arxiv_data1/oa_pdf/2e/8f/JGP_201511475.PMC4621748.pdf
"http://dx.doi.org/10.1016/ j.cjca.2012.08.002 Davis, L.M., M.E.",OADS,/arxiv_data1/oa_pdf/2e/8f/JGP_201511475.PMC4621748.pdf
"http://dx.doi.org/10.1007/ PL00008086 Gollob, M.H., D.L.",OADS,/arxiv_data1/oa_pdf/2e/8f/JGP_201511475.PMC4621748.pdf
"http://dx.doi.org/10.1056/NEJMoa052800 Gros, D., T. Jarry-Guichard, I.",OADS,/arxiv_data1/oa_pdf/2e/8f/JGP_201511475.PMC4621748.pdf
"http://dx.doi .org/10.1161/01.RES.74.5.839 Hall, J.E., and R.G.",OADS,/arxiv_data1/oa_pdf/2e/8f/JGP_201511475.PMC4621748.pdf
"http://dx.doi.org/10.1002/jemt.1070310513 Hernandez, V.H., M. Bortolozzi, V. Pertegato, M. Beltramello, M.  Giarin, M. Zaccolo, S. Pantano, and F. Mammano.",Non-OADS,/arxiv_data1/oa_pdf/2e/8f/JGP_201511475.PMC4621748.pdf
"http://dx.doi.org/10.1016/j.yjmcc.2009.08.018 Kamp, T.J., and J.W.",OADS,/arxiv_data1/oa_pdf/2e/8f/JGP_201511475.PMC4621748.pdf
"http://dx.doi.org/10.1161/01.RES.87.12.1095 Kanaporis, G., G. Mese, L. Valiuniene, T.W.",Non-OADS,/arxiv_data1/oa_pdf/2e/8f/JGP_201511475.PMC4621748.pdf
"http://dx.doi.org/10.1085/jgp.200709934 Kanaporis, G., P.R.",OADS,/arxiv_data1/oa_pdf/2e/8f/JGP_201511475.PMC4621748.pdf
"http://dx.doi.org/10.1152/ajpcell.00316.2010 Kanter, H.L., J.G.",OADS,/arxiv_data1/oa_pdf/2e/8f/JGP_201511475.PMC4621748.pdf
"http://dx.doi.org/10.1161/ 01.RES.73.2.344 Kostin, S., G. Klein, Z. Szalay, S. Hein, E.P.",Non-OADS,/arxiv_data1/oa_pdf/2e/8f/JGP_201511475.PMC4621748.pdf
"http://dx.doi.org/10.1016/ S0008-6363(02)00273-0 Lepecq, J.-B., and C. Paoletti.",OADS,/arxiv_data1/oa_pdf/2e/8f/JGP_201511475.PMC4621748.pdf
"http://dx.doi.org/10.1016/ 0022-2836(67)90353-1 Lübkemeier, I., R. Andrié, L. Lickfett, F. Bosen, F. Stöckigt, R.  Dobrowolski, A.M. Draffehn, J. Fregeac, J.L.",OADS,/arxiv_data1/oa_pdf/2e/8f/JGP_201511475.PMC4621748.pdf
"http://dx.doi.org/10.1016/j.yjmcc.2013.09.008Meşe, G., V. Valiunas, P.R.",OADS,/arxiv_data1/oa_pdf/2e/8f/JGP_201511475.PMC4621748.pdf
"http://dx.doi.org/10.1152/ajpcell.00008.2008 Molina, C.E., J. Leroy, W. Richter, M. Xie, C. Scheitrum, I.O.",OADS,/arxiv_data1/oa_pdf/2e/8f/JGP_201511475.PMC4621748.pdf
"http://dx.doi.org/10.1016/j.jacc.2012.01.060 Patel, D., J. Gemel, Q. Xu, A.R.",OADS,/arxiv_data1/oa_pdf/2e/8f/JGP_201511475.PMC4621748.pdf
"http://dx.doi.org/10.1016/j.febslet.2014 .01.010 Peters, N.S., J. Coromilas, N.J. Severs, and A.L.",OADS,/arxiv_data1/oa_pdf/2e/8f/JGP_201511475.PMC4621748.pdf
"http://dx.doi.org/10.1161/01.CIR.95.4.988 Podzuweit, T., G.C.",OADS,/arxiv_data1/oa_pdf/2e/8f/JGP_201511475.PMC4621748.pdf
"http://dx.doi.org/10.1016/j.jacc.2005.08.059 Saffitz, J.E.",OADS,/arxiv_data1/oa_pdf/2e/8f/JGP_201511475.PMC4621748.pdf
"http://dx.doi.org/10.1056/NEJMe068088 Spach, M.S., and M.E.",OADS,/arxiv_data1/oa_pdf/2e/8f/JGP_201511475.PMC4621748.pdf
"http://dx.doi.org/10.1111/j.1540-8167.1994.tb01157.x Valiunas, V., R. Vogel, and R. Weingart.",OADS,/arxiv_data1/oa_pdf/2e/8f/JGP_201511475.PMC4621748.pdf
"http://dx.doi.org/10 .1007/s004240000376 Valiunas, V., J. Gemel, P.R.",OADS,/arxiv_data1/oa_pdf/2e/8f/JGP_201511475.PMC4621748.pdf
"http://dx.doi.org/10.1161/01.RES.0000025638.24255.AA Vozzi, C., E. Dupont, S.R.",OADS,/arxiv_data1/oa_pdf/2e/8f/JGP_201511475.PMC4621748.pdf
"http://dx.doi.org/ 10.1006/jmcc.1999.0937 Welsh, M.J., and A.E.",OADS,/arxiv_data1/oa_pdf/2e/8f/JGP_201511475.PMC4621748.pdf
"73:1251– 1254. http://dx.doi.org/10.1016/0092-8674(93)90353-R Wit, A.L., and N.S.",OADS,/arxiv_data1/oa_pdf/2e/8f/JGP_201511475.PMC4621748.pdf
"http://dx.doi.org/10.1016/j.hrthm.2011.09.056 Zonta, F., G. Polles, G. Zanotti, and F. Mammano.",OADS,/arxiv_data1/oa_pdf/2e/8f/JGP_201511475.PMC4621748.pdf
29:985– 998. http://dx.doi.org/10.1080/073911012010525027,Non-OADS,/arxiv_data1/oa_pdf/2e/8f/JGP_201511475.PMC4621748.pdf
© 2015 Liu and Qin  This article is distributed under the terms of an Attribution–  Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publi- cation date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/02/c7/JGP_201511454.PMC4621749.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).The Journal of General Physiology",Non-OADS,/arxiv_data1/oa_pdf/02/c7/JGP_201511454.PMC4621749.pdf
"http://dx.doi.org/10.1016/j.neuron .2007.02.024 Gau, P., J. Poon, C. Ufret-Vincenty, C.D.",OADS,/arxiv_data1/oa_pdf/02/c7/JGP_201511454.PMC4621749.pdf
"http://dx.doi.org/10.1523/JNEUROSCI.5403-12.2013 Gracheva, E.O., N.T.",OADS,/arxiv_data1/oa_pdf/02/c7/JGP_201511454.PMC4621749.pdf
"http://dx.doi.org/10.1038/nature08943 Hu, H., J. Grandl, M. Bandell, M. Petrus, and A. Patapoutian.",Non-OADS,/arxiv_data1/oa_pdf/02/c7/JGP_201511454.PMC4621749.pdf
"http://dx.doi.org/10.1016/j.bpj.2013.03.055 Kindt, K.S., V. Viswanath, L. Macpherson, K. Quast, H. Hu, A.  Patapoutian, and W.R. Schafer.",OADS,/arxiv_data1/oa_pdf/02/c7/JGP_201511454.PMC4621749.pdf
"http://dx.doi.org/10.1085/jgp.201110689 Majhi, R.K., A. Kumar, M. Yadav, N. Swain, S. Kumari, A. Saha,  A. Pradhan, L. Goswami, S. Saha, L. Samanta, et al.",Non-OADS,/arxiv_data1/oa_pdf/02/c7/JGP_201511454.PMC4621749.pdf
"http://dx.doi .org/10.4161/chan.25793 McKemy, D.D., W.M.",Non-OADS,/arxiv_data1/oa_pdf/02/c7/JGP_201511454.PMC4621749.pdf
"http://dx.doi.org/10.1038/ nature719 Moqrich, A., S.W.",OADS,/arxiv_data1/oa_pdf/02/c7/JGP_201511454.PMC4621749.pdf
"http://dx.doi .org/10.1126/science.1108609 Ohkita, M., S. Saito, T. Imagawa, K. Takahashi, M. Tominaga, and T.  Ohta.",OADS,/arxiv_data1/oa_pdf/02/c7/JGP_201511454.PMC4621749.pdf
"http://dx.doi .org/10.1074/jbc.M111.305698 Peier, A.M., A. Moqrich, A.C. Hergarden, A.J.",Non-OADS,/arxiv_data1/oa_pdf/02/c7/JGP_201511454.PMC4621749.pdf
"http://dx.doi.org/10.1016/ S0092-8674(02)00652-9 Peier, A.M., A.J.",OADS,/arxiv_data1/oa_pdf/02/c7/JGP_201511454.PMC4621749.pdf
"http://dx.doi.org/10.1126/science.1073140 Prober, D.A., S. Zimmerman, B.R.",OADS,/arxiv_data1/oa_pdf/02/c7/JGP_201511454.PMC4621749.pdf
"http://dx.doi .org/10.1523/JNEUROSCI.2740-08.2008 Qin, F. 2013.",Non-OADS,/arxiv_data1/oa_pdf/02/c7/JGP_201511454.PMC4621749.pdf
"104:2118– 2120. http://dx.doi.org/10.1016/j.bpj.2013.04.017such variability, this endogenous cold sensitivity could  be manifested in different ways.",Non-OADS,/arxiv_data1/oa_pdf/02/c7/JGP_201511454.PMC4621749.pdf
"http://dx.doi.org/10.1038/nature05910 Caterina, M.J., M.A.",OADS,/arxiv_data1/oa_pdf/02/c7/JGP_201511454.PMC4621749.pdf
"http://dx.doi.org/10.1038/39807 Caterina, M.J., T.A.",Non-OADS,/arxiv_data1/oa_pdf/02/c7/JGP_201511454.PMC4621749.pdf
"http://dx.doi.org/ 10.1038/18906 Caterina, M.J., A. Leffler, A.B.",Non-OADS,/arxiv_data1/oa_pdf/02/c7/JGP_201511454.PMC4621749.pdf
"http://dx.doi .org/10.1126/science.288.5464.306 Chowdhury, S., B.W.",Non-OADS,/arxiv_data1/oa_pdf/02/c7/JGP_201511454.PMC4621749.pdf
"http://dx.doi.org/10.1016/j.cell.2014.07.026 Clapham, D.E., and C. Miller.",OADS,/arxiv_data1/oa_pdf/02/c7/JGP_201511454.PMC4621749.pdf
"http://dx.doi.org/ 10.1371/journal.pgen.1002041 Smith, G.D., M.J. Gunthorpe, R.E.",Non-OADS,/arxiv_data1/oa_pdf/02/c7/JGP_201511454.PMC4621749.pdf
"http://dx.doi.org/10.1038/nature00894 Spray, D.C. 1986.",Non-OADS,/arxiv_data1/oa_pdf/02/c7/JGP_201511454.PMC4621749.pdf
"http://dx.doi.org/10.1146/annurev.ph.48.030186  .003205 Viswanath, V., G.M.",Non-OADS,/arxiv_data1/oa_pdf/02/c7/JGP_201511454.PMC4621749.pdf
"http://dx.doi.org/ 10.1038/423822aWatanabe, H., J. Vriens, S.H.",OADS,/arxiv_data1/oa_pdf/02/c7/JGP_201511454.PMC4621749.pdf
"http://dx.doi .org/10.1074/jbc.M208277200 Xu, H., I.S.",OADS,/arxiv_data1/oa_pdf/02/c7/JGP_201511454.PMC4621749.pdf
"http://dx.doi.org/10.1038/nature00882 Xu, H., M. Delling, J.C. Jun, and D.E.",OADS,/arxiv_data1/oa_pdf/02/c7/JGP_201511454.PMC4621749.pdf
"http://dx.doi .org/10.1038/nn1692 Yao, J., B. Liu, and F. Qin.",OADS,/arxiv_data1/oa_pdf/02/c7/JGP_201511454.PMC4621749.pdf
http://dx.doi.org/10.1016/j.bpj.2009.02.016,OADS,/arxiv_data1/oa_pdf/02/c7/JGP_201511454.PMC4621749.pdf
This article is distributed under the terms of an Attribution–Noncom - mercial–Share Alike–No Mirror Sites license for the first six months after the publication  date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/7e/59/JGP_201511503.PMC4621750.pdf
"After six months it is available under a Creative  Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as de- scribed at http://creativecommons.org/licenses/by-nc-sa/3.0/).The Journal of General Physiology",Non-OADS,/arxiv_data1/oa_pdf/7e/59/JGP_201511503.PMC4621750.pdf
"http://dx.doi.org/10 .1085/jgp.200709859 Jackson, M.B.",OADS,/arxiv_data1/oa_pdf/7e/59/JGP_201511503.PMC4621750.pdf
"http://dx.doi.org/10.1016/ S0006-3495(86)83693-1 Jadey, S., and A. Auerbach.",OADS,/arxiv_data1/oa_pdf/7e/59/JGP_201511503.PMC4621750.pdf
"http://dx.doi.org/10.1085/jgp.201210801 Jadey, S.V., P. Purohit, I. Bruhova, T.M.",OADS,/arxiv_data1/oa_pdf/7e/59/JGP_201511503.PMC4621750.pdf
"http://dx.doi.org/10 .1113/jphysiol.2005.099093 Magleby, K.L.",OADS,/arxiv_data1/oa_pdf/7e/59/JGP_201511503.PMC4621750.pdf
"http://dx.doi.org/10.1016/j.tins.2004.03.001 McManus, O.B., and K.L.",OADS,/arxiv_data1/oa_pdf/7e/59/JGP_201511503.PMC4621750.pdf
"http://dx.doi .org/10.1113/jphysiol.1988.sp017195 Naranjo, D., and P. Brehm.",OADS,/arxiv_data1/oa_pdf/7e/59/JGP_201511503.PMC4621750.pdf
"http://dx.doi.org/10.1126/science.8511590 Nayak, T.K., P.G.",OADS,/arxiv_data1/oa_pdf/7e/59/JGP_201511503.PMC4621750.pdf
"http://dx.doi.org/ 10.1085/jgp.201110752 Nayak, T.K., I. Bruhova, S. Chakraborty, S. Gupta, W. Zheng, and  A. Auerbach.",OADS,/arxiv_data1/oa_pdf/7e/59/JGP_201511503.PMC4621750.pdf
"http://dx.doi.org/ 10.1142/S1793048013300053 Nilius, B.",Non-OADS,/arxiv_data1/oa_pdf/7e/59/JGP_201511503.PMC4621750.pdf
"http://dx.doi.org/10.1016/j.bpj.2010.06.058 Popescu, G., and A. Auerbach.",OADS,/arxiv_data1/oa_pdf/7e/59/JGP_201511503.PMC4621750.pdf
"http://dx.doi.org/10.1523/ JNEUROSCI.5613-09.2010 Purohit, P., and A. Auerbach.",OADS,/arxiv_data1/oa_pdf/7e/59/JGP_201511503.PMC4621750.pdf
http://dx.doi.org/10.1085/jgp.200910384influenced by loop C and the complementary  sheet.,OADS,/arxiv_data1/oa_pdf/7e/59/JGP_201511503.PMC4621750.pdf
"http://dx.doi.org/10.1093/protein/gzm029 Auerbach, A.",OADS,/arxiv_data1/oa_pdf/7e/59/JGP_201511503.PMC4621750.pdf
"http://dx.doi .org/10.1113/jphysiol.2011.214684 Auerbach, A., and C.J.",OADS,/arxiv_data1/oa_pdf/7e/59/JGP_201511503.PMC4621750.pdf
"http://dx.doi.org/10.1113/jphysiol.1986 .sp016211 Beene, D.L., G.S.",OADS,/arxiv_data1/oa_pdf/7e/59/JGP_201511503.PMC4621750.pdf
"http://dx.doi.org/10.1021/bi020266d Blatz, A.L., and K.L.",OADS,/arxiv_data1/oa_pdf/7e/59/JGP_201511503.PMC4621750.pdf
"http://dx.doi.org/10.1113/jphysiol.1986 .sp016212 Bruhova, I., T. Gregg, and A. Auerbach.",OADS,/arxiv_data1/oa_pdf/7e/59/JGP_201511503.PMC4621750.pdf
"http://dx.doi.org/10.1016/j.bpj .2012.11.3833 Chakrapani, S., J.F.",OADS,/arxiv_data1/oa_pdf/7e/59/JGP_201511503.PMC4621750.pdf
"http://dx.doi.org/10.1038/nsmb.1968 Elenes, S., and A. Auerbach.",OADS,/arxiv_data1/oa_pdf/7e/59/JGP_201511503.PMC4621750.pdf
"http://dx.doi.org/10.1113/jphysiol.2001.016022 Grutter, T., L. Prado de Carvalho, N. Le Novère, P.J.",OADS,/arxiv_data1/oa_pdf/7e/59/JGP_201511503.PMC4621750.pdf
"http://dx.doi.org/10.1093/emboj/cdg197 Gupta, S., P. Purohit, and A. Auerbach.",Non-OADS,/arxiv_data1/oa_pdf/7e/59/JGP_201511503.PMC4621750.pdf
http://dx.doi .org/10.1016/j.bpj.2014.11.2360,OADS,/arxiv_data1/oa_pdf/7e/59/JGP_201511503.PMC4621750.pdf
"141:467– 478. http://dx.doi.org/10.1085/jgp.201210946 Purohit, P., I. Bruhova, and A. Auerbach.",OADS,/arxiv_data1/oa_pdf/7e/59/JGP_201511503.PMC4621750.pdf
"http://dx.doi.org/ 10.1073/pnas.1203633109 Purohit, P., S. Gupta, S. Jadey, and A. Auerbach.",OADS,/arxiv_data1/oa_pdf/7e/59/JGP_201511503.PMC4621750.pdf
"http://dx.doi .org/10.1038/286071a0Smith, M.A., and M.L.",OADS,/arxiv_data1/oa_pdf/7e/59/JGP_201511503.PMC4621750.pdf
"http://dx.doi.org/10.1111/j.1469-7793.1998.733ba.x Taly, A., M. Delarue, T. Grutter, M. Nilges, N. Le Novère, P.-J.",OADS,/arxiv_data1/oa_pdf/7e/59/JGP_201511503.PMC4621750.pdf
"http://dx.doi.org/10.1529/ biophysj.104.050229 Zhang, W., J.R. Howe, and G.K. Popescu.",Non-OADS,/arxiv_data1/oa_pdf/7e/59/JGP_201511503.PMC4621750.pdf
"http://dx.doi.org/10.1038/ nn.2214 Zhong, W., J.P. Gallivan, Y. Zhang, L. Li, H.A.",Non-OADS,/arxiv_data1/oa_pdf/7e/59/JGP_201511503.PMC4621750.pdf
This article is distributed under the terms of an Attribution–Noncommer - cial–Share Alike–No Mirror Sites license for the first six months after the publication date  (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/a1/48/JGP_201511491.PMC4621751.pdf
"After six months it is available under a Creative Com - mons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described  at http://creativecommons.org/licenses/by-nc-sa/3.0/).The Journal of General Physiology",Non-OADS,/arxiv_data1/oa_pdf/a1/48/JGP_201511491.PMC4621751.pdf
"http://dx.doi .org/10.1124/mol.106.026401 Chen, J., J.S.",OADS,/arxiv_data1/oa_pdf/a1/48/JGP_201511491.PMC4621751.pdf
"http://dx.doi.org/10.1371/journal .pone.0006330 Craven, K.B., and W.N.",Non-OADS,/arxiv_data1/oa_pdf/a1/48/JGP_201511491.PMC4621751.pdf
"http://dx.doi .org/10.1146/annurev.physiol.68.040104.134728 Dai, G., C. Peng, C. Liu, and M.D.",OADS,/arxiv_data1/oa_pdf/a1/48/JGP_201511491.PMC4621751.pdf
"http://dx.doi .org/10.1085/jgp.201210944 Decher, N., J. Chen, and M.C.",OADS,/arxiv_data1/oa_pdf/a1/48/JGP_201511491.PMC4621751.pdf
"http://dx.doi.org/10 .1074/jbc.M313704200 de la Peña, P., C. Alonso-Ron, A. Machín, J. Fernández-Trillo, L.  Carretero, P. Domínguez, and F. Barros.",Non-OADS,/arxiv_data1/oa_pdf/a1/48/JGP_201511491.PMC4621751.pdf
"http://dx.doi.org/10.1074/ jbc.M111.238899 de la Peña, P., A. Machín, J. Fernández-Trillo, P. Domínguez,   and F. Barros.",Non-OADS,/arxiv_data1/oa_pdf/a1/48/JGP_201511491.PMC4621751.pdf
"http://dx.doi .org/10.1007/s00424-014-1612-1 Engeland, B., A. Neu, J. Ludwig, J. Roeper, and O. Pongs.",Non-OADS,/arxiv_data1/oa_pdf/a1/48/JGP_201511491.PMC4621751.pdf
"http://dx.doi.org/10.1111/ j.1469-7793.1998.647ba.x Flynn, G.E., and W.N.",OADS,/arxiv_data1/oa_pdf/a1/48/JGP_201511491.PMC4621751.pdf
"http://dx.doi .org/10.1074/jbc.M110.214650 Ganetzky, B., G.A.",OADS,/arxiv_data1/oa_pdf/a1/48/JGP_201511491.PMC4621751.pdf
"http://dx.doi .org/10.1111/j.1749-6632.1999.tb11297.x Gianulis, E.C., Q. Liu, and M.C.",OADS,/arxiv_data1/oa_pdf/a1/48/JGP_201511491.PMC4621751.pdf
"http://dx.doi.org/10.1085/jgp .201310995 Goodchild, S.J., L.C.",OADS,/arxiv_data1/oa_pdf/a1/48/JGP_201511491.PMC4621751.pdf
"24:1592– 1598. http://dx.doi.org/10.1016/j.cellsig.2012.04.004 Haitin, Y., A.E.",OADS,/arxiv_data1/oa_pdf/a1/48/JGP_201511491.PMC4621751.pdf
"http://dx.doi.org/10.1038/nature12487 Halaszovich, C.R., D.N.",OADS,/arxiv_data1/oa_pdf/a1/48/JGP_201511491.PMC4621751.pdf
"http://dx.doi.org/10.1016/ S0092-8674(00)80728-X Alonso-Ron, C., P. de la Peña, P. Miranda, P. Domínguez, and F.  Barros.",OADS,/arxiv_data1/oa_pdf/a1/48/JGP_201511491.PMC4621751.pdf
"http://dx.doi.org/10 .1529/biophysj.107.116731 Bian, J.S., and T.V.",OADS,/arxiv_data1/oa_pdf/a1/48/JGP_201511491.PMC4621751.pdf
"http://dx.doi.org/10.1007/s00424-007-0292-5 Bian, J., J. Cui, and T.V.",OADS,/arxiv_data1/oa_pdf/a1/48/JGP_201511491.PMC4621751.pdf
"http://dx.doi.org/10.1161/hh2401.101375 Bian, J.S., A. Kagan, and T.V.",OADS,/arxiv_data1/oa_pdf/a1/48/JGP_201511491.PMC4621751.pdf
"http://dx.doi.org/10.1152/ajpheart .00120.2004 Brady, J.D., E.D.",OADS,/arxiv_data1/oa_pdf/a1/48/JGP_201511491.PMC4621751.pdf
"http://dx.doi.org/10 .1073/pnas.1401917111 Brelidze, T.I., A.E.",OADS,/arxiv_data1/oa_pdf/a1/48/JGP_201511491.PMC4621751.pdf
"http://dx.doi.org/10.1074/ jbc.M109.016337 Brelidze, T.I., A.E.",OADS,/arxiv_data1/oa_pdf/a1/48/JGP_201511491.PMC4621751.pdf
"http://dx.doi.org/10.1038/nature10735 Brelidze, T.I., E.C.",OADS,/arxiv_data1/oa_pdf/a1/48/JGP_201511491.PMC4621751.pdf
"http://dx.doi.org/10.1016/S0092-8674 (00)81635-9 Murata, Y., H. Iwasaki, M. Sasaki, K. Inaba, and Y. Okamura.",OADS,/arxiv_data1/oa_pdf/a1/48/JGP_201511491.PMC4621751.pdf
"http://dx.doi.org/10.1038/ nature03650 Muskett, F.W., S. Thouta, S.J.",OADS,/arxiv_data1/oa_pdf/a1/48/JGP_201511491.PMC4621751.pdf
"286:6184– 6191. http://dx.doi.org/10.1074/jbc.M110.199364 Peters, H.C., H. Hu, O. Pongs, J.F.",OADS,/arxiv_data1/oa_pdf/a1/48/JGP_201511491.PMC4621751.pdf
"http://dx.doi.org/10.1038/nn1375 Piper, D.R., A. Varghese, M.C.",Non-OADS,/arxiv_data1/oa_pdf/a1/48/JGP_201511491.PMC4621751.pdf
"http://dx.doi.org/10.1074/jbc.M114.613620 Rodriguez, N., M.Y.",Non-OADS,/arxiv_data1/oa_pdf/a1/48/JGP_201511491.PMC4621751.pdf
"http://dx.doi.org/10.1016/j.bpj.2010.06.013 Rodriguez-Menchaca, A.A., S.K.",OADS,/arxiv_data1/oa_pdf/a1/48/JGP_201511491.PMC4621751.pdf
"3:170. http://dx.doi.org/10.3389/ fphar.2012.00170 Rohács, T., C.M.",OADS,/arxiv_data1/oa_pdf/a1/48/JGP_201511491.PMC4621751.pdf
"http://dx.doi.org/10.1038/nn1451 Sanguinetti, M.C., C. Jiang, M.E.",Non-OADS,/arxiv_data1/oa_pdf/a1/48/JGP_201511491.PMC4621751.pdf
"http://dx.doi.org/10.1016/0092-8674(95)90340-2 Schachtman, D.P., J.I.",OADS,/arxiv_data1/oa_pdf/a1/48/JGP_201511491.PMC4621751.pdf
"http://dx.doi.org/10.1126/science.8966547 Sentenac, H., N. Bonneaud, M. Minet, F. Lacroute, J.M.",Non-OADS,/arxiv_data1/oa_pdf/a1/48/JGP_201511491.PMC4621751.pdf
"http://dx.doi.org/10.1126/science.1585180 Shi, W., H.S.",OADS,/arxiv_data1/oa_pdf/a1/48/JGP_201511491.PMC4621751.pdf
"http://dx.doi.org/10.1111/j.1469-7793.1998.675bg.x Suh, B.C., and B. Hille.",OADS,/arxiv_data1/oa_pdf/a1/48/JGP_201511491.PMC4621751.pdf
"http://dx.doi.org/10.1074/jbc .M803543200 Hilgemann, D.W. 2012.",Non-OADS,/arxiv_data1/oa_pdf/a1/48/JGP_201511491.PMC4621751.pdf
"http://dx.doi.org/10.1085/ jgp.201210874 Hilgemann, D.W., S. Feng, and C. Nasuhoglu.",OADS,/arxiv_data1/oa_pdf/a1/48/JGP_201511491.PMC4621751.pdf
"http://dx.doi.org/10.2174/138620709787047957 Jegla, T., H.Q.",OADS,/arxiv_data1/oa_pdf/a1/48/JGP_201511491.PMC4621751.pdf
"http://dx.doi.org/10.1371/journal.pone.0051366 Keating, M.T., and M.C.",OADS,/arxiv_data1/oa_pdf/a1/48/JGP_201511491.PMC4621751.pdf
"http://dx.doi.org/10.1085/jgp.201210806 Li, X., H. Liu, J. Chu Luo, S.A. Rhodes, L.M.",OADS,/arxiv_data1/oa_pdf/a1/48/JGP_201511491.PMC4621751.pdf
"http://dx.doi.org/10.1242/jeb.110080 Li, Y., N. Gamper, D.W. Hilgemann, and M.S.",OADS,/arxiv_data1/oa_pdf/a1/48/JGP_201511491.PMC4621751.pdf
"http://dx.doi.org/10.1126/science .1116269 Long, S.B., E.B.",OADS,/arxiv_data1/oa_pdf/a1/48/JGP_201511491.PMC4621751.pdf
"http://dx.doi.org/10.1126/science.1116270 Martinson, A.S., D.B.",OADS,/arxiv_data1/oa_pdf/a1/48/JGP_201511491.PMC4621751.pdf
"http://dx.doi .org/10.1073/pnas.1321716111 McDonald, T.V., Z. Yu, Z. Ming, E. Palma, M.B.",Non-OADS,/arxiv_data1/oa_pdf/a1/48/JGP_201511491.PMC4621751.pdf
388:289– 292. http://dx.doi.org/10.1038/40882,Non-OADS,/arxiv_data1/oa_pdf/a1/48/JGP_201511491.PMC4621751.pdf
"http://dx.doi.org/10.1016/ j.neuron.2010.07.001 Tan, P.S., M.D.",OADS,/arxiv_data1/oa_pdf/a1/48/JGP_201511491.PMC4621751.pdf
"http://dx.doi.org/10.1085/jgp.201110761 Terlau, H., S.H.",OADS,/arxiv_data1/oa_pdf/a1/48/JGP_201511491.PMC4621751.pdf
"http://dx.doi.org/10.1111/j.1469-7793 .1997.537bj.x Tristani-Firouzi, M., J. Chen, and M.C.",OADS,/arxiv_data1/oa_pdf/a1/48/JGP_201511491.PMC4621751.pdf
"277:18994– 19000. http://dx.doi.org/10.1074/jbc.M200410200 Trudeau, M.C., J.W.",OADS,/arxiv_data1/oa_pdf/a1/48/JGP_201511491.PMC4621751.pdf
"http://dx.doi.org/ 10.1126/science.7604285 Trudeau, M.C., S.A. Titus, J.L.",OADS,/arxiv_data1/oa_pdf/a1/48/JGP_201511491.PMC4621751.pdf
"http://dx.doi.org/10.1146/ annurev.biochem.70.1.535 Villalba-Galea, C.A., W. Sandtner, D.M.",OADS,/arxiv_data1/oa_pdf/a1/48/JGP_201511491.PMC4621751.pdf
"http://dx.doi.org/10 .1073/pnas.0807387105 Wang, J., M.C.",OADS,/arxiv_data1/oa_pdf/a1/48/JGP_201511491.PMC4621751.pdf
"http://dx.doi.org/10.1085/ jgp.112.5.637 Warmke, J.W., and B. Ganetzky.",OADS,/arxiv_data1/oa_pdf/a1/48/JGP_201511491.PMC4621751.pdf
"http://dx.doi.org/10.1073/ pnas.91.8.3438 Womack, K.B., S.E.",Non-OADS,/arxiv_data1/oa_pdf/a1/48/JGP_201511491.PMC4621751.pdf
"http://dx.doi.org/10.1038/nature01118 Yu, F.H., and W.A.",OADS,/arxiv_data1/oa_pdf/a1/48/JGP_201511491.PMC4621751.pdf
"5:195. http://dx.doi .org/10.3389/fphys.2014.00195 Zaydman, M.A., J.R. Silva, K. Delaloye, Y. Li, H. Liang, H.P.",Non-OADS,/arxiv_data1/oa_pdf/a1/48/JGP_201511491.PMC4621751.pdf
"http://dx.doi.org/10.1007/s00232- 004-0707-4 Zhang, X., F. Bertaso, J.W.",Non-OADS,/arxiv_data1/oa_pdf/a1/48/JGP_201511491.PMC4621751.pdf
"http://dx.doi .org/10.1038/nn.2610 Zhen, X.G., C. Xie, Y. Yamada, Y. Zhang, C. Doyle, and J. Yang.",OADS,/arxiv_data1/oa_pdf/a1/48/JGP_201511491.PMC4621751.pdf
"http://dx.doi.org/10.1085/jgp.201310981 Zou, A., Z. Lin, M. Humble, C.D.",OADS,/arxiv_data1/oa_pdf/a1/48/JGP_201511491.PMC4621751.pdf
http://dx.doi.org/ 10.1152/ajpcell.00179.2003,Non-OADS,/arxiv_data1/oa_pdf/a1/48/JGP_201511491.PMC4621751.pdf
This article is distributed under the terms of an Attribution–  Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publi- cation date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/01/01/JGP_201511456.PMC4621752.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).The Journal of General Physiology",Non-OADS,/arxiv_data1/oa_pdf/01/01/JGP_201511456.PMC4621752.pdf
The online supplemental material is available at http://www.jgp .org/cgi/content/full/jgp.201511456/DC1.diversity of the effects of Trp mutation indicates that  this residue plays a pivotal role in the H V1 protein.,Non-OADS,/arxiv_data1/oa_pdf/01/01/JGP_201511456.PMC4621752.pdf
"http://dx.doi .org/10.1002/wmts.17 Fogel, M., and J.W.",OADS,/arxiv_data1/oa_pdf/01/01/JGP_201511456.PMC4621752.pdf
"3:816. http://dx.doi .org/10.1038/ncomms1823 Gallivan, J.P., and D.A.",OADS,/arxiv_data1/oa_pdf/01/01/JGP_201511456.PMC4621752.pdf
"http://dx.doi.org/10.1042/bj2460325 Hondares, E., M.A.",OADS,/arxiv_data1/oa_pdf/01/01/JGP_201511456.PMC4621752.pdf
"http://dx.doi.org/10.1085/ jgp.200910379 Killian, J.A., and G. von Heijne.",OADS,/arxiv_data1/oa_pdf/01/01/JGP_201511456.PMC4621752.pdf
"348:1283– 1298. http://dx.doi.org/10.1016/j.jmb.2005.03.051 Koch, H.P., T. Kurokawa, Y. Okochi, M. Sasaki, Y. Okamura, and  H.P.",OADS,/arxiv_data1/oa_pdf/01/01/JGP_201511456.PMC4621752.pdf
"http://dx.doi .org/10.1073/pnas.0801553105 Kulleperuma, K., S.M.E.",OADS,/arxiv_data1/oa_pdf/01/01/JGP_201511456.PMC4621752.pdf
"134:191– 205. http://dx.doi.org/10.1085/jgp.200910213 Lacroix, J.J., F.V.",Non-OADS,/arxiv_data1/oa_pdf/01/01/JGP_201511456.PMC4621752.pdf
"79:651– 657. http://dx.doi.org/10.1016/j.neuron.2013.05.036 Lee, S.Y., J.A.",OADS,/arxiv_data1/oa_pdf/01/01/JGP_201511456.PMC4621752.pdf
"http://dx.doi .org/10.1073/pnas.0803277105 Li, Q., S. Wanderling, M. Paduch, D. Medovoy, A. Singharoy, R.  McGreevy, C.A.",OADS,/arxiv_data1/oa_pdf/01/01/JGP_201511456.PMC4621752.pdf
"21:244– 252. http://dx.doi.org/10.1038/nsmb.2768 Lishko, P.V., I.L.",OADS,/arxiv_data1/oa_pdf/01/01/JGP_201511456.PMC4621752.pdf
"http://dx.doi.org/10.1016/ 0014-5793(86)80730-X Capasso, M., M.K.",OADS,/arxiv_data1/oa_pdf/01/01/JGP_201511456.PMC4621752.pdf
"http://dx.doi.org/10.1038/ni.1843 Chamberlin, A., F. Qiu, S. Rebolledo, Y. Wang, S.Y.",OADS,/arxiv_data1/oa_pdf/01/01/JGP_201511456.PMC4621752.pdf
"http://dx.doi.org/10.1085/jgp.105.6.861 Chester, R., and T.D.",OADS,/arxiv_data1/oa_pdf/01/01/JGP_201511456.PMC4621752.pdf
"http://dx.doi.org/  10.1002/9781118349083 DeCoursey, T.E.",Non-OADS,/arxiv_data1/oa_pdf/01/01/JGP_201511456.PMC4621752.pdf
"http://dx.doi .org/10.1152/physrev.00028.2002 DeCoursey, T.E.",OADS,/arxiv_data1/oa_pdf/01/01/JGP_201511456.PMC4621752.pdf
"http://dx.doi.org/10.1152/physiol.00039.2009 DeCoursey, T.E.",Non-OADS,/arxiv_data1/oa_pdf/01/01/JGP_201511456.PMC4621752.pdf
"http://dx.doi.org/10.1152/physrev.00011.2012 DeCoursey, T.E., and V.V.",OADS,/arxiv_data1/oa_pdf/01/01/JGP_201511456.PMC4621752.pdf
"http://dx.doi.org/10.1085/ jgp.109.4.415 DeCoursey, T.E., and V.V.",OADS,/arxiv_data1/oa_pdf/01/01/JGP_201511456.PMC4621752.pdf
"112:503– 522. http://dx.doi.org/10.1085/jgp.112.4.503 DeCoursey, T.E., and E. Ligeti.",OADS,/arxiv_data1/oa_pdf/01/01/JGP_201511456.PMC4621752.pdf
"http://dx.doi.org/10.1038/ nature01523 Dudev, T., B. Musset, D. Morgan, V.V.",OADS,/arxiv_data1/oa_pdf/01/01/JGP_201511456.PMC4621752.pdf
5:10320.  http://dx.doi.org/10.1038/srep10320,Non-OADS,/arxiv_data1/oa_pdf/01/01/JGP_201511456.PMC4621752.pdf
"http://dx.doi .org/10.1016/j.cell.2009.12.053 MacCallum, J.L., W.F.D.",OADS,/arxiv_data1/oa_pdf/01/01/JGP_201511456.PMC4621752.pdf
"http://dx.doi.org/10.1529/ biophysj.107.112805 Morgan, D., and T.E.",OADS,/arxiv_data1/oa_pdf/01/01/JGP_201511456.PMC4621752.pdf
"http://dx.doi.org/10.1007/978-1-62703- 845-4_9 Morgan, D., M. Capasso, B. Musset, V.V.",Non-OADS,/arxiv_data1/oa_pdf/01/01/JGP_201511456.PMC4621752.pdf
"http://dx.doi.org/10.1113/ jphysiol.2007.149427 Musset, B., D. Morgan, V.V.",OADS,/arxiv_data1/oa_pdf/01/01/JGP_201511456.PMC4621752.pdf
"http://dx.doi.org/ 10.4161/chan.4.4.12789 Musset, B., S.M.E.",Non-OADS,/arxiv_data1/oa_pdf/01/01/JGP_201511456.PMC4621752.pdf
"http://dx.doi.org/10.1038/nature10557 Musset, B., R.A. Clark, T.E.",OADS,/arxiv_data1/oa_pdf/01/01/JGP_201511456.PMC4621752.pdf
"http://dx.doi.org/10.1074/ jbc.M111.314955 Papazian, D.M., X.M.",Non-OADS,/arxiv_data1/oa_pdf/01/01/JGP_201511456.PMC4621752.pdf
"http://dx.doi .org/10.1016/0896-6273(95)90276-7 Pettersen, E.F., T.D.",OADS,/arxiv_data1/oa_pdf/01/01/JGP_201511456.PMC4621752.pdf
"http://dx.doi.org/10.1002/ jcc.20084 Ramsey, I.S., M.M.",OADS,/arxiv_data1/oa_pdf/01/01/JGP_201511456.PMC4621752.pdf
"http://dx.doi.org/10.1038/nature04700 Ramsey, I.S., Y. Mokrab, I. Carvacho, Z.A.",OADS,/arxiv_data1/oa_pdf/01/01/JGP_201511456.PMC4621752.pdf
"17:869– 875. http://dx.doi.org/10.1038/nsmb.1826 Roos, A., and W.F.",OADS,/arxiv_data1/oa_pdf/01/01/JGP_201511456.PMC4621752.pdf
"http://dx.doi.org/10.1002/bip.21436 Smith, S.M.E., D. Morgan, B. Musset, V.V.",Non-OADS,/arxiv_data1/oa_pdf/01/01/JGP_201511456.PMC4621752.pdf
"http://dx.doi.org/ 10.1038/nsmb.2783 Tatko, C.D., and M.L.",OADS,/arxiv_data1/oa_pdf/01/01/JGP_201511456.PMC4621752.pdf
"http://dx.doi.org/10.1110/ ps.03284003 Taylor, A.R., A. Chrachri, G. Wheeler, H. Goddard, and C.  Brownlee.",Non-OADS,/arxiv_data1/oa_pdf/01/01/JGP_201511456.PMC4621752.pdf
"http://dx.doi.org/10.1371/journal.pbio.1001085 Tombola, F., M.H.",Non-OADS,/arxiv_data1/oa_pdf/01/01/JGP_201511456.PMC4621752.pdf
"http://dx.doi.org/10.1016/ j.neuron.2008.03.026 Villalba-Galea, C.A.",OADS,/arxiv_data1/oa_pdf/01/01/JGP_201511456.PMC4621752.pdf
"http://dx.doi.org/10.1016/j.bpj.2014.08.017 Wang, Y., S.J.",OADS,/arxiv_data1/oa_pdf/01/01/JGP_201511456.PMC4621752.pdf
"http://dx.doi.org/10.1074/jbc.M112.345280 Wood, M.L., E.V.",OADS,/arxiv_data1/oa_pdf/01/01/JGP_201511456.PMC4621752.pdf
"http://dx.doi .org/10.1016/j.bbamem.2011.07.045 Wu, L.J., G. Wu, M.R.",OADS,/arxiv_data1/oa_pdf/01/01/JGP_201511456.PMC4621752.pdf
http://dx.doi.org/10.1038/nn.3059,Non-OADS,/arxiv_data1/oa_pdf/01/01/JGP_201511456.PMC4621752.pdf
"http://dx.doi.org/ 10.1016/j.mam.2012.12.001 Berman, H.M., J. Westbrook, Z. Feng, G. Gilliland, T.N.",OADS,/arxiv_data1/oa_pdf/e2/c6/JGP_201511481.PMC4621753.pdf
"http://dx.doi.org/10.1093/ nar/28.1.235 Bolla, J.R., C.C.",OADS,/arxiv_data1/oa_pdf/e2/c6/JGP_201511481.PMC4621753.pdf
"6:6874. http://dx.doi.org/ 10.1038/ncomms7874 Boudker, O., R.M.",OADS,/arxiv_data1/oa_pdf/e2/c6/JGP_201511481.PMC4621753.pdf
"http://dx.doi.org/10.1038/nature05455 Chen, J.S., V. Reddy, J.H.",OADS,/arxiv_data1/oa_pdf/e2/c6/JGP_201511481.PMC4621753.pdf
"http://dx.doi.org/10.1159/000334611 Crisman, T.J., S. Qu, B.I.",Non-OADS,/arxiv_data1/oa_pdf/e2/c6/JGP_201511481.PMC4621753.pdf
"http://dx.doi.org/10.1101/gr.849004 Edgar, R.C.",Non-OADS,/arxiv_data1/oa_pdf/e2/c6/JGP_201511481.PMC4621753.pdf
"http://dx.doi.org/ 10.1093/bioinformatics/btq461 Ehrnstorfer, I.A., E.R.",OADS,/arxiv_data1/oa_pdf/e2/c6/JGP_201511481.PMC4621753.pdf
"http://dx.doi.org/10.1038/nsmb.2904 Fang, Y., H. Jayaram, T. Shane, L. Kolmakova-Partensky, F. Wu,  C. Williams, Y. Xiong, and C. Miller.",Non-OADS,/arxiv_data1/oa_pdf/e2/c6/JGP_201511481.PMC4621753.pdf
"http://dx.doi.org/10.1016/j.bpj.2014.01.043 Finn, R.D., J. Clements, and S.R.",OADS,/arxiv_data1/oa_pdf/e2/c6/JGP_201511481.PMC4621753.pdf
"http://dx.doi.org/10.1093/nar/gkr367 Folster, J.P., and W.M.",OADS,/arxiv_data1/oa_pdf/e2/c6/JGP_201511481.PMC4621753.pdf
"http://dx.doi.org/10.1128/ JB.187.11.3713-3720.2005 Forrest, L.R.",Non-OADS,/arxiv_data1/oa_pdf/e2/c6/JGP_201511481.PMC4621753.pdf
"http://dx.doi.org/10.1146/annurev- biophys-051013-023008 Forrest, L.R., Y.-W. Zhang, M.T.",OADS,/arxiv_data1/oa_pdf/e2/c6/JGP_201511481.PMC4621753.pdf
"http://dx.doi.org/10.1016/j.bbabio.2010.10.014 Forster, I., N. Hernando, J. Biber, and H. Murer.",OADS,/arxiv_data1/oa_pdf/e2/c6/JGP_201511481.PMC4621753.pdf
"http://dx.doi .org/10.1085/jgp.112.1.1 Forster, I.C., N. Hernando, J. Biber, and H. Murer.",OADS,/arxiv_data1/oa_pdf/e2/c6/JGP_201511481.PMC4621753.pdf
"http://dx.doi.org/10.1038/nature10882 Kabsch, W., and C. Sander.",OADS,/arxiv_data1/oa_pdf/e2/c6/JGP_201511481.PMC4621753.pdf
"http://dx.doi.org/ 10.1002/bip.360221211 Katoh, K., and D.M.",OADS,/arxiv_data1/oa_pdf/e2/c6/JGP_201511481.PMC4621753.pdf
"http://dx.doi.org/10.1093/ molbev/mst010 Lomize, M.A., A.L.",OADS,/arxiv_data1/oa_pdf/e2/c6/JGP_201511481.PMC4621753.pdf
"http://dx.doi.org/10.1093/ bioinformatics/btk023 Ma, D., P. Lu, C. Yan, C. Fan, P. Yin, J. Wang, and Y. Shi.",OADS,/arxiv_data1/oa_pdf/e2/c6/JGP_201511481.PMC4621753.pdf
"http://dx.doi.org/10.1038/nature10917 Malinauskaite, L., M. Quick, L. Reinhard, J.A.",OADS,/arxiv_data1/oa_pdf/e2/c6/JGP_201511481.PMC4621753.pdf
"http://dx.doi.org/10.1038/nsmb.2894 Mancusso, R., G.G.",Non-OADS,/arxiv_data1/oa_pdf/e2/c6/JGP_201511481.PMC4621753.pdf
"http://dx.doi.org/ 10.1038/nature11542 Mulligan, C., G.A.",OADS,/arxiv_data1/oa_pdf/e2/c6/JGP_201511481.PMC4621753.pdf
"9:531. http://dx.doi.org/ 10.1186/1471-2105-9-531 Petřek, M., M. Otyepka, P. Banás, P. Kosinová, J. Koca, and J.  Damborský.",Non-OADS,/arxiv_data1/oa_pdf/e2/c6/JGP_201511481.PMC4621753.pdf
"http://dx.doi.org/10.1016/j.bbamem.2003.10.010Ressl, S., A.C. Terwisscha van Scheltinga, C. Vonrhein, V. Ott, and  C. Ziegler.",OADS,/arxiv_data1/oa_pdf/e2/c6/JGP_201511481.PMC4621753.pdf
"http://dx.doi.org/10.1038/nature08616 Saier, M.H., Jr., C.V. Tran, and R.D.",OADS,/arxiv_data1/oa_pdf/e2/c6/JGP_201511481.PMC4621753.pdf
"http://dx.doi.org/10.1093/nar/gkj001 Shaffer, P.L., A. Goehring, A. Shankaranarayanan, and E. Gouaux.",Non-OADS,/arxiv_data1/oa_pdf/e2/c6/JGP_201511481.PMC4621753.pdf
"http://dx.doi.org/10.1126/ science.1176088 Stamm, M., and L.R.",OADS,/arxiv_data1/oa_pdf/e2/c6/JGP_201511481.PMC4621753.pdf
"http://dx.doi.org/10.1002/prot .24857 Su, C.C., J.R. Bolla, N. Kumar, A. Radhakrishnan, F. Long, J.A.",Non-OADS,/arxiv_data1/oa_pdf/e2/c6/JGP_201511481.PMC4621753.pdf
"11:61– 70. http://dx.doi.org/10.1016/j.celrep.2015.03.003 Watanabe, A., S. Choe, V. Chaptal, J.M.",OADS,/arxiv_data1/oa_pdf/e2/c6/JGP_201511481.PMC4621753.pdf
"http://dx.doi.org/10.1038/nature09580 Waterhouse, A.M., J.B. Procter, D.M.",OADS,/arxiv_data1/oa_pdf/e2/c6/JGP_201511481.PMC4621753.pdf
"http://dx.doi.org/10.1093/bioinformatics/btp033 Weyand, S., T. Shimamura, S. Yajima, S. Suzuki, O. Mirza, K.  Krusong, E.P.",OADS,/arxiv_data1/oa_pdf/e2/c6/JGP_201511481.PMC4621753.pdf
"322:709– 713. http://dx.doi.org/10.1126/science.1164440 Yamashita, A., S.K.",OADS,/arxiv_data1/oa_pdf/e2/c6/JGP_201511481.PMC4621753.pdf
"http://dx.doi.org/10.1038/nature03018 Zhang, Y., and J. Skolnick.",OADS,/arxiv_data1/oa_pdf/e2/c6/JGP_201511481.PMC4621753.pdf
57:702– 710. http://dx.doi.org/10.1002/prot.20264,Non-OADS,/arxiv_data1/oa_pdf/e2/c6/JGP_201511481.PMC4621753.pdf
Editor: Jochen Guck./C2112015 The Authors 0006-3495/15/07/0194/15 $2.00 http://dx.doi.org/10.1016/j.bpj.2015.06.021 194 Biophysical Journal Volume 109 July 2015 194–208,Non-OADS,/arxiv_data1/oa_pdf/bb/92/main.PMC4621811.pdf
Editor: Ruth Baker./C2112015 The Authors 0006-3495/15/07/0182/12 $2.00 http://dx.doi.org/10.1016/j.bpj.2015.06.027 182 Biophysical Journal Volume 109 July 2015 182–193,Non-OADS,/arxiv_data1/oa_pdf/b0/0c/main.PMC4621813.pdf
This article is distributed under the terms of an Attribution–Noncommercial– Share Alike–No Mirror Sites license for the first six months after the publication date (see  http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/c5/8c/JCB_201501035.PMC4621824.pdf
"After six months it is available under a Creative Commons  License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at  http://creativecommons.org/licenses/by-nc-sa/3.0/).Correspondence to Yasushi Hiraoka: hiraoka@fbs.osaka-u.ac.jp Abbreviations used in this paper: APC, anaphase-promoting complex; DSB,  double-strand break; KMN, KNL1–Spc7-Mis12-Nuf2; ME, malt extract; SAC,  spindle assembly checkpoint; Sgo1, S.  pombe  shugoshin; SPB, spindle pole  body; YES, yeast extract with supplements.THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/c5/8c/JCB_201501035.PMC4621824.pdf
Online supplemental material is available at http://www.jcb.org/cgi/content/full/jcb.201501035/DC1.,Non-OADS,/arxiv_data1/oa_pdf/c5/8c/JCB_201501035.PMC4621824.pdf
"http://dx.doi.org/10.1038/sj.emboj.7601582 Asakawa, H., and Y .",OADS,/arxiv_data1/oa_pdf/c5/8c/JCB_201501035.PMC4621824.pdf
"http://dx.doi.org/10.1007/978-1-60761-103-5_4 Asakawa, H., A. Hayashi, T. Haraguchi, and Y .",OADS,/arxiv_data1/oa_pdf/c5/8c/JCB_201501035.PMC4621824.pdf
"16:2325– 2338. http://dx.doi.org/10.1091/mbc.E04-11-0996 Asakawa, H., T.  Haraguchi, and Y .",OADS,/arxiv_data1/oa_pdf/c5/8c/JCB_201501035.PMC4621824.pdf
"2:17. http://dx.doi.org/10.1186/1747-1028-2-17 Asakawa, H., T. Kojidani, C. Mori, H. Osakada, M. Sato, D.-Q.",OADS,/arxiv_data1/oa_pdf/c5/8c/JCB_201501035.PMC4621824.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/c5/8c/JCB_201501035.PMC4621824.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c5/8c/JCB_201501035.PMC4621824.pdf
"http://dx.doi.org/10.1128/MCB.24.14.6379-6392.2004 Belgareh, N., G. Rabut, S.W.",Non-OADS,/arxiv_data1/oa_pdf/c5/8c/JCB_201501035.PMC4621824.pdf
"http://dx.doi.org/10.1083/jcb.143.7.1775 Bernard, P., J.F.",Non-OADS,/arxiv_data1/oa_pdf/c5/8c/JCB_201501035.PMC4621824.pdf
"http://dx.doi.org/10.1038/35074598 Bolhy, S., I.  Bouhlel, E.  Dultz, T.  Nayak, M.  Zuccolo, X.  Gatti, R.  Vallee,  J.  Ellenberg, and V .",Non-OADS,/arxiv_data1/oa_pdf/c5/8c/JCB_201501035.PMC4621824.pdf
"http://dx.doi.org/10.1083/jcb.201007118 Boratyn, G.M., A.A.  Schäffer, R.  Agarwala, S.F.",Non-OADS,/arxiv_data1/oa_pdf/c5/8c/JCB_201501035.PMC4621824.pdf
"7:12. http://dx.doi.org/10.1186/1745-6150-7-12 Boulanger, J., C. Kervrann, and P. Bouthemy.",Non-OADS,/arxiv_data1/oa_pdf/c5/8c/JCB_201501035.PMC4621824.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/c5/8c/JCB_201501035.PMC4621824.pdf
"http://dx.doi.org/10.1126/ science.8146661 Chikashige, Y ., D.Q.D.",OADS,/arxiv_data1/oa_pdf/c5/8c/JCB_201501035.PMC4621824.pdf
"http://dx.doi.org/10.1093/emboj/16.1.193 Chikashige, Y ., R. Kurokawa, T. Haraguchi, and Y .",OADS,/arxiv_data1/oa_pdf/c5/8c/JCB_201501035.PMC4621824.pdf
"http://dx.doi.org/10.1111/j.1356-9597.2004.00760.x Chikashige, Y ., C.  Tsutsumi, M.  Yamane, K.  Okamasa, T.  Haraguchi, and  Y .",OADS,/arxiv_data1/oa_pdf/c5/8c/JCB_201501035.PMC4621824.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c5/8c/JCB_201501035.PMC4621824.pdf
"http://dx.doi.org/10.1101/gad.1126303 Ding, D.-Q., A. Yamamoto, T. Haraguchi, and Y .",OADS,/arxiv_data1/oa_pdf/c5/8c/JCB_201501035.PMC4621824.pdf
"http://dx.doi.org/10.1016/S1534-5807(04)00059-0 Ding, D.-Q., N.  Sakurai, Y .",OADS,/arxiv_data1/oa_pdf/c5/8c/JCB_201501035.PMC4621824.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c5/8c/JCB_201501035.PMC4621824.pdf
"http://dx.doi.org/10.1038/381438a0 Gascoigne, K.E., and I.M.",Non-OADS,/arxiv_data1/oa_pdf/c5/8c/JCB_201501035.PMC4621824.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c5/8c/JCB_201501035.PMC4621824.pdf
"http://dx.doi.org/10.1016/j.cell.2004.10.014 Hauf, S., A.  Biswas, M.  Langegger, S.A.S.",OADS,/arxiv_data1/oa_pdf/c5/8c/JCB_201501035.PMC4621824.pdf
http://dx.doi.org/10.1091/mbc.,Non-OADS,/arxiv_data1/oa_pdf/c5/8c/JCB_201501035.PMC4621824.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c5/8c/JCB_201501035.PMC4621824.pdf
"http://dx.doi.org/10.1002/yea.1291 Hirose, Y ., R.  Suzuki, T.  Ohba, Y .",OADS,/arxiv_data1/oa_pdf/c5/8c/JCB_201501035.PMC4621824.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c5/8c/JCB_201501035.PMC4621824.pdf
"http://dx.doi.org/10.1126/ science.279.5353.1045 Kitajima, T.S., S.A. Kawashima, and Y .",OADS,/arxiv_data1/oa_pdf/c5/8c/JCB_201501035.PMC4621824.pdf
"http://dx.doi.org/10.1038/nature02312 Kitajima, T.S.T., Y .",OADS,/arxiv_data1/oa_pdf/c5/8c/JCB_201501035.PMC4621824.pdf
"http://dx.doi.org/10.1093/emboj/cdg527 Krawchuk, M.D., and W.P.",OADS,/arxiv_data1/oa_pdf/c5/8c/JCB_201501035.PMC4621824.pdf
"http://dx.doi.org/10.1002/ (SICI)1097-0061(19990930)15:13<1419::AID-YEA466>3.0.CO;2-Q Masuda, H., R.  Miyamoto, T.  Haraguchi, and Y .",OADS,/arxiv_data1/oa_pdf/c5/8c/JCB_201501035.PMC4621824.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c5/8c/JCB_201501035.PMC4621824.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c5/8c/JCB_201501035.PMC4621824.pdf
"http://dx.doi.org/10.1016/0076-6879(91)94059-L Nabeshima, K., T.  Nakagawa, A.F.A.",OADS,/arxiv_data1/oa_pdf/c5/8c/JCB_201501035.PMC4621824.pdf
"http://dx.doi.org/10.1091/mbc.9.11.3211 Ohta, M., M. Sato, and M. Yamamoto.",OADS,/arxiv_data1/oa_pdf/c5/8c/JCB_201501035.PMC4621824.pdf
"http://dx.doi.org/10.1091/mbc.E11-11-0951 Parra, M.T., A. Viera, R. Gómez, J.",Non-OADS,/arxiv_data1/oa_pdf/c5/8c/JCB_201501035.PMC4621824.pdf
"http://dx.doi.org/10.1242/jcs.00947Przewloka, M.R., Z.  Venkei, V .M.",Non-OADS,/arxiv_data1/oa_pdf/c5/8c/JCB_201501035.PMC4621824.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/c5/8c/JCB_201501035.PMC4621824.pdf
"http://dx.doi.org/10.1083/jcb.201211113 Ródenas, E., C. González-Aguilera, C. Ayuso, and P. Askjaer.",OADS,/arxiv_data1/oa_pdf/c5/8c/JCB_201501035.PMC4621824.pdf
"http://dx.doi.org/10.1091/mbc.E11-11-0927 Ruan, K., T.G.",Non-OADS,/arxiv_data1/oa_pdf/c5/8c/JCB_201501035.PMC4621824.pdf
"http://dx.doi.org/10.1016/j.cub.2012.03.051 Uchida, K.S.K., K. Takagaki, K. Kumada, Y .",OADS,/arxiv_data1/oa_pdf/c5/8c/JCB_201501035.PMC4621824.pdf
"http://dx.doi.org/10.1083/jcb.200811028 Unsworth, A., H. Masuda, S. Dhut, and T. Toda.",OADS,/arxiv_data1/oa_pdf/c5/8c/JCB_201501035.PMC4621824.pdf
"http://dx.doi.org/10.1091/mbc.E08-02-0224 Watanabe, Y ., and P.  Nurse.",OADS,/arxiv_data1/oa_pdf/c5/8c/JCB_201501035.PMC4621824.pdf
"http://dx.doi.org/10.1038/22774 West, R.R., E.V .",Non-OADS,/arxiv_data1/oa_pdf/c5/8c/JCB_201501035.PMC4621824.pdf
"http://dx.doi.org/10.1091/ mbc.9.10.2839 Yamamoto, A., and Y .",OADS,/arxiv_data1/oa_pdf/c5/8c/JCB_201501035.PMC4621824.pdf
"http://dx.doi.org/10.1093/ emboj/cdg222 Yamamoto, A., K. Kitamura, D. Hihara, Y .",OADS,/arxiv_data1/oa_pdf/c5/8c/JCB_201501035.PMC4621824.pdf
"http://dx.doi.org/10.1083/jcb.200802053 Yokobayashi, S., and Y .",OADS,/arxiv_data1/oa_pdf/c5/8c/JCB_201501035.PMC4621824.pdf
"123:803– 817. http://dx.doi.org/10.1016/j.cell.2005.09.013 Zimmerman, S., R.R.",OADS,/arxiv_data1/oa_pdf/c5/8c/JCB_201501035.PMC4621824.pdf
"http://dx.doi.org/10.1038/ncb1200 Zuccolo, M., A.  Alves, V .",Non-OADS,/arxiv_data1/oa_pdf/c5/8c/JCB_201501035.PMC4621824.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c5/8c/JCB_201501035.PMC4621824.pdf
This article is distributed under the terms of an  Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after  the publication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/e2/bb/JCB_201503081.PMC4621825.pdf
"After six months it is available  under a Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported  license, as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).*Z.S.",Non-OADS,/arxiv_data1/oa_pdf/e2/bb/JCB_201503081.PMC4621825.pdf
Online supplemental material is available  at http://www.jcb.org/cgi/content/full/jcb.201503081/DC1.,Non-OADS,/arxiv_data1/oa_pdf/e2/bb/JCB_201503081.PMC4621825.pdf
"http://dx.doi.org/10.1038/nrm3048 Benhamouche, S., M. Curto, I. Saotome, A.B.",Non-OADS,/arxiv_data1/oa_pdf/e2/bb/JCB_201503081.PMC4621825.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e2/bb/JCB_201503081.PMC4621825.pdf
"http://dx.doi.org/10.1083/jcb.200910041 Boggiano, J.C., and R.G. Fehon.",OADS,/arxiv_data1/oa_pdf/e2/bb/JCB_201503081.PMC4621825.pdf
"http://dx.doi.org/10.1016/j.devcel.2012.03.013 Buckley, C.D., J.  Tan, K.L.",OADS,/arxiv_data1/oa_pdf/e2/bb/JCB_201503081.PMC4621825.pdf
"346:1254211. http://dx.doi.org/10.1126/science.1254211Cairo, C.W., R. Mirchev, and D.E. Golan.",OADS,/arxiv_data1/oa_pdf/e2/bb/JCB_201503081.PMC4621825.pdf
"http://dx.doi.org/10.1016/j.immuni.2006.06.012 Carreno, S., I. Kouranti, E.S.",OADS,/arxiv_data1/oa_pdf/e2/bb/JCB_201503081.PMC4621825.pdf
"http://dx.doi.org/10.1083/jcb.200709161 Chua, J., R. Rikhy, and J. Lippincott-Schwartz.",Non-OADS,/arxiv_data1/oa_pdf/e2/bb/JCB_201503081.PMC4621825.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e2/bb/JCB_201503081.PMC4621825.pdf
"http://dx.doi.org/10.1083/jcb.200703010 Dawes-Hoang, R.E., K.M.",OADS,/arxiv_data1/oa_pdf/e2/bb/JCB_201503081.PMC4621825.pdf
"http://dx.doi.org/10.1038/nrm3112 Dunagan, M., K. Chaudhry, G. Samak, and R.K. Rao.",Non-OADS,/arxiv_data1/oa_pdf/e2/bb/JCB_201503081.PMC4621825.pdf
"http://dx.doi.org/10.1152/ajpgi.00526.2011 Fehon, R.G., A.I.",OADS,/arxiv_data1/oa_pdf/e2/bb/JCB_201503081.PMC4621825.pdf
"http://dx.doi.org/10.1038/nrm2866 García-Sáez, A.J., and P.  Schwille.",OADS,/arxiv_data1/oa_pdf/e2/bb/JCB_201503081.PMC4621825.pdf
"http://dx.doi.org/10.1007/s00253-007-1007-8 Gauthier, N.C., T.A.",Non-OADS,/arxiv_data1/oa_pdf/e2/bb/JCB_201503081.PMC4621825.pdf
"http://dx.doi.org/10.1016/j.tcb.2012.07.005 Giovannini, M., E.  Robanus-Maandag, M.  van der Valk, M.  Niwa-Kawakita,  V .",OADS,/arxiv_data1/oa_pdf/e2/bb/JCB_201503081.PMC4621825.pdf
"http://dx.doi.org/10.1016/j.devcel.2010.10.008 Hanahan, D., and R.A. Weinberg.",OADS,/arxiv_data1/oa_pdf/e2/bb/JCB_201503081.PMC4621825.pdf
"http://dx.doi.org/10.1016/j.cell.2011.02.013 Hansen, S.D., A.V .",OADS,/arxiv_data1/oa_pdf/e2/bb/JCB_201503081.PMC4621825.pdf
"http://dx.doi.org/10.1091/mbc.E13-07-0388 Hebert, A.M., B. DuBoff, J.B. Casaletto, A.B.",Non-OADS,/arxiv_data1/oa_pdf/e2/bb/JCB_201503081.PMC4621825.pdf
"http://dx.doi.org/10.1101/ gad.194027.112 Hildebrand, J.D. 2005.",Non-OADS,/arxiv_data1/oa_pdf/e2/bb/JCB_201503081.PMC4621825.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/e2/bb/JCB_201503081.PMC4621825.pdf
"29:278– 292. http://dx.doi.org/10.1016/j.nbd.2007.09.002 Jaqaman, K., and S. Grinstein.",OADS,/arxiv_data1/oa_pdf/e2/bb/JCB_201503081.PMC4621825.pdf
"http://dx.doi.org/10.1016/j.tcb.2012.07.006 Kim, J.H., and A.R. Asthagiri.",OADS,/arxiv_data1/oa_pdf/e2/bb/JCB_201503081.PMC4621825.pdf
"http://dx.doi.org/10.1242/jcs.078394 Kim, J.H., K.  Kushiro, N.A.",OADS,/arxiv_data1/oa_pdf/e2/bb/JCB_201503081.PMC4621825.pdf
"http://dx.doi.org/10.4161/cam.21076 Kunda, P., A.E.",OADS,/arxiv_data1/oa_pdf/e2/bb/JCB_201503081.PMC4621825.pdf
"http://dx.doi.org/10.1016/j.cub.2007.12.051 Kusumi, A., Y .",OADS,/arxiv_data1/oa_pdf/e2/bb/JCB_201503081.PMC4621825.pdf
"http://dx.doi.org/10.1016/S0006-3495(93)81253-0 Lallemand, D., M.  Curto, I.  Saotome, M.  Giovannini, and A.I.",OADS,/arxiv_data1/oa_pdf/e2/bb/JCB_201503081.PMC4621825.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e2/bb/JCB_201503081.PMC4621825.pdf
"http://dx.doi.org/10.1146/annurev-cellbio-100109-104027 Leerberg, J.M., G.A.",OADS,/arxiv_data1/oa_pdf/e2/bb/JCB_201503081.PMC4621825.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/e2/bb/JCB_201503081.PMC4621825.pdf
"http://dx.doi.org/10.1016/j.cell.2010.06.011 Lenne, P.F., L. Wawrezinieck, F. Conchonaud, O. Wurtz, A. Boned, X.J.",OADS,/arxiv_data1/oa_pdf/e2/bb/JCB_201503081.PMC4621825.pdf
"http://dx.doi.org/10.1038/ sj.emboj.7601214 Lidke, D.S., K.A.",OADS,/arxiv_data1/oa_pdf/e2/bb/JCB_201503081.PMC4621825.pdf
"http://dx.doi.org/10.1083/jcb.200503140 Lien, W.H., V .I.",OADS,/arxiv_data1/oa_pdf/e2/bb/JCB_201503081.PMC4621825.pdf
"http://dx.doi.org/10.1083/jcb.200805041 Luxenburg, C., H.A.",OADS,/arxiv_data1/oa_pdf/e2/bb/JCB_201503081.PMC4621825.pdf
"http://dx.doi.org/10.1038/ncb2163 Martin, A.C., and B. Goldstein.",Non-OADS,/arxiv_data1/oa_pdf/e2/bb/JCB_201503081.PMC4621825.pdf
"http://dx.doi.org/10.1242/dev.102228 Martin, A.C., M. Kaschube, and E.F. Wieschaus.",Non-OADS,/arxiv_data1/oa_pdf/e2/bb/JCB_201503081.PMC4621825.pdf
"http://dx.doi.org/10.1038/nature07522 Maruthamuthu, V ., B.  Sabass, U.S.  Schwarz, and M.L.",OADS,/arxiv_data1/oa_pdf/e2/bb/JCB_201503081.PMC4621825.pdf
"http://dx.doi.org/10.1242/jcs.098343 McClatchey, A.I., and R.G. Fehon.",OADS,/arxiv_data1/oa_pdf/e2/bb/JCB_201503081.PMC4621825.pdf
"http://dx.doi.org/10.1016/j.tcb.2009.02.006McClatchey, A.I., and A.S.  Yap.",OADS,/arxiv_data1/oa_pdf/e2/bb/JCB_201503081.PMC4621825.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/e2/bb/JCB_201503081.PMC4621825.pdf
"http://dx.doi.org/10.1006/bcmd.2000.0367 Morris, Z.S., and A.I. McClatchey.",OADS,/arxiv_data1/oa_pdf/e2/bb/JCB_201503081.PMC4621825.pdf
"http://dx.doi.org/10.1242/dev.019646 Otani, T., T.  Ichii, S.  Aono, and M.  Takeichi.",OADS,/arxiv_data1/oa_pdf/e2/bb/JCB_201503081.PMC4621825.pdf
"http://dx.doi.org/10.1083/jcb.200605012 Postic, C., and M.A.",OADS,/arxiv_data1/oa_pdf/e2/bb/JCB_201503081.PMC4621825.pdf
"http://dx.doi.org/10.1002/ (SICI)1526-968X(200002)26:2<149::AID-GENE16>3.0.CO;2-V Saxton, M.J., and K. Jacobson.",OADS,/arxiv_data1/oa_pdf/e2/bb/JCB_201503081.PMC4621825.pdf
"http://dx.doi.org/10.1371/journal.pone.0104994 Tse, J.R., and A.J. Engler.",OADS,/arxiv_data1/oa_pdf/e2/bb/JCB_201503081.PMC4621825.pdf
"http://dx.doi.org/10.1002/0471143030.cb1016s47 van der Flier, L.G., and H. Clevers.",Non-OADS,/arxiv_data1/oa_pdf/e2/bb/JCB_201503081.PMC4621825.pdf
"http://dx.doi.org/10.1091/mbc.E12-08-0574 Viswanatha, R., P.Y .",Non-OADS,/arxiv_data1/oa_pdf/e2/bb/JCB_201503081.PMC4621825.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e2/bb/JCB_201503081.PMC4621825.pdf
"http://dx.doi.org/10.1038/ncb2900 Yonemura, S., Y .",OADS,/arxiv_data1/oa_pdf/e2/bb/JCB_201503081.PMC4621825.pdf
http://dx.doi.org/10.1038/ncb2055,Non-OADS,/arxiv_data1/oa_pdf/e2/bb/JCB_201503081.PMC4621825.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/ad/43/JCB_201503067.PMC4621827.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).*W.",Non-OADS,/arxiv_data1/oa_pdf/ad/43/JCB_201503067.PMC4621827.pdf
Online supplemental material is available at http://www.jcb.org/cgi/content/full/jcb.201503067/DC1.,Non-OADS,/arxiv_data1/oa_pdf/ad/43/JCB_201503067.PMC4621827.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ad/43/JCB_201503067.PMC4621827.pdf
"http://dx.doi.org/10.1042/ bj3620001 Bell, G.P., G.C.",OADS,/arxiv_data1/oa_pdf/ad/43/JCB_201503067.PMC4621827.pdf
"http://dx.doi.org/10.1016/j.cub.2014.10.052 Betschinger, J., K. Mechtler, and J.A. Knoblich.",OADS,/arxiv_data1/oa_pdf/ad/43/JCB_201503067.PMC4621827.pdf
"http://dx.doi.org/10.1038/nature01486 Betschinger, J., F. Eisenhaber, and J.A. Knoblich.",OADS,/arxiv_data1/oa_pdf/ad/43/JCB_201503067.PMC4621827.pdf
"http://dx.doi.org/10.1016/j.cub.2005.01.012 Bickeböller, M., K.E.",OADS,/arxiv_data1/oa_pdf/ad/43/JCB_201503067.PMC4621827.pdf
"http://dx.doi.org/10.1038/onc.2014.40 Bloor, J.W., and D.P. Kiehart.",OADS,/arxiv_data1/oa_pdf/ad/43/JCB_201503067.PMC4621827.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ad/43/JCB_201503067.PMC4621827.pdf
"http://dx.doi.org/10.1534/ genetics.106.065961 Carvalho, C.A., S.  Moreira, G.  Ventura, C.E.",OADS,/arxiv_data1/oa_pdf/ad/43/JCB_201503067.PMC4621827.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ad/43/JCB_201503067.PMC4621827.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ad/43/JCB_201503067.PMC4621827.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ad/43/JCB_201503067.PMC4621827.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ad/43/JCB_201503067.PMC4621827.pdf
"http://dx.doi.org/10.1074/ jbc.274.46.33097 DiGregorio, P.J., J.A.",Non-OADS,/arxiv_data1/oa_pdf/ad/43/JCB_201503067.PMC4621827.pdf
"http://dx.doi.org/10.1074/ jbc.M003911200 Froldi, F., M. Ziosi, G. Tomba, F. Parisi, F. Garoia, A. Pession, and D. Grifoni.",Non-OADS,/arxiv_data1/oa_pdf/ad/43/JCB_201503067.PMC4621827.pdf
"http://dx.doi.org/10.2174/138920208784340786 Grzeschik, N.A., L.M.",Non-OADS,/arxiv_data1/oa_pdf/ad/43/JCB_201503067.PMC4621827.pdf
"http://dx.doi.org/10.1083/jcb.201312072 Hattendorf, D.A., A.  Andreeva, A.  Gangar, P.J.",OADS,/arxiv_data1/oa_pdf/ad/43/JCB_201503067.PMC4621827.pdf
"http://dx.doi.org/10.1038/nature05635 Heo, W.D., T.  Inoue, W.S.",OADS,/arxiv_data1/oa_pdf/ad/43/JCB_201503067.PMC4621827.pdf
"http://dx.doi.org/10.1126/science.1134389 Huang, J., W. Zhou, W. Dong, A.M. Watson, and Y .",OADS,/arxiv_data1/oa_pdf/ad/43/JCB_201503067.PMC4621827.pdf
"http://dx.doi.org/10.1534/genetics.111.129247 Huang, J., L. Huang, Y .-J.",Non-OADS,/arxiv_data1/oa_pdf/ad/43/JCB_201503067.PMC4621827.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ad/43/JCB_201503067.PMC4621827.pdf
"http://dx.doi.org/10.1073/ pnas.1211305109 Kaelin, W.G., Jr., and P.J. Ratcliffe.",Non-OADS,/arxiv_data1/oa_pdf/ad/43/JCB_201503067.PMC4621827.pdf
"http://dx.doi.org/10.1016/j.molcel.2008.04.009 Keith, B., and M.C.",OADS,/arxiv_data1/oa_pdf/ad/43/JCB_201503067.PMC4621827.pdf
"http://dx.doi.org/10.1016/j.cell.2007.04.019 Kelso, R.J., M.  Buszczak, A.T.  Quiñones, C.  Castiblanco, S.  Mazzalupo, and  L. Cooley.",OADS,/arxiv_data1/oa_pdf/ad/43/JCB_201503067.PMC4621827.pdf
"http://dx.doi.org/10.1093/nar/gkh014 Kim, A.Y ., Z.  Tang, Q.  Liu, K.N.",OADS,/arxiv_data1/oa_pdf/ad/43/JCB_201503067.PMC4621827.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ad/43/JCB_201503067.PMC4621827.pdf
"http://dx.doi.org/10.1128/MCB.22.19.6842-6853.2002 Lisovsky, M., K.  Dresser, S.  Baker, A.  Fisher, B.  Woda, B.",OADS,/arxiv_data1/oa_pdf/ad/43/JCB_201503067.PMC4621827.pdf
"http://dx.doi.org/10.1038/ modpathol.2009.68 Manfruelli, P., N. Arquier, W.P.",OADS,/arxiv_data1/oa_pdf/ad/43/JCB_201503067.PMC4621827.pdf
"http://dx.doi.org/10.1006/exnr.1999.7033 Plant, P.J., J.P.  Fawcett, D.C.  Lin, A.D.  Holdorf, K.  Binns, S.  Kulkarni, and  T. Pawson.",OADS,/arxiv_data1/oa_pdf/ad/43/JCB_201503067.PMC4621827.pdf
"http://dx.doi.org/10.1038/ncb948 Poggioli, J., S.J.",Non-OADS,/arxiv_data1/oa_pdf/ad/43/JCB_201503067.PMC4621827.pdf
"http://dx.doi.org/10.1083/jcb.201309079 Rolls, M.M., R. Albertson, H.P.",OADS,/arxiv_data1/oa_pdf/ad/43/JCB_201503067.PMC4621827.pdf
"http://dx.doi.org/10.1083/ jcb.200306079Royou, A., C. Field, J.C. Sisson, W. Sullivan, and R. Karess.",OADS,/arxiv_data1/oa_pdf/ad/43/JCB_201503067.PMC4621827.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ad/43/JCB_201503067.PMC4621827.pdf
"http://dx.doi.org/10.1038/sj.onc.1208520 Sotillos, S., M.T.",Non-OADS,/arxiv_data1/oa_pdf/ad/43/JCB_201503067.PMC4621827.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ad/43/JCB_201503067.PMC4621827.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ad/43/JCB_201503067.PMC4621827.pdf
"http://dx.doi.org/10.1126/science.1152066 Zhou, W., and Y .",OADS,/arxiv_data1/oa_pdf/ad/43/JCB_201503067.PMC4621827.pdf
"http://dx.doi.org/10.1242/dev.083162 Zhu, J., Y .",OADS,/arxiv_data1/oa_pdf/ad/43/JCB_201503067.PMC4621827.pdf
http://dx.doi.org/10.1038/cr.2014.16,Non-OADS,/arxiv_data1/oa_pdf/ad/43/JCB_201503067.PMC4621827.pdf
"These new maps—comprehensive  nanometer-scale cellular cartographies—will reveal how  the molecular organization of cells influences their diverse  and changeable activities.Cell biology of the future: Nanometer- scale cellular cartography Justin W. Taraska Biochemistry and Biophysics Center, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892 Copyright © 2015 Taraska This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms).",Non-OADS,/arxiv_data1/oa_pdf/c7/8e/JCB_201508021.PMC4621831.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).Correspondence to Justin W. Taraska: justin.taraska@nih.gov Abbreviations used in this paper: cryo-EM, cryogenic EM; SRF, super-resolution  fluorescence.THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/c7/8e/JCB_201508021.PMC4621831.pdf
"http://dx.doi.org/10.1126/science.1261197 Chong, Y .T., J.L.",OADS,/arxiv_data1/oa_pdf/c7/8e/JCB_201508021.PMC4621831.pdf
162:221) http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/c7/8e/JCB_201508021.PMC4621831.pdf
"http://dx.doi.org/10.1038/nmeth.3400 Doyon, J.B., B.  Zeitler, J.  Cheng, A.T.  Cheng, J.M.",OADS,/arxiv_data1/oa_pdf/c7/8e/JCB_201508021.PMC4621831.pdf
"http://dx.doi.org/10.1038/ncb2175 Farquhar, M.G. 2012.",Non-OADS,/arxiv_data1/oa_pdf/c7/8e/JCB_201508021.PMC4621831.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c7/8e/JCB_201508021.PMC4621831.pdf
"21:1347– 1355. http://dx.doi.org/10.1038/nbt895 Helma, J., M.C.",Non-OADS,/arxiv_data1/oa_pdf/c7/8e/JCB_201508021.PMC4621831.pdf
"http://dx.doi.org/10.1091/mbc.E14-05-1016 Huang, B., M. Bates, and X. Zhuang.",OADS,/arxiv_data1/oa_pdf/c7/8e/JCB_201508021.PMC4621831.pdf
"http://dx.doi.org/10.1146/ annurev.biochem.77.061906.092014 Huh, W.K., J.V .",OADS,/arxiv_data1/oa_pdf/c7/8e/JCB_201508021.PMC4621831.pdf
"http://dx.doi.org/10.1038/nature02026 Irannejad, R., J.C. Tomshine, J.R. Tomshine, M. Chevalier, J.P. Mahoney, J. Steyaert,  S.G.  Rasmussen, R.K.  Sunahara, H.  El-Samad, B.  Huang, and M.  von Zastrow.",OADS,/arxiv_data1/oa_pdf/c7/8e/JCB_201508021.PMC4621831.pdf
"http://dx.doi.org/10.1038/nature12000 Kanchanawong, P., G. Shtengel, A.M. Pasapera, E.B.",Non-OADS,/arxiv_data1/oa_pdf/c7/8e/JCB_201508021.PMC4621831.pdf
"http://dx.doi.org/10.1038/ nature09621 Kukulski, W., M. Schorb, M. Kaksonen, and J.A. Briggs.",OADS,/arxiv_data1/oa_pdf/c7/8e/JCB_201508021.PMC4621831.pdf
"http://dx.doi.org/10.1016/j.cell.2012.05.046 Larson, B.T., K.A.",OADS,/arxiv_data1/oa_pdf/c7/8e/JCB_201508021.PMC4621831.pdf
"http://dx.doi.org/10.1091/mbc.E14-02-0771 Li, D., L.  Shao, B.C.",OADS,/arxiv_data1/oa_pdf/c7/8e/JCB_201508021.PMC4621831.pdf
"http://dx.doi.org/10.1126/science.aab3500 Liu, Z., L.D.",OADS,/arxiv_data1/oa_pdf/c7/8e/JCB_201508021.PMC4621831.pdf
"http://dx.doi.org/10.1016/j.molcel.2015.02.033 Lučič, V ., A. Rigort, and W. Baumeister.",OADS,/arxiv_data1/oa_pdf/c7/8e/JCB_201508021.PMC4621831.pdf
"http://dx.doi.org/10.1083/jcb.201304193 Palade, G. 1975.",Non-OADS,/arxiv_data1/oa_pdf/c7/8e/JCB_201508021.PMC4621831.pdf
http://dx.doi.org/10.1126/science.1096303,Non-OADS,/arxiv_data1/oa_pdf/c7/8e/JCB_201508021.PMC4621831.pdf
"http://dx.doi.org/10.1177/26.12.366014 Sochacki, K.A., G. Shtengel, S.B.",Non-OADS,/arxiv_data1/oa_pdf/c7/8e/JCB_201508021.PMC4621831.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c7/8e/JCB_201508021.PMC4621831.pdf
"347:1260419.  http://dx.doi.org/10.1126/science.1260419 Wilson, E.B. 1925.",Non-OADS,/arxiv_data1/oa_pdf/c7/8e/JCB_201508021.PMC4621831.pdf
http://dx.doi.org/10.1126/science.1232251,Non-OADS,/arxiv_data1/oa_pdf/c7/8e/JCB_201508021.PMC4621831.pdf
This article is distributed under the terms of an Attribution–Noncommercial– Share Alike–No Mirror Sites license for the first six months after the publication date (see  http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/f4/73/JCB_201502032.PMC4621839.pdf
"After six months it is available under a Creative Commons  License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at  http://creativecommons.org/licenses/by-nc-sa/3.0/).Correspondence to Tim Megraw: timothy.megraw@med.fsu.edu; or Jieyan  Chen: jc09n@my.fsu.edu O.A.",Non-OADS,/arxiv_data1/oa_pdf/f4/73/JCB_201502032.PMC4621839.pdf
Online supplemental material is  available at http://www.jcb.org/cgi/content/full/jcb.201502032/DC1.,Non-OADS,/arxiv_data1/oa_pdf/f4/73/JCB_201502032.PMC4621839.pdf
Additional data are available in the JCB DataViewer at http://dx.doi.,OADS,/arxiv_data1/oa_pdf/f4/73/JCB_201502032.PMC4621839.pdf
"http://dx.doi.org/10.1083/jcb.200504107 Basto, R., J.Lau, T.Vinogradova, A.Gardiol, C.G.Woods, A.Khodjakov, and  J.W.Raff.",Non-OADS,/arxiv_data1/oa_pdf/f4/73/JCB_201502032.PMC4621839.pdf
"http://dx.doi.org/10.1534/ genetics.109.101709 Caldwell, J.C., M.M.Miller, S.Wing, D.R.Soll, and D.F.Eberl.",OADS,/arxiv_data1/oa_pdf/f4/73/JCB_201502032.PMC4621839.pdf
"http://dx.doi.org/10.1073/ pnas.2535546100 Carvalho-Santos, Z., P.Machado, I.Alvarez-Martins, S.M.Gouveia, S.C.Jana,  P.Duarte, T.Amado, P.Branco, M.C.Freitas, S.T.Silva, et al.2012.",OADS,/arxiv_data1/oa_pdf/f4/73/JCB_201502032.PMC4621839.pdf
"http://dx.doi.org/10.1016/j.devcel.2012.06.001 Chen, J.V ., and T.L.Megraw.",OADS,/arxiv_data1/oa_pdf/f4/73/JCB_201502032.PMC4621839.pdf
"http://dx.doi.org/10.1371/ journal.pone.0108802 Cherbas, P., L.Cherbas, S.S.Lee, and K.Nakanishi.",OADS,/arxiv_data1/oa_pdf/f4/73/JCB_201502032.PMC4621839.pdf
"http://dx.doi.org/10.4161/fly.7366 Dix, C.I., and J.W.Raff.",OADS,/arxiv_data1/oa_pdf/f4/73/JCB_201502032.PMC4621839.pdf
"http://dx.doi.org/10.1016/j.cub.2007.08.065 Eberl, D.F., and G.Boekhoff-Falk.",OADS,/arxiv_data1/oa_pdf/f4/73/JCB_201502032.PMC4621839.pdf
"http://dx.doi.org/10.1387/ ijdb.072364de Eberl, D.F., and M.J.Kernan.",OADS,/arxiv_data1/oa_pdf/f4/73/JCB_201502032.PMC4621839.pdf
"http://dx.doi.org/10.1101/pdb.prot5576 Eberl, D.F., R.W.Hardy, and M.J.Kernan.",Non-OADS,/arxiv_data1/oa_pdf/f4/73/JCB_201502032.PMC4621839.pdf
"http://dx.doi.org/10.1083/jcb.201109148 Fawcett, D.W., and K.R.Porter.",Non-OADS,/arxiv_data1/oa_pdf/f4/73/JCB_201502032.PMC4621839.pdf
"http://dx.doi.org/10.1002/ jmor.1050940202 Foelix, R.F., R.F.Stocker, and R.A.Steinbrecht.",OADS,/arxiv_data1/oa_pdf/f4/73/JCB_201502032.PMC4621839.pdf
"http://dx.doi.org/10.1007/BF00239448 Galletta, B.J., R.X.Guillen, C.J.Fagerstrom, C.W.Brownlee, D.A.Lerit,  T.L.Megraw, G.C.Rogers, and N.M.Rusan.",Non-OADS,/arxiv_data1/oa_pdf/f4/73/JCB_201502032.PMC4621839.pdf
"http://dx.doi.org/10.1091/mbc.E13-10-0617 Gallio, M., T.A.Ofstad, L.J.Macpherson, J.W.Wang, and C.S.Zuker.",Non-OADS,/arxiv_data1/oa_pdf/f4/73/JCB_201502032.PMC4621839.pdf
"http://dx.doi.org/10.1016/j.cell.2011.01.028 Gargano, J.W., I.Martin, P.Bhandari, and M.S.Grotewiel.",OADS,/arxiv_data1/oa_pdf/f4/73/JCB_201502032.PMC4621839.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f4/73/JCB_201502032.PMC4621839.pdf
"http://dx.doi.org/10.1016/j.cub.2008.01.058 Gillespie, P.G., and R.G.Walker.",OADS,/arxiv_data1/oa_pdf/f4/73/JCB_201502032.PMC4621839.pdf
"http://dx.doi.org/10.1038/35093011 Goetz, S.C., and K.V .Anderson.",Non-OADS,/arxiv_data1/oa_pdf/f4/73/JCB_201502032.PMC4621839.pdf
"http://dx.doi.org/10.1016/j.cub.2003.08.034 Henikoff, S., B.J.Till, and L.Comai.",OADS,/arxiv_data1/oa_pdf/f4/73/JCB_201502032.PMC4621839.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f4/73/JCB_201502032.PMC4621839.pdf
"http://dx.doi.org/10.1056/NEJMra1010172 Hyams, J.S., and G.G.Borisy.",OADS,/arxiv_data1/oa_pdf/f4/73/JCB_201502032.PMC4621839.pdf
"http://dx.doi.org/10.1126/science.1098148 Januschke, J., S.Llamazares, J.Reina, and C.Gonzalez.",Non-OADS,/arxiv_data1/oa_pdf/f4/73/JCB_201502032.PMC4621839.pdf
Commun.2:243. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f4/73/JCB_201502032.PMC4621839.pdf
"http://dx.doi.org/10.1038/ncb2671 Jarman, A.P.2002.",OADS,/arxiv_data1/oa_pdf/f4/73/JCB_201502032.PMC4621839.pdf
"http://dx.doi.org/10.1093/hmg/11.10.1215 Kamikouchi, A., H.K.Inagaki, T.Effertz, O.Hendrich, A.Fiala, M.C.Göpfert, and  K.Ito.",OADS,/arxiv_data1/oa_pdf/f4/73/JCB_201502032.PMC4621839.pdf
"http://dx.doi.org/10.1038/nature07810 Kao, L.R., and T.L.Megraw.",OADS,/arxiv_data1/oa_pdf/f4/73/JCB_201502032.PMC4621839.pdf
http://dx.doi.org/10.1016/j.cub.2009.04.037,OADS,/arxiv_data1/oa_pdf/f4/73/JCB_201502032.PMC4621839.pdf
"http://dx.doi.org/10.1016/0896-6273(94)90437-5 Kim, K., S.Lee, J.Chang, and K.Rhee.",OADS,/arxiv_data1/oa_pdf/f4/73/JCB_201502032.PMC4621839.pdf
"http://dx.doi.org/10.1016/j.yexcr.2008.09.016 Lechtreck, K.F., and M.Melkonian.",OADS,/arxiv_data1/oa_pdf/f4/73/JCB_201502032.PMC4621839.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f4/73/JCB_201502032.PMC4621839.pdf
"http://dx.doi.org/10.1016/S0896-6273(00)80701-1 Lee, E., E.Sivan-Loukianova, D.F.Eberl, and M.J.Kernan.",OADS,/arxiv_data1/oa_pdf/f4/73/JCB_201502032.PMC4621839.pdf
"http://dx.doi.org/10.1016/j.cub.2008.11.020 Lerit, D.A., and N.M.Rusan.",OADS,/arxiv_data1/oa_pdf/f4/73/JCB_201502032.PMC4621839.pdf
"http://dx.doi.org/10.1016/0896-6273(94)90022-1 Martinez-Campos, M., R.Basto, J.Baker, M.Kernan, and J.W.Raff.",OADS,/arxiv_data1/oa_pdf/f4/73/JCB_201502032.PMC4621839.pdf
"http://dx.doi.org/10.1083/jcb.200402130 Mayor, T., Y .D.Stierhof, K.Tanaka, A.M.Fry, and E.A.Nigg.",OADS,/arxiv_data1/oa_pdf/f4/73/JCB_201502032.PMC4621839.pdf
"http://dx.doi.org/10.1083/jcb.151.4.837 Mayor, T., U.Hacker, Y .D.Stierhof, and E.A.Nigg.",OADS,/arxiv_data1/oa_pdf/f4/73/JCB_201502032.PMC4621839.pdf
"http://dx.doi.org/10.1016/j.cub.2013.08.033 Mottier-Pavie, V ., and T.L.Megraw.",OADS,/arxiv_data1/oa_pdf/f4/73/JCB_201502032.PMC4621839.pdf
"http://dx.doi.org/10.1091/mbc.E08-11-1115 Ni, L., P.Bronk, E.C.Chang, A.M.Lowell, J.O.Flam, V .C.Panzano, D.L.Theobald,  L.C.Griffith, and P.A.Garrity.",Non-OADS,/arxiv_data1/oa_pdf/f4/73/JCB_201502032.PMC4621839.pdf
"Biol.5:4. http://dx.doi.org/10.1186/1471-213X-5-4 Park, J., J.Lee, J.Shim, W.Han, J.Lee, Y .C.Bae, Y .D.Chung, C.H.Kim, and  S.J.Moon.",OADS,/arxiv_data1/oa_pdf/f4/73/JCB_201502032.PMC4621839.pdf
"http://dx.doi.org/10.1371/journal.pgen.1003814Phelps, C.B., and A.H.Brand.",Non-OADS,/arxiv_data1/oa_pdf/f4/73/JCB_201502032.PMC4621839.pdf
"http://dx.doi.org/10.1006/meth.1998.0592 Rhodenizer, D., I.Martin, P.Bhandari, S.D.Pletcher, and M.Grotewiel.",OADS,/arxiv_data1/oa_pdf/f4/73/JCB_201502032.PMC4621839.pdf
"http://dx.doi.org/10.1016/j.exger.2008.04.011 Rodrigues-Martins, A., M.Bettencourt-Dias, M.Riparbelli, C.Ferreira, I.Ferreira,  G.Callaini, and D.M.Glover.",OADS,/arxiv_data1/oa_pdf/f4/73/JCB_201502032.PMC4621839.pdf
"http://dx.doi.org/10.1016/j.cub.2007.07.034 Sarpal, R., S.V .Todi, E.Sivan-Loukianova, S.Shirolikar, N.Subramanian,  E.C.Raff, J.W.Erickson, K.Ray, and D.F.Eberl.",OADS,/arxiv_data1/oa_pdf/f4/73/JCB_201502032.PMC4621839.pdf
"http://dx.doi.org/10.1016/j.cub.2003.09.025 Sedat, J.",OADS,/arxiv_data1/oa_pdf/f4/73/JCB_201502032.PMC4621839.pdf
"http://flybase.org/reports/FBrf0205896.html  (accessed January 10, 2015).",Non-OADS,/arxiv_data1/oa_pdf/f4/73/JCB_201502032.PMC4621839.pdf
"http://dx.doi.org/10.1002/gene.10127 Shiraiwa, T., and J.R.Carlson.",OADS,/arxiv_data1/oa_pdf/f4/73/JCB_201502032.PMC4621839.pdf
"http://dx.doi.org/10.1093/nar/gkt1092 Styczynska-Soczka, K., and A.P.Jarman.",OADS,/arxiv_data1/oa_pdf/f4/73/JCB_201502032.PMC4621839.pdf
Cilia.4:9.  http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f4/73/JCB_201502032.PMC4621839.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f4/73/JCB_201502032.PMC4621839.pdf
"http://dx.doi.org/10.1016/j.cub.2007.09.031 Yang, J., and T.Li.",OADS,/arxiv_data1/oa_pdf/f4/73/JCB_201502032.PMC4621839.pdf
"http://dx.doi.org/10.1016/j.yexcr.2005.05.026 Yang, J., X.Liu, G.Yue, M.Adamian, O.Bulgakov, and T.Li.",OADS,/arxiv_data1/oa_pdf/f4/73/JCB_201502032.PMC4621839.pdf
"http://dx.doi.org/10.1083/jcb.200207153 Yang, J., J.Gao, M.Adamian, X.H.Wen, B.Pawlyk, L.Zhang, M.J.Sanderson,  J.Zuo, C.L.Makino, and T.Li.",OADS,/arxiv_data1/oa_pdf/f4/73/JCB_201502032.PMC4621839.pdf
"http://dx.doi.org/10.1091/mbc.E05-10-0943 Zhang, J., and T.L.Megraw.",OADS,/arxiv_data1/oa_pdf/f4/73/JCB_201502032.PMC4621839.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f4/73/JCB_201502032.PMC4621839.pdf
"Our findings indicate that dynein activity is directly switched “on” by Num1, which induces  Pac1/LIS1 removal.The dynein cortical anchor Num1 activates dynein  motility by relieving Pac1/LIS1-mediated inhibition Lindsay G. Lammers and Steven M. Markus Department of Biochemistry and Molecular Biology, Colorado State University, Fort Collins, CO 80523 © 2015 Lammers and Markus This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms ).",Non-OADS,/arxiv_data1/oa_pdf/af/e5/JCB_201506119.PMC4621840.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/ ).Correspondence to Steven M. Markus: steven.markus@colostate.edu Abbreviations used in this paper: MTBD, microtubule-binding domain; PH,  pleckstrin homology; SPB, spindle pole body.THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/af/e5/JCB_201506119.PMC4621840.pdf
Online supplemental material is available at http://www.jcb.org/ cgi/content/full/jcb.201506119/DC1 .,Non-OADS,/arxiv_data1/oa_pdf/af/e5/JCB_201506119.PMC4621840.pdf
"http://dx.doi.org/10.1083/jcb.149.4.863Ananthanarayanan, V ., M.  Schattat, S.K.",Non-OADS,/arxiv_data1/oa_pdf/af/e5/JCB_201506119.PMC4621840.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/af/e5/JCB_201506119.PMC4621840.pdf
"http://dx.doi.org/10.1083/jcb.138.3.629 Carvalho, P., M.L.",OADS,/arxiv_data1/oa_pdf/af/e5/JCB_201506119.PMC4621840.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/af/e5/JCB_201506119.PMC4621840.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/af/e5/JCB_201506119.PMC4621840.pdf
"http://dx.doi.org/10.1038/ nmeth.1318 Goshima, G., F. Nédélec, and R.D. Vale.",OADS,/arxiv_data1/oa_pdf/af/e5/JCB_201506119.PMC4621840.pdf
"http://dx.doi.org/10.1083/jcb.200505107 Gray, M., M. Kupiec, and S.M. Honigberg.",OADS,/arxiv_data1/oa_pdf/af/e5/JCB_201506119.PMC4621840.pdf
"4:7.  http://dx.doi.org/10.1186/1472-6750-4-7 Huang, J., A.J.",Non-OADS,/arxiv_data1/oa_pdf/af/e5/JCB_201506119.PMC4621840.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/af/e5/JCB_201506119.PMC4621840.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/af/e5/JCB_201506119.PMC4621840.pdf
"http://dx.doi.org/10.1002/(SICI)1097-0061(199907)15:   10B<963::AID-YEA399>3.0.CO;2-W Kushnirov, V .V .",OADS,/arxiv_data1/oa_pdf/af/e5/JCB_201506119.PMC4621840.pdf
"http://dx.doi.org/10.1002/1097- 0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B Lee, W.L., J.R.  Oberle, and J.A.",OADS,/arxiv_data1/oa_pdf/af/e5/JCB_201506119.PMC4621840.pdf
"http://dx.doi.org/10.1083/jcb.200209022 Lee, W.L., M.A.",OADS,/arxiv_data1/oa_pdf/af/e5/JCB_201506119.PMC4621840.pdf
"168:201– 207. http://dx.doi.org/10.1083/jcb.200407036 Li, Y .Y ., E. Yeh, T. Hays, and K. Bloom.",OADS,/arxiv_data1/oa_pdf/af/e5/JCB_201506119.PMC4621840.pdf
"http://dx.doi.org/10.1002/ (SICI)1097-0061(199807)14:10<953::AID-YEA293>3.0.CO;2-U Markus, S.M., and W.L. Lee.",OADS,/arxiv_data1/oa_pdf/af/e5/JCB_201506119.PMC4621840.pdf
"http://dx.doi.org/10.1016/j.cub.2008.12.047 Markus, S.M., K.M.",OADS,/arxiv_data1/oa_pdf/af/e5/JCB_201506119.PMC4621840.pdf
http://dx.doi.org/10.1002/ cm.20502,Non-OADS,/arxiv_data1/oa_pdf/af/e5/JCB_201506119.PMC4621840.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/af/e5/JCB_201506119.PMC4621840.pdf
"http://dx.doi.org/10.1111/tra.12276 Matanis, T., A.  Akhmanova, P.  Wulf, E.  Del Nery, T.  Weide, T.  Stepanova,  N. Galjart, F. Grosveld, B. Goud, C.I.",Non-OADS,/arxiv_data1/oa_pdf/af/e5/JCB_201506119.PMC4621840.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/af/e5/JCB_201506119.PMC4621840.pdf
"http://dx.doi.org/10.1016/j.cell.2010.02.035 McKenney, R.J., W.  Huynh, M.E.",OADS,/arxiv_data1/oa_pdf/af/e5/JCB_201506119.PMC4621840.pdf
"http://dx.doi.org/10.1126/ science.1254198 Miura, M., A.  Matsubara, T.  Kobayashi, M.  Edamatsu, and Y .Y .",OADS,/arxiv_data1/oa_pdf/af/e5/JCB_201506119.PMC4621840.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/af/e5/JCB_201506119.PMC4621840.pdf
"http://dx.doi.org/10.7554/eLife.02641 Rusan, N.M., U.S. Tulu, C. Fagerstrom, and P. Wadsworth.",OADS,/arxiv_data1/oa_pdf/af/e5/JCB_201506119.PMC4621840.pdf
"http://dx.doi.org/10.1083/jcb.200204109 Samora, C.P., B. Mogessie, L. Conway, J.L.",Non-OADS,/arxiv_data1/oa_pdf/af/e5/JCB_201506119.PMC4621840.pdf
"http://dx.doi.org/10.15252/ embj.201488792Schmidt, H. 2015.",Non-OADS,/arxiv_data1/oa_pdf/af/e5/JCB_201506119.PMC4621840.pdf
"http://dx.doi.org/10.1002/bies.201400215 Sheeman, B., P.  Carvalho, I.  Sagot, J.  Geiser, D.  Kho, M.A.",OADS,/arxiv_data1/oa_pdf/af/e5/JCB_201506119.PMC4621840.pdf
"http://dx.doi.org/10.1016/ S0960-9822(03)00013-7 Siller, K.H., and C.Q. Doe.",OADS,/arxiv_data1/oa_pdf/af/e5/JCB_201506119.PMC4621840.pdf
"http://dx.doi.org/10.1038/ncb0409-365 Splinter, D., D.S.",Non-OADS,/arxiv_data1/oa_pdf/af/e5/JCB_201506119.PMC4621840.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/af/e5/JCB_201506119.PMC4621840.pdf
"http://dx.doi.org/10.1083/jcb.201112017 Tokunaga, M., N.  Imamoto, and K.  Sakata-Sogawa.",OADS,/arxiv_data1/oa_pdf/af/e5/JCB_201506119.PMC4621840.pdf
"http://dx.doi.org/10.1038/nmeth1171 Toropova, K., S. Zou, A.J.",OADS,/arxiv_data1/oa_pdf/af/e5/JCB_201506119.PMC4621840.pdf
3:3.  http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/af/e5/JCB_201506119.PMC4621840.pdf
"http://dx.doi.org/10.1083/ jcb.201407039 Urnavicius, L., K.  Zhang, A.G.  Diamant, C.  Motz, M.A.",OADS,/arxiv_data1/oa_pdf/af/e5/JCB_201506119.PMC4621840.pdf
"http://dx.doi.org/10.1126/science.aaa4080 Williams, S.E., S. Beronja, H.A.",OADS,/arxiv_data1/oa_pdf/af/e5/JCB_201506119.PMC4621840.pdf
"http://dx.doi.org/10.1038/nature09793 Woodruff, J.B., D.G.",OADS,/arxiv_data1/oa_pdf/af/e5/JCB_201506119.PMC4621840.pdf
"http://dx.doi.org/10.1091/ mbc.E09-03-0186 Yamada, M., S. Toba, Y .",OADS,/arxiv_data1/oa_pdf/af/e5/JCB_201506119.PMC4621840.pdf
"http://dx.doi.org/10.1038/emboj.2008.182 Yang, Z., U.S. Tulu, P. Wadsworth, and C.L. Rieder.",OADS,/arxiv_data1/oa_pdf/af/e5/JCB_201506119.PMC4621840.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/af/e5/JCB_201506119.PMC4621840.pdf
This article is distributed under the terms of an Attribution–Noncommercial– Share Alike–No Mirror Sites license for the first six months after the publication date (see  http://www.rupress.org/terms).,Non-OADS,/arxiv_data1/oa_pdf/09/78/JCB_201409035.PMC4621841.pdf
"After six months it is available under a Creative Commons  License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at  http://creativecommons.org/licenses/by-nc-sa/3.0/).Correspondence to Needhi Bhalla: nbhalla@ucsc.edu Abbreviations used in this paper: APC, anaphase-promoting complex; IP, immu - noprecipitation; NPC, nuclear pore complex; PC, pairing center; SAC, spindle  assembly checkpoint; SC, synaptonemal complex.THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/09/78/JCB_201409035.PMC4621841.pdf
Online supplemental material is available  at http://www.jcb.org/cgi/content/full/jcb.201409035/DC1.,Non-OADS,/arxiv_data1/oa_pdf/09/78/JCB_201409035.PMC4621841.pdf
"http://dx.doi.org/10.1101/ gad.1865909 Bhalla, N., and A.F. Dernburg.",Non-OADS,/arxiv_data1/oa_pdf/09/78/JCB_201409035.PMC4621841.pdf
"310:1683– 1686. http://dx.doi.org/10.1126/science.1117468 Bhalla, N., and A.F.",Non-OADS,/arxiv_data1/oa_pdf/09/78/JCB_201409035.PMC4621841.pdf
"http://dx.doi.org/10.1146/annurev.cellbio.23.090506.123245 Brenner, S. 1974.",OADS,/arxiv_data1/oa_pdf/09/78/JCB_201409035.PMC4621841.pdf
"http://dx.doi.org/10.1038/nrm2310 Davis, L.I., and G.  Blobel.",OADS,/arxiv_data1/oa_pdf/09/78/JCB_201409035.PMC4621841.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/09/78/JCB_201409035.PMC4621841.pdf
"http://dx.doi.org/10.1083/jcb.153.6.F33 Dernburg, A.F., K.  McDonald, G.  Moulder, R.  Barstead, M.  Dresser, and  A.M.  Villeneuve.",Non-OADS,/arxiv_data1/oa_pdf/09/78/JCB_201409035.PMC4621841.pdf
"http://dx.doi.org/10.1016/S0092-8674(00)81481-6 Derry, W.B., A.P.",OADS,/arxiv_data1/oa_pdf/09/78/JCB_201409035.PMC4621841.pdf
"http://dx.doi.org/10.1126/science.1065486 Deshong, A.J., A.L.",OADS,/arxiv_data1/oa_pdf/09/78/JCB_201409035.PMC4621841.pdf
http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/09/78/JCB_201409035.PMC4621841.pdf
"http://dx.doi.org/10.1091/mbc.E08-10-1047 Foley, E.A., and T.M. Kapoor.",Non-OADS,/arxiv_data1/oa_pdf/09/78/JCB_201409035.PMC4621841.pdf
"http://dx.doi.org/10.1038/nrm3494 Fraser, A.G., R.S.",Non-OADS,/arxiv_data1/oa_pdf/09/78/JCB_201409035.PMC4621841.pdf
"http://dx.doi.org/10.1038/35042517 Golden, A., P.L.",Non-OADS,/arxiv_data1/oa_pdf/09/78/JCB_201409035.PMC4621841.pdf
"http://dx.doi.org/10.1083/jcb.151.7.1469 Gourguechon, S., L.J.",Non-OADS,/arxiv_data1/oa_pdf/09/78/JCB_201409035.PMC4621841.pdf
"http://dx.doi.org/10.1242/jcs.121632 Hamill, D.R., A.F.",Non-OADS,/arxiv_data1/oa_pdf/09/78/JCB_201409035.PMC4621841.pdf
"http://dx.doi.org/10.1038/35066065 Herman, R.K., and C.K. Kari.",Non-OADS,/arxiv_data1/oa_pdf/09/78/JCB_201409035.PMC4621841.pdf
"http://dx.doi.org/10.1016/j.cell.2009.04.043 Jaramillo-Lambert, A., M. Ellefson, A.M. Villeneuve, and J. Engebrecht.",OADS,/arxiv_data1/oa_pdf/09/78/JCB_201409035.PMC4621841.pdf
"http://dx.doi.org/10.1016/j.ydbio.2007.05.019 Kitagawa, R., and A.M. Rose.",OADS,/arxiv_data1/oa_pdf/09/78/JCB_201409035.PMC4621841.pdf
http://dx.doi.org/10.1038/70309,Non-OADS,/arxiv_data1/oa_pdf/09/78/JCB_201409035.PMC4621841.pdf
"http://dx.doi.org/10.1016/j.devcel.2011.07.011 Labrador, L., C.  Barroso, J.  Lightfoot, T.  Müller-Reichert, S.  Flibotte,  J.  Taylor, D.G.",OADS,/arxiv_data1/oa_pdf/09/78/JCB_201409035.PMC4621841.pdf
http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/09/78/JCB_201409035.PMC4621841.pdf
"http://dx.doi.org/10.1101/gad.1011602 MacQueen, A.J., C.M.",Non-OADS,/arxiv_data1/oa_pdf/09/78/JCB_201409035.PMC4621841.pdf
"http://dx.doi.org/10.1016/j.cell.2005.09.034 Maresca, T.J., and E.D. Salmon.",OADS,/arxiv_data1/oa_pdf/09/78/JCB_201409035.PMC4621841.pdf
"http://dx.doi.org/10.1242/jcs.064790 Murray, A.W. 1992.",Non-OADS,/arxiv_data1/oa_pdf/09/78/JCB_201409035.PMC4621841.pdf
"http://dx.doi.org/10.1038/359599a0 O’Rourke, S.M., M.D.",Non-OADS,/arxiv_data1/oa_pdf/09/78/JCB_201409035.PMC4621841.pdf
http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/09/78/JCB_201409035.PMC4621841.pdf
"http://dx.doi.org/10.1016/j.devcel.2007.05.004 Penkner, A.M., A.  Fridkin, J.  Gloggnitzer, A.  Baudrimont, T.  Machacek,  A.  Woglar, E.  Csaszar, P.  Pasierbek, G.  Ammerer, Y .",OADS,/arxiv_data1/oa_pdf/09/78/JCB_201409035.PMC4621841.pdf
"139:920– 933. http://dx.doi.org/10.1016/j.cell.2009.10.045 Phillips, C.M., and A.F.",OADS,/arxiv_data1/oa_pdf/09/78/JCB_201409035.PMC4621841.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/09/78/JCB_201409035.PMC4621841.pdf
"123:1051– 1063. http://dx.doi.org/10.1016/j.cell.2005.09.035 Ródenas, E., C. González-Aguilera, C. Ayuso, and P. Askjaer.",OADS,/arxiv_data1/oa_pdf/09/78/JCB_201409035.PMC4621841.pdf
"http://dx.doi.org/10.1091/mbc.E11-11-0927Rog, O., and A.F. Dernburg.",OADS,/arxiv_data1/oa_pdf/09/78/JCB_201409035.PMC4621841.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/09/78/JCB_201409035.PMC4621841.pdf
"139:907– 919. http://dx.doi.org/10.1016/j.cell.2009.10.039 Schumacher, B., K. Hofmann, S. Boulton, and A. Gartner.",OADS,/arxiv_data1/oa_pdf/09/78/JCB_201409035.PMC4621841.pdf
"http://dx.doi.org/10.1016/S0960-9822(01)00534-6 Shonn, M.A., A.L.",OADS,/arxiv_data1/oa_pdf/09/78/JCB_201409035.PMC4621841.pdf
"http://dx.doi.org/10.1016/j.cub.2003.10.057 Stein, K.K., E.S.",OADS,/arxiv_data1/oa_pdf/09/78/JCB_201409035.PMC4621841.pdf
"http://dx.doi.org/10.1016/j.cub.2013.10.015 Sudakin, V ., G.K. Chan, and T.J. Yen.",OADS,/arxiv_data1/oa_pdf/09/78/JCB_201409035.PMC4621841.pdf
"http://dx.doi.org/10.1083/ jcb.200102093 Takeo, S., C.M.",OADS,/arxiv_data1/oa_pdf/09/78/JCB_201409035.PMC4621841.pdf
"http://dx.doi.org/10.1016/j.cub.2011.10.005 Tsubouchi, T., and G.S.",OADS,/arxiv_data1/oa_pdf/09/78/JCB_201409035.PMC4621841.pdf
"http://dx.doi.org/10.1126/science.1108283 Tsubouchi, T., A.J.",OADS,/arxiv_data1/oa_pdf/09/78/JCB_201409035.PMC4621841.pdf
"22:3217– 3226. http://dx.doi.org/10.1101/gad.1709408 Vicente, J.J., and W.Z. Cande.",Non-OADS,/arxiv_data1/oa_pdf/09/78/JCB_201409035.PMC4621841.pdf
"http://dx.doi.org/10.1091/mbc.E14-05-0975 Villeneuve, A.M. 1994.",Non-OADS,/arxiv_data1/oa_pdf/09/78/JCB_201409035.PMC4621841.pdf
"http://dx.doi.org/10.1371/journal.pgen.1003335 Wynne, D.J., O. Rog, P.M. Carlton, and A.F. Dernburg.",Non-OADS,/arxiv_data1/oa_pdf/09/78/JCB_201409035.PMC4621841.pdf
"http://dx.doi.org/10.1083/jcb.201106022 Yamamoto, T.G., S. Watanabe, A. Essex, and R. Kitagawa.",OADS,/arxiv_data1/oa_pdf/09/78/JCB_201409035.PMC4621841.pdf
http://dx.doi.org/10.1083/jcb.200805185,Non-OADS,/arxiv_data1/oa_pdf/09/78/JCB_201409035.PMC4621841.pdf
This article is distributed under the terms of an Attribution– Noncommercial–Share Alike–No Mirror Sites license for the first six months after the pub - lication date (see http://www.rupress.org/terms ).,Non-OADS,/arxiv_data1/oa_pdf/8f/cc/JCB_201506123.PMC4621842.pdf
"After six months it is available under a  Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license,  as described at http://creativecommons.org/licenses/by-nc-sa/3.0/ ).Correspondence to Edward Avezov: ea347@cam.ac.uk ; or David Ron: dr360@ medschl.cam.ac.uk Abbreviations used in this paper: DKO, double knockout; MEF, mouse embry - onic fibroblast; PDI, protein disulfide isomerase; PKO, peroxiredoxin 4 knock - out; roGFP, redox-sensitive GFP; TKO, triple knockout.THE JOURNAL OF CELL BIOLOGY",Non-OADS,/arxiv_data1/oa_pdf/8f/cc/JCB_201506123.PMC4621842.pdf
Online supplemental material is available at http://www.jcb.org/ cgi/content/full/jcb.201506123/DC1 .,Non-OADS,/arxiv_data1/oa_pdf/8f/cc/JCB_201506123.PMC4621842.pdf
Additional data are available in  the JCB DataViewer at http://dx.doi.org/10.1083/jcb.201506123.dv .,OADS,/arxiv_data1/oa_pdf/8f/cc/JCB_201506123.PMC4621842.pdf
"http://dx.doi.org/10.1083/jcb.201303027 Avezov, E., B.C.",OADS,/arxiv_data1/oa_pdf/8f/cc/JCB_201506123.PMC4621842.pdf
"http://dx.doi.org/10.1083/jcb.201211155 Avezov, E., T. Konno, A. Zyryanova, W. Chen, R. Laine, A. Crespillo-Casado,  E.P.",Non-OADS,/arxiv_data1/oa_pdf/8f/cc/JCB_201506123.PMC4621842.pdf
"13:2.  http://dx.doi.org/10.1186/ s12915-014-0112-2 Belousov, V .V ., A.F.",Non-OADS,/arxiv_data1/oa_pdf/8f/cc/JCB_201506123.PMC4621842.pdf
"http://dx.doi.org/10.1038/nmeth866 Frand, A.R., and C.A.",OADS,/arxiv_data1/oa_pdf/8f/cc/JCB_201506123.PMC4621842.pdf
"http://dx.doi.org/10.1016/S1097-2765(00)80017-9 Gross, E., C.S.",OADS,/arxiv_data1/oa_pdf/8f/cc/JCB_201506123.PMC4621842.pdf
"http://dx.doi.org/10.1073/ pnas.0506448103 Gutscher, M., M.C.",OADS,/arxiv_data1/oa_pdf/8f/cc/JCB_201506123.PMC4621842.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8f/cc/JCB_201506123.PMC4621842.pdf
"http://dx.doi.org/10.1074/jbc.M312846200 Hudson, D.A., S.A. Gannon, and C. Thorpe.",Non-OADS,/arxiv_data1/oa_pdf/8f/cc/JCB_201506123.PMC4621842.pdf
"http://dx.doi.org/10.1042/BJ20081526 Lohman, J.R., and S.J. Remington.",OADS,/arxiv_data1/oa_pdf/8f/cc/JCB_201506123.PMC4621842.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8f/cc/JCB_201506123.PMC4621842.pdf
"http://dx.doi.org/10.1016/j.bmc.2010.07.014 Mehmeti, I., S. Lortz, and S. Lenzen.",OADS,/arxiv_data1/oa_pdf/8f/cc/JCB_201506123.PMC4621842.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8f/cc/JCB_201506123.PMC4621842.pdf
"http://dx.doi.org/10.1016/ S1097-2765(00)80018-0 Tavender, T.J., and N.J. Bulleid.",OADS,/arxiv_data1/oa_pdf/8f/cc/JCB_201506123.PMC4621842.pdf
"http://dx.doi.org/10.1242/jcs.067843 Tavender, T.J., J.J.  Springate, and N.J.  Bulleid.",OADS,/arxiv_data1/oa_pdf/8f/cc/JCB_201506123.PMC4621842.pdf
"http://dx.doi.org/10.1038/ emboj.2010.273 Tiedge, M., S. Lortz, J. Drinkgern, and S. Lenzen.",OADS,/arxiv_data1/oa_pdf/8f/cc/JCB_201506123.PMC4621842.pdf
"http://dx.doi.org/10.2337/ diab.46.11.1733 Tiedge, M., S. Lortz, R. Munday, and S. Lenzen.",OADS,/arxiv_data1/oa_pdf/8f/cc/JCB_201506123.PMC4621842.pdf
"http://dx.doi.org/10.2337/diabetes.47.10.1578 Tien, A.C., A.  Rajan, K.L.",Non-OADS,/arxiv_data1/oa_pdf/8f/cc/JCB_201506123.PMC4621842.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/8f/cc/JCB_201506123.PMC4621842.pdf
"http://dx.doi.org/10.1083/ jcb.200207120 Tsunoda, S., E.  Avezov, A.  Zyryanova, T.  Konno, L.  Mendes-Silva, E.  Pinho  Melo, H.P.",Non-OADS,/arxiv_data1/oa_pdf/8f/cc/JCB_201506123.PMC4621842.pdf
"http://dx.doi.org/10.1242/jcs.085530 Zheng, M., F. Aslund, and G. Storz.",OADS,/arxiv_data1/oa_pdf/8f/cc/JCB_201506123.PMC4621842.pdf
"http://dx.doi.org/10.1126/science.279.5357.1718 Zito, E., K.T.",Non-OADS,/arxiv_data1/oa_pdf/8f/cc/JCB_201506123.PMC4621842.pdf
"http://dx.doi.org/10.1083/ jcb.200911086 Zito, E., E.P.",OADS,/arxiv_data1/oa_pdf/8f/cc/JCB_201506123.PMC4621842.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/8f/cc/JCB_201506123.PMC4621842.pdf
http://dx.doi.org/10.1016   /j.molcel.2012.08.010,OADS,/arxiv_data1/oa_pdf/8f/cc/JCB_201506123.PMC4621842.pdf
"http://dx.doi.org/10.1083/jcb.201506002)  describe a tug-of-war mechanism regulating dynein and  kinesin motors to drive endosome tubulation and MT1- MMP delivery to the surface of cancer cells, identifying a  crucial regulatory axis for tumor metastasis.MT1-MMP: Endosomal delivery drives breast cancer  metastasis Stefan Linder Institute for Medical Microbiology, Virology, and Hygiene, University Medical Center Eppendorf, 20246 Hamburg, Germany © 2015 Linder This article is distributed under the terms of an Attribution–Noncommercial– Share Alike–No Mirror Sites license for the first six months after the publication date (see  http://www.rupress.org/terms).",Non-OADS,/arxiv_data1/oa_pdf/5c/35/JCB_201510009.PMC4621844.pdf
"After six months it is available under a Creative Commons  License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at  http://creativecommons.org/licenses/by-nc-sa/3.0/).",Non-OADS,/arxiv_data1/oa_pdf/5c/35/JCB_201510009.PMC4621844.pdf
"http://dx.doi.org/10.1016/S0092-8674(00)00162-8D’Souza-Schorey, C., and P. Chavrier.",OADS,/arxiv_data1/oa_pdf/5c/35/JCB_201510009.PMC4621844.pdf
"http://dx.doi.org/10.1038/nrm1910 French, C.L., F.  Ye, F.  Revetta, B.  Zhang, R.J.  Coffey, M.K.",Non-OADS,/arxiv_data1/oa_pdf/5c/35/JCB_201510009.PMC4621844.pdf
"http://dx.doi.org/10.1083/jcb.201403127 Fukata, M., T. Watanabe, J. Noritake, M. Nakagawa, M. Yamaga, S. Kuroda,  Y .",OADS,/arxiv_data1/oa_pdf/5c/35/JCB_201510009.PMC4621844.pdf
"http://dx.doi.org/10.1016/S0092-8674(02)00800-0 Granger, E., G. McNee, V .",OADS,/arxiv_data1/oa_pdf/5c/35/JCB_201510009.PMC4621844.pdf
"http://dx.doi.org/10.1016/j.semcdb.2014.04.011 Itoh, Y .",OADS,/arxiv_data1/oa_pdf/5c/35/JCB_201510009.PMC4621844.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/5c/35/JCB_201510009.PMC4621844.pdf
"http://dx.doi.org/10.1146/annurev-cellbio-092910-154216 Marchesin, V ., A.  Castro-Castro, C.  Lodillinsky, A.  Castagnino, J.  Cyrta,  H. Bonsang-Kitzis, L. Fuhrmann, M. Irondelle, E. Infante, G. Montagnac,  et al.. 2015.",OADS,/arxiv_data1/oa_pdf/5c/35/JCB_201510009.PMC4621844.pdf
"http://dx.doi.org/10.1083/jcb.201506002 Mazzone, M., M.  Baldassarre, G.  Beznoussenko, G.  Giacchetti, J.  Cao,  S. Zucker, A. Luini, and R. Buccione.",Non-OADS,/arxiv_data1/oa_pdf/5c/35/JCB_201510009.PMC4621844.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5c/35/JCB_201510009.PMC4621844.pdf
"http://dx.doi.org/10.1016/j.cub.2008.12.043 Monteiro, P., C.  Rossé, A.  Castro-Castro, M.  Irondelle, E.  Lagoutte, P.  Paul- Gilloteaux, C.  Desnos, E.  Formstecher, F.  Darchen, D.  Perrais, et al.",OADS,/arxiv_data1/oa_pdf/5c/35/JCB_201510009.PMC4621844.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5c/35/JCB_201510009.PMC4621844.pdf
"http://dx.doi.org/10.1038/nrm3141 Remacle, A., G. Murphy, and C. Roghi.",Non-OADS,/arxiv_data1/oa_pdf/5c/35/JCB_201510009.PMC4621844.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/5c/35/JCB_201510009.PMC4621844.pdf
"http://dx.doi.org/10.1083/jcb.200709076 Steffen, A., G. Le Dez, R. Poincloux, C. Recchi, P. Nassoy, K. Rottner, T. Galli,  and P.  Chavrier.",Non-OADS,/arxiv_data1/oa_pdf/5c/35/JCB_201510009.PMC4621844.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/5c/35/JCB_201510009.PMC4621844.pdf
"http://dx.doi.org/10.1182/blood-2009-12-257089 Wiesner, C., K. El Azzouzi, and S. Linder.",Non-OADS,/arxiv_data1/oa_pdf/5c/35/JCB_201510009.PMC4621844.pdf
"http://dx.doi.org/10.1242/jcs.122358 Wolf, K., and P. Friedl.",OADS,/arxiv_data1/oa_pdf/5c/35/JCB_201510009.PMC4621844.pdf
"448Editorial http://dx.doi.org/10.1590/1678-77572015ed005 2015;23(5):448-9The clinical challenge of achieving marginal adaptation  in direct and indirect restorations  Karin Hermana Neppelenbroek Co-Editor-in-Chief - Journal of Applied Oral Science Dear Readers, The clinical longevity of tooth-coloured  restorations, whether direct or indirect, using composites and ceramics, greatly depends on the quality and stability of their marginal adaptation.",Non-OADS,/arxiv_data1/oa_pdf/e5/58/1678-7757-jaos-23-5-0448.PMC4621935.pdf
"459ABSTRACTwww.scielo.br/jaos http://dx.doi.org/10.1590/1678-775720150139 Acinar autolysis and mucous extravasation in human sublingual glands: a microscopic postmortem study Luciana Reis AZEVEDO-ALANIS1, Elen de Souza TOLENTINO2, Gerson Francisco de ASSIS3, Tânia Mary CESTARI3,  Vanessa Soares LARA4, José Humberto DAMANTE4 1- Pontifícia Universidade Católica do Paraná, Escola de Saúde e Biociências, Programa de Graduação em Odontologia, Curitiba, P R, Brazil.",Non-OADS,/arxiv_data1/oa_pdf/7a/81/1678-7757-jaos-23-5-0459.PMC4621937.pdf
"467ABSTRACTwww.scielo.br/jaos http://dx.doi.org/10.1590/1678-775720150170 Biocompatibility and bioactivity of calcium silicate-based endodontic sealers in human dental pulp cells Leticia Boldrin MESTIERI1, Ana Lívia GOMES-CORNÉLIO1, Elisandra Márcia RODRIGUES1, Loise Pedrosa SALLES2,  Roberta BOSSO-MARTELO1, Juliane Maria GUERREIRO-TANOMARU1, Mário TANOMARU-FILHO1 1- Universidade Estadual Paulista, Escola de Odontologia, Departamento de Odontologia Restauradora, Araraquara, SP, Brazil.",Non-OADS,/arxiv_data1/oa_pdf/51/12/1678-7757-jaos-23-5-0467.PMC4621938.pdf
"472ABSTRACTwww.scielo.br/jaos http://dx.doi.org/10.1590/1678-775720150150 $OWHUHGǃFDWHQLQH[SUHVVLRQLQRUDOPXFRVDOdysplasia: a comparative study Brunno Santos de Freitas SILVA1, Caroline Alves de CASTRO2, Sandra Lúcia Ventorin VON ZEIDLER3, Suzana  Cantanhede Orsini Machado de SOUSA4, Aline Carvalho BATISTA1, Fernanda Paula YAMAMOTO-SILVA1 1- Universidade Federal de Goiás, Faculdade de Odontologia, Departamento de Ciências Estomatológicas, Goiânia, GO, Brazil.",Non-OADS,/arxiv_data1/oa_pdf/26/5a/1678-7757-jaos-23-5-0472.PMC4621939.pdf
"479ABSTRACTwww.scielo.br/jaos http://dx.doi.org/10.1590/1678-775720150224 Cone beam computed tomography study of apical root resorption induced by Herbst appliance João Paulo SCHWARTZ1, Taísa Boamorte RAVELI1, Kélei Cristina de Mathias ALMEIDA1, Humberto Osvaldo  SCHWARTZ-FILHO2, Dirceu Barnabé RAVELI1 1- Universidade Estadual Paulista, Faculdade de Odontologia, Departamento de Clínica Infantil, Disciplina de Ortodontia, Araraq uara, SP, Brazil.",Non-OADS,/arxiv_data1/oa_pdf/35/d1/1678-7757-jaos-23-5-0479.PMC4621940.pdf
"486ABSTRACTwww.scielo.br/jaos http://dx.doi.org/10.1590/1678-775720150127 Protective effect of experimental mouthrinses containing NaF and TiF 4 on dentin erosive loss in  vitro Aline Rogéria Freire de CASTILHO1, Priscila Maria Aranda SALOMÃO2, Marília Afonso Rabelo BUZALAF2, Ana  Carolina MAGALHÃES2 1- Universidade Estadual de Campinas, Faculdade de Odontologia de Piracicaba, Departamento de Ciências Fisiológicas, Campinas, SP, Brazil.",Non-OADS,/arxiv_data1/oa_pdf/6c/b2/1678-7757-jaos-23-5-0486.PMC4621941.pdf
"491ABSTRACTwww.scielo.br/jaos http://dx.doi.org/10.1590/1678-775720150125 Serum big endothelin-1 as a biomarker in oral squamous cell carcinoma patients: an analytical study Pritam Kumar MANKAPURE, Suresh Ramchandra BARPANDE, Jyoti Dilip BHAVTHANKAR, Manda MANDALE Government Dental College and Hospital, Department of Oral Pathology and Microbiology, Aurangabad, India.",Non-OADS,/arxiv_data1/oa_pdf/54/58/1678-7757-jaos-23-5-0491.PMC4621942.pdf
"497ABSTRACTwww.scielo.br/jaos http://dx.doi.org/10.1590/1678-775720150235 Effects on gastric mucosa induced by dental bleaching – an experimental study with 6% hydrogen peroxide in rats Anabela Baptista PAULA1, Maria Isabel DIAS2, Manuel Marques FERREIRA1, Teresa CARRILHO1, Carlos Miguel  MARTO1, João CASALTA1, António Silvério CABRITA1, Eunice CARRILHO1 1- Universidade de Coimbra,  Escola de Medicina, Coimbra, Portugal.",Non-OADS,/arxiv_data1/oa_pdf/73/ba/1678-7757-jaos-23-5-0497.PMC4621943.pdf
"515ABSTRACTwww.scielo.br/jaos http://dx.doi.org/10.1590/1678-775720150081 Effect of software version and parameter settings on the marginal and internal adaptation of crowns fabricated with the CAD/CAM system  Ji Suk SHIM1, Jin Sook LEE3,Jeong Yol LEE2, Yeon Jo CHOI3, Sang Wan SHIN2, Jae Jun RYU3 1- Korea University Ansan Hospital, Department of Prosthodontics, Gyeonggi-do, Republic of Korea.",Non-OADS,/arxiv_data1/oa_pdf/55/47/1678-7757-jaos-23-5-0515.PMC4621944.pdf
"523ABSTRACTwww.scielo.br/jaos http://dx.doi.org/10.1590/1678-775720150244 Microbial contamination and disinfection methods of Saci¿ers Paulo NELSON-FILHO1, Márcia Costa LOUVAIN2, Soraia MACARI30DUtOLD3DFt¿FR/8&,6$121, Raquel Assed  Bezerra da SILVA1, Alexandra Mussolino de QUEIROZ1, Patrícia GATON-HERNÁNDEZ4, Léa Assed Bezerra da SILVA1 1- Universidade de São Paulo, Faculdade de Odontologia de Ribeirão Preto, Departamento de Odontopediatria, Ribeirão Preto, SP, Brazil.",Non-OADS,/arxiv_data1/oa_pdf/46/01/1678-7757-jaos-23-5-0523.PMC4621945.pdf
"536ABSTRACTwww.scielo.br/jaos http://dx.doi.org/10.1590/1678-775720150285 Differential expression of CC chemokines (CCLs) and receptors (CCRs) by human T lymphocytes in response to different Aggregatibacter  actinomycetemcomitans  serotypes Carla ALVAREZ1, Alvaro BENÍTEZ1, Leticia ROJAS1, Myriam PUJOL1, Paola CARVAJAL2, Jaime DÍAZ-ZÚÑIGA2,  Rolando VERNAL1,2 1- Universidad de Chile, Facultad de Odontología, Laboratorio de Biología Periodontal, Santiago, Chile.",Non-OADS,/arxiv_data1/oa_pdf/8e/99/1678-7757-jaos-23-5-0536.PMC4621946.pdf
"508ABSTRACTwww.scielo.br/jaos http://dx.doi.org/10.1590/1678-775720140049 Analysis of the reaction of subcutaneous tissues in rats and the antimicrobial activity of calcium hydroxide paste used in association with different substances Raquel Zanin MIDENA1, Roberto Brandão GARCIA1, Bruno Cavalini CAVENAGO1, Marina Angélica MARCIANO1,  Paloma Gagliardi MINOTTI1, Ronald ORDINOLA-ZAPATA1, Paulo Henrique WECKWERTH2, Flaviana Bombarda de  ANDRADE1, Marco Antonio Hungaro DUARTE1 1- Universidade de São Paulo, Faculdade de Odontologia de Bauru, Departamento de Dentística, Endodontia e Materiais Dentários, Bauru, SP, Brazil.",Non-OADS,/arxiv_data1/oa_pdf/3e/f0/1678-7765-jaos-23-5-0508.PMC4621947.pdf
"For quanti ¿cation purposes, the  Bioimage-L software (http://www.bioimagel.com)  was used to determine the percentage of live cells5.",OADS,/arxiv_data1/oa_pdf/3e/f0/1678-7765-jaos-23-5-0508.PMC4621947.pdf
"529ABSTRACTwww.scielo.br/jaos http://dx.doi.org/10.1590/1678-775720140438 Management of painful temporomandibular joint clicking with different intraoral devices and counseling: a controlled study Paulo César Rodrigues CONTI1, Ana Silvia da Mota CORRÊA1, José Roberto Pereira LAURIS2, Juliana STUGINSKI- BARBOSA1 1- Department of Prosthodontics, Bauru School of Dentistry, University of São Paulo, Bauru, SP, Brazil.",Non-OADS,/arxiv_data1/oa_pdf/87/16/1678-7765-jaos-23-5-0529.PMC4621948.pdf
"It typically occurs with tumors of theparathyroid glands, the pancreatic islet cells, and the Open AccessH Remde and others Novel mutations causing MEN1 and HMOID: 14-0120; March 2015 DOI: 10.1530/EDM-14-0120 This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 3.0Unported License .q2015 The authors http://www.edmcasereports.com Published by Bioscientiﬁca Ltd",Non-OADS,/arxiv_data1/oa_pdf/1c/e2/EDM14-0120.PMC4621953.pdf
H Remde and others Novel mutations causing MEN1 and HMOID: 14-0120; March 2015 DOI: 10.1530/EDM-14-0120 http://www.edmcasereports.com 2,Non-OADS,/arxiv_data1/oa_pdf/1c/e2/EDM14-0120.PMC4621953.pdf
H Remde and others Novel mutations causing MEN1 and HMOID: 14-0120; March 2015 DOI: 10.1530/EDM-14-0120 http://www.edmcasereports.com 3,Non-OADS,/arxiv_data1/oa_pdf/1c/e2/EDM14-0120.PMC4621953.pdf
"By using in silico prediction (integrated Software Alamut V.2.4, Interaktive Biosoftware http://www.interactive-biosoft- ware.com ) for the EXT1 splicing mutation, we predict that EXT1 mutation c.1418-2A OC activates an exonic cryptic acceptor splice site (ASS) of exon 6.",Non-OADS,/arxiv_data1/oa_pdf/1c/e2/EDM14-0120.PMC4621953.pdf
Mutations are described according to the current mutation nomenclature guidelines (http://www.hgvs.org ).,Non-OADS,/arxiv_data1/oa_pdf/1c/e2/EDM14-0120.PMC4621953.pdf
H Remde and others Novel mutations causing MEN1 and HMOID: 14-0120; March 2015 DOI: 10.1530/EDM-14-0120 http://www.edmcasereports.com 4,Non-OADS,/arxiv_data1/oa_pdf/1c/e2/EDM14-0120.PMC4621953.pdf
5200409 ) Received in ﬁnal form 30 January 2015 Accepted 25 February 2015 H Remde and others Novel mutations causing MEN1 and HMOID: 14-0120; March 2015 DOI: 10.1530/EDM-14-0120 http://www.edmcasereports.com 5,Non-OADS,/arxiv_data1/oa_pdf/1c/e2/EDM14-0120.PMC4621953.pdf
http://www.who.int/mediacentre/events/H%26SD_Plaq_ no9.pdf.,Non-OADS,/arxiv_data1/oa_pdf/5b/34/CD011870-0001.PMC4621954.pdf
http://www.euro.who.int/__data/assets/pdf_ﬁle/0005/78638/E90038.pdf 2005 (accessed 7 October 2014).,OADS,/arxiv_data1/oa_pdf/5b/34/CD011870-0001.PMC4621954.pdf
http://www.who.int/indoorair/ publications/household-fuel-combustion/en/ 2014 (accessed 10 July 2015).,Non-OADS,/arxiv_data1/oa_pdf/5b/34/CD011870-0001.PMC4621954.pdf
"3DNA methylation has traditionally been considered to be a mitotically stable modiﬁcation that couldchange only over long periods of time, e.g., in disease © Mal /C19ene E Lindholm, Francesco Marabita, David Gomez-Cabrero, Helene Rundqvist, Tomas J Ekstr €om, Jesper Tegn /C19er, and Carl Johan Sundberg *Correspondence to: Mal /C19ene Lindholm; Email: malene.lindholm@ki.se; Francesco Marabita; Email: francesco.marabita@ki.se Submitted: 07/02/2014; Revised: 09/01/2014; Accepted: 10/23/2014 http://dx.doi.org/10.4161/15592294.2014.982445 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/11/57/kepi-09-12-982445.PMC4622000.pdf
Additional sources includedNIH Roadmap Epigenomic (http://www.roadmapepigenomics.org) data for skeletal muscle and ChromHMM chromatin seg-mentation tracks for HSMM cell line in Encode (http://encode-project.org).,OADS,/arxiv_data1/oa_pdf/11/57/kepi-09-12-982445.PMC4622000.pdf
GREAT (http://great.stanford.edu) was used to discover functional categories associ-ated with DMPs.,OADS,/arxiv_data1/oa_pdf/11/57/kepi-09-12-982445.PMC4622000.pdf
The enrichment for known transcriptionalmotifs was tested with HOMER (http://homer.salk.edu/homer/)and motifs were clustered using STAMP (http://www.benoslab.pitt.edu/stamp/index.php).,OADS,/arxiv_data1/oa_pdf/11/57/kepi-09-12-982445.PMC4622000.pdf
"For each independent network domain, gene ontol- ogy was tested using the BiNGO tool (http://www.psb.ugent.be/ cbd/papers/BiNGO/Home.html).",OADS,/arxiv_data1/oa_pdf/11/57/kepi-09-12-982445.PMC4622000.pdf
Sports Med 2013; 43:1075-88; PMID:24129783; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/11/57/kepi-09-12-982445.PMC4622000.pdf
Sports Med 2007; 37:737-63; PMID: 17722947; http://dx.doi.org/10.2165/00007256-200737090-00001 3.,Non-OADS,/arxiv_data1/oa_pdf/11/57/kepi-09-12-982445.PMC4622000.pdf
Nat Rev Genet 2012; 13:484-92; PMID:22641018; http://dx.doi.org/ 10.1038/nrg3230 4.,OADS,/arxiv_data1/oa_pdf/11/57/kepi-09-12-982445.PMC4622000.pdf
Nat Rev Genet 2012; 13:679-92; PMID:22945394; http://dx.doi.org/10.1038/nrg3270 5.,OADS,/arxiv_data1/oa_pdf/11/57/kepi-09-12-982445.PMC4622000.pdf
Cell 2007; 128:683-92; PMID:17320506; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/11/57/kepi-09-12-982445.PMC4622000.pdf
JAMA 2008; 299:1345-50; PMID: 18349095; http://dx.doi.org/10.1001/jama.299.11.,Non-OADS,/arxiv_data1/oa_pdf/11/57/kepi-09-12-982445.PMC4622000.pdf
Human Molecular Genetics 2013; 22:R7-R15; PMID:23918660; http://dx.doi.org/10.1093/hmg/ddt375 8.,Non-OADS,/arxiv_data1/oa_pdf/11/57/kepi-09-12-982445.PMC4622000.pdf
JAMA2008; 299:2877-83; PMID:18577732; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/11/57/kepi-09-12-982445.PMC4622000.pdf
Diabetologia 2012; 55:3341-9; PMID:22961225; http://dx.doi.org/ 10.1007/s00125-012-2717-8 12.,Non-OADS,/arxiv_data1/oa_pdf/11/57/kepi-09-12-982445.PMC4622000.pdf
Cell Metab 2012; 15:405-11; http://dx.doi.org/10.1016/j.cmet.2012.01.001 13.,OADS,/arxiv_data1/oa_pdf/11/57/kepi-09-12-982445.PMC4622000.pdf
Diabetes 2012; 61:3322- 32; PMID:23028138; http://dx.doi.org/10.2337/db11-1653 14.,Non-OADS,/arxiv_data1/oa_pdf/11/57/kepi-09-12-982445.PMC4622000.pdf
Exp Cell Res 2006; 312:1989-95; PMID:16624287; http://dx.doi.org/ 10.1016/j.yexcr.2006.03.006 17.,OADS,/arxiv_data1/oa_pdf/11/57/kepi-09-12-982445.PMC4622000.pdf
Nature 2011; 473:43-9; PMID:21441907; http://dx.doi.org/10.1038/nature09906 18.,Non-OADS,/arxiv_data1/oa_pdf/11/57/kepi-09-12-982445.PMC4622000.pdf
EMBO J 2011; 30:3028-39; PMID:21701563; http://dx.doi.org/10.1038/emboj.,OADS,/arxiv_data1/oa_pdf/11/57/kepi-09-12-982445.PMC4622000.pdf
Genome Biol 2013; 14:R21; PMID: 23497655; http://dx.doi.org/10.1186/gb-2013-14-3-r21 20.,OADS,/arxiv_data1/oa_pdf/11/57/kepi-09-12-982445.PMC4622000.pdf
Reg- ulation of angiogenesis by ETS transcription factors.Biochem Soc Trans 2009; 37:1248-53; PMID: 19909256; http://dx.doi.org/10.1042/BST0371248 22.,Non-OADS,/arxiv_data1/oa_pdf/11/57/kepi-09-12-982445.PMC4622000.pdf
Genomics 1997; 40:493-6; PMID: 9073519; http://dx.doi.org/10.1006/geno.1996.4586 23.,Non-OADS,/arxiv_data1/oa_pdf/11/57/kepi-09-12-982445.PMC4622000.pdf
Nat Biotechnol2013; 31:142-7; PMID:23334450; http://dx.doi.org/ 10.1038/nbt.2487 25.,OADS,/arxiv_data1/oa_pdf/11/57/kepi-09-12-982445.PMC4622000.pdf
BMC Genomics 2011; 12:98; PMID:21299892; http://dx.doi.org/10.1186/1471-2164-12-98 26.,OADS,/arxiv_data1/oa_pdf/11/57/kepi-09-12-982445.PMC4622000.pdf
J Biol Chem 2011; 286:26516-23; PMID: 21602272; http://dx.doi.org/10.1074/jbc.M110.212506 27.,OADS,/arxiv_data1/oa_pdf/11/57/kepi-09-12-982445.PMC4622000.pdf
J Biol Chem 2004; 279:41131-40; PMID:15271982; http://dx.doi.org/10.1074/jbc.M402902200 28.,OADS,/arxiv_data1/oa_pdf/11/57/kepi-09-12-982445.PMC4622000.pdf
J Appl Physiol 2010; 108:1487-96; PMID:20133430; http://dx.doi.org/ 10.1152/japplphysiol.01295.2009 29.,Non-OADS,/arxiv_data1/oa_pdf/11/57/kepi-09-12-982445.PMC4622000.pdf
Nat Rev Genet 2011; 12:529-41; PMID: 21747404; http://dx.doi.org/10.1038/nrg3000 30.,Non-OADS,/arxiv_data1/oa_pdf/11/57/kepi-09-12-982445.PMC4622000.pdf
BMC Bioinformatics 2012;13:86; PMID:22568884; http://dx.doi.org/10.1186/ 1471-2105-13-86 32.,OADS,/arxiv_data1/oa_pdf/11/57/kepi-09-12-982445.PMC4622000.pdf
Biochem Soc Trans 2011; 39:1628-32; PMID:22103498; http://dx.doi.org/10.1042/BST20110720 33.,OADS,/arxiv_data1/oa_pdf/11/57/kepi-09-12-982445.PMC4622000.pdf
Nat Biotechnol 2010; 28:1097-105; PMID:20852635; http://dx.doi.org/ 10.1038/nbt.1682 34.,Non-OADS,/arxiv_data1/oa_pdf/11/57/kepi-09-12-982445.PMC4622000.pdf
Genome Research 2010;20:1719-29; PMID:21045081; http://dx.doi.org/ 10.1101/gr.110601.110 35.,OADS,/arxiv_data1/oa_pdf/11/57/kepi-09-12-982445.PMC4622000.pdf
J Appl Physiol 2011; 110:46-59; PMID: 20930125; http://dx.doi.org/10.1152/japplphysiol.00634.2010 37.,Non-OADS,/arxiv_data1/oa_pdf/11/57/kepi-09-12-982445.PMC4622000.pdf
Cell Metab 2006; 3:187-97; PMID:16517406; http://dx.doi.org/10.1016/j.cmet.2006.01.012 38.,OADS,/arxiv_data1/oa_pdf/11/57/kepi-09-12-982445.PMC4622000.pdf
Am J Physiol Regul Integr Comp Physiol 2014; 307:R248-55; PMID:24898836; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/11/57/kepi-09-12-982445.PMC4622000.pdf
Nature 2009; 459:108-12; PMID:19295514; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/11/57/kepi-09-12-982445.PMC4622000.pdf
Biol Rev Camb Philos Soc 2011; 86:564-600; PMID:21040371; http://dx.doi.org/10.1111/j.1469- 185X.2010.00161.x 41.,OADS,/arxiv_data1/oa_pdf/11/57/kepi-09-12-982445.PMC4622000.pdf
J Biol Chem 2009; 284:21872-80; PMID:19553684; http://dx.doi.org/ 10.1074/jbc.M109.022749 42.,OADS,/arxiv_data1/oa_pdf/11/57/kepi-09-12-982445.PMC4622000.pdf
Development 2007; 134:4131-40; PMID:17959722; http://dx.doi.org/10.1242/dev.008367 43.,OADS,/arxiv_data1/oa_pdf/11/57/kepi-09-12-982445.PMC4622000.pdf
Nature 2008; 451:202-6; PMID:18185590; http://dx.doi.org/10.1038/nature06468 44.,OADS,/arxiv_data1/oa_pdf/11/57/kepi-09-12-982445.PMC4622000.pdf
2008; 3:e3686; PMID:18997871; http://dx.doi.org/ 10.1371/journal.pone.0003686 45.,Non-OADS,/arxiv_data1/oa_pdf/11/57/kepi-09-12-982445.PMC4622000.pdf
Circul Res 2006; 99:1159- 66; PMID:17122446; http://dx.doi.org/10.1161/01.RES.0000251056.85990.db 47.,Non-OADS,/arxiv_data1/oa_pdf/11/57/kepi-09-12-982445.PMC4622000.pdf
IUBMB Life 2006; 58:15-24; PMID:16540428; http://dx.doi.org/10.1080/15216540500507390 48.,OADS,/arxiv_data1/oa_pdf/11/57/kepi-09-12-982445.PMC4622000.pdf
Genes Dev 2007; 21:1882-94; PMID: 17652178; http://dx.doi.org/10.1101/gad.1561707 49.,Non-OADS,/arxiv_data1/oa_pdf/11/57/kepi-09-12-982445.PMC4622000.pdf
Cell Metab 2012; 16:9-17; PMID:22768835; http://dx.doi.org/10.1016/j.cmet.2012.06.00150.,OADS,/arxiv_data1/oa_pdf/11/57/kepi-09-12-982445.PMC4622000.pdf
Genomics 2011; 98:288-95;PMID:21839163; http://dx.doi.org/10.1016/j.ygeno.,OADS,/arxiv_data1/oa_pdf/11/57/kepi-09-12-982445.PMC4622000.pdf
Epigenetics 2013; 8:333-46; PMID:23422812;http://dx.doi.org/10.4161/epi.24008 52.,Non-OADS,/arxiv_data1/oa_pdf/11/57/kepi-09-12-982445.PMC4622000.pdf
"Bioinformatics (Oxford, England) 2013; 29:189-96; PMID:23175756; http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/11/57/kepi-09-12-982445.PMC4622000.pdf
Stat Appl Genet Mol Biol 2004; 3; PMID:16646809; http://dx.doi.org/10.2202/1544-6115.1027 54.,OADS,/arxiv_data1/oa_pdf/11/57/kepi-09-12-982445.PMC4622000.pdf
Genome Biol 2010; 11:R14; PMID:20132535; http://dx.doi.org/10.1186/gb-2010- 11-2-r14 56.,OADS,/arxiv_data1/oa_pdf/11/57/kepi-09-12-982445.PMC4622000.pdf
"Bioinformatics (Oxford, England) 2013; 29:1830-1; PMID:23740750; http://dx.doi.org/10.1093/bioinformatics/btt285 57.",Non-OADS,/arxiv_data1/oa_pdf/11/57/kepi-09-12-982445.PMC4622000.pdf
Nat Genet 2005; 37:382- 90; PMID:15778709; http://dx.doi.org/10.1038/ ng1532 www.landesbioscience.com 1569 Epigenetics,Non-OADS,/arxiv_data1/oa_pdf/11/57/kepi-09-12-982445.PMC4622000.pdf
"12Although butyrate plays a major role regulating apoptosi s, differentiation and prolifer- ation in the colonic epithelium,13some in vitro studies have demonstrated that CRC cells can escape from butyrate- induced apoptosis and beco me butyrate-resistant.14,15Human CRC cells, selected in vitro for this ability to grow in thepresence of butyrate, produce tumors with more aggressivephenotypes than did unselected cells from the parental CRC © Shusuke Toden, Trevor J Lockett, David L Topping, Benjamin L Scherer, Emma-Jane L Watson, Jessica G Southwood, and Julie M Clarke *Correspondence to: Julie M Clarke; Email: mailto:julie.clarke@csiro.auSubmitted: 05/16/2014; Revised: 07/22/2014; Accepted: 08/01/2014 http://dx.doi.org/10.4161/15384047.2014.955764 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c4/76/kcbt-15-11-955764.PMC4622003.pdf
J Clin Pathol 1982; 35:323-6; PMID:7068924; http://dx.doi.org/10.1136/jcp.35.3.323 3.,Non-OADS,/arxiv_data1/oa_pdf/c4/76/kcbt-15-11-955764.PMC4622003.pdf
Carcinogenesis 2012; 33:197-202; PMID:22080572; http://dx.doi.org/10.1093/carcin/bgr254 5.,Non-OADS,/arxiv_data1/oa_pdf/c4/76/kcbt-15-11-955764.PMC4622003.pdf
Clin Cancer Res 2014; 20:799-803; PMID:24270685; http://dx.doi.org/10.1158/1078-0432.CCR-13-2483 8.,Non-OADS,/arxiv_data1/oa_pdf/c4/76/kcbt-15-11-955764.PMC4622003.pdf
"Clarke JM, Topping DL, Christophersen CT, Bird AR, Lange K, Saunders I, Cobiac L. Butyrate esteriﬁed to starch is released in the human gastrointestinal tract.Am J Clin Nutr 2011; 94:1276-83; PMID:21940597; http://dx.doi.org/10.3945/ajcn.111.017228 10.",Non-OADS,/arxiv_data1/oa_pdf/c4/76/kcbt-15-11-955764.PMC4622003.pdf
Carcinogene- sis 2008; 29:2190-4; PMID:18701436; http://dx.doi.org/10.1093/carcin/bgn192 13.,Non-OADS,/arxiv_data1/oa_pdf/c4/76/kcbt-15-11-955764.PMC4622003.pdf
JProteome Res 2009; 8:1220-7; PMID:19195990; http://dx.doi.org/10.1021/pr8009929 15.,Non-OADS,/arxiv_data1/oa_pdf/c4/76/kcbt-15-11-955764.PMC4622003.pdf
Gastroenterology 2001; 120:889-99; PMID:11231943; http://dx.doi.org/ 10.1053/gast.2001.22472 16.,Non-OADS,/arxiv_data1/oa_pdf/c4/76/kcbt-15-11-955764.PMC4622003.pdf
J Biol Chem 2010; 285:39211-23; PMID:20926374; http://dx.doi.org/10.1074/jbc.M110.156026 17.,OADS,/arxiv_data1/oa_pdf/c4/76/kcbt-15-11-955764.PMC4622003.pdf
Br J Nutr 2008; 100:711-21; PMID:18279550; http://dx.doi.org/10.1017/ S0007114508901276 18.,Non-OADS,/arxiv_data1/oa_pdf/c4/76/kcbt-15-11-955764.PMC4622003.pdf
Trends in genetics: TIG 1993; 9:138-41; PMID:8516849; http://dx.doi.org/10.1016/0168- 9525(93)90209-Z 1522 Volume 15 Issue 11 Cancer Biology & Therapy,Non-OADS,/arxiv_data1/oa_pdf/c4/76/kcbt-15-11-955764.PMC4622003.pdf
Cancer Res 2010; 70:609-20; PMID:20068171; http://dx.doi.org/10.1158/ 0008-5472.CAN-09-2327 21.,Non-OADS,/arxiv_data1/oa_pdf/c4/76/kcbt-15-11-955764.PMC4622003.pdf
J Int Med Res2009; 37:803-11; PMID:19589263; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c4/76/kcbt-15-11-955764.PMC4622003.pdf
Cell Death Differ 2011; 18:602-18; PMID:20930850; http://dx.doi.org/10.1038/cdd.,Non-OADS,/arxiv_data1/oa_pdf/c4/76/kcbt-15-11-955764.PMC4622003.pdf
Int J Cancer 2011; 128:847-56; PMID:20979106; http://dx.doi.org/10.1002/ ijc.25638 24.,Non-OADS,/arxiv_data1/oa_pdf/c4/76/kcbt-15-11-955764.PMC4622003.pdf
Pharmacol Ther 2009; 121:29-40;PMID:18992769; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/c4/76/kcbt-15-11-955764.PMC4622003.pdf
J Gastrointest Surgery 2008; 12:1773-81; PMID:18661192; http://dx.doi.org/10.1007/s11605-008-0573-0 27.,Non-OADS,/arxiv_data1/oa_pdf/c4/76/kcbt-15-11-955764.PMC4622003.pdf
Bioessays 2002; 24:91-8;PMID:11782954; http://dx.doi.org/10.1002/bies.,OADS,/arxiv_data1/oa_pdf/c4/76/kcbt-15-11-955764.PMC4622003.pdf
Stem Cells 2013; 31:2287-95; PMID:23836510; http://dx.doi.org/10.1002/stem.147529.,Non-OADS,/arxiv_data1/oa_pdf/c4/76/kcbt-15-11-955764.PMC4622003.pdf
Curr Opin Cell Biol 2013; 25:177-83; PMID:23402869; http://dx.doi.org/10.1016/j.ceb.2013.01.007 30.,OADS,/arxiv_data1/oa_pdf/c4/76/kcbt-15-11-955764.PMC4622003.pdf
Br J Nutr 2006; 96:276-82; PMID:16923221; http://dx.doi.org/10.1079/BJN20061807 31.,Non-OADS,/arxiv_data1/oa_pdf/c4/76/kcbt-15-11-955764.PMC4622003.pdf
Proc Nutr Soc2003; 62:245-9; PMID:12756974; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/c4/76/kcbt-15-11-955764.PMC4622003.pdf
Gut 1995; 36:93-9; PMID:7890244; http://dx.doi.org/10.1136/gut.36.1.93 39.,Non-OADS,/arxiv_data1/oa_pdf/c4/76/kcbt-15-11-955764.PMC4622003.pdf
Biochem Biophys Res Commun 2007; 356:599-603; PMID:17374366; http://dx.doi.org/ 10.1016/j.bbrc.2007.03.025 42.,OADS,/arxiv_data1/oa_pdf/c4/76/kcbt-15-11-955764.PMC4622003.pdf
Eur J Gastroenterol Hepatol 2002; 14:757-65; PMID:12169985; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c4/76/kcbt-15-11-955764.PMC4622003.pdf
Gut 2004; 53:1479-84; PMID:15361498; http://dx.doi.org/10.1136/gut.,Non-OADS,/arxiv_data1/oa_pdf/c4/76/kcbt-15-11-955764.PMC4622003.pdf
Available fromhttp://www.nhmrc.gov.au/publications/synopses/ ea16syn.htm 47.,OADS,/arxiv_data1/oa_pdf/c4/76/kcbt-15-11-955764.PMC4622003.pdf
Car- cinogenesis 1992; 13:2305-12; PMID:1473238; http://dx.doi.org/10.1093/carcin/13.12.2305 48.,OADS,/arxiv_data1/oa_pdf/c4/76/kcbt-15-11-955764.PMC4622003.pdf
Mutat Res 2008; 638:37-47; PMID:17920640; http://dx.doi.org/10.1016/j.mrfmmm.2007.08.012 49.,OADS,/arxiv_data1/oa_pdf/c4/76/kcbt-15-11-955764.PMC4622003.pdf
Nat Protoc2006; 1:23-9; PMID:17406208; http://dx.doi.org/ 10.1038/nprot.2006.5 50.,OADS,/arxiv_data1/oa_pdf/c4/76/kcbt-15-11-955764.PMC4622003.pdf
Nutr Cancer 2005; 51:45-51; PMID:15749629; http://dx.doi.org/ 10.1207/s15327914nc5101_7 www.landesbioscience.com 1523 Cancer Biology & Therapy,Non-OADS,/arxiv_data1/oa_pdf/c4/76/kcbt-15-11-955764.PMC4622003.pdf
Korean J Thorac Cardiovasc Surg 2015;48:318-327 □ Clinical Research  □ http://dx.doi.or g/10.5090/k jtcs.2015.48.5.318,Non-OADS,/arxiv_data1/oa_pdf/11/f0/kjtcv-48-318.PMC4622025.pdf
Available from: http://www.hira.or.kr/rd/dissdic/infoMdfeeList.,OADS,/arxiv_data1/oa_pdf/11/f0/kjtcv-48-318.PMC4622025.pdf
Korean J Thorac Cardiovasc Surg 2015;48:311-317 □ Clinical Research  □ http://dx.doi.or g/10.5090/k jtcs.2015.48.5.311,Non-OADS,/arxiv_data1/oa_pdf/6a/dc/kjtcv-48-311.PMC4622026.pdf
Because in situ material was  u s e d  f o r  t h e  r i g h t  v e n t r i c u l a r  o u t f l o w  t r a c t  ( R V O T )  r e c o n -Korean J Thorac Cardiovasc Surg 2015;48:351-354 □ Case Report  □ http://dx.doi.or g/10.5090/k jtcs.2015.48.5.351,Non-OADS,/arxiv_data1/oa_pdf/5d/e4/kjtcv-48-351.PMC4622027.pdf
This type of chest tube may be another method Korean J Thorac Cardiovasc Surg 2015;48:378-379 □ How to Do It  □ http://dx.doi.or g/10.5090/k jtcs.2015.48.5.378,Non-OADS,/arxiv_data1/oa_pdf/60/94/kjtcv-48-378.PMC4622028.pdf
The renal vessels were  Korean J Thorac Cardiovasc Surg 2015;48:371-374 □ Case Report  □ http://dx.doi.or g/10.5090/k jtcs.2015.48.5.371,Non-OADS,/arxiv_data1/oa_pdf/a3/78/kjtcv-48-371.PMC4622029.pdf
The aim of this study was to evaluate our experience and short-term outcomes of plication for diaphragmati c eventration  (acquired or congenital) in infants and children.Korean J Thorac Cardiovasc Surg 2015;48:307-310 □ Clinical Research  □ http://dx.doi.or g/10.5090/k jtcs.2015.48.5.307,Non-OADS,/arxiv_data1/oa_pdf/91/ca/kjtcv-48-307.PMC4622030.pdf
After the Korean J Thorac Cardiovasc Surg 2015;48:355-358 □ Case Report  □ http://dx.doi.or g/10.5090/k jtcs.2015.48.5.355,Non-OADS,/arxiv_data1/oa_pdf/7b/93/kjtcv-48-355.PMC4622031.pdf
Korean J Thorac Cardiovasc Surg 2015;48:368-370 □ Case Report  □ http://dx.doi.or g/10.5090/k jtcs.2015.48.5.368,Non-OADS,/arxiv_data1/oa_pdf/bb/a5/kjtcv-48-368.PMC4622032.pdf
One suc h factor can be serum carci-Korean J Thorac Cardiovasc Surg 2015;48:335-344 □ Clinical Research  □ http://dx.doi.or g/10.5090/k jtcs.2015.48.5.335,Non-OADS,/arxiv_data1/oa_pdf/5c/77/kjtcv-48-335.PMC4622033.pdf
The mechanism Korean J Thorac Cardiovasc Surg 2015;48:345-350 □ Clinical Research  □ http://dx.doi.or g/10.5090/k jtcs.2015.48.5.345,Non-OADS,/arxiv_data1/oa_pdf/ee/e9/kjtcv-48-345.PMC4622034.pdf
Available from: http://emedicine.medscape.com/ar- ticle/1815850-overview.,Non-OADS,/arxiv_data1/oa_pdf/ee/e9/kjtcv-48-345.PMC4622034.pdf
"VATS exploration using a 30 o thoracoscope (Karl Storz endo scope; Karl Storz, Tuttlin- gen, Germany) revealed minimal hemothorax and multiple ap-ical multiple bullae as indicated  by the preoperative computed Korean J Thorac Cardiovasc Surg 2015;48:375-377 □ Case Report  □ http://dx.doi.or g/10.5090/k jtcs.2015.48.5.375",Non-OADS,/arxiv_data1/oa_pdf/98/32/kjtcv-48-375.PMC4622035.pdf
The AVP in the prior operation consisted of two main procedures: (1) STJ re-Korean J Thorac Cardiovasc Surg 2015;48:359-363 □ Case Report  □ http://dx.doi.or g/10.5090/k jtcs.2015.48.5.359,Non-OADS,/arxiv_data1/oa_pdf/87/b1/kjtcv-48-359.PMC4622036.pdf
"Massive hemorrhage during the reopening of the sternum  and consequent catastrophic ev ents were anticipated; there- f o r e ,  d e e p  h y p o t h e r m i c  c i r c u l a t o r y  a r r e s t  ( D H C A )  w a s  i m -Korean J Thorac Cardiovasc Surg 2015;48:364-367 □ Case Report  □ http://dx.doi.or g/10.5090/k jtcs.2015.48.5.364",Non-OADS,/arxiv_data1/oa_pdf/45/2c/kjtcv-48-364.PMC4622037.pdf
A number of studies have demonstrated the possibility of mitral valve  repair for rheumatic mitral Korean J Thorac Cardiovasc Surg 2015;48:328-334 □ Clinical Research  □ http://dx.doi.or g/10.5090/k jtcs.2015.48.5.328,Non-OADS,/arxiv_data1/oa_pdf/dd/fe/kjtcv-48-328.PMC4622038.pdf
"This is an Open Access articledistributed under the terms of theCreative Commons AttributionNon-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution,and reproduction in any medium,provided the original work isproperly cited.",Non-OADS,/arxiv_data1/oa_pdf/09/24/sjv116.PMC4622047.pdf
"This is an Open Access articledistributed under the terms of theCreative Commons Attribution-NonCommercial-NoDerivs licence(http://creativecommons.org/licenses/by-nc-nd/4.0/), whichpermits non-commercialreproduction and distribution ofthe work, in any medium, providedthe original work is not altered ortransformed in any way, and thatthe work is properly cited.DOI: 10.1093/asj/sjv080 www.aestheticsurgeryjournal.com",Non-OADS,/arxiv_data1/oa_pdf/fc/75/sjv080.PMC4622048.pdf
http://www.fda.gov/downloads/MedicalDevices/ ProductsandMedicalProcedures/ImplantsandProsthetics/ BreastImplants/UCM260090.pdf .,Non-OADS,/arxiv_data1/oa_pdf/fc/75/sjv080.PMC4622048.pdf
http://www.fda.,Non-OADS,/arxiv_data1/oa_pdf/fc/75/sjv080.PMC4622048.pdf
"Defects in COP1 orSPA1 genes cause constitutive © Alexander Maier and Ute Hoecker *Correspondence to: Ute Hoecker; Email: hoeckeru@uni-koeln.deSubmitted: 07/02/2014; Accepted: 07/09/2014 http://dx.doi.org/10.4161/15592316.2014.970440 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f7/9d/kpsb-10-01-970440.PMC4622049.pdf
Curr Opin Plant Biol 2014;19c:81-90; http://dx.doi.org/10.1016/j.pbi.2014.05.011.,OADS,/arxiv_data1/oa_pdf/f7/9d/kpsb-10-01-970440.PMC4622049.pdf
J BiomedBiotechnol 2004; 2004:314-20; PMID:15577195; http://dx.doi.org/10.1155/S1110724304406147 3.,Non-OADS,/arxiv_data1/oa_pdf/f7/9d/kpsb-10-01-970440.PMC4622049.pdf
Photochem Photobiol 1999; 70:1-9; http://dx.doi.org/10.1111/j.1751-1097.1999.tb01944.x 4.,Non-OADS,/arxiv_data1/oa_pdf/f7/9d/kpsb-10-01-970440.PMC4622049.pdf
Annu Rev Plant Physiol Plant Mol Biol 1999; 50:333-59; PMID:15012213; http://dx.doi.org/10.1146/annurev.arplant.50.1.333 6.,Non-OADS,/arxiv_data1/oa_pdf/f7/9d/kpsb-10-01-970440.PMC4622049.pdf
Mol Cell 1998; 1:213-22; PMID:9659918; http://dx.doi.org/10.1016/S1097-2765(00)80022-2 7.,OADS,/arxiv_data1/oa_pdf/f7/9d/kpsb-10-01-970440.PMC4622049.pdf
Trends Plant Sci 2005; 10:236-42; PMID:15882656; http://dx.doi.org/10.1016/j.tplants.2005.03.002 8.,OADS,/arxiv_data1/oa_pdf/f7/9d/kpsb-10-01-970440.PMC4622049.pdf
Plant J 2007; 49:981-94;PMID:17319847; http://dx.doi.org/10.1111/j.1365- 313X.2006.03021.x 10.,OADS,/arxiv_data1/oa_pdf/f7/9d/kpsb-10-01-970440.PMC4622049.pdf
Plant J 2011; 66:94-116;PMID:21443626; http://dx.doi.org/10.1111/j.1365- 313X.2010.04459.x 11.,OADS,/arxiv_data1/oa_pdf/f7/9d/kpsb-10-01-970440.PMC4622049.pdf
Nature 2000; 405:462-6; PMID:10839542; http://dx.doi.org/10.1038/35013076 12.,Non-OADS,/arxiv_data1/oa_pdf/f7/9d/kpsb-10-01-970440.PMC4622049.pdf
Plant J 2013; 74:638-51; PMID:23425305; http://dx.doi.org/10.1111/tpj.12153 13.,OADS,/arxiv_data1/oa_pdf/f7/9d/kpsb-10-01-970440.PMC4622049.pdf
J Plant Physiol 2008; 165:886-94; PMID:17766004; http://dx.doi.org/10.1016/j.jplph.2007.06.010 14.,OADS,/arxiv_data1/oa_pdf/f7/9d/kpsb-10-01-970440.PMC4622049.pdf
FEBS Lett 2013; 587:1543-7; PMID:23583450; http://dx.doi.org/10.1016/j.febslet.2013.03.037 15.,OADS,/arxiv_data1/oa_pdf/f7/9d/kpsb-10-01-970440.PMC4622049.pdf
The SPA quar- tet: a family of WD-repeat proteins with a central role in suppression of photomorphogenesis in Arabidopsis.Plant Cell 2004; 16:2293-306; PMID:15308756; http://dx.doi.org/10.1105/tpc.104.024216 16.,OADS,/arxiv_data1/oa_pdf/f7/9d/kpsb-10-01-970440.PMC4622049.pdf
Genes Dev 1991; 5:1172-82; PMID:2065972; http://dx.doi.org/ 10.1101/gad.5.7.1172 17.,OADS,/arxiv_data1/oa_pdf/f7/9d/kpsb-10-01-970440.PMC4622049.pdf
Curr Opin Plant Biol 2005; 8:469-76; PMID:16039154; http://dx.doi.org/10.1016/j.pbi.,OADS,/arxiv_data1/oa_pdf/f7/9d/kpsb-10-01-970440.PMC4622049.pdf
Plant Phys- iol 2007; 144:1391-406; PMID:17478635; http://dx.doi.org/10.1104/pp.107.098293 20.,Non-OADS,/arxiv_data1/oa_pdf/f7/9d/kpsb-10-01-970440.PMC4622049.pdf
Planta 2002; 215:745-53; PMID:12244439; http://dx.doi.org/10.1007/s00425-002-0801-x www.tandfonline.com e970440-3 Plant Signaling & Behavior,OADS,/arxiv_data1/oa_pdf/f7/9d/kpsb-10-01-970440.PMC4622049.pdf
"3 Individually or in combination, these sets of mutations negatively © Michael D Oberst, Stacy Fuhrmann, Kathy Mulgrew, Maria Amann, Lily Cheng, Petra Lutterbuese, Laura Richman, Steve Coats, Patrick A Baeuerle, and Scott A Hammond*Correspondence to: Michael D Oberst; Email: oberstm@medimmune.comSubmitted: 03/11/2014; Accepted: 09/16/2014 http://dx.doi.org/10.4161/19420862.2014.975660 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7c/47/kmab-06-06-975660.PMC4622052.pdf
Somatic muta-tion status for the indicated genes for each cell line was compiled from the COSMIC database (http://www.sanger.ac.uk/cosmic).,OADS,/arxiv_data1/oa_pdf/7c/47/kmab-06-06-975660.PMC4622052.pdf
Br J Cancer 2009; 101:465-72; PMID:19603024; http://dx.doi.org/ 10.1038/sj.bjc.6605164 2.,Non-OADS,/arxiv_data1/oa_pdf/7c/47/kmab-06-06-975660.PMC4622052.pdf
Science 2007; 318:1108-13; PMID:17932254; http://dx.doi.org/10.1126/science.1145720 4.,OADS,/arxiv_data1/oa_pdf/7c/47/kmab-06-06-975660.PMC4622052.pdf
N Engl J Med 2008; 359:1757-65; PMID:18946061; http://dx.doi.org/10.1056/ NEJMoa0804385 5.,OADS,/arxiv_data1/oa_pdf/7c/47/kmab-06-06-975660.PMC4622052.pdf
Lancet Oncol 2010; 11:753- 62; PMID:20619739; http://dx.doi.org/10.1016/S1470-2045(10)70130-36.,Non-OADS,/arxiv_data1/oa_pdf/7c/47/kmab-06-06-975660.PMC4622052.pdf
J Clin Oncol2009; 27:5924-30; PMID:19884556; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/7c/47/kmab-06-06-975660.PMC4622052.pdf
J Clin Oncol2005; 23:7518-28; PMID:16172461; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/7c/47/kmab-06-06-975660.PMC4622052.pdf
Cancer Res 2008; 68:1953-61; PMID:18339877; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/7c/47/kmab-06-06-975660.PMC4622052.pdf
J Cell Biochem 2010; 111:1082-6;PMID:21053280; http://dx.doi.org/10.1002/ jcb.22905 12.,Non-OADS,/arxiv_data1/oa_pdf/7c/47/kmab-06-06-975660.PMC4622052.pdf
J Clin Oncol 2008; 26:5705-12; PMID:19001320; http://dx.doi.org/ 10.1200/JCO.2008.18.0786 13.,Non-OADS,/arxiv_data1/oa_pdf/7c/47/kmab-06-06-975660.PMC4622052.pdf
Nat Rev Clin Oncol 2009; 6:519-27; PMID:19636327;http://dx.doi.org/10.1038/nrclinonc.2009.111 14.,Non-OADS,/arxiv_data1/oa_pdf/7c/47/kmab-06-06-975660.PMC4622052.pdf
Clin Cancer Res 2010; 16:2921-6; PMID:20460490; http://dx.doi.org/10.1158/1078- 0432.CCR-09-2029 15.,Non-OADS,/arxiv_data1/oa_pdf/7c/47/kmab-06-06-975660.PMC4622052.pdf
J Clin Oncol 2008; 26:1626-34; PMID:18316791;http://dx.doi.org/10.1200/JCO.2007.14.7116 16.,Non-OADS,/arxiv_data1/oa_pdf/7c/47/kmab-06-06-975660.PMC4622052.pdf
PMID:17363584; http://dx.doi.org/10.1158/0008- 5472.CAN-06-4158 17.,Non-OADS,/arxiv_data1/oa_pdf/7c/47/kmab-06-06-975660.PMC4622052.pdf
Br J Cancer 2007; 97:1139-45; PMID:17940504; http://dx.doi.org/10.1038/sj.,Non-OADS,/arxiv_data1/oa_pdf/7c/47/kmab-06-06-975660.PMC4622052.pdf
J Clin Oncol 2008; 26:374-9; PMID:18202412; http://dx.doi.org/10.1200/ JCO.2007.12.5906 19.,Non-OADS,/arxiv_data1/oa_pdf/7c/47/kmab-06-06-975660.PMC4622052.pdf
Ann Oncol 2009; 20:84-90; PMID:18669866; http://dx.doi.org/10.1093/annonc/ mdn541 20.,Non-OADS,/arxiv_data1/oa_pdf/7c/47/kmab-06-06-975660.PMC4622052.pdf
Oncogene 1998; 16:3269-77; PMID:9681825; http://dx.doi.org/10.1038/sj.onc.1201867 21.,Non-OADS,/arxiv_data1/oa_pdf/7c/47/kmab-06-06-975660.PMC4622052.pdf
J Clin Invest1999; 104:263-9; PMID:10430607; http://dx.doi.org/ 10.1172/JCI6863 23.,Non-OADS,/arxiv_data1/oa_pdf/7c/47/kmab-06-06-975660.PMC4622052.pdf
Gynecol Oncol 1998; 70:378-85; PMID:9790791; http://dx.doi.org/10.1006/ gyno.1998.5094 24.,Non-OADS,/arxiv_data1/oa_pdf/7c/47/kmab-06-06-975660.PMC4622052.pdf
Eur J Cancer 1998; 34:845-50; PMID:9797696; http://dx.doi.org/10.1016/S0959-8049(97)10169-1 26.,Non-OADS,/arxiv_data1/oa_pdf/7c/47/kmab-06-06-975660.PMC4622052.pdf
Pathol Res Pract 2000;196:469-75; PMID:10926324; http://dx.doi.org/ 10.1016/S0344-0338(00)80048-5 27.,Non-OADS,/arxiv_data1/oa_pdf/7c/47/kmab-06-06-975660.PMC4622052.pdf
Lancet 1997;349:1556; PMID:9167490; http://dx.doi.org/ 10.1016/S0140-6736(05)62140-X 29.,Non-OADS,/arxiv_data1/oa_pdf/7c/47/kmab-06-06-975660.PMC4622052.pdf
Br J Cancer 1997; 75:230-5; PMID:9010031; http://dx.doi.org/10.1038/bjc.1997.38 30.,Non-OADS,/arxiv_data1/oa_pdf/7c/47/kmab-06-06-975660.PMC4622052.pdf
Cancer Metasta- sis Rev 2007; 26:373-400; PMID:17717638; http://dx.doi.org/10.1007/s10555-007-9072-0 33.,Non-OADS,/arxiv_data1/oa_pdf/7c/47/kmab-06-06-975660.PMC4622052.pdf
Science 2011; 331:1565-70; PMID:21436444; http://dx.doi.org/10.1126/science.1203486 34.,Non-OADS,/arxiv_data1/oa_pdf/7c/47/kmab-06-06-975660.PMC4622052.pdf
ExpertOpin Biol Ther 2010; 10:1019-35; PMID:20415597; http://dx.doi.org/10.1517/14712598.2010.482207 35.,Non-OADS,/arxiv_data1/oa_pdf/7c/47/kmab-06-06-975660.PMC4622052.pdf
Cancer Res 2009; 69:4941-4; PMID:19509221; http://dx.doi.org/10.1158/0008-5472.CAN-09-0547 36.,Non-OADS,/arxiv_data1/oa_pdf/7c/47/kmab-06-06-975660.PMC4622052.pdf
Curr Opin Chem Biol2013; 17:385-92; PMID:23623807; http://dx.doi.org/ 10.1016/j.cbpa.2013.03.029 37.,OADS,/arxiv_data1/oa_pdf/7c/47/kmab-06-06-975660.PMC4622052.pdf
Drug Discov Today 2005; 10:1237-44; PMID:16213416; http://dx.doi.org/ 10.1016/S1359-6446(05)03554-3 38.,OADS,/arxiv_data1/oa_pdf/7c/47/kmab-06-06-975660.PMC4622052.pdf
J Immunother 2007; 30:798-807; PMID:18049331; http://dx.doi.org/10.1097/ CJI.0b013e318156750c 39.,Non-OADS,/arxiv_data1/oa_pdf/7c/47/kmab-06-06-975660.PMC4622052.pdf
Mol Immunol 2006; 43:763-71; PMID:16360021; http://dx.doi.org/10.1016/j.molimm.2005.03.007 40.,Non-OADS,/arxiv_data1/oa_pdf/7c/47/kmab-06-06-975660.PMC4622052.pdf
Int J Cancer 2005; 115:98-104; PMID:15688411; http://dx.doi.org/10.1002/ijc.20908 41.,Non-OADS,/arxiv_data1/oa_pdf/7c/47/kmab-06-06-975660.PMC4622052.pdf
Mol Immunol 2007; 44:1935-43; PMID:17083975; http://dx.doi.org/10.1016/j.molimm.2006.09.032 42.,Non-OADS,/arxiv_data1/oa_pdf/7c/47/kmab-06-06-975660.PMC4622052.pdf
J Immunother 2009;32:452-64; PMID:19609237; http://dx.doi.org/ 10.1097/CJI.0b013e3181a1c097 43.,Non-OADS,/arxiv_data1/oa_pdf/7c/47/kmab-06-06-975660.PMC4622052.pdf
Science 2008; 321:974-7; PMID:18703743; http://dx.doi.org/ 10.1126/science.1158545 44.,Non-OADS,/arxiv_data1/oa_pdf/7c/47/kmab-06-06-975660.PMC4622052.pdf
Leukemia 2011; 25:181-4; PMID:20944674; http://dx.doi.org/ 10.1038/leu.2010.239 45.,Non-OADS,/arxiv_data1/oa_pdf/7c/47/kmab-06-06-975660.PMC4622052.pdf
Blood 2012;119:6226-33; PMID:22592608; http://dx.doi.org/ 10.1182/blood-2012-01-400515 47.,Non-OADS,/arxiv_data1/oa_pdf/7c/47/kmab-06-06-975660.PMC4622052.pdf
Exp Cell Res 2011; 317:1255-60; PMID:21419116; http://dx.doi.org/10.1016/j.yexcr.,OADS,/arxiv_data1/oa_pdf/7c/47/kmab-06-06-975660.PMC4622052.pdf
J Clin Oncol 2011; 29:2493-8; PMID:21576633; http://dx.doi.org/10.1200/JCO.2010.32.7270 50.,Non-OADS,/arxiv_data1/oa_pdf/7c/47/kmab-06-06-975660.PMC4622052.pdf
Immunobiology 2009; 214:441-53;PMID:19157637; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/7c/47/kmab-06-06-975660.PMC4622052.pdf
Breast Cancer Res Treat 2009; 117:471-81; PMID:18819003; http://dx.doi.org/10.1007/s10549-008-0185-0 52.,Non-OADS,/arxiv_data1/oa_pdf/7c/47/kmab-06-06-975660.PMC4622052.pdf
PLoS One 2010; 5:e13474; PMID:20976159; http://dx.doi.org/ 10.1371/journal.pone.0013474 53.,Non-OADS,/arxiv_data1/oa_pdf/7c/47/kmab-06-06-975660.PMC4622052.pdf
Cancer 2002; 94:1373-81; PMID:11877768; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/7c/47/kmab-06-06-975660.PMC4622052.pdf
Eur J Nucl Med 1993; 20:690-8; PMID:8404956; http://dx.doi.org/10.1007/BF00181760 55.,Non-OADS,/arxiv_data1/oa_pdf/7c/47/kmab-06-06-975660.PMC4622052.pdf
Br J Cancer 2002; 87:600-7; PMID:12237768; http://dx.doi.org/10.1038/sj.,Non-OADS,/arxiv_data1/oa_pdf/7c/47/kmab-06-06-975660.PMC4622052.pdf
Ann Surg 1998; 228:59-63; PMID:9671067; http://dx.doi.org/ 10.1097/00000658-199807000-00009 60.,OADS,/arxiv_data1/oa_pdf/7c/47/kmab-06-06-975660.PMC4622052.pdf
J Clin Oncol 2006; 24:5313-27; PMID:17060676; http://dx.doi.org/10.1200/JCO.2006.08.2644 62.,Non-OADS,/arxiv_data1/oa_pdf/7c/47/kmab-06-06-975660.PMC4622052.pdf
J Clin Oncol 2007; 25:1293-4; author reply 4; PMID:17401025; http://dx.doi.org/ 10.1200/JCO.2006.10.0974 63.,Non-OADS,/arxiv_data1/oa_pdf/7c/47/kmab-06-06-975660.PMC4622052.pdf
JImmunother 2009; 32:341-52; PMID:19342971; http://dx.doi.org/10.1097/CJI.0b013e31819b7c7064.,OADS,/arxiv_data1/oa_pdf/7c/47/kmab-06-06-975660.PMC4622052.pdf
Br J Cancer 2010; 102:124-33; PMID:19953093; http://dx.doi.org/10.1038/sj.bjc.6605364 65.,Non-OADS,/arxiv_data1/oa_pdf/7c/47/kmab-06-06-975660.PMC4622052.pdf
Int J Can- cer 1994; 57:67-72; PMID:8150543; http://dx.doi.org/10.1002/ijc.2910570113 66.,OADS,/arxiv_data1/oa_pdf/7c/47/kmab-06-06-975660.PMC4622052.pdf
J Interferon Cytokine Res 2004; 24:560-72; PMID:15450132; http://dx.doi.org/10.1089/jir.2004.24.560 67.,OADS,/arxiv_data1/oa_pdf/7c/47/kmab-06-06-975660.PMC4622052.pdf
Mol Immunol 2006; 43:1129-43; PMID:16139892; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/7c/47/kmab-06-06-975660.PMC4622052.pdf
Clin Cancer Res 2006; 12:6985-8; PMID:17145818; http://dx.doi.org/ 10.1158/1078-0432.CCR-06-1931 70.,Non-OADS,/arxiv_data1/oa_pdf/7c/47/kmab-06-06-975660.PMC4622052.pdf
Drugs of the Future 2008; 33:137-47; http://dx.doi.org/10.1358/ dof.2008.033.02.1172578 71.,Non-OADS,/arxiv_data1/oa_pdf/7c/47/kmab-06-06-975660.PMC4622052.pdf
Oncogene 2010; 29:1093-102;PMID:19946335; http://dx.doi.org/10.1038/ onc.2009.416 72.,Non-OADS,/arxiv_data1/oa_pdf/7c/47/kmab-06-06-975660.PMC4622052.pdf
Cancer Res 2007; 67:3927-35; PMID:17440108; http://dx.doi.org/10.1158/0008-5472.CAN-06-2760 73.,Non-OADS,/arxiv_data1/oa_pdf/7c/47/kmab-06-06-975660.PMC4622052.pdf
Blood 2013; 123:356-65; PMID:24300852; http://dx.doi.org/10.1182/blood-2013-08-523548 75.,Non-OADS,/arxiv_data1/oa_pdf/7c/47/kmab-06-06-975660.PMC4622052.pdf
Nat Rev Cancer 2007; 7:295-308; PMID:17384584; http://dx.doi.org/ 10.1038/nrc2109 76.,Non-OADS,/arxiv_data1/oa_pdf/7c/47/kmab-06-06-975660.PMC4622052.pdf
Nat Rev Cancer 2009; 9:550-62; PMID:19629070; http://dx.doi.org/10.1038/nrc2664 77.,Non-OADS,/arxiv_data1/oa_pdf/7c/47/kmab-06-06-975660.PMC4622052.pdf
Clin Cancer Res 2009; 15:3184-8; PMID:19366826; http://dx.doi.org/10.1158/1078-0432.CCR-08-2961 79.,Non-OADS,/arxiv_data1/oa_pdf/7c/47/kmab-06-06-975660.PMC4622052.pdf
Cancer Chemo- ther Pharmacol 2011; 68:1045-55; PMID:21340604; http://dx.doi.org/10.1007/s00280-011-1586-z 80.,Non-OADS,/arxiv_data1/oa_pdf/7c/47/kmab-06-06-975660.PMC4622052.pdf
Br J Cancer 2009; 100:1330-5; PMID:19367287; http://dx.doi.org/10.1038/sj.bjc.6605008 1584 Volume 6 Issue 6 mAbs,Non-OADS,/arxiv_data1/oa_pdf/7c/47/kmab-06-06-975660.PMC4622052.pdf
"*Correspondence to: Audrey E Baker; Email: abaker8@its.jnj.comSubmitted: 06/11/2014; Revised: 08/26/2014; Accepted: 09/15/2014 http://dx.doi.org/10.4161/19420862.2014.975100 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3a/d9/kmab-06-06-975100.PMC4622053.pdf
Br J Pharmacol 2009; 157 (2):220-33; PMID:19459844; http://dx.doi.org/ 10.1111/j.1476-5381.2009.00190.x 2.,Non-OADS,/arxiv_data1/oa_pdf/3a/d9/kmab-06-06-975100.PMC4622053.pdf
Development trends for human monoclonal antibody therapeutics.Nat Rev Drug Disc 2010; 9(10):767-74; PMID:20811384; http://dx.doi.org/10.1038/nrd3229 3.,Non-OADS,/arxiv_data1/oa_pdf/3a/d9/kmab-06-06-975100.PMC4622053.pdf
Nat Biotechnol 2007; 25(12):1342; PMID:18066015; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/3a/d9/kmab-06-06-975100.PMC4622053.pdf
Adv DrugDeliv Rev 2006; 58(5-6):686-706; PMID:16839640; http://dx.doi.org/10.1016/j.addr.2006.03.011 7.,OADS,/arxiv_data1/oa_pdf/3a/d9/kmab-06-06-975100.PMC4622053.pdf
Drugs 1989; 37(6):871-99; PMID:2503348; http://dx.doi.org/10.2165/00003495-198937060-00004 8.,Non-OADS,/arxiv_data1/oa_pdf/3a/d9/kmab-06-06-975100.PMC4622053.pdf
JClin Endocrinol Metab 1980; 51(4):691-7; PMID:7419661; http://dx.doi.org/10.1210/jcem-51-4-691 9.,Non-OADS,/arxiv_data1/oa_pdf/3a/d9/kmab-06-06-975100.PMC4622053.pdf
Int Arch Allergy Appl Immunol 1996; 30(5):446-55; PMID:17728549; http://dx.doi.org/10.1159/ 000229829 11.,Non-OADS,/arxiv_data1/oa_pdf/3a/d9/kmab-06-06-975100.PMC4622053.pdf
mAbs 2010; 2(3):347-56; PMID:20400863; http://dx.doi.org/10.4161/mabs.2.3.11779 12.,Non-OADS,/arxiv_data1/oa_pdf/3a/d9/kmab-06-06-975100.PMC4622053.pdf
Pharm Res 2012; 29 (2):490-9; PMID:21887597; http://dx.doi.org/10.1007/s11095-011-0578-3 15.,Non-OADS,/arxiv_data1/oa_pdf/3a/d9/kmab-06-06-975100.PMC4622053.pdf
Nature Rev Drug Disc 2002; 1(6):457-62; PMID:12119747; http://dx.doi.org/ 10.1038/nrd818 16.,Non-OADS,/arxiv_data1/oa_pdf/3a/d9/kmab-06-06-975100.PMC4622053.pdf
AAPS J 2010; 12(1):33-43; PMID:19924542; http://dx.doi.org/10.1208/s12248- 009-9157-5 17.,Non-OADS,/arxiv_data1/oa_pdf/3a/d9/kmab-06-06-975100.PMC4622053.pdf
J Pharm Sci 2012; 101(10):3586-92; PMID:22736238; http://dx.doi.org/10.1002/jps.23248 18.,Non-OADS,/arxiv_data1/oa_pdf/3a/d9/kmab-06-06-975100.PMC4622053.pdf
mAbs 2012; 4(6):740-52;PMID:22951518; http://dx.doi.org/10.4161/mabs.22066 19.,Non-OADS,/arxiv_data1/oa_pdf/3a/d9/kmab-06-06-975100.PMC4622053.pdf
Pharm Res 2012; 29(8):2202-12; PMID:22467219; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/3a/d9/kmab-06-06-975100.PMC4622053.pdf
Exp and Mol Pathol 2007; 82(2):121-9; PMID:17320864;http://dx.doi.org/10.1016/j.yexmp.2007.01.001 21.,OADS,/arxiv_data1/oa_pdf/3a/d9/kmab-06-06-975100.PMC4622053.pdf
J Pharm Sci 2007; 96(11):2861-78; PMID:17847076; http://dx.doi.org/10.1002/jps.2089523.,Non-OADS,/arxiv_data1/oa_pdf/3a/d9/kmab-06-06-975100.PMC4622053.pdf
Analyst 2012; 137:5730-5;PMID:23085689; http://dx.doi.org/10.1039/c2an35942a 24.,OADS,/arxiv_data1/oa_pdf/3a/d9/kmab-06-06-975100.PMC4622053.pdf
Appl Spectrosc 2007; 61 (1):11-8; PMID:17311710; http://dx.doi.org/10.1366/000370207779701514 25.,Non-OADS,/arxiv_data1/oa_pdf/3a/d9/kmab-06-06-975100.PMC4622053.pdf
Nat Protoc 2006; 1(6):2876-90; PMID:17406547; http://dx.doi.org/ 10.1038/nprot.2006.202 26.,Non-OADS,/arxiv_data1/oa_pdf/3a/d9/kmab-06-06-975100.PMC4622053.pdf
Curr Opin Pulmonary Med 2003; 9(1):21-7; PMID:12476080; http://dx.doi.org/10.1097/000631 98-200301000-00004 27.,Non-OADS,/arxiv_data1/oa_pdf/3a/d9/kmab-06-06-975100.PMC4622053.pdf
Protein Eng Des Sel 2012; 25:531-7; PMID:22915597; http://dx.doi.org/10.1093/protein/gzs047 28.,OADS,/arxiv_data1/oa_pdf/3a/d9/kmab-06-06-975100.PMC4622053.pdf
J Mol Biol 2009; 389(1):115-23; PMID:19361524; http://dx.doi.org/10.1016/j.jmb.2009.03.076 29.,OADS,/arxiv_data1/oa_pdf/3a/d9/kmab-06-06-975100.PMC4622053.pdf
Protein Eng Des Sel 2010; 23 (8):643-51; PMID:20543007; http://dx.doi.org/ 10.1093/protein/gzq037 30.,OADS,/arxiv_data1/oa_pdf/3a/d9/kmab-06-06-975100.PMC4622053.pdf
Clin Exp Immunol 2008; 151(1):42-50; PMID:18005364; http://dx.doi.org/10.1111/j.1365- 2249.2007.03545.x 33.,Non-OADS,/arxiv_data1/oa_pdf/3a/d9/kmab-06-06-975100.PMC4622053.pdf
Appl Spectrosc 1988; 42(1):83-90; http://dx.doi.org/10.1366/ 0003702884428653 35.,Non-OADS,/arxiv_data1/oa_pdf/3a/d9/kmab-06-06-975100.PMC4622053.pdf
Can J Chem 1956; 34 (2):170-8; http://dx.doi.org/10.1139/v56-021 36.,Non-OADS,/arxiv_data1/oa_pdf/3a/d9/kmab-06-06-975100.PMC4622053.pdf
JPhys Chem 2003; 107:8746-55; http://dx.doi.org/ 10.1021/jp035594h 37.,OADS,/arxiv_data1/oa_pdf/3a/d9/kmab-06-06-975100.PMC4622053.pdf
J Virol 2013; 87(6):3130-42; PMID:23283947; http://dx.doi.org/10.1128/JVI.03220- 12 38.,Non-OADS,/arxiv_data1/oa_pdf/3a/d9/kmab-06-06-975100.PMC4622053.pdf
Adv Protein Chem 1994; 45:153-203; PMID:8154369; http://dx.doi.org/10.1016/S0065-3233(08)60640-3 39.,OADS,/arxiv_data1/oa_pdf/3a/d9/kmab-06-06-975100.PMC4622053.pdf
Biotechnology 2009;4(9):1305-19; PMID:19579219; http://dx.doi.org/ 10.1002/biot.200800274 41.,Non-OADS,/arxiv_data1/oa_pdf/3a/d9/kmab-06-06-975100.PMC4622053.pdf
PNAS 2012; 109 (33):13359-61; PMID:22847421; http://dx.doi.org/ 10.1073/pnas.1211723109 42.,OADS,/arxiv_data1/oa_pdf/3a/d9/kmab-06-06-975100.PMC4622053.pdf
Langmuir 2008; 24(6):2799- 807; PMID:18229962; http://dx.doi.org/10.1021/ la703223f 43.,Non-OADS,/arxiv_data1/oa_pdf/3a/d9/kmab-06-06-975100.PMC4622053.pdf
Biophys J 2014; 106(8):1763-70; PMID:24739175; http://dx.doi.org/10.1016/j.bpj.2014.02.036 www.landesbioscience.com 1517 mAbs,OADS,/arxiv_data1/oa_pdf/3a/d9/kmab-06-06-975100.PMC4622053.pdf
"5Further- more, it has become increasingly apparent that antibody engagement of select Fc gRs can drive efﬁcacy for both pro- apoptotic and immune-modulatory antibodies.6-11 © Michelle Kinder, Allison R Greenplate, William R Strohl, Robert E Jordan, and Randall J Brezski *Correspondence to: Michelle Kinder; Email: mkinder@its.jnj.com; Randall J Brezski; Email: rjbrezski@hotmail.comSubmitted: 12/17/2014; Revised: 02/13/2015; Accepted: 02/14/2015 http://dx.doi.org/10.1080/19420862.2015.1022692 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/27/6b/kmab-07-03-1022692.PMC4622058.pdf
Cancer Cell 2010; 18:160-70; PMID:20708157; http://dx.doi.org/10.1016/j.ccr.,OADS,/arxiv_data1/oa_pdf/27/6b/kmab-07-03-1022692.PMC4622058.pdf
Augmented HER-2 speciﬁc immunity during treatment with trastuzumab and chemotherapy.Clin Cancer Res 2007; 13:5133-43; PMID:17785568; http://dx.doi.org/10.1158/1078-0432.CCR-07-0507 3.,Non-OADS,/arxiv_data1/oa_pdf/27/6b/kmab-07-03-1022692.PMC4622058.pdf
Blood 2010; 116:926-34; PMID:20439625; http://dx.doi.org/ 10.1182/blood-2009-10-248609 5.,Non-OADS,/arxiv_data1/oa_pdf/27/6b/kmab-07-03-1022692.PMC4622058.pdf
Clin Cancer Res 2013; 19:1858- 72; PMID:23444227; http://dx.doi.org/10.1158/ 1078-0432.CCR-12-2426 6.,Non-OADS,/arxiv_data1/oa_pdf/27/6b/kmab-07-03-1022692.PMC4622058.pdf
J Exp Med 2013; 210:1647-51; PMID:23980122; http://dx.doi.org/10.1084/jem.20131625 7.,OADS,/arxiv_data1/oa_pdf/27/6b/kmab-07-03-1022692.PMC4622058.pdf
J Exp Med 2013; 210:1685-93; PMID:23897982; http://dx.doi.org/10.1084/jem.,OADS,/arxiv_data1/oa_pdf/27/6b/kmab-07-03-1022692.PMC4622058.pdf
Cancer Immunol Res 2013; 1:32-42; PMID:24777248; http://dx.doi.org/10.1158/2326- 6066.CIR-13-0013 9.,Non-OADS,/arxiv_data1/oa_pdf/27/6b/kmab-07-03-1022692.PMC4622058.pdf
J Exp Med 2013; 210:1695-710; PMID:23897981; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/27/6b/kmab-07-03-1022692.PMC4622058.pdf
J Immunol 2011; 187:1754-63;PMID:21742972; http://dx.doi.org/10.4049/ jimmunol.1101135 11.,Non-OADS,/arxiv_data1/oa_pdf/27/6b/kmab-07-03-1022692.PMC4622058.pdf
Nat Rev Immunol 2008; 8:34-47; PMID:18064051; http://dx.doi.org/10.1038/ nri220613.,Non-OADS,/arxiv_data1/oa_pdf/27/6b/kmab-07-03-1022692.PMC4622058.pdf
"Woof JM, Partridge LJ, Jefferis R, Burton DR. Local- isation of the monocyte-binding region on humanimmunoglobulin G. Mol Immunol 1986; 23:319-30; PMID:3487030; http://dx.doi.org/10.1016/0161- 5890(86)90059-3 14.",OADS,/arxiv_data1/oa_pdf/27/6b/kmab-07-03-1022692.PMC4622058.pdf
Blood 2009; 113:3716-25; PMID:19018092; http://dx.doi.org/10.1182/blood-2008-09-179754 15.,Non-OADS,/arxiv_data1/oa_pdf/27/6b/kmab-07-03-1022692.PMC4622058.pdf
Infect Immun 2007; 75:1424-35; PMID:17220317; http://dx.doi.org/10.1128/IAI.01161-06 16.,Non-OADS,/arxiv_data1/oa_pdf/27/6b/kmab-07-03-1022692.PMC4622058.pdf
J Immunol 2010; 184:512-20; PMID:19949082; http://dx.doi.org/10.4049/jimmunol.0900847 17.,Non-OADS,/arxiv_data1/oa_pdf/27/6b/kmab-07-03-1022692.PMC4622058.pdf
J Exp Med 1989; 169:549-67; PMID:2536067; http://dx.doi.org/ 10.1084/jem.169.2.549 19.,Non-OADS,/arxiv_data1/oa_pdf/27/6b/kmab-07-03-1022692.PMC4622058.pdf
J Clin Invest 2002; 110:983-92;PMID:12370276; http://dx.doi.org/10.1172/ JCI0215950 20.,Non-OADS,/arxiv_data1/oa_pdf/27/6b/kmab-07-03-1022692.PMC4622058.pdf
MAbs 2012; 4:532-41; PMID:22665069; http://dx.doi.org/10.4161/mabs.20577 21.,Non-OADS,/arxiv_data1/oa_pdf/27/6b/kmab-07-03-1022692.PMC4622058.pdf
Cytokine Growth Factor Rev 2002; 13:95-109; PMID:11900986; http://dx.doi.org/10.1016/S1359-6101(01)00038-7 22.,Non-OADS,/arxiv_data1/oa_pdf/27/6b/kmab-07-03-1022692.PMC4622058.pdf
Nat Rev Immunol 2011;11:723-37; PMID:21997792; http://dx.doi.org/ 10.1038/nri3073 23.,Non-OADS,/arxiv_data1/oa_pdf/27/6b/kmab-07-03-1022692.PMC4622058.pdf
Nat Immunol 2010; 11:889-96;PMID:20856220; http://dx.doi.org/10.1038/ni.1937 24.,Non-OADS,/arxiv_data1/oa_pdf/27/6b/kmab-07-03-1022692.PMC4622058.pdf
Reversal of proinﬂammatory responses by ligating themacrophage Fcgamma receptor type I. J Exp Med 1998; 188:217-22; PMID:9653099; http://dx.doi.org/ 10.1084/jem.188.1.217 25.,Non-OADS,/arxiv_data1/oa_pdf/27/6b/kmab-07-03-1022692.PMC4622058.pdf
Clin Cancer Res 2011;17:5668-73; PMID:21788356; http://dx.doi.org/ 10.1158/1078-0432.CCR-11-023926.,Non-OADS,/arxiv_data1/oa_pdf/27/6b/kmab-07-03-1022692.PMC4622058.pdf
N Engl J Med 2009; 360:563-72; PMID:19196673;http://dx.doi.org/10.1056/NEJMoa0808268 27.,OADS,/arxiv_data1/oa_pdf/27/6b/kmab-07-03-1022692.PMC4622058.pdf
Cancer Cell 2013; 23:277-86; PMID:23518347; http://dx.doi.org/ 10.1016/j.ccr.2013.02.013 28.,Non-OADS,/arxiv_data1/oa_pdf/27/6b/kmab-07-03-1022692.PMC4622058.pdf
J Biol Chem 2013; 288:30843-54; PMID:23986451; http://dx.doi.org/10.1074/jbc.M113.486142 29.,OADS,/arxiv_data1/oa_pdf/27/6b/kmab-07-03-1022692.PMC4622058.pdf
Proc Natl Acad Sci U S A 2006; 103:4005-10; PMID:16537476; http://dx.doi.org/10.1073/ pnas.0508123103 31.,OADS,/arxiv_data1/oa_pdf/27/6b/kmab-07-03-1022692.PMC4622058.pdf
"High reso- lution mapping of the binding site on human IgG1 forFc gamma RI, Fc gamma RII, Fc gamma RIII, and FcRn and design of IgG1 variants with improved bind- ing to the Fc gamma R. J Biol Chem 2001; 276:6591-604; PMID:11096108; http://dx.doi.org/10.1074/jbc.",Non-OADS,/arxiv_data1/oa_pdf/27/6b/kmab-07-03-1022692.PMC4622058.pdf
Cancer Res 2007; 67:8882-90;PMID:17875730; http://dx.doi.org/10.1158/0008- 5472.CAN-07-0696 33.,Non-OADS,/arxiv_data1/oa_pdf/27/6b/kmab-07-03-1022692.PMC4622058.pdf
Mol Cancer Ther 2008; 7:2517-27; PMID:18723496; http://dx.doi.org/10.1158/1535- 7163.MCT-08-0201 34.,Non-OADS,/arxiv_data1/oa_pdf/27/6b/kmab-07-03-1022692.PMC4622058.pdf
J Immunol 2001; 166:2571-5; PMID:11160318; http://dx.doi.org/10.4049/ jimmunol.166.4.2571 35.,Non-OADS,/arxiv_data1/oa_pdf/27/6b/kmab-07-03-1022692.PMC4622058.pdf
MAbs 2010; 2:181-9; PMID:20150767; http://dx.doi.org/10.4161/ mabs.2.2.11158 36.,Non-OADS,/arxiv_data1/oa_pdf/27/6b/kmab-07-03-1022692.PMC4622058.pdf
Cancer Res 2008; 68:3863-72; PMID:18483271; http://dx.doi.org/10.1158/0008-5472.CAN-07-6297 37.,Non-OADS,/arxiv_data1/oa_pdf/27/6b/kmab-07-03-1022692.PMC4622058.pdf
J Immunol 2008; 181:3183-92; PMID:18713989; http://dx.doi.org/10.4049/ jimmunol.181.5.3183 38.,Non-OADS,/arxiv_data1/oa_pdf/27/6b/kmab-07-03-1022692.PMC4622058.pdf
67; PMID:22123056; http://dx.doi.org/10.4161/ mabs.3.6.18119 39.,OADS,/arxiv_data1/oa_pdf/27/6b/kmab-07-03-1022692.PMC4622058.pdf
MAbs 2014; 6:1265-73; PMID:25517311; http://dx.doi.org/ 10.4161/mabs.29825 41.,Non-OADS,/arxiv_data1/oa_pdf/27/6b/kmab-07-03-1022692.PMC4622058.pdf
Nat Med 2000; 6:443-6; PMID:10742152; http://dx.doi.org/10.1038/74704 42.,Non-OADS,/arxiv_data1/oa_pdf/27/6b/kmab-07-03-1022692.PMC4622058.pdf
J Immunol 2012; 189:5457- 66; PMID:23105143; http://dx.doi.org/10.4049/ jimmunol.1201889 43.,Non-OADS,/arxiv_data1/oa_pdf/27/6b/kmab-07-03-1022692.PMC4622058.pdf
Br J Cancer 2009; 100:113-7; PMID:19066610; http://dx.doi.org/10.1038/sj.bjc.6604812 44.,Non-OADS,/arxiv_data1/oa_pdf/27/6b/kmab-07-03-1022692.PMC4622058.pdf
Blood 2007; 110:4370-2; PMID:17909075; http://dx.doi.org/10.1182/blood-2007-06-097014 45.,Non-OADS,/arxiv_data1/oa_pdf/27/6b/kmab-07-03-1022692.PMC4622058.pdf
Clin Cancer Res 2007; 13:5784-9; PMID:17908969;http://dx.doi.org/10.1158/1078-0432.CCR-07-0778 46.,Non-OADS,/arxiv_data1/oa_pdf/27/6b/kmab-07-03-1022692.PMC4622058.pdf
J Mol Recognit 2012; 25:147-54; PMID:22407978;http://dx.doi.org/10.1002/jmr.2155 47.,Non-OADS,/arxiv_data1/oa_pdf/27/6b/kmab-07-03-1022692.PMC4622058.pdf
Expert Opin Biol Ther 2007; 7:1401-13; PMID:17727329; http://dx.doi.org/10.1517/ 14712598.7.9.1401 48.,Non-OADS,/arxiv_data1/oa_pdf/27/6b/kmab-07-03-1022692.PMC4622058.pdf
Curr Opin Biotechnol 2009; 20:685-91; PMID:19896358; http://dx.doi.org/10.1016/j.copbio.2009.10.011 49.,OADS,/arxiv_data1/oa_pdf/27/6b/kmab-07-03-1022692.PMC4622058.pdf
J Mol Med (Berl) 2002; 80:248-57; PMID:11976734; http://dx.doi.org/10.1007/ s00109-001-0294-2 51.,Non-OADS,/arxiv_data1/oa_pdf/27/6b/kmab-07-03-1022692.PMC4622058.pdf
J Immunol 2013;190:4315-23; PMID:23509345; http://dx.doi.org/ 10.4049/jimmunol.1200501 53.,Non-OADS,/arxiv_data1/oa_pdf/27/6b/kmab-07-03-1022692.PMC4622058.pdf
Immunol Lett2002; 81:41-8; PMID:11841844; http://dx.doi.org/ 10.1016/S0165-2478(01)00333-9 55.,Non-OADS,/arxiv_data1/oa_pdf/27/6b/kmab-07-03-1022692.PMC4622058.pdf
Mol Immunol 2008; 45:1837-46; PMID:18157932; http://dx.doi.org/10.1016/j.molimm.2007.10.043 56.,Non-OADS,/arxiv_data1/oa_pdf/27/6b/kmab-07-03-1022692.PMC4622058.pdf
Breast Cancer Res 2012;14:R116; PMID:22873525; http://dx.doi.org/ 10.1186/bcr3240 58.,Non-OADS,/arxiv_data1/oa_pdf/27/6b/kmab-07-03-1022692.PMC4622058.pdf
Int J Cancer 2007; 120:1261-7; PMID:17192924; http://dx.doi.org/10.1002/ijc.22426 59.,Non-OADS,/arxiv_data1/oa_pdf/27/6b/kmab-07-03-1022692.PMC4622058.pdf
"6In 1998 the US Food and Drug Administration (FDA) approved the humanized IgG1/ ktrastuzumab – initially obtained by © Claudia T Mendler, Lars Friedrich, Iina Laitinen, Martin Schlapschy, Markus Schwaiger, Hans-J €urgen Wester, and Arne Skerra *Correspondence to: Arne Skerra; Email: skerra@tum.deSubmitted: 08/24/2014; Revised: 10/15/2014; Accepted: 10/28/2014 http://dx.doi.org/10.4161/19420862.2014.985522 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/a3/d3/kmab-07-01-985522.PMC4622060.pdf
Nat Biotechnol 2009;27:331-337; PMID:19352366; http://dx.doi.org/ 10.1038/nbt0409-331 2.,Non-OADS,/arxiv_data1/oa_pdf/a3/d3/kmab-07-01-985522.PMC4622060.pdf
MAbs 2012; 4:413-415; PMID:22531442; http://dx.doi.org/10.4161/mabs.19931 3.,OADS,/arxiv_data1/oa_pdf/a3/d3/kmab-07-01-985522.PMC4622060.pdf
Methods Mol Biol 2009; 525:1-27;PMID:19252861; http://dx.doi.org/10.1007/978-1- 59745-554-1_1 4.,Non-OADS,/arxiv_data1/oa_pdf/a3/d3/kmab-07-01-985522.PMC4622060.pdf
J Clin Oncol 2002; 20:2453-2463; PMID:12011122; http://dx.doi.org/10.1200/JCO.2002.11.076 5.,Non-OADS,/arxiv_data1/oa_pdf/a3/d3/kmab-07-01-985522.PMC4622060.pdf
Science 1987; 235:177-182; PMID:3798106; http://dx.doi.org/10.1126/science.3798106 6.,Non-OADS,/arxiv_data1/oa_pdf/a3/d3/kmab-07-01-985522.PMC4622060.pdf
Ann Oncol 2001; 12 Suppl 1:S81-S87; PMID:11521727; http://dx.doi.org/10.1093/ annonc/12.suppl_1.S81 7.,Non-OADS,/arxiv_data1/oa_pdf/a3/d3/kmab-07-01-985522.PMC4622060.pdf
Eur J Cancer 2001; 37 Suppl 1:S18-S24; PMID:11167087; http://dx.doi.org/10.1016/S0959- 8049(00)00404-4 9.,Non-OADS,/arxiv_data1/oa_pdf/a3/d3/kmab-07-01-985522.PMC4622060.pdf
Expert Opin Biol Ther 2013; 13:607-614; PMID:23477731; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a3/d3/kmab-07-01-985522.PMC4622060.pdf
Clin Immunol 2005; 117:207-213; PMID:16169773; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a3/d3/kmab-07-01-985522.PMC4622060.pdf
Leukemia 2002; 16:2004- 2015; PMID:12357351; http://dx.doi.org/10.1038/sj.leu.2402639 12.,Non-OADS,/arxiv_data1/oa_pdf/a3/d3/kmab-07-01-985522.PMC4622060.pdf
Clin Cancer Res 2010; 16:4331-4338; PMID:20601446; http://dx.doi.org/10.1158/1078-0432.CCR-10-0570 13.,Non-OADS,/arxiv_data1/oa_pdf/a3/d3/kmab-07-01-985522.PMC4622060.pdf
Blood 2008; 111:5486-5495; PMID:18390837; http://dx.doi.org/10.1182/blood-2007-10-117671 14.,Non-OADS,/arxiv_data1/oa_pdf/a3/d3/kmab-07-01-985522.PMC4622060.pdf
Blood 2004; 104:1793-1800; PMID:15172969; http://dx.doi.org/ 10.1182/blood-2004-01-003915.,Non-OADS,/arxiv_data1/oa_pdf/a3/d3/kmab-07-01-985522.PMC4622060.pdf
"Nat Rev Drug Discov 2004; 3:488-499; PMID:15173838; http://dx.doi.org/ 10.1038/nrd1413 16. van Dongen GA, Poot AJ, Vugts DJ.",OADS,/arxiv_data1/oa_pdf/a3/d3/kmab-07-01-985522.PMC4622060.pdf
Tumour Biol 2012; 33:607-615; PMID:22270450; http://dx.doi.org/ 10.1007/s13277-012-0316-4 17.,Non-OADS,/arxiv_data1/oa_pdf/a3/d3/kmab-07-01-985522.PMC4622060.pdf
Clin Pharmacol Ther 2010; 87:586-592; PMID:20357763; http://dx.doi.org/10.1038/clpt.2010.12 18.,Non-OADS,/arxiv_data1/oa_pdf/a3/d3/kmab-07-01-985522.PMC4622060.pdf
J Clin Oncol 2012; 30:e74-75; PMID:22203768; http://dx.doi.org/10.1200/JCO.,Non-OADS,/arxiv_data1/oa_pdf/a3/d3/kmab-07-01-985522.PMC4622060.pdf
Lancet Oncol 2007; 8:304-310; PMID:17395103; http://dx.doi.org/ 10.1016/S1470-2045(07)70044-X 20.,Non-OADS,/arxiv_data1/oa_pdf/a3/d3/kmab-07-01-985522.PMC4622060.pdf
J Pharm Sci 2004; 93:2645-2668; PMID:15389672; http://dx.doi.org/ 10.1002/jps.20178 21.,Non-OADS,/arxiv_data1/oa_pdf/a3/d3/kmab-07-01-985522.PMC4622060.pdf
Drug Discov Today 2006; 11:812-818; PMID:16935749; http://dx.doi.org/10.1016/j.drudis.2006.07.005 22.,Non-OADS,/arxiv_data1/oa_pdf/a3/d3/kmab-07-01-985522.PMC4622060.pdf
JNatl Cancer Inst 2006; 98:335-344; PMID:16507830; http://dx.doi.org/10.1093/jnci/djj070 24.,Non-OADS,/arxiv_data1/oa_pdf/a3/d3/kmab-07-01-985522.PMC4622060.pdf
Nat Biotechnol 2005; 23:1137-1146; PMID:16151407; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a3/d3/kmab-07-01-985522.PMC4622060.pdf
Nat Biotechnol 2005;23:1126-1136; PMID:16151406; http://dx.doi.org/ 10.1038/nbt1142 26.,OADS,/arxiv_data1/oa_pdf/a3/d3/kmab-07-01-985522.PMC4622060.pdf
Expert Opin Drug Deliv 2006; 3:53- 70; PMID:16370940; http://dx.doi.org/10.1517/ 17425247.3.1.53 27.,Non-OADS,/arxiv_data1/oa_pdf/a3/d3/kmab-07-01-985522.PMC4622060.pdf
Cancer Res 2007; 67:254-261; PMID:17210705; http://dx.doi.org/10.1158/0008-5472.CAN-06-2531 28.,Non-OADS,/arxiv_data1/oa_pdf/a3/d3/kmab-07-01-985522.PMC4622060.pdf
J Nucl Med 2007; 48:995-999; PMID:17504872; http://dx.doi.org/10.2967/jnumed.106.037069 29.,Non-OADS,/arxiv_data1/oa_pdf/a3/d3/kmab-07-01-985522.PMC4622060.pdf
Semin Immunopathol 2009; 31:223-236; PMID:19495758; http://dx.doi.org/10.1007/s00281-009-0160-930.,Non-OADS,/arxiv_data1/oa_pdf/a3/d3/kmab-07-01-985522.PMC4622060.pdf
Crit Rev Oncol Hematol 1997; 26:77-100; PMID:9298326; http://dx.doi.org/10.1016/S1040-8428(97)00015-2 32.,Non-OADS,/arxiv_data1/oa_pdf/a3/d3/kmab-07-01-985522.PMC4622060.pdf
Front Physiol 2014; 5:299; PMID:25161624; http://dx.doi.org/10.3389/fphys.2014.00299 33.,Non-OADS,/arxiv_data1/oa_pdf/a3/d3/kmab-07-01-985522.PMC4622060.pdf
J Control Release 2012; 161:461-472; PMID:22094104; http://dx.doi.org/10.1016/j.jconrel.,OADS,/arxiv_data1/oa_pdf/a3/d3/kmab-07-01-985522.PMC4622060.pdf
Cancer Res 2010;70:1595-1605; PMID:20124480; http://dx.doi.org/ 10.1158/0008-5472.CAN-09-2724 35.,Non-OADS,/arxiv_data1/oa_pdf/a3/d3/kmab-07-01-985522.PMC4622060.pdf
J Biol Chem 2006; 281:35186-35201; PMID:16963450; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a3/d3/kmab-07-01-985522.PMC4622060.pdf
Protein Eng Des Sel 2013; 26:489-501; PMID:23754528; http://dx.doi.org/10.1093/protein/ gzt023 37.,OADS,/arxiv_data1/oa_pdf/a3/d3/kmab-07-01-985522.PMC4622060.pdf
Mol Immunol 2009; 46:2419-2423; PMID:19427037; http://dx.doi.org/10.1016/j.molimm.2009.04.009 39.,Non-OADS,/arxiv_data1/oa_pdf/a3/d3/kmab-07-01-985522.PMC4622060.pdf
Drugs 2002; 62:209-243; PMID:11790161; http://dx.doi.org/10.2165/ 00003495-200262010-00008 40.,Non-OADS,/arxiv_data1/oa_pdf/a3/d3/kmab-07-01-985522.PMC4622060.pdf
Protein Eng Des Sel 2007; 20:273-284;PMID:17595342; http://dx.doi.org/10.1093/protein/ gzm020 41.,OADS,/arxiv_data1/oa_pdf/a3/d3/kmab-07-01-985522.PMC4622060.pdf
Proteins 1995; 23:561-565;PMID:8749852; http://dx.doi.org/10.1002/prot.,OADS,/arxiv_data1/oa_pdf/a3/d3/kmab-07-01-985522.PMC4622060.pdf
FEBS Lett 1996; 378:190-194; PMID:8549831; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a3/d3/kmab-07-01-985522.PMC4622060.pdf
Eur J Biochem 1996; 241:468-475; PMID:8917444; http://dx.doi.org/10.1111/j.1432-1033.1996.00468.x 45.,Non-OADS,/arxiv_data1/oa_pdf/a3/d3/kmab-07-01-985522.PMC4622060.pdf
Science 1992; 256:1205-1210; PMID:1350381; http://dx.doi.org/10.1126/science.,OADS,/arxiv_data1/oa_pdf/a3/d3/kmab-07-01-985522.PMC4622060.pdf
Cancer Genet Cytogenet 2004; 153:144-150; PMID:15350304; http://dx.doi.org/ 10.1016/j.cancergencyto.2004.01.006 47.,Non-OADS,/arxiv_data1/oa_pdf/a3/d3/kmab-07-01-985522.PMC4622060.pdf
Cancer Sci 2010; 101:201-209; PMID:19930155; http://dx.doi.org/10.1111/j.1349- 7006.2009.01392.x 49.,Non-OADS,/arxiv_data1/oa_pdf/a3/d3/kmab-07-01-985522.PMC4622060.pdf
Biochem Biophys Res Commun 1978; 80:849-857;PMID:637870; http://dx.doi.org/10.1016/0006-291X (78)91322-0 50.,OADS,/arxiv_data1/oa_pdf/a3/d3/kmab-07-01-985522.PMC4622060.pdf
Radiat Environ Biophys2013; 52:189-193; PMID:23475155; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/a3/d3/kmab-07-01-985522.PMC4622060.pdf
Bioorg Med Chem 2009; 17:49-56;PMID:19054678; http://dx.doi.org/10.1016/j.bmc.,OADS,/arxiv_data1/oa_pdf/a3/d3/kmab-07-01-985522.PMC4622060.pdf
Nucl Med Biol 2007; 34:257-265;PMID:17383575; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/a3/d3/kmab-07-01-985522.PMC4622060.pdf
Nucl Med Biol 2011; 38:19-28; PMID:21220126; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/a3/d3/kmab-07-01-985522.PMC4622060.pdf
Cancer Biother Radiopharm 2002; 17:689-697; PMID:12537673; http://dx.doi.org/ 10.1089/108497802320970307 57.,Non-OADS,/arxiv_data1/oa_pdf/a3/d3/kmab-07-01-985522.PMC4622060.pdf
Drug Saf 2004; 27:1115-1133; PMID:15554746; http://dx.doi.org/ 10.2165/00002018-200427140-00004 58.,Non-OADS,/arxiv_data1/oa_pdf/a3/d3/kmab-07-01-985522.PMC4622060.pdf
Mol Cancer Ther 2009; 8:2861-2871; PMID:19825804; http://dx.doi.org/10.1158/1535-7163.MCT-09-0195 59.,Non-OADS,/arxiv_data1/oa_pdf/a3/d3/kmab-07-01-985522.PMC4622060.pdf
Methods Enzymol 2012; 503:255-268; PMID:22230572; http://dx.doi.org/10.1016/B978-0-12-396962-0.00010-0 60.,OADS,/arxiv_data1/oa_pdf/a3/d3/kmab-07-01-985522.PMC4622060.pdf
Br J Cancer 1996; 73:175-182;PMID:8546903; http://dx.doi.org/10.1038/bjc.,Non-OADS,/arxiv_data1/oa_pdf/a3/d3/kmab-07-01-985522.PMC4622060.pdf
Eur J Nucl Med Mol Imaging 2009; 36:1460-1468; PMID:19430786;http://dx.doi.org/10.1007/s00259-009-1134-9 62.,Non-OADS,/arxiv_data1/oa_pdf/a3/d3/kmab-07-01-985522.PMC4622060.pdf
Nat Biotechnol 2004; 22:701-706; PMID:15133471;http://dx.doi.org/10.1038/nbt968 63.,OADS,/arxiv_data1/oa_pdf/a3/d3/kmab-07-01-985522.PMC4622060.pdf
J Nucl Med 2009; 50:1500-1508; PMID:19690034; http://dx.doi.org/10.2967/jnumed.108.060426 64.,OADS,/arxiv_data1/oa_pdf/a3/d3/kmab-07-01-985522.PMC4622060.pdf
J Med Chem 2013; 56:9418-9426; PMID:24131491; http://dx.doi.org/10.1021/jm401365h 66.,Non-OADS,/arxiv_data1/oa_pdf/a3/d3/kmab-07-01-985522.PMC4622060.pdf
J Immunol Meth-ods 1998; 218:73-83; PMID:9819124; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/a3/d3/kmab-07-01-985522.PMC4622060.pdf
Gene 1994; 141:79-84;PMID:8163179; http://dx.doi.org/10.1016/0378- 1119(94)90131-7 68.,OADS,/arxiv_data1/oa_pdf/a3/d3/kmab-07-01-985522.PMC4622060.pdf
Gene 1994; 151:131-135; PMID:7828861; http://dx.doi.org/10.1016/0378- 1119(94)90643-2 69.,OADS,/arxiv_data1/oa_pdf/a3/d3/kmab-07-01-985522.PMC4622060.pdf
"A myriad ofengineered NPs for drug delivery have been developed, andinclude liposomes, polymeric-based NPs, silica, carbon, metal © Karin Taylor, Christopher B Howard, Martina L Jones, Ilya Sedliarou, Jennifer MacDiarmid, Himanshu Brahmbhatt, Trent P Munro, and Stephen M Mahler *Correspondence to: Karin Taylor; Email: karin.taylor@uq.edu.auSubmitted: 09/29/2014; Revised: 10/29/2014; Accepted: 11/04/2014 http://dx.doi.org/10.4161/19420862.2014.985952 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c5/dc/kmab-07-01-985952.PMC4622061.pdf
Nat Rev Drug Discov 2011; 10:521-35;PMID:21720407; http://dx.doi.org/10.1038/nrd3499 3.,Non-OADS,/arxiv_data1/oa_pdf/c5/dc/kmab-07-01-985952.PMC4622061.pdf
Int J Pharm 2013; 440:83-98; PMID:22227342; http://dx.doi.org/10.1016/j.ijpharm.,OADS,/arxiv_data1/oa_pdf/c5/dc/kmab-07-01-985952.PMC4622061.pdf
Protein Eng Des Sel 2012; 25:591-602; PMID:22843678; http://dx.doi.org/10.1093/protein/gzs042 5.,OADS,/arxiv_data1/oa_pdf/c5/dc/kmab-07-01-985952.PMC4622061.pdf
Drug Discov Today 2012; 17:954-63;PMID:22561895; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/c5/dc/kmab-07-01-985952.PMC4622061.pdf
J Immunother 2011; 34:611-28; PMID:21989410; http://dx.doi.org/ 10.1097/CJI.0b013e318234ecf5 9.,Non-OADS,/arxiv_data1/oa_pdf/c5/dc/kmab-07-01-985952.PMC4622061.pdf
Mol Immunol 2006; 43:1129-43; PMID:16139892; http://dx.doi.org/10.1016/j.molimm.,OADS,/arxiv_data1/oa_pdf/c5/dc/kmab-07-01-985952.PMC4622061.pdf
Nat Biotechnol 2005;23:1126-36; PMID:16151406; http://dx.doi.org/ 10.1038/nbt1142 11.,OADS,/arxiv_data1/oa_pdf/c5/dc/kmab-07-01-985952.PMC4622061.pdf
mAbs 2012; 4:182-97; PMID:22453100; http://dx.doi.org/10.4161/mabs.4.2.19000 12.,Non-OADS,/arxiv_data1/oa_pdf/c5/dc/kmab-07-01-985952.PMC4622061.pdf
BiochemPharmacol 2012; 84:1105-12; PMID:22858161; http://dx.doi.org/10.1016/j.bcp.2012.07.011 14.,OADS,/arxiv_data1/oa_pdf/c5/dc/kmab-07-01-985952.PMC4622061.pdf
MAbs 2009; 1:539-47; PMID:20073127; http://dx.doi.org/ 10.4161/mabs.1.6.10015 15.,Non-OADS,/arxiv_data1/oa_pdf/c5/dc/kmab-07-01-985952.PMC4622061.pdf
Trends Biotechnol 2013; 31:621-32; PMID:24094861; http://dx.doi.org/ 10.1016/j.tibtech.2013.08.007 16.,OADS,/arxiv_data1/oa_pdf/c5/dc/kmab-07-01-985952.PMC4622061.pdf
J Mol Biol2010; 399:436-49; PMID:20382161; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/c5/dc/kmab-07-01-985952.PMC4622061.pdf
MAbs 2010; 2:129- 36; PMID:20190561; http://dx.doi.org/10.4161/mabs.2.2.11221 20.,Non-OADS,/arxiv_data1/oa_pdf/c5/dc/kmab-07-01-985952.PMC4622061.pdf
MAbs 2010; 2:309-19;PMID:20418662; http://dx.doi.org/10.4161/mabs.2.3.,OADS,/arxiv_data1/oa_pdf/c5/dc/kmab-07-01-985952.PMC4622061.pdf
Cancer Cell 2007; 11:431-45; PMID:17482133; http://dx.doi.org/ 10.1016/j.ccr.2007.03.012 22.,Non-OADS,/arxiv_data1/oa_pdf/c5/dc/kmab-07-01-985952.PMC4622061.pdf
Nat Biotechnol2009; 27:643-51; PMID:19561595; http://dx.doi.org/ 10.1038/nbt.1547 23.,Non-OADS,/arxiv_data1/oa_pdf/c5/dc/kmab-07-01-985952.PMC4622061.pdf
Nat Rev Drug Discov 2005; 4:145- 60; PMID:15688077; http://dx.doi.org/10.1038/nrd1632 24.,OADS,/arxiv_data1/oa_pdf/c5/dc/kmab-07-01-985952.PMC4622061.pdf
Nat Rev Cancer 2005; 5:161-71;PMID:15738981; http://dx.doi.org/10.1038/nrc1566 25.,Non-OADS,/arxiv_data1/oa_pdf/c5/dc/kmab-07-01-985952.PMC4622061.pdf
Eur J Pharm Biopharm2013; 84:1-20; PMID:23313176; http://dx.doi.org/10.1016/j.ejpb.2012.12.009 26.,OADS,/arxiv_data1/oa_pdf/c5/dc/kmab-07-01-985952.PMC4622061.pdf
Adv Drug Deliv Rev 2013; 65:21-3;PMID:22580334; http://dx.doi.org/10.1016/j.addr.,OADS,/arxiv_data1/oa_pdf/c5/dc/kmab-07-01-985952.PMC4622061.pdf
J Control Release 2012; 161:175-87; PMID:21945285; http://dx.doi.org/10.1016/j.jconrel.,OADS,/arxiv_data1/oa_pdf/c5/dc/kmab-07-01-985952.PMC4622061.pdf
Eur J Pharm Sci 2013; 48:416-27; PMID:23262059; http://dx.doi.org/10.1016/j.ejps.2012.12.006 29.,OADS,/arxiv_data1/oa_pdf/c5/dc/kmab-07-01-985952.PMC4622061.pdf
Curr Opin Biotechnol 2011; 22:909-16; PMID:21550793; http://dx.doi.org/10.1016/j.copbio.,OADS,/arxiv_data1/oa_pdf/c5/dc/kmab-07-01-985952.PMC4622061.pdf
Mater Sci Eng C-Mater Biol Appl 2014; 41:178-95; PMID:24907751; http://dx.doi.org/10.1016/j.msec.2014.04.049.,OADS,/arxiv_data1/oa_pdf/c5/dc/kmab-07-01-985952.PMC4622061.pdf
Immunotherapy 2011; 3:381-94; PMID:21395380; http://dx.doi.org/10.2217/imt.11.5 35.,Non-OADS,/arxiv_data1/oa_pdf/c5/dc/kmab-07-01-985952.PMC4622061.pdf
Small 2013; 9:4027-35; PMID:23737360; http://dx.doi.org/10.1002/smll.,OADS,/arxiv_data1/oa_pdf/c5/dc/kmab-07-01-985952.PMC4622061.pdf
Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology.Adv Drug Deliv Rev 2014; 66:2-25; PMID:24270007; http://dx.doi.org/10.1016/j.addr.2013.11.009 39.,Non-OADS,/arxiv_data1/oa_pdf/c5/dc/kmab-07-01-985952.PMC4622061.pdf
Proc Nati Acad Sci U S A 1993;90:6444-8; PMID:8341653; http://dx.doi.org/ 10.1073/pnas.90.14.6444 41.,OADS,/arxiv_data1/oa_pdf/c5/dc/kmab-07-01-985952.PMC4622061.pdf
Blood 2011; 117:4542-51; PMID:21300981; http://dx.doi.org/10.1182/blood-2010-09-306449 44.,Non-OADS,/arxiv_data1/oa_pdf/c5/dc/kmab-07-01-985952.PMC4622061.pdf
Pro- tein Eng Des Sel 2010; 23:289-97; PMID:20150180; http://dx.doi.org/10.1093/protein/gzq005 45.,OADS,/arxiv_data1/oa_pdf/c5/dc/kmab-07-01-985952.PMC4622061.pdf
Curr Opin Biotechnol 2009; 20:405-11; PMID:19709876; http://dx.doi.org/10.1016/j.copbio.,OADS,/arxiv_data1/oa_pdf/c5/dc/kmab-07-01-985952.PMC4622061.pdf
Curr Opin Immunol 2008; 20:460- 70; PMID:18656541; http://dx.doi.org/10.1016/j.coi.2008.06.012 48.,OADS,/arxiv_data1/oa_pdf/c5/dc/kmab-07-01-985952.PMC4622061.pdf
Cell Biol Int 1995; 19:413-30; PMID:7640657; http://dx.doi.org/10.1006/cbir.1995.1086 49.,OADS,/arxiv_data1/oa_pdf/c5/dc/kmab-07-01-985952.PMC4622061.pdf
33:369-85; PMID:16890793; http://dx.doi.org/ 10.1053/j.seminoncol.2006.04.003 51.,Non-OADS,/arxiv_data1/oa_pdf/c5/dc/kmab-07-01-985952.PMC4622061.pdf
Anti-Cancer Drugs 2007; 18:7-15; PMID:17159497; http://dx.doi.org/10.1097/CAD.,Non-OADS,/arxiv_data1/oa_pdf/c5/dc/kmab-07-01-985952.PMC4622061.pdf
Am J Neuroradiol 2011; 32:1002-3; PMID:21596817;http://dx.doi.org/10.3174/ajnr.A2601 53.,Non-OADS,/arxiv_data1/oa_pdf/c5/dc/kmab-07-01-985952.PMC4622061.pdf
Nat Biotechnol 2007; 25:1134-43; PMID:17921999; http://dx.doi.org/10.1038/nbt1337 54.,Non-OADS,/arxiv_data1/oa_pdf/c5/dc/kmab-07-01-985952.PMC4622061.pdf
Biotechnol Adv 2012;30:1158-70; PMID:21968146; http://dx.doi.org/ 10.1016/j.biotechadv.2011.08.022 55.,OADS,/arxiv_data1/oa_pdf/c5/dc/kmab-07-01-985952.PMC4622061.pdf
Biotechnol Bio- eng 2005; 91:180-9; PMID:15880827; http://dx.doi.org/10.1002/bit.20499 56.,OADS,/arxiv_data1/oa_pdf/c5/dc/kmab-07-01-985952.PMC4622061.pdf
Protein Eng Des Sel 2012; 25:571-80; http://dx.doi.org/10.1093/protein/gzs064 57.,OADS,/arxiv_data1/oa_pdf/c5/dc/kmab-07-01-985952.PMC4622061.pdf
Molecular Cell 2009; 34:569-79; PMID:19524537; http://dx.doi.org/10.1016/j.molcel.,OADS,/arxiv_data1/oa_pdf/c5/dc/kmab-07-01-985952.PMC4622061.pdf
Nat Genet 1997; 15:146-56; PMID:9020839; http://dx.doi.org/10.1038/ ng0297-146 60.,Non-OADS,/arxiv_data1/oa_pdf/c5/dc/kmab-07-01-985952.PMC4622061.pdf
Proc Nati Acad Sci U S A 1998; 95:4607-12; PMID:9539785; http://dx.doi.org/ 10.1073/pnas.95.8.4607 61.,OADS,/arxiv_data1/oa_pdf/c5/dc/kmab-07-01-985952.PMC4622061.pdf
MAbs 2013; 5:513-7; PMID:23727858; http://dx.doi.org/10.4161/mabs.24990 63.,OADS,/arxiv_data1/oa_pdf/c5/dc/kmab-07-01-985952.PMC4622061.pdf
Nat Biotechnol 1998; 16:677-81;PMID:9661204; http://dx.doi.org/10.1038/nbt0798- 677 64.,Non-OADS,/arxiv_data1/oa_pdf/c5/dc/kmab-07-01-985952.PMC4622061.pdf
mAbs 2010; 2:20-34; PMID:20065654; http://dx.doi.org/10.4161/mabs.2.1.10498 65.,OADS,/arxiv_data1/oa_pdf/c5/dc/kmab-07-01-985952.PMC4622061.pdf
Protein Eng 1996; 9:617-21; PMID:8844834; http://dx.doi.org/10.1093/protein/ 9.7.617 66.,OADS,/arxiv_data1/oa_pdf/c5/dc/kmab-07-01-985952.PMC4622061.pdf
J Biol Chem 2003; 278:47812-9; PMID:12947084; http://dx.doi.org/ 10.1074/jbc.M307002200 69.,OADS,/arxiv_data1/oa_pdf/c5/dc/kmab-07-01-985952.PMC4622061.pdf
Trends Biotechnol 2013; 31:612-20; PMID:23932102; http://dx.doi.org/ 10.1016/j.tibtech.2013.07.002 71.,OADS,/arxiv_data1/oa_pdf/c5/dc/kmab-07-01-985952.PMC4622061.pdf
Protein Eng Des Sel 2010; 23:549-57; PMID:20457695; http://dx.doi.org/10.1093/protein/ gzq028 72.,OADS,/arxiv_data1/oa_pdf/c5/dc/kmab-07-01-985952.PMC4622061.pdf
Antimicrob Agents Chemother 2011; 55:2369-78; PMID:21300827; http://dx.doi.org/10.1128/AAC.,Non-OADS,/arxiv_data1/oa_pdf/c5/dc/kmab-07-01-985952.PMC4622061.pdf
Protein Eng Design Sel 2009; 23:115-27; http://dx.doi.org/10.1093/protein/gzp073 75.,OADS,/arxiv_data1/oa_pdf/c5/dc/kmab-07-01-985952.PMC4622061.pdf
mAbs 2011; 3:546-57; PMID:22123055; http://dx.doi.org/10.4161/mabs.3.6.,Non-OADS,/arxiv_data1/oa_pdf/c5/dc/kmab-07-01-985952.PMC4622061.pdf
Future Oncol 2012; 8:687-95; PMID:22764766; http://dx.doi.org/10.2217/fon.12.54 77.,Non-OADS,/arxiv_data1/oa_pdf/c5/dc/kmab-07-01-985952.PMC4622061.pdf
Growth Factors 2009; 27:141-54; PMID:19333814; http://dx.doi.org/ 10.1080/08977190902843565 79.,Non-OADS,/arxiv_data1/oa_pdf/c5/dc/kmab-07-01-985952.PMC4622061.pdf
J Mol Biol 1997; 270:26-35; PMID:9231898; http://dx.doi.org/ 10.1006/jmbi.1997.1116 81.,Non-OADS,/arxiv_data1/oa_pdf/c5/dc/kmab-07-01-985952.PMC4622061.pdf
J Immunol Methods 2010; 354:85-90; PMID:20153332; http://dx.doi.org/10.1016/j.jim.2010.02.001 82.,OADS,/arxiv_data1/oa_pdf/c5/dc/kmab-07-01-985952.PMC4622061.pdf
J Chem Technol Biotechnol2011; 86:923-34; http://dx.doi.org/10.1002/jctb.2572 www.tandfonline.com 65 mAbs,Non-OADS,/arxiv_data1/oa_pdf/c5/dc/kmab-07-01-985952.PMC4622061.pdf
"Interestingly, the phase advancement was not observed in *Correspondence to: Motomu Endo; E-mail: moendo@lif.kyoto-u.ac.jp Submitted: 12/08/2014; Revised: 01/04/2015; Accepted: 01/05/2015 http://dx.doi.org/10.1080/15592324.2015.1010933 www.tandfonline.com e1010933-1 Plant Signaling & BehaviorPlant Signaling & Behavior 10:6, e1010933; June 2015; Published with license by Taylor & Francis Group, LLCSHORT COMMUNICATION",OADS,/arxiv_data1/oa_pdf/10/2b/kpsb-10-06-1010933.PMC4622067.pdf
Nature 2014; 515: 419–22; PMID: 25363766; http://dx.doi.org/10.1038/nature13919 2.,Non-OADS,/arxiv_data1/oa_pdf/10/2b/kpsb-10-06-1010933.PMC4622067.pdf
Proc Natl Acad Sci U S A 2003; 100: 6878–83; PMID: 12736379; http://dx.doi.org/ 10.1073/pnas.11319951003.,OADS,/arxiv_data1/oa_pdf/10/2b/kpsb-10-06-1010933.PMC4622067.pdf
Plant Cell 2007; 19: 2111–23; PMID: 17616736; http://dx.doi.org/10.1105/tpc.107.050807 4.,OADS,/arxiv_data1/oa_pdf/10/2b/kpsb-10-06-1010933.PMC4622067.pdf
Science 2007; 318:261–65; PMID: 17872410; http://dx.doi.org/10.1126/ science.11469945.,OADS,/arxiv_data1/oa_pdf/10/2b/kpsb-10-06-1010933.PMC4622067.pdf
Plant Cell 2007; 19: 84–93; PMID: 17259260; http://dx.doi.org/10.1105/tpc.106.048157 6.,OADS,/arxiv_data1/oa_pdf/10/2b/kpsb-10-06-1010933.PMC4622067.pdf
Plant Physiol 2013; 163: 625–34; PMID:24027243; http://dx.doi.org/10.1104/pp.113.222901 Figure 1.,Non-OADS,/arxiv_data1/oa_pdf/10/2b/kpsb-10-06-1010933.PMC4622067.pdf
"In this study, we sought to investigate whether © MedImmune *Correspondence to: Natalie J Tigue; Email: tiguen@medimmune.comSubmitted: 08/08/2014; Revised: 09/29/2014; Accepted: 11/03/2014 http://dx.doi.org/10.4161/19420862.2014.985489 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/76/0c/kmab-07-01-985489.PMC4622073.pdf
Nature 2010; 464:1367-70; PMID:20200518; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/76/0c/kmab-07-01-985489.PMC4622073.pdf
PLoS One 2008; 3:e3331; PMID:18836528; http://dx.doi.org/10.1371/journal.pone.0003331 4.,Non-OADS,/arxiv_data1/oa_pdf/76/0c/kmab-07-01-985489.PMC4622073.pdf
Immunity2005; 23:479-90; PMID:16286016; http://dx.doi.org/ 10.1016/j.immuni.2005.09.015 6.,OADS,/arxiv_data1/oa_pdf/76/0c/kmab-07-01-985489.PMC4622073.pdf
J Immunol 2009; 183:5094-103; PMID:19801525; http://dx.doi.org/10.4049/jimmunol.0802387 7.,Non-OADS,/arxiv_data1/oa_pdf/76/0c/kmab-07-01-985489.PMC4622073.pdf
J Immunol2007; 179:2051-4; PMID:17675461; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/76/0c/kmab-07-01-985489.PMC4622073.pdf
Lab Invest 2007; 87:971-8;PMID:17700564; http://dx.doi.org/10.1038/labinvest.,OADS,/arxiv_data1/oa_pdf/76/0c/kmab-07-01-985489.PMC4622073.pdf
Inﬂamm Res 2010; 59:207-18; PMID:19763788; http://dx.doi.org/10.1007/s00011- 009-0088-5 11.,Non-OADS,/arxiv_data1/oa_pdf/76/0c/kmab-07-01-985489.PMC4622073.pdf
PLoS One 2009; 4:e6087; PMID:19564921; http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/76/0c/kmab-07-01-985489.PMC4622073.pdf
Clin Vaccine Immunol 2006; 13:98-105; PMID:16426006; http://dx.doi.org/10.1128/ CVI.13.1.98-105.2006 13.,Non-OADS,/arxiv_data1/oa_pdf/76/0c/kmab-07-01-985489.PMC4622073.pdf
PLoS One2010; 5:e12892; PMID:20886120; http://dx.doi.org/ 10.1371/journal.pone.0012892 14.,Non-OADS,/arxiv_data1/oa_pdf/76/0c/kmab-07-01-985489.PMC4622073.pdf
Vet Microbiol 2007; 123:367-76; PMID:17499458;http://dx.doi.org/10.1016/j.vetmic.2007.03.032 15.,Non-OADS,/arxiv_data1/oa_pdf/76/0c/kmab-07-01-985489.PMC4622073.pdf
Eur J Immunol 1971; 1:18-27; PMID:14978857; http://dx.doi.org/10.1002/ eji.1830010104 16.,Non-OADS,/arxiv_data1/oa_pdf/76/0c/kmab-07-01-985489.PMC4622073.pdf
Mol Immunol 1997; 34:599-608; PMID:9393963; http://dx.doi.org/10.1016/S0161-5890(97)00078-3 34.,Non-OADS,/arxiv_data1/oa_pdf/76/0c/kmab-07-01-985489.PMC4622073.pdf
"J Immunol 2000; 164:1625- 33; PMID:10640784; http://dx.doi.org/10.4049/ jimmunol.164.3.1625 35. del Guercio MF, Alexander J, Kubo RT, Arrhenius T, Maewal A, Appella E, Hoffman SL, Jones T, Valmori D, Sakaguchi K, et al.",OADS,/arxiv_data1/oa_pdf/76/0c/kmab-07-01-985489.PMC4622073.pdf
Vaccine 1997; 15:441-8;PMID:9141216; http://dx.doi.org/10.1016/S0264- 410X(97)00186-2 36.,Non-OADS,/arxiv_data1/oa_pdf/76/0c/kmab-07-01-985489.PMC4622073.pdf
Open Biol 2013; 3:120139; PMID:23303307; http://dx.doi.org/10.1098/rsob.120139 38.,OADS,/arxiv_data1/oa_pdf/76/0c/kmab-07-01-985489.PMC4622073.pdf
J Leukoc Biol 2007; 82:1481-90; PMID:17881510; http://dx.doi.org/ 10.1189/jlb.0407200 www.tandfonline.com 137 mAbs,Non-OADS,/arxiv_data1/oa_pdf/76/0c/kmab-07-01-985489.PMC4622073.pdf
"9,19-21Mono-speciﬁcity of an antibody reagent is thus established only when it recognizes a single antigen on a prote- ome microarray.9,21 © Shuang Liu, Hongyan Zhang, Jun Dai, Shaohu Hu, Ignacio Pino, Daniel J Eichinger, Huibin Lyu, and Heng Zhu *Correspondence to: Huibin Lyu; Email: hblu@aphy.ac.cn; Heng Zhu; Email: hzhu4@jhmi.eduSubmitted: 09/19/2014; Revised: 10/17/2014; Accepted: 10/30/2014 http://dx.doi.org/10.4161/19420862.2014.985919 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/48/93/kmab-07-01-985919.PMC4622085.pdf
Antigen production All of the antigens used in this study were provided by Dr. Ste- ven Anderson’s group at Rutgers University as part of the NIHProtein Capture Reagents Initiative funded by the NIH CommonFund (https://commonfund.nih.gov/proteincapture/index).,OADS,/arxiv_data1/oa_pdf/48/93/kmab-07-01-985919.PMC4622085.pdf
Biotechni- ques 2008; 44:649; http://dx.doi.org/10.2144/ 000112803 2.,Non-OADS,/arxiv_data1/oa_pdf/48/93/kmab-07-01-985919.PMC4622085.pdf
Nat Rev Cancer 2008; 8:473-80; PMID:18469827; http://dx.doi.org/ 10.1038/nrc2394 3.,Non-OADS,/arxiv_data1/oa_pdf/48/93/kmab-07-01-985919.PMC4622085.pdf
Nature 1975; 256:495-7; PMID:1172191; http://dx.doi.org/ 10.1038/256495a0 4.,Non-OADS,/arxiv_data1/oa_pdf/48/93/kmab-07-01-985919.PMC4622085.pdf
Naunyn Schmiedebergs Arch Pharmacol 2009; 379:409-12; PMID:18989658; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/48/93/kmab-07-01-985919.PMC4622085.pdf
Nat Rev Drug Discov 2010; 9:665-7; PMID:20811367; http://dx.doi.org/10.1038/nrd3270 6.,OADS,/arxiv_data1/oa_pdf/48/93/kmab-07-01-985919.PMC4622085.pdf
MAbs: Landes Bioscience 2009; 1:583-9; http://dx.doi.org/10.4161/mabs.1.6.9884 7.,Non-OADS,/arxiv_data1/oa_pdf/48/93/kmab-07-01-985919.PMC4622085.pdf
Nat Biotechnol 2003; 21:1509-12;PMID:14608365; http://dx.doi.org/10.1038/nbt910 8.,Non-OADS,/arxiv_data1/oa_pdf/48/93/kmab-07-01-985919.PMC4622085.pdf
J Virol 2008; 82:652-63; PMID:17977963; http://dx.doi.org/10.1128/JVI.01706-07 9.,Non-OADS,/arxiv_data1/oa_pdf/48/93/kmab-07-01-985919.PMC4622085.pdf
Mol Cell Proteomics 2009; 8:924-35; PMID:19112181; http://dx.doi.org/10.1074/mcp.,Non-OADS,/arxiv_data1/oa_pdf/48/93/kmab-07-01-985919.PMC4622085.pdf
Mol Cell Proteomics 2003; 2:1342-9; PMID:14517340; http://dx.doi.org/10.1074/mcp.T300001-MCP200 13.,OADS,/arxiv_data1/oa_pdf/48/93/kmab-07-01-985919.PMC4622085.pdf
Genomics 2000; 65:1-8;PMID:10777659; http://dx.doi.org/10.1006/geno.,OADS,/arxiv_data1/oa_pdf/48/93/kmab-07-01-985919.PMC4622085.pdf
Proteomics 2007; 7:2151-61; PMID: 17549792; http://dx.doi.org/10.1002/pmic.200600923 15.,Non-OADS,/arxiv_data1/oa_pdf/48/93/kmab-07-01-985919.PMC4622085.pdf
Proteomics 2007; 7:2738-50; PMID:17639606;http://dx.doi.org/10.1002/pmic.200700155 16.,OADS,/arxiv_data1/oa_pdf/48/93/kmab-07-01-985919.PMC4622085.pdf
Mol Cell Proteomics 2008; 7:2019-27;PMID:18669619; http://dx.doi.org/10.1074/mcp.,Non-OADS,/arxiv_data1/oa_pdf/48/93/kmab-07-01-985919.PMC4622085.pdf
J Mol Recognit 2009; 22:57-64; PMID:18546091; http://dx.doi.org/10.1002/jmr.891 18.,OADS,/arxiv_data1/oa_pdf/48/93/kmab-07-01-985919.PMC4622085.pdf
Nat Methods 2011; 8:551-8; PMID:21572409; http://dx.doi.org/10.1038/ nmeth.1607 19.,OADS,/arxiv_data1/oa_pdf/48/93/kmab-07-01-985919.PMC4622085.pdf
Mol Cell Proteomics 2009; 8:1765-76;PMID:19357087; http://dx.doi.org/10.1074/mcp.,Non-OADS,/arxiv_data1/oa_pdf/48/93/kmab-07-01-985919.PMC4622085.pdf
J Proteome Res 2010; 9:30-9; PMID:19545157; http://dx.doi.org/10.1021/pr900131e 21.,Non-OADS,/arxiv_data1/oa_pdf/48/93/kmab-07-01-985919.PMC4622085.pdf
Rapid identiﬁcation of monospeciﬁc mono- clonal antibodies using a human proteome microarray.Mol Cell Proteomics 2012; 11(6):O111.016253; PMID:22307071; http://dx.doi.org/10.1074/mcp.,Non-OADS,/arxiv_data1/oa_pdf/48/93/kmab-07-01-985919.PMC4622085.pdf
Electrophoresis 2002; 23:836-46; PMID:11920868; http://dx.doi.org/10.1002/1522-2683(200203)23:6%3c836::AID- ELPS836%3e3.0.CO;2-J 23.,OADS,/arxiv_data1/oa_pdf/48/93/kmab-07-01-985919.PMC4622085.pdf
Biosens Bioelectron 2004;20:1140-8; PMID:15556360; http://dx.doi.org/ 10.1016/j.bios.2004.05.020 24.,OADS,/arxiv_data1/oa_pdf/48/93/kmab-07-01-985919.PMC4622085.pdf
Anal Chem2003; 75:6119-23; PMID:14615990; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/48/93/kmab-07-01-985919.PMC4622085.pdf
J Opt Soc Am B 2001; 18:1031-5; http://dx.doi.org/10.1364/JOSAB.18.001031 28.,OADS,/arxiv_data1/oa_pdf/48/93/kmab-07-01-985919.PMC4622085.pdf
Opt Lett 2004; 29:581-3; PMID:15035477; http://dx.doi.org/ 10.1364/OL.29.000581 29.,OADS,/arxiv_data1/oa_pdf/48/93/kmab-07-01-985919.PMC4622085.pdf
Chinese Phys Lett 2010; 27:107801; PMID:17356635; http://dx.doi.org/10.1088/0256-307X/27/10/107801 30.,Non-OADS,/arxiv_data1/oa_pdf/48/93/kmab-07-01-985919.PMC4622085.pdf
J Opt 2010; 12:095301;PMID:21781038; http://dx.doi.org/10.1088/2040- 8978/12/9/095301 31.,Non-OADS,/arxiv_data1/oa_pdf/48/93/kmab-07-01-985919.PMC4622085.pdf
Rev Sci Instrum 2008;79:013708; PMID:18248040; http://dx.doi.org/ 10.1063/1.2830286 33.,Non-OADS,/arxiv_data1/oa_pdf/48/93/kmab-07-01-985919.PMC4622085.pdf
Cell 1978; 14:9-20; PMID:667938;http://dx.doi.org/10.1016/0092-8674(78)90296-9 35.,OADS,/arxiv_data1/oa_pdf/48/93/kmab-07-01-985919.PMC4622085.pdf
Biochem Bioph Res Co 1996; 225:1073-7; PMID:8780736; http://dx.doi.org/10.1006/bbrc.1996.1297 www.tandfonline.com 119 mAbs,Non-OADS,/arxiv_data1/oa_pdf/48/93/kmab-07-01-985919.PMC4622085.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/3e/ef/ott-8-2981.PMC4622090.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 2981–2988OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  2981Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S8945 9Microrna-766 targeting regulation of sOX6  expression promoted cell proliferation of human  colorectal cancer Y ong-chao li1 chang-feng li2 li-bo chen2 Dan-dan li2 lei Yang2 Jing-peng Jin2 Bin Zhang2 1Department of gastrointestinal  surgery, 2Department of endoscopy  center, china–Japan Union hospital  of Jilin University, changchun, People’s  republic of chinaAbstract:  MicroRNAs (miRNAs) have emerged as important regulators of cancer-cell  biological processes.",Non-OADS,/arxiv_data1/oa_pdf/3e/ef/ott-8-2981.PMC4622090.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/3e/ef/ott-8-2981.PMC4622090.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/3e/ef/ott-8-2981.PMC4622090.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/5a/c5/ccid-8-521.PMC4622091.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinical, Cosmetic and Investigational Dermatology 2015:8 521–527Clinical, Cosmetic and Investigational Dermatology Dove press submit your manuscript | www.dovepress.co m Dove press  521RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CCID.S7590 8Management of pemphigus vulgaris: challenges   and solutions Stamatis Gregoriou Ourania efthymiou Christina Stefanaki Dimitris Rigopoulos 2nd Department of Dermatology and  venereology, University of Athens  Medical School, Attikon Hospital,   Athens, Greece Correspondence: Stamatis Gregoriou   2nd Department of Dermatology   venereology, University of Athens   Medical School, Attikon Hospital,   1 Rimini Street, Athens 12462, Greece   Tel +30 21 0583 2396   Fax +30 21 0583 2397   email stamgreg@yahoo.g rAbstract:  The main objective in the treatment of pemphigus vulgaris is to control the disease,  prevent relapses, and avoid adverse events associated with the prolonged use of steroids and  immunosuppressive agents.",Non-OADS,/arxiv_data1/oa_pdf/5a/c5/ccid-8-521.PMC4622091.pdf
"Clinical, Cosmetic and Investigational Dermatology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-cosmetic-and-investigational-dermatology-journa lClinical, Cosmetic and Investigational Dermatology is an interna - tional, peer-reviewed, open access, online journal that focuses on  the latest clinical and experimental research in all aspects of skin  disease and cosmetic interventions.",Non-OADS,/arxiv_data1/oa_pdf/5a/c5/ccid-8-521.PMC4622091.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/5a/c5/ccid-8-521.PMC4622091.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b3/db/ott-8-3047.PMC4622093.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 3047–3054OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3047Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S8915 4combined olaparib and oxaliplatin inhibits  tumor proliferation and induces g2/M arrest and  γ-h2aX foci formation in colorectal cancer Kaiwu Xu1,* Zhihui chen2,* Yi cui1 changjiang Qin2 Yulong he2 Xinming song2 1endoscopy center, 2gastrointestinal  surgery center, The First affiliated  hospital of sun Yat-sen University,   guangzhou, guangdong Province,   People’s republic of china *These authors contributed equally  to this workBackground:  Poly (ADP-ribose) polymerase 1 (PARP1) has an important role in homologous  recombination repair.",Non-OADS,/arxiv_data1/oa_pdf/b3/db/ott-8-3047.PMC4622093.pdf
"Oxaliplatin is a third-generation platinum analog of the 1,2-diaminocyclohexane  family, and has a spectrum of activity and mechanisms of action that appear to be   different from those of other platinum-containing compounds.4,5 Moreover, its antican - cer effects are optimized when it is administered in combination with other anticancer  agents, such as 5-fluorouracil5 and S-1.6,7 Oxaliplatin can induce DNA cross-links and  lead to DNA double-strand breaks (DSBs).8,9 After DSBs are induced by irradiation correspondence: Xinming song gastrointestinal surgery center, The  First Affiliated Hospital of Sun Yat-sen  University, Zhongshan second road,  510080 guangzhou, guangdong Province,  People’s republic of china Tel +86 20 8775 5766 email songxm2010@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2015 Volume: 8 Running head verso: Xu et al Running head recto: Combined olaparib and oxaliplatin inhibits tumor proliferation DOI: http://dx.doi.org/10.2147/OTT.S8915 4",Non-OADS,/arxiv_data1/oa_pdf/b3/db/ott-8-3047.PMC4622093.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/b3/db/ott-8-3047.PMC4622093.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/b3/db/ott-8-3047.PMC4622093.pdf
http://dx.doi.org/10.1038/nature10766 .,Non-OADS,/arxiv_data1/oa_pdf/7d/f9/zcd1166.PMC4622110.pdf
http://dx.doi.org/10.1093/infdis/jiu485 .,Non-OADS,/arxiv_data1/oa_pdf/7d/f9/zcd1166.PMC4622110.pdf
http://dx.doi.org/10.1093/infdis/jis670 .,Non-OADS,/arxiv_data1/oa_pdf/7d/f9/zcd1166.PMC4622110.pdf
Curr Opin HIV AIDS8:402– 411. http://dx.doi.org/10.1097/COH.0b013e328363d389 .,Non-OADS,/arxiv_data1/oa_pdf/7d/f9/zcd1166.PMC4622110.pdf
http://dx.doi.org/10.1038/nm.2089 .,OADS,/arxiv_data1/oa_pdf/7d/f9/zcd1166.PMC4622110.pdf
http://dx.doi.org/10.1093/bioinformatics/btn251 .,Non-OADS,/arxiv_data1/oa_pdf/7d/f9/zcd1166.PMC4622110.pdf
http://dx.doi.org/10.1038 /nm1461 .,OADS,/arxiv_data1/oa_pdf/7d/f9/zcd1166.PMC4622110.pdf
http://dx.doi.org/10.1128/JVI.01779-12 .,Non-OADS,/arxiv_data1/oa_pdf/7d/f9/zcd1166.PMC4622110.pdf
"http://dx.doi.org/10.1038/nm.2108 .12.Janes H, Frahm N, DeCamp A, Rolland M, Gabriel E, Wolfson J, Hertz T, Kallas E, Goepfert P, Friedrich DP, Corey L, Mullins JI, McElrathMJ, Gilbert P. 2012.",OADS,/arxiv_data1/oa_pdf/7d/f9/zcd1166.PMC4622110.pdf
http://dx.doi.org /10.1371/journal.pone.0043396 .,Non-OADS,/arxiv_data1/oa_pdf/7d/f9/zcd1166.PMC4622110.pdf
http://dx.doi.org/10.1371 /journal.pone.0031177 .,Non-OADS,/arxiv_data1/oa_pdf/7d/f9/zcd1166.PMC4622110.pdf
http://dx.doi.org/10.1371/journal.pone .0115476 .,Non-OADS,/arxiv_data1/oa_pdf/7d/f9/zcd1166.PMC4622110.pdf
Compar- ative seroprevalence and immunogenicity of six rare serotype recombi-nant adenovirus vaccine vectors from subgroups B and D. J Virol 81: 4654 – 4663. http://dx.doi.org/10.1128/JVI.02696-06 .,Non-OADS,/arxiv_data1/oa_pdf/7d/f9/zcd1166.PMC4622110.pdf
Immunogenicity of recombinant adenovi- rus serotype 35 vaccine in the presence of pre-existing anti-Ad5 immunity.J Immunol 172:6290 – 6297. http://dx.doi.org/10.4049/jimmunol.172.10 .6290 .,Non-OADS,/arxiv_data1/oa_pdf/7d/f9/zcd1166.PMC4622110.pdf
http://dx.doi.org/10 .1128/JVI.01348-06 .,Non-OADS,/arxiv_data1/oa_pdf/7d/f9/zcd1166.PMC4622110.pdf
http://dx.doi.org/10.1128/JVI.02950-14 .,Non-OADS,/arxiv_data1/oa_pdf/7d/f9/zcd1166.PMC4622110.pdf
http://dx.doi.org/10.1371 /journal.pone.0076344 .,Non-OADS,/arxiv_data1/oa_pdf/7d/f9/zcd1166.PMC4622110.pdf
http://dx.doi.org/10.1016/j.vaccine.2009.10.145 .,OADS,/arxiv_data1/oa_pdf/7d/f9/zcd1166.PMC4622110.pdf
Cell 132:397– 409. http://dx.doi.org/10.1016 /j.cell.2008.01.016 .,OADS,/arxiv_data1/oa_pdf/7d/f9/zcd1166.PMC4622110.pdf
J Virol 82:4844 – 4852. http://dx.doi.org/10.1128/JVI .02616-07 .,Non-OADS,/arxiv_data1/oa_pdf/7d/f9/zcd1166.PMC4622110.pdf
http://dx.doi .org/10.1038/nature07469 .,Non-OADS,/arxiv_data1/oa_pdf/7d/f9/zcd1166.PMC4622110.pdf
http://dx.doi .org/10.4049/jimmunol.179.3.1721 .,Non-OADS,/arxiv_data1/oa_pdf/7d/f9/zcd1166.PMC4622110.pdf
http://dx.doi.org/10 .1128/JVI.00928-12 .,Non-OADS,/arxiv_data1/oa_pdf/7d/f9/zcd1166.PMC4622110.pdf
J Virol 86:9590 – 9598. http://dx.doi.org/10.1128/JVI.00740-12 .,Non-OADS,/arxiv_data1/oa_pdf/7d/f9/zcd1166.PMC4622110.pdf
http://dx.doi.org/10.1126/science.1470917 .,Non-OADS,/arxiv_data1/oa_pdf/7d/f9/zcd1166.PMC4622110.pdf
http://dx.doi.org/10.1006 /viro.1996.8419 .,Non-OADS,/arxiv_data1/oa_pdf/7d/f9/zcd1166.PMC4622110.pdf
Vaccine 29:6191– 6218. http://dx.doi.org/10.1016/j.vaccine .2011.06.085 .,Non-OADS,/arxiv_data1/oa_pdf/7d/f9/zcd1166.PMC4622110.pdf
http://dx.doi.org/10.1038/nature12519 .,Non-OADS,/arxiv_data1/oa_pdf/7d/f9/zcd1166.PMC4622110.pdf
http://dx.doi.org/10.1097 /QCO.0000000000000059 .,OADS,/arxiv_data1/oa_pdf/7d/f9/zcd1166.PMC4622110.pdf
http://dx.doi.org/10.1586/14760584.7.1.25 .,Non-OADS,/arxiv_data1/oa_pdf/7d/f9/zcd1166.PMC4622110.pdf
http://dx.doi.org/10 .1016/j.vaccine.2013.05.016 .,OADS,/arxiv_data1/oa_pdf/7d/f9/zcd1166.PMC4622110.pdf
http://dx.doi.org/10.1371/journal.pone.0082380 .Attenuation of rcAd26-Based Vaccine Vector November 2015 Volume 22 Number 11 cvi.asm.org 1175 Clinical and Vaccine Immunology,Non-OADS,/arxiv_data1/oa_pdf/7d/f9/zcd1166.PMC4622110.pdf
"4   October,  2015 pISSN: 2093-0879   eISSN: 2093-0887 http://dx.doi.org/10.5056/jnm15144 455Expanding Indications of Gastric Electrical  Stimulation Jung Hwan Oh  Division of Gastroenter ology, Department of Internal Medicine, College of Medicine, The Catholic  University of Korea, Seoul, K orea Article :Temporary endoscopic stimulation in gastroparesis-like syndrome Singh S, McCrary J, Kedar A, et al (J Neurogastroenterol Motil 2015;21:520-527) Received: September 8, 2015 Revised: September 10, 2015 Accepted: September 13, 2015 CC This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.",Non-OADS,/arxiv_data1/oa_pdf/b0/80/jnm-21-455.PMC4622126.pdf
"*Correspondence: Jung Hwan Oh, MD Department of Internal Medicine, St. Paul’s hospital, College of Medicine, The Catholic University of Korea, 180, Wangsan-ro, Dongdaemun-gu, Seoul 02559, KoreaTel: +82-2-958-2114, Fax: +82-2-968-7250, E-mail: ojh@catholic.ac.kr Financial support: None.Conflicts of interest: None.ORCID: Jung Hwan Oh, http://orcid.org/0000-0002-9274-882X.Gastroparesis is a chronic motility disorder that delays, in the  absence of mechanical obstruction, the occurrence of gastric  emptying.",Non-OADS,/arxiv_data1/oa_pdf/b0/80/jnm-21-455.PMC4622126.pdf
"4   October,  2015 pISSN: 2093-0879   eISSN: 2093-0887 http://dx.doi.org/10.5056/jnm15142 457Modulation of the Bitter Taste to Reduce  Calorie Intake Hee Man Kim Department of Internal Medicine, Yonsei University Wonju Colleg e of Medicine, Wonju, Korea Article : The bitter taste receptor agonist  quinine reduces calorie inta ke and increases the postprandial release of  cholecystokinin in healthy subjects Andreozzi P, Sarnelli G, Pesce M, et al (J Neurogastroenterol Motil 2015;21:511-519) Received: September 2, 2015 Revised: September 12, 2015 Accepted: September 13, 2015 CC This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.",Non-OADS,/arxiv_data1/oa_pdf/21/83/jnm-21-457.PMC4622127.pdf
"4   October,  2015 pISSN: 2093-0879   eISSN: 2093-0887 http://dx.doi.org/10.5056/jnm15111 459The Low FODMAP Diet and Its Application in  East and Southeast Asia Marina Iacovou,1* Victoria Tan,2 Jane G Muir,1 and Peter R Gibson1 1Department of Gastroenterology, Monash University and Alfred Ho spital, Melbourne, Australia; and 2Department of Medicine, University of  Hong Kong, Hong Kong There is growing interest in using food choice/dietary change to  influence clinical outcomes in patients with irritable bowel s yn- drome (IBS).",Non-OADS,/arxiv_data1/oa_pdf/1e/4f/jnm-21-459.PMC4622128.pdf
"ORCID: Marina Iacovou, http://orcid.org/0000-0001-5209-0624.Introduction The epidemiology of functional gastrointestinal disorders  (FGID) varies across countries and cultures, but irritable bowel syndrome (IBS) appears to be a global phenomenon.1,2 Preva- lence varies according to the criteria used for diagnosis, but in  East and Southeast Asia prevalence varies across countries, from  South Korea 6-15%, China 2-10%, Japan 6-14% to Thailand 6%.",Non-OADS,/arxiv_data1/oa_pdf/1e/4f/jnm-21-459.PMC4622128.pdf
Available from URL: http://www.med.monash.edu.au/cecs/gastro/ fodmap/iphone-app.html (accessed 9 Sep 2015).,Non-OADS,/arxiv_data1/oa_pdf/1e/4f/jnm-21-459.PMC4622128.pdf
"4   October,  2015 pISSN: 2093-0879   eISSN: 2093-0887 http://dx.doi.org/10.5056/jnm15071 471Probiotic Therapy of the Irritable Bowel  Syndrome: Why Is the Evidence Still Poor and  What Can Be Done About It?",Non-OADS,/arxiv_data1/oa_pdf/6e/e0/jnm-21-471.PMC4622129.pdf
"ORCID: Nazar Mazurak, http://orcid.org/0000-0002-1205-3893.",Non-OADS,/arxiv_data1/oa_pdf/6e/e0/jnm-21-471.PMC4622129.pdf
"4   October,  2015 pISSN: 2093-0879   eISSN: 2093-0887 http://dx.doi.org/10.5056/jnm15075 486Is Interstitial Cells of Cajal ‒opathy Present in  Gastroparesis?",Non-OADS,/arxiv_data1/oa_pdf/33/26/jnm-21-486.PMC4622130.pdf
"ORCID: Mohammad Bashashati, http://orcid.org/0000-0002-3237-4715; Richard W McCallum, http://orcid.org/0000-0002-6652-8049.Introduction Gastroparesis (GP), affecting up to 10 million individuals in  the United States (US), is a relatively common gastrointestinal (GI) motility disorder and is defined as delayed gastric emptying  without any mechanical obstruction.",Non-OADS,/arxiv_data1/oa_pdf/33/26/jnm-21-486.PMC4622130.pdf
"4   October,  2015 pISSN: 2093-0879   eISSN: 2093-0887 http://dx.doi.org/10.5056/jnm15061 494Targeting Ion Channels: An Important  Therapeutic Implication in Gastrointestinal  Dysmotility in Patients With Spinal Cord Injury Miroslav Radulovic,1,2 Preeti Anand,3 Mark A Korsten,1,2 and Bing Gong1,3* Departments of1Medicine and3Neurology, Icahn School of Medicine at Mount Sinai, New York, N Y, USA; and2National Center of Excellence  for the Medical Consequences of SCI, James J Peters Veteran Aff airs Medical Center, Bronx, NY, USA Gastrointestinal (GI) dysmotility is a severe, and common complication in patients with spinal cord injury (SCI).",Non-OADS,/arxiv_data1/oa_pdf/76/9e/jnm-21-494.PMC4622131.pdf
"4   October,  2015 pISSN: 2093-0879   eISSN: 2093-0887 http://dx.doi.org/10.5056/jnm15060 503Comparing the Areas of Interest in the Field  of Functional Gastrointestinal Disorder and  Neurogastroenterology and Motility Between the East and the West Ju Yup Lee,1,2 Nayoung Kim,1,3* Gwang Ha Kim,4 and Gi Hyun Kim1 1Department of Internal Medicine, Seoul National University Bund ang Hospital, Seongnam, Korea;2Department of Internal  Medicine, Keimyung  University School of Medicine, Daegu, Korea;3Department of Internal Medicine and Liver Research Institute, S eoul National University College  of Medicine, Seoul, Korea; and4Department of Internal Medicine, Pusan National University Scho ol of Medicine; and Biomedical Research  Institute, Pusan National University Hospital, Busan, Korea There is a paucity of studies that compare the differences in published articles submitted from the East and the West in the ar ea  of neurogastroenterology and motility (NM).",Non-OADS,/arxiv_data1/oa_pdf/be/0a/jnm-21-503.PMC4622132.pdf
"ORCID: Nayoung Kim, http://orcid.org/0000-0002-9397-0406; Ju Yup Lee, http://orcid.org/0000-0003-0021-5354.",Non-OADS,/arxiv_data1/oa_pdf/be/0a/jnm-21-503.PMC4622132.pdf
"4   October,  2015 pISSN: 2093-0879   eISSN: 2093-0887 http://dx.doi.org/10.5056/jnm15028 511Received: February 18, 2015 Revised: April 20, 2015 Accepted: April 21, 2015 CC This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.",Non-OADS,/arxiv_data1/oa_pdf/d8/e6/jnm-21-511.PMC4622133.pdf
"ORCID: Paolo Andreozzi, http://orcid.org/0000-0002-4604-0126; Giovanni Sarnelli, http://orcid.org/0000-0002-1467-1134; Marcella  Pesce,  http://orcid.org/0000-0001-5996-4259; Francesco Paolo Zito, http://orcid.org/0000-0002-1084-3373; Viviana Verlezza, http://orcid.org/0000-0001-9569-2369; Ilaria Palumbo, http://orcid.org/0000-0003-0387-1461; Fabio Turco, http://orcid.org/0000-0001-9149-3872; Katherine Esposito, http://orcid.org/0000-0002-3652-5154; Rosario Cuomo, http://orcid.org/0000-0003-0768-8381.The Bitter Taste Receptor Agonist Quinine  Reduces Calorie Intake and Increases the  Postprandial Release of Cholecystokinin in Healthy Subjects Paolo Andreozzi,1 Giovanni Sarnelli,1 Marcella Pesce,1 Francesco P Zito,1 Alessandra D’Alessandro,1 Viviana Verlezza,1  Ilaria Palumbo,1 Fabio Turco,1 Katherine Esposito,2 and Rosario Cuomo1* 1Department of Clinical Medicine and Surgery, “Federico II ” University, Naples, Italy; and2Department of Clinical and Experimental Medicine,  Second University of Naples, Italy Background/Aims Bitter taste receptors are expressed throughout the digestive trac t. Data on animals have suggested these receptors are involve d  in the gut hormone release, but no data are available in humans .",Non-OADS,/arxiv_data1/oa_pdf/d8/e6/jnm-21-511.PMC4622133.pdf
"4   October,  2015 pISSN: 2093-0879   eISSN: 2093-0887 http://dx.doi.org/10.5056/jnm15046 520Received: March 15, 2015 Revised: May 27, 2015 Accepted: June 23, 2015 CC This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.",Non-OADS,/arxiv_data1/oa_pdf/9e/7c/jnm-21-520.PMC4622134.pdf
"ORCID: Thomas Abell, http://orcid.org/0000-0002-3175-5161.Temporary Endoscopic Stimulation in  Gastroparesis-like Syndrome Sanjeev Singh,1,2 Jeff McCrary,3 Archana Kedar,2 Stephen Weeks,3 Brian Beauerle,2 Andrew Weeks,3 Omer Endashaw,2 Chris Lahr,4  Warren Starkebaum,5 and Thomas Abell1,2* 1Department of General Internal Medicine, Palliative Medicine an d Medical Education, Department of Medicine, University of Loui sville School  of Medicine, Louisville, Kentucky;2Division of Gastroenterology, Hepatology, & Nutrition, Departme nt of Medicine, University of Louisville  School of Medicine, Louisville, Kentucky; USA;3Division of Gastroenterology, Department of Medicine, Universit y of Mississippi Medical Center,  Jackson, Mississippi, USA;4Department of Surgery, University of Mississippi Medical Center , Jackson, Mississippi, USA; and5Starkebaum and  Associates, Plymouth, Minnesota, USA Background/Aims Gastroparesis-like syndrome (GLS) is defined as gastroparesis-like symptoms with normal gastric scintigraphy.",Non-OADS,/arxiv_data1/oa_pdf/9e/7c/jnm-21-520.PMC4622134.pdf
"4   October,  2015 pISSN: 2093-0879   eISSN: 2093-0887 http://dx.doi.org/10.5056/jnm15074 528Association of the Extent  of Atrophic Gastritis  With Specific Dyspeptic Symptoms  Sook Hee Chung,1 Kwang Jae Lee,1* Ja Yeon Kim,2 Seon Gyo Im,1 Eunkyung Kim,1 Min Jae Yang,1 and Seo Hee Ryu1 1Department of Gastroenterology and2Office of Biostatistics, Ajou University School of Medicine, Su won, Gyeonggido, Korea  Background/Aims It remains unclear whether atrophic gastritis can affect dyspeptic symptoms.",Non-OADS,/arxiv_data1/oa_pdf/0d/0d/jnm-21-528.PMC4622135.pdf
"All authors approved the final version of the article, including the authorship li st. ORCID: Kwang Jae Lee, http://orcid.org/0000-0002-8534-0850.",Non-OADS,/arxiv_data1/oa_pdf/0d/0d/jnm-21-528.PMC4622135.pdf
"4   October,  2015 pISSN: 2093-0879   eISSN: 2093-0887 http://dx.doi.org/10.5056/jnm15016 537Validity and Reliability of the Japanese Version  of the Rome III Diagnostic Questionnaire for  Irritable Bowel Syndrome and Functional Dyspepsia Motoyori Kanazawa,1* Shigemi Nakajima,2 Tadayuki Oshima,3 William E Whitehead,4 Ami D Sperber,5 Olafur S Palsson,4  Douglas A Drossman,4 Hiroto Miwa,3 and Shin Fukudo1 1Department of Behavioral Medicine, Tohoku University Graduate S chool of Medicine, Sendai, Japan;2Department of Medicine,  Gastroenterology and Health Care, Japan Community Health care O rganization Shiga Hospital, Otsu, Shiga, Japan;3Division of Upper  Gastroenterology, Department of Internal Medicine, Hyogo Colleg e of Medicine, Nishinomiya, Hyogo, Japan;4Center for Functional GI and  Motility Disorders, University of North Carolina at Chapel Hill , Chapel Hill, NC, USA; and5Department of Gastroenterology, Tel Aviv Medical  Center, Levahim, Israel Background/Aims Reliable diagnostic instruments for measuring the presence of functional gastrointestinal disorders based on the Rome III crite ria  have been lacking in Japan.",Non-OADS,/arxiv_data1/oa_pdf/8c/bd/jnm-21-537.PMC4622136.pdf
"ORCID: Motoyori Kanazawa, http://orcid.org/0000-0003-1953-3336.",Non-OADS,/arxiv_data1/oa_pdf/8c/bd/jnm-21-537.PMC4622136.pdf
"Principal investigator of these grants was Professor Shin  Fukudo, Tohoku University.Supplementary Materials Note: To access the supplementary Figure mentioned in this ar- ticle, visit the online version of Journal of Neurogastroenterology and Motility at http://www.jnmjournal.org/, and at http://dx.do- i.org/10.5056/jnm15016.",Non-OADS,/arxiv_data1/oa_pdf/8c/bd/jnm-21-537.PMC4622136.pdf
"4   October,  2015 pISSN: 2093-0879   eISSN: 2093-0887 http://dx.doi.org/10.5056/jnm15020 Small Intestinal Bacterial Overgrowth  Diagnosed by Glucose Hydrogen Breath Test  in Post-cholecystectomy Patients  Hea Jung Sung,1 Chang-Nyol Paik,1* Woo Chul Chung,1 Kang-Moon Lee,1 Jin-Mo Yang,1 and Myung-Gyu Choi2 1Division of Gastroenterology, Department of Internal Medicine, St. Vincent ’s Hospital, College of Medicine, The Catholic University of Kor ea,  Seoul, Korea; and2Division of Gastroenterology, Department of Internal Medicine, Seoul St. Mary ’s Hospital, College of Medicine, The Catholic  University of Korea, Seoul, Korea Background/Aims Patients undergoing cholecystectomy may have small intestinal bact erial overgrowth (SIBO).",Non-OADS,/arxiv_data1/oa_pdf/29/9d/jnm-21-545.PMC4622137.pdf
"4   October,  2015 pISSN: 2093-0879   eISSN: 2093-0887 http://dx.doi.org/10.5056/jnm15079 552Surgical Intervention to Rescue Hirschsprung  Disease in a Rat Model Lincon A Stamp,1* Florian Obermayr,1,2 Louise Pontell,1 Heather M Young,1 Dan Xie,3 David H Croaker,4 Zan-Min Song,3 and  John B Furness1 1Department of Anatomy and Neuroscience, University of Melbourne , Parkville, VIC, Australia;2Department of Pediatric Surgery and Pediatric  Urology, University Children ’s Hospital Tuebingen, Tuebingen, Germany;3Eccles Institute of Neuroscience, John Curtin School of Medical   Research and Medical School, Australian National University, Ca nberra, ACT, Australia; and4Department of Pediatrics and Child Health,  Canberra Hospital, Canberra, Australia Background/Aims Rats with a spontaneous null mutation in endothelin receptor type B or Ednrb  (sl/sl; spotting lethal) lack enteric neurons in the  distal bowel and usually die within the first week after birth.",Non-OADS,/arxiv_data1/oa_pdf/ea/69/jnm-21-552.PMC4622138.pdf
"ORCID: Heather M Young, http://orcid.org/0000-0002-0457-8710.",Non-OADS,/arxiv_data1/oa_pdf/ea/69/jnm-21-552.PMC4622138.pdf
"4   October,  2015 pISSN: 2093-0879   eISSN: 2093-0887 http://dx.doi.org/10.5056/jnm15048 560Molecular and Cellular Characteristics of the  Colonic Pseudo-obstruction in Patients With  Intractable Constipation Yoon Suh Do,1 Seung-Jae Myung,1 Sun-Young Kwak,2 Soohan Cho,2 Enoch Lee,2 Min Jeong Song,3 Chang Sik Yu,4  Yong Sik Yoon,4 and Hye Kyung Lee2* 1Department of Gastroenterology, Asan Digestive Disease Research  Institute, Departments of 2Pharmacology, 3Pathology, and 4Colon and Rectal  Surgery, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea Background/Aims Chronic intestinal pseudo-obstruction (CIPO) is a disorder characterized by recurrent symptoms suggestive of obstruction such  as abdominal pain, proximal distension with extremely suppressed motility in the absence of lumen-occluding lesion, whose eti-ology/pathophysiology is poorly understood.",Non-OADS,/arxiv_data1/oa_pdf/22/b3/jnm-21-560.PMC4622139.pdf
"4   October,  2015 pISSN: 2093-0879   eISSN: 2093-0887 http://dx.doi.org/10.5056/jnm15019 571Received: January 30, 2015 Revised: June 11, 2015 Accepted: June 30, 2015 CC This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.",Non-OADS,/arxiv_data1/oa_pdf/e8/54/jnm-21-571.PMC4622140.pdf
"ORCID: Lu Bin, http://orcid.org /0000-0002-3381-6976, Li Meng, http://orcid.org /0000-0001-8921-2533.Corticotropin-releasing Factor Changes the  Phenotype and Function of Dendritic Cells in  Mouse Mesenteric Lymph Nodes Li Meng, Zhang Lu, Wang Xiaoteng, Hu Yue, Lu Bin, * Meng Lina, and Chen Zhe Department of Gastroenterology, First Affiliated Hospital of Zh ejiang Chinese Medical University, Hangzhou, China Background/Aims Dendritic cells (DCs) are a significant contributor to the pathology of numerous chronic inflammatory autoimmune disorders;  however, the effects of Corticotropin-releasing factor (CRF) on intestinal DCs are poorly understood.",Non-OADS,/arxiv_data1/oa_pdf/e8/54/jnm-21-571.PMC4622140.pdf
"4   October,  2015 pISSN: 2093-0879   eISSN: 2093-0887 http://dx.doi.org/10.5056/jnm15058 581Received: April 1, 2015 Revised: June 23, 2015 Accepted: June 30, 2015 CC This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.",Non-OADS,/arxiv_data1/oa_pdf/a2/5f/jnm-21-581.PMC4622141.pdf
"ORCID: Tae Wan Kim, http://orcid.org/0000-0002-7943-4682.Visceral Hypersensitivity and Altered Colonic  Motility in Type 2 Diabetic Rat Tae Sik Sung,1 Jun-Ho La,2 Tong Mook Kang,3 Tae Wan Kim,4* and Il-Suk Yang5* 1Department of Physiology and Cell Biology, University of Nevada  School of Medicine, Reno, NV, USA;2Center for Pain Research, Department of  Anesthesiology, University of Pittsburgh School of Medicine, Pi ttsburgh, PA, USA;3Department of Physiology, Sungkyunkwan University School  of Medicine, Suwon, Gyeonggi-do, Korea;4Department of Veterinary Physiology, College of Veterinary Medi cine, Kyungpook National University,  Daegu, Korea; and 5Department of Veterinary Physiology, College of Veterinary Medi cine, Seoul National University, Seoul, Korea Background/Aims Abnormal visceral sensitivity and disordered motility are common in patients with diabetes mellitus.",Non-OADS,/arxiv_data1/oa_pdf/a2/5f/jnm-21-581.PMC4622141.pdf
"4   October,  2015 pISSN: 2093-0879   eISSN: 2093-0887 http://dx.doi.org/10.5056/jnm15063 Serum Response Factor Is Essential for  Prenatal Gastrointestinal Smooth Muscle  Development and Maintenance of Differentiated Phenotype Chanjae Park,1 Moon Young Lee,1,2 Paul J Park,1 Se Eun Ha,1 Robyn M Berent,1 Robert Fuchs,1 Joseph M Miano,3 Laren S  Becker,4 Kenton M Sanders,1 and Seungil Ro1* 1Department of Physiology and Cell Biology, University of Nevada  School of Medicine, Reno, Nevada, USA;2Department of Physiology,  Wonkwang Digestive Disease Resear ch Institute and Institute of Wonkwang Medical Science, School of Medicine, Wonkwang Universi ty, Iksan,  Jeollabuk-do, Korea;3Aab Cardiovascular Research Institute, University of Rochester School of Medicine and Dentistry, Rochester, New York,  USA; and4Gastroenterology and Hepatology , Stanford University School of Medicine, Stanford, California, USA  Background/Aims Smooth muscle cells (SMCs) characteristically express serum response factor (SRF), which regulates their development.",Non-OADS,/arxiv_data1/oa_pdf/6c/fe/jnm-21-589.PMC4622142.pdf
"ORCID: Seungil Ro, http://orcid.org/0000-0003-0861-8334.",Non-OADS,/arxiv_data1/oa_pdf/6c/fe/jnm-21-589.PMC4622142.pdf
"Supplementary Materials Note: To access the supplementary Video mentioned in this  article, visit the online version of Journal of Neurogastroenterology  and Motility  at http://www.jnmjournal.org/, and at http://dx.do- i.org/10.5056/jnm15063.",Non-OADS,/arxiv_data1/oa_pdf/6c/fe/jnm-21-589.PMC4622142.pdf
"4   October,  2015 pISSN: 2093-0879   eISSN: 2093-0887 http://dx.doi.org/10.5056/jnm14124 603Received: October 16, 2014 Revised: April 16, 2015 Accepted: July 16, 2015 CC This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.",Non-OADS,/arxiv_data1/oa_pdf/6e/98/jnm-21-603.PMC4622143.pdf
"ORCID: Guy D Eslick, http://orcid.org/0000-0002-0098-1705.Dysmotility Symptoms Are Independently  Associated With Weight Change:  A Population-based Study of Australian Adults  Guy D Eslick,1,2* Stuart C Howell,1,2 and Nicholas J Talley2,3 1School of Public Health, The University of Sydney, Sydney, New South Wales, Australia;2Department of Medicine, The University of Sydney,  Nepean Hospital, Penrith, New South Wales, Australia; and3Faculty of Health, The University of Newcastle, Callaghan, New South Wales, Australia Background/Aims Weight loss is a recognized alarm symptom for organic gastrointestinal (GI) disease, yet the association between weight change  (loss or gain) and specific GI symptoms remains poorly described.",Non-OADS,/arxiv_data1/oa_pdf/6e/98/jnm-21-603.PMC4622143.pdf
"4   October,  2015 pISSN: 2093-0879   eISSN: 2093-0887 http://dx.doi.org/10.5056/jnm15034 612Radiofrequency Catheter Ablation for Atrial  Fibrillation Elicited “Jackhammer Esophagus”:  A New Complication Due to Vagal Nerve Stimulation?",Non-OADS,/arxiv_data1/oa_pdf/32/70/jnm-21-612.PMC4622144.pdf
"ORCID: Salvatore Tolone, http://orcid.org/0000-0002-1653-9903.",Non-OADS,/arxiv_data1/oa_pdf/32/70/jnm-21-612.PMC4622144.pdf
"4   October,  2015 pISSN: 2093-0879   eISSN: 2093-0887 http://dx.doi.org/10.5056/jnm15106 616Clinical Significance of Esophageal  Hypertensive Peristaltic Contractions on  High-resolution Manometry (Neurogastroenterol Motil 2015;27:229-236) Jung Ho Park Department of Internal Medicine, Kangbuk Samsung Hospital, Sung kyunkwan University College  of Medicine, Seoul, Korea Received: June 17, 2015 Revised: None Accepted: June 30, 2015 CC This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.",Non-OADS,/arxiv_data1/oa_pdf/74/a6/jnm-21-616.PMC4622145.pdf
"*Correspondence: Jung Ho Park, MD  Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, 29, Saemunan-ro, Jongno-gu, Seoul 03181, KoreaTel: +82-2-2001-2059, Fax: +82-2-2001-2485, E-mail: pjho3@hotmail.com Financial support: None.Conflicts of interest: None.ORCID: Jung Ho Park, http://orcid.org/0000-0003-2568-128X.Summary Esophageal peristalsis consists of a chain of relaxing sphinc- ters and contracting segments.",Non-OADS,/arxiv_data1/oa_pdf/74/a6/jnm-21-616.PMC4622145.pdf
"4   October,  2015 pISSN: 2093-0879   eISSN: 2093-0887 http://dx.doi.org/10.5056/jnm15108 618Opioid-induced Lower Esophageal Sphincter  Dysfunction Esteban Sáez González,1* Vicente Ortiz Bellver,1 Francia Carolina Díaz Jaime,1 Juan Antonio Ortuño Cortés,1 and  Vicente Garrigues Gil1,2 1Digestive Functional Disorders Unit, Gastroenterology Departmen t, Hospital Universitari i Polit ècnic La Fe, Valencia, Spain and2Department  of Medicine, Universitat de Valencia, Valencia, Spain Received: June 19, 2015 Revised: July 8, 2015 Accepted: July 16, 2015 CC This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:// creativecommons.",Non-OADS,/arxiv_data1/oa_pdf/99/a6/jnm-21-618.PMC4622146.pdf
"ORCID: Vicente Ortiz, http://orcid.org/0000-0002-3237-9145.Table.",Non-OADS,/arxiv_data1/oa_pdf/99/a6/jnm-21-618.PMC4622146.pdf
"4   October,  2015 pISSN: 2093-0879   eISSN: 2093-0887 http://dx.doi.org/10.5056/jnm15085 621A More In-depth Evaluation of Impedance-pH  Could Assist in Distinguishing Reflux-related  From Reflux-unrelated Heartburn  TO THE EDITOR:  We read with interest the study by Penagini  et al,1 who investigated 50 refractory patients with a diagnosis of  functional heartburn (FH) according to Rome III criteria in the first 24 hours of wireless pH monitoring.",Non-OADS,/arxiv_data1/oa_pdf/de/32/jnm-21-621.PMC4622147.pdf
"4   October,  2015 pISSN: 2093-0879   eISSN: 2093-0887 http://dx.doi.org/10.5056/jnm15069 623Measuring Gastrointestinal Electrical Activity  With Extracellular Electrodes Figure.",Non-OADS,/arxiv_data1/oa_pdf/7e/c3/jnm-21-623.PMC4622148.pdf
"4   October,  2015 pISSN: 2093-0879   eISSN: 2093-0887 http://dx.doi.org/10.5056/jnm15133 625Measuring Gastrointestinal Electrical Activity  With Extracellular Electrodes:  Author's Reply TO THE EDITOR:  In our recent paper1 we found that 2 points  of intracellular microelectrode recording were insufficient to de- scribe significant disruptions in gastric motor patterns that were caused by inhibition of acetylcholinesterase.",Non-OADS,/arxiv_data1/oa_pdf/6e/f2/jnm-21-625.PMC4622149.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/ 4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/07/52/hyv124.PMC4622168.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/ 4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/11/43/hyv126.PMC4622169.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/ ),whichpermitsnon-commercialre-use,distribution,andreproductioninanymedium,pro- vided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/11/75/ftv076.PMC4622172.pdf
"Genomic DNA was extracted from the isolate using the Sigma GenElute genomic kit (Sigma-Aldrich) and sequenced using Illumina MiSeq sequencing of a paired-end library at the University of Maryland School of Medicine, Institute for Genome Sciences, Genome Resource Center with standard operating procedures (http://www.igs.umaryland.edu/resources/grc/ ).",OADS,/arxiv_data1/oa_pdf/11/75/ftv076.PMC4622172.pdf
Homologous blocks present in each genome were concatenated with the bx-python toolkit ( https://bitbucket.org/james˙taylor/bx-python ); the total amount of conserved sequence in the core genome was ∼2.5 Mb.,OADS,/arxiv_data1/oa_pdf/11/75/ftv076.PMC4622172.pdf
The resulting phylogeny was visualized with FigTree v.1.4.2 ( http://tree.bio.ed.ac.uk/software/figtree/ )( F i g .1).,OADS,/arxiv_data1/oa_pdf/11/75/ftv076.PMC4622172.pdf
Analysis of seven standard genes indicates that this strain belongs to multilocus sequence type 12 (https://cge.cbs.dtu.dk/services/MLST/ ).,Non-OADS,/arxiv_data1/oa_pdf/11/75/ftv076.PMC4622172.pdf
"(https://cge.cbs.dtu.dk/services/SerotypeFinder/ ), is O4:H1.",Non-OADS,/arxiv_data1/oa_pdf/11/75/ftv076.PMC4622172.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/49/18/iev123.PMC4622176.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/41/71/iev131.PMC4622178.pdf
"For commercial re-use, please c ontact journals.permissions@oup.comJournal of Insect Science RESEARCHDownloaded from https://academic.oup.com/jinsectscience/article-abstract/15/1/148/2583464 by OUP Preview on 20 November 2018",Non-OADS,/arxiv_data1/oa_pdf/41/71/iev131.PMC4622178.pdf
"Nanpan River) in Yunnan (A) and the suitability maps of overwintering S. furcifera produced by MaxEnt (B), color scales indicate altitudes and suitability levels, respectively.2 JOURNAL OF INSECT SCIENCE VOLUME 15Downloaded from https://academic.oup.com/jinsectscience/article-abstract/15/1/148/2583464 by OUP Preview on 20 November 2018",Non-OADS,/arxiv_data1/oa_pdf/41/71/iev131.PMC4622178.pdf
Score matrices of the eight EGVs important for overwinter- ing S. furcifera in PCA and the ENFA EGVs PCA ENFA C1 (65%) C2 (21%) C3 (12%) F1 (59%) F2 (14%) F3 (9%) F4 (8%) Bio3 /C00.526 0.686 0.480 0.247 /C00.366 /C00.126 /C00.288 Bio4 0.754 /C00.525 /C00.343 /C00.303 /C00.086 /C00.410 /C00.254 Bio6 /C00.870 0.067 /C00.479 0.462 0.149 0.339 /C00.440 Bio9 /C00.914 0.233 /C00.318 0.506 /C00.067 /C00.239 0.248 Bio11 /C00.909 0.218 /C00.350 0.485 0.041 /C00.166 0.113 Bio14 /C00.772 /C00.535 0.132 0.201 0.419 0.207 /C00.072 Bio17 /C00.799 /C00.526 0.242 0.222 /C00.719 0.309 0.611 Bio19 /C00.814 /C00.481 0.268 0.229 0.370 /C00.691 /C00.4542015 HU ET AL: OVERWINTERING AREA OF S. FURCIFERA 3Downloaded from https://academic.oup.com/jinsectscience/article-abstract/15/1/148/2583464 by OUP Preview on 20 November 2018,Non-OADS,/arxiv_data1/oa_pdf/41/71/iev131.PMC4622178.pdf
"Statistical charts of MaxEnt analysis, (A) the jackknife of the regularized training gain of the EGVs, (B) the ROC and AUC of prediction, and (C) the omission and predicted area, where the values indicate the training gain with only variables.4 JOURNAL OF INSECT SCIENCE VOLUME 15Downloaded from https://academic.oup.com/jinsectscience/article-abstract/15/1/148/2583464 by OUP Preview on 20 November 2018",Non-OADS,/arxiv_data1/oa_pdf/41/71/iev131.PMC4622178.pdf
(http://www.diva-gis.org/documentation) (accessed 13 October2013).,Non-OADS,/arxiv_data1/oa_pdf/41/71/iev131.PMC4622178.pdf
31: 42–49.2015 HU ET AL: OVERWINTERING AREA OF S. FURCIFERA 5Downloaded from https://academic.oup.com/jinsectscience/article-abstract/15/1/148/2583464 by OUP Preview on 20 November 2018,Non-OADS,/arxiv_data1/oa_pdf/41/71/iev131.PMC4622178.pdf
Received 30 October 2014; accepted 1 October 2015.6 JOURNAL OF INSECT SCIENCE VOLUME 15Downloaded from https://academic.oup.com/jinsectscience/article-abstract/15/1/148/2583464 by OUP Preview on 20 November 2018,Non-OADS,/arxiv_data1/oa_pdf/41/71/iev131.PMC4622178.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/de/f2/iev129.PMC4622180.pdf
(http://arxiv.org/abs/1012.2908) (accessed 10 August 2015).,Non-OADS,/arxiv_data1/oa_pdf/de/f2/iev129.PMC4622180.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/bb/21/omv058.PMC4622181.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c2/8a/omv059.PMC4622182.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/ licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/7e/69/omv057.PMC4622183.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/9e/23/10.1177_2325967115605801.PMC4622290.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/36/92/10.1177_2325967115606393.PMC4622291.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/0c/6b/10.1177_2325967115607434.PMC4622292.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/3c/98/10.1177_2325967115610069.PMC4622293.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/49/d7/10.1177_2325967115601030.PMC4622294.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/9e/4e/10.1177_2325967115601031.PMC4622295.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/76/73/10.1177_2325967115601853.PMC4622296.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/af/f1/10.1177_2325967115602255.PMC4622297.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/d8/05/10.1177_2325967115603654.PMC4622298.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/ef/e8/10.1177_2325967115603924.PMC4622299.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/33/f5/10.1177_2325967115603979.PMC4622300.pdf
2013. https://iom.nationalacademies.,Non-OADS,/arxiv_data1/oa_pdf/33/f5/10.1177_2325967115603979.PMC4622300.pdf
2008. http://www.ncys.org/pdfs/2008/ 2008-ncys-market-research-report.pdf.,Non-OADS,/arxiv_data1/oa_pdf/33/f5/10.1177_2325967115603979.PMC4622300.pdf
2014. http://www.popwarner.com/football/footballstructure.htm.,Non-OADS,/arxiv_data1/oa_pdf/33/f5/10.1177_2325967115603979.PMC4622300.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/fd/7d/10.1177_2325967115597641.PMC4622304.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/8b/1e/10.1177_2325967115597882.PMC4622305.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/1e/85/10.1177_2325967115599154.PMC4622306.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/38/44/10.1177_2325967115599347.PMC4622307.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/07/46/10.1177_2325967115599539.PMC4622308.pdf
Statistical analyses were performed using R software (http://www.R-project.org) and SPSS Statistics for Windows (version 21.0; IBM Corp).,OADS,/arxiv_data1/oa_pdf/07/46/10.1177_2325967115599539.PMC4622308.pdf
Available at http://eric.ed.gov/?id ¼ED446513.,OADS,/arxiv_data1/oa_pdf/07/46/10.1177_2325967115599539.PMC4622308.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/ec/5d/10.1177_2325967115599733.PMC4622309.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/0a/86/10.1177_2325967115600687.PMC4622310.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/57/04/10.1177_2325967115601021.PMC4622311.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/b5/63/10.1177_2325967115590379.PMC4622326.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/eb/86/10.1177_2325967115590968.PMC4622327.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/37/5c/10.1177_2325967115592621.PMC4622328.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/17/37/10.1177_2325967115592844.PMC4622329.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/a0/1b/10.1177_2325967115592875.PMC4622330.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/59/14/10.1177_2325967115594578.PMC4622331.pdf
doi: http://dx.doi.org/10.4085/1062- 6050-50.5.04 4.,Non-OADS,/arxiv_data1/oa_pdf/59/14/10.1177_2325967115594578.PMC4622331.pdf
http://www.iom.edu/ */media/Files/ Report%20Files/2013/Concussions/concussions-RB.pdf.,Non-OADS,/arxiv_data1/oa_pdf/59/14/10.1177_2325967115594578.PMC4622331.pdf
http://www.popwarner.com/About_Us/Pop_Warner_ News/Rule_Changes_Regarding_Practice___Concussion_Prevention_ s1_p3977.htm.,Non-OADS,/arxiv_data1/oa_pdf/59/14/10.1177_2325967115594578.PMC4622331.pdf
http://www2.usafootball.,Non-OADS,/arxiv_data1/oa_pdf/59/14/10.1177_2325967115594578.PMC4622331.pdf
http://usafootball.com/headsup.,Non-OADS,/arxiv_data1/oa_pdf/59/14/10.1177_2325967115594578.PMC4622331.pdf
http://www.wsj.com/articles/SB1000142405270230 3519404579350892629229918.,Non-OADS,/arxiv_data1/oa_pdf/59/14/10.1177_2325967115594578.PMC4622331.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/a5/fb/10.1177_2325967115595802.PMC4622332.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/21/84/10.1177_2325967115596194.PMC4622333.pdf
http://www.worldrugby.org/ rankings.,Non-OADS,/arxiv_data1/oa_pdf/21/84/10.1177_2325967115596194.PMC4622333.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/5e/34/10.1177_2325967115596517.PMC4622334.pdf
2004. https://www.usfigureskating.org/Content/ parentsarticles/Health% 20Fitness_MayJuneJuly04.pdf.,Non-OADS,/arxiv_data1/oa_pdf/5e/34/10.1177_2325967115596517.PMC4622334.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/76/d8/10.1177_2325967115575719.PMC4622335.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/3d/8b/10.1177_2325967115576910.PMC4622336.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/f4/cd/10.1177_2325967115577359.PMC4622337.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/44/8e/10.1177_2325967115577596.PMC4622338.pdf
http://www.womenssportsfoundation.org/home/research/ articles-and-reports/athletes/womens-sports-facts.,Non-OADS,/arxiv_data1/oa_pdf/44/8e/10.1177_2325967115577596.PMC4622338.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/c7/f6/10.1177_2325967115577957.PMC4622339.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/13/97/10.1177_2325967115579052.PMC4622340.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/bc/ab/10.1177_2325967115579171.PMC4622341.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/19/6b/10.1177_2325967115579188.PMC4622342.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/15/04/10.1177_2325967115581594.PMC4622343.pdf
O’Leary C. Pitching mechanics 101. http://chrisoleary.com/projects/ PitchingMechanics101/index.html.,Non-OADS,/arxiv_data1/oa_pdf/15/04/10.1177_2325967115581594.PMC4622343.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/fe/bc/10.1177_2325967115581163.PMC4622344.pdf
http://www.drugs.com/pro.,Non-OADS,/arxiv_data1/oa_pdf/fe/bc/10.1177_2325967115581163.PMC4622344.pdf
http://www.pharmacopeia.cn/usp.asp.,Non-OADS,/arxiv_data1/oa_pdf/fe/bc/10.1177_2325967115581163.PMC4622344.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/80/da/10.1177_2325967115581593.PMC4622345.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/55/e1/10.1177_2325967115583632.PMC4622346.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/be/35/10.1177_2325967115583653.PMC4622347.pdf
METHODS National Football League Injury Reports Official NFL injury reports are published weekly online by all 32 teams on each team’s official website as well as on the NFL league-wide website (http://www.nfl.com/injuries).,Non-OADS,/arxiv_data1/oa_pdf/be/35/10.1177_2325967115583653.PMC4622347.pdf
http://www.nfl.com/news/story/09000d5d81bb1c51/ article/players-crackdown-on-helmet- hits-could-increase-knee-injuries.,Non-OADS,/arxiv_data1/oa_pdf/be/35/10.1177_2325967115583653.PMC4622347.pdf
http://www.nfl.com/news/story/0ap1000000133506/ article/nfl-expects-to-soon-have -neurological-consultants-on-side lines.,Non-OADS,/arxiv_data1/oa_pdf/be/35/10.1177_2325967115583653.PMC4622347.pdf
http://www.nfl.com/news/story/0ap2000000281814/article/ nfl-to-look-at-expan ding-protection-for-q uarterbacks.,Non-OADS,/arxiv_data1/oa_pdf/be/35/10.1177_2325967115583653.PMC4622347.pdf
http://www.usatoday.com/story/sports/nfl/2014/01/27/nfl- players-injury-survey-knee-head-concussions/4918341/.,Non-OADS,/arxiv_data1/oa_pdf/be/35/10.1177_2325967115583653.PMC4622347.pdf
http://www.cbssports.com/nfl/injuries.,Non-OADS,/arxiv_data1/oa_pdf/be/35/10.1177_2325967115583653.PMC4622347.pdf
http://www.ncaa.org/sites/default/files/Probability-of-going-pro-methodology_Update 2013.pdf.,Non-OADS,/arxiv_data1/oa_pdf/be/35/10.1177_2325967115583653.PMC4622347.pdf
http://www.chargers.com/team/ injury-report.,Non-OADS,/arxiv_data1/oa_pdf/be/35/10.1177_2325967115583653.PMC4622347.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/89/1c/10.1177_2325967115583954.PMC4622348.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/f3/2e/10.1177_2325967115584318.PMC4622349.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/76/15/10.1177_2325967115584596.PMC4622350.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/f9/3e/10.1177_2325967115584883.PMC4622351.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/22/a8/10.1177_2325967115585092.PMC4622352.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/74/ce/10.1177_2325967115573222.PMC4622354.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/bc/56/10.1177_2325967115573701.PMC4622355.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/12/6c/10.1177_2325967115573706.PMC4622356.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/1c/ff/10.1177_2325967115574476.PMC4622357.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/50/ab/10.1177_2325967115574670.PMC4622358.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/c3/b5/10.1177_2325967115575691.PMC4622359.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/4a/30/10.1177_2325967115575900.PMC4622360.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/62/c7/10.1177_2325967115576100.PMC4622361.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/d7/aa/10.1177_2325967115576120.PMC4622362.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/03/a7/10.1177_2325967115585113.PMC4622363.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/3c/2d/10.1177_2325967115586559.PMC4622364.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/78/cf/10.1177_2325967115586768.PMC4622365.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/3d/da/10.1177_2325967115587861.PMC4622367.pdf
http://hgserver2.amc.nl/cgi-bin/miner/miner2.,Non-OADS,/arxiv_data1/oa_pdf/3d/da/10.1177_2325967115587861.PMC4622367.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/8f/4c/10.1177_2325967115588280.PMC4622368.pdf
http://www.nsaa.org/.,Non-OADS,/arxiv_data1/oa_pdf/8f/4c/10.1177_2325967115588280.PMC4622368.pdf
http://www.yellowstoneclub.com/.,Non-OADS,/arxiv_data1/oa_pdf/8f/4c/10.1177_2325967115588280.PMC4622368.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/77/b3/10.1177_2325967115588896.PMC4622369.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/2e/af/10.1177_2325967115589076.PMC4622370.pdf
http://www.pdga.com/introduction.,Non-OADS,/arxiv_data1/oa_pdf/2e/af/10.1177_2325967115589076.PMC4622370.pdf
http://www.pdga.com/demographics.,Non-OADS,/arxiv_data1/oa_pdf/2e/af/10.1177_2325967115589076.PMC4622370.pdf
http://www.pdga.com/pdga-documents/ demographics-current/2013-pdga-year-end.,OADS,/arxiv_data1/oa_pdf/2e/af/10.1177_2325967115589076.PMC4622370.pdf
"For reprints and permission queries, plea se visit SAGE’s Web site at http://www.sagepub.com/journalsPermissions.nav.",Non-OADS,/arxiv_data1/oa_pdf/db/e9/10.1177_2325967115590114.PMC4622371.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/57/6d/ott-8-3079.PMC4622414.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 3079–3086OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3079Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S8949 7Transarterial oily chemoembolization with  lidamycin shows potent therapeutic efficacy in  VX2 rabbit liver tumor genshen Zhong1,* Jinsong Qi2,* shuhua huo1 huichao Xue3 Zhishan Xu1 Jinsong li4 Yanjun Zhou5 Minna Wu1 liang li6 1laboratory of cancer Biotherapy,   institute of neurology, The First  affiliated hospital of Xinxiang  Medical University, Weihui, henan  Province, People’s republic of  china; 2Department of intervention,   3Department of general surgery,   4Department of Pathology,   5Department of clinical laboratory,   The First affiliated hospital of  Xinxiang Medical University, Weihui,   henan Province, People’s republic  of china; 6institute of Medicinal  Biotechnology, chinese academy of  Medical sciences and Peking Union  Medical college, Beijing, People’s  republic of china *These authors contributed equally  to this workAbstract:  Transarterial oily chemoembolization (TOCE) is one of the most effective approaches  for the treatment of patients with hepatocellular carcinoma (HCC), who are not suitable for  surgical therapy.",Non-OADS,/arxiv_data1/oa_pdf/57/6d/ott-8-3079.PMC4622414.pdf
"Currently, the reported 5-year survival rate for patients with HCC is  far from satisfactory and the question of how to improve the clinical efficacy of HCC  treatments needs further exploration.correspondence: genshen Zhong laboratory of cancer Biotherapy,  Institute of Neurology, The First Affiliated  hospital of Xinxiang Medical University,  Jiankang road 88, Weihui 453100, henan  Province, People’s republic of china Tel +86 373 440 4277 email zhonggs@xxmu.edu.c n Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2015 Volume: 8 Running head verso: Zhong et al Running head recto: Transarterial oily chemoembolization with lidamycin DOI: http://dx.doi.org/10.2147/OTT.S89497",Non-OADS,/arxiv_data1/oa_pdf/57/6d/ott-8-3079.PMC4622414.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/57/6d/ott-8-3079.PMC4622414.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/57/6d/ott-8-3079.PMC4622414.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/fe/f1/tcrm-11-1635.PMC4622415.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpTherapeutics and Clinical Risk Management 2015:11 1635–1640Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  1635Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TCRM.S8197 9Critical appraisal of extended-release hydrocodone  for chronic pain: patient considerations Correspondence: Harry J Gould iii Department of Neurology, Louisiana  State University Health Sciences Center,  533 Bolivar Street, New Orleans,  LA 70112, USA Tel +1 504 568 4090 Fax +1 504 568 7130 email hgould@lsuhsc.ed u Harry J Gould iii1,3–7 Dennis Paul1–8 1Department of Neurology,   2Department of Pharmacology  and experimental Therapeutics,   3Department of internal Medicine,   Section of Physical Medicine and  Rehabilitation, 4Department of  Anesthesiology, 5Neuroscience  Center of excellence, 6Center of  excellence for Oral and Craniofacial  Biology, 7Pain Mastery Center of  Louisiana, 8Alcohol and Drug Abuse  Center of excellence, Louisiana State  University Health Sciences Center,   New Orleans,  LA, USAAbstract:  Opioid analgesics are currently the most effective pharmacologic option for the  management of both acute and chronic forms of moderate-to-severe pain.",Non-OADS,/arxiv_data1/oa_pdf/fe/f1/tcrm-11-1635.PMC4622415.pdf
"Pain is one of the most frequent reasons that people seek the counsel of a health  care professional.9–11 In its acute form, pain is essential for survival and for reducing Journal name: Therapeutics and Clinical Risk Management Article Designation: Review Y ear: 2015 Volume: 11 Running head verso: Gould and Paul Running head recto: Extended-release hydrocodone: patient considerations DOI: http://dx.doi.org/10.2147/TCRM.S81979",Non-OADS,/arxiv_data1/oa_pdf/fe/f1/tcrm-11-1635.PMC4622415.pdf
"Available from: http://www.painmed.org/patientcenter/ facts_on_pain.aspx#incidenc e. Accessed July 21, 2015.",Non-OADS,/arxiv_data1/oa_pdf/fe/f1/tcrm-11-1635.PMC4622415.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/fe/f1/tcrm-11-1635.PMC4622415.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/fe/f1/tcrm-11-1635.PMC4622415.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/7b/39/ott-8-3105.PMC4622416.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 3105–3114OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3105Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9294 5Prognostic value of notch-1 expression in  hepatocellular carcinoma: a meta-analysis Tao Wu1 Min Jiao1 li Jing1 Min-cong Wang1 hai-Feng sun2 Qing li1 Yi-Yang Bai1 Y ong-chang Wei1 Ke-Jun nan1 hui guo1 1Department of Medical Oncology,   The First affiliated hospital of Xi’an  Jiaotong University, 2Department of  Oncology, shaanxi cancer hospital,   Xi’an, People’s republic of chinaAbstract:  Association of Notch-1 expression with prognosis of patients with hepatocellular  carcinoma (HCC) remains controversial.",Non-OADS,/arxiv_data1/oa_pdf/7b/39/ott-8-3105.PMC4622416.pdf
"A variety of potential therapies exist to modulate Notch signaling in HCC, includ - ing neutralizing antibodies, siRNAs, and miRNA therapies, which target specific  Notch tumorigenic subunits.5 Indeed, the Notch signaling is a highly evolutionally  conserved pathway that regulates cell fate, proliferation, apoptosis, differentiation, and  survival, and dysregulation of this pathway is the basis of different diseases, includ - ing cancer.6 However, mounting evidence indicates that the Notch signaling pathway  can exert oncogenic or tumor-suppressive action in various cancers.7 For example, correspondence: Ke-Jun nan Department of Medical Oncology,  The First Affiliated Hospital of Xi’an  Jiaotong University, 277 Yanta West  road, Xi’an 710061, shaanxi, People’s  republic of china Tel/fax +86 29 8532 4086 email nankj@163.co m  hui guo Department of Medical Oncology,  The First Affiliated Hospital of Xi’an  Jiaotong University, 277 Yanta West  road, Xi’an 710061, shaanxi, People’s  republic of china email guohuihappy97@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2015 Volume: 8 Running head verso: Wu et al Running head recto: Notch-1 expression in HCC: a meta-analysis DOI: http://dx.doi.org/10.2147/OTT.S92945",Non-OADS,/arxiv_data1/oa_pdf/7b/39/ott-8-3105.PMC4622416.pdf
"When these data were  not directly provided in the eligible articles, we calcu - lated the HR and its 95% CI from Kaplan–Meier survival  curve using Engauge Digitizer version 4.1 (free software  downloaded from http://sourceforge.ne t).",OADS,/arxiv_data1/oa_pdf/7b/39/ott-8-3105.PMC4622416.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/7b/39/ott-8-3105.PMC4622416.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/7b/39/ott-8-3105.PMC4622416.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/7e/78/ott-8-3095.PMC4622417.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 3095–3104OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3095Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9112 2Potential therapeutic strategy for gastric cancer  peritoneal metastasis by NKG2D ligands-specific  T cells Xianqiang liu1 Meili sun2 shui Yu3 Kai liu4 Xirui li5 huan shi6 1Department of Breast and Thyroid  surgery, 2Department of Oncology,   Jinan central hospital affiliated to  shandong University, 3Department  of radiation Oncology, 4Department  of gastrointestinal surgery, 5Medical  Department, 6Department of  Oncology, shandong cancer hospital  and institute, Jinan, shandong, People’s  republic of chinaPurpose:  Despite advancements in its treatment, gastric cancer continues to be one of the leading  causes of cancer deaths worldwide.",Non-OADS,/arxiv_data1/oa_pdf/7e/78/ott-8-3095.PMC4622417.pdf
"Recently, much attention has been paid  to chimeric antigen receptor (CAR) T cell-based cancer immunotherapy because these  cells can secrete cytokines and exert potent cytotoxicity against a wide range of cancer  cells.6–8 Gastric cancers expressing NKG2D ligands (NKG2DLs) are highly susceptible  to destruction by natural killer (NK) cells.9 Targeting NKG2DLs with T  cells engineered  to express a chimeric NKG2D (chNKG2D) receptor has been shown to induce tumor  elimination and long-term tumor-free survival in mouse models.10 Given these data, we  therefore developed a similar chNKG2D receptor, which contained the extracellular  domain of the NKG2D receptor to allow to recognize NKG2DLs on the cancer cell correspondence: huan shi Department of Oncology, shandong  cancer hospital and institute, 440  Jiyan road, Jinan, shandong 250117,  People’s republic of china Tel +86 531 6762 6992 email huanshidoc@gmail.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2015 Volume: 8 Running head verso: Liu et al Running head recto: Potential therapeutic strategy for gastric cancer peritoneal metastasis DOI: http://dx.doi.org/10.2147/OTT.S91122",Non-OADS,/arxiv_data1/oa_pdf/7e/78/ott-8-3095.PMC4622417.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/7e/78/ott-8-3095.PMC4622417.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/7e/78/ott-8-3095.PMC4622417.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/8c/41/ott-8-3041.PMC4622418.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 3041–3045OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3041Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S8974 6rs712 polymorphism within let-7 micro rna-binding   site might be involved in the initiation and progression  of colorectal cancer in chinese population Qiang-hua Jiang1,* hong-Xin Peng2,3,* Yi Zhang4 Peng Tian4 Zu-lian Xi4 hao chen4 1Department of surgery, Dongyang  People’s hospital, Dongyang,   Zhejiang, 2Medical college, southeast  University, 3central laboratory,   nanjing First hospital, nanjing,   Jiangsu, 4hubei Key laboratory of  Biological Targeted Therapy, Yichang  Yiling hospital, Yichang, hubei,   People’s republic of china *These authors contributed equally  to this workAbstract:  rs712 within 3 ′-untranslated region of KRAS can affect the specific binding between  the mRNA and its targeted microRNAs, leading to the activation of KRAS oncogene.",Non-OADS,/arxiv_data1/oa_pdf/8c/41/ott-8-3041.PMC4622418.pdf
"Recently, accumulating evidence indicated that single nucleotide polymor - phisms (SNPs) of oncogenes and suppressed genes were involved in the onset of CRC.4  A recent meta-analysis reported that rs16892766 polymorphism within the region of correspondence: hao chen hubei Key laboratory of Biological  Targeted Therapy, Yichang Yiling  hospital, Yichang 443100, hubei,  People’s republic of china Tel/fax +86 0717 753 3236 email clockren@126.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2015 Volume: 8 Running head verso: Jiang et al Running head recto: rs712 and colorectal cancer DOI: http://dx.doi.org/10.2147/OTT.S89746",Non-OADS,/arxiv_data1/oa_pdf/8c/41/ott-8-3041.PMC4622418.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/8c/41/ott-8-3041.PMC4622418.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/8c/41/ott-8-3041.PMC4622418.pdf
"© Ryoichi Araki, Kosuke Namba, Yoshiko Murata, and Jun Murata *Correspondence to: Jun Murata; Email: murata-j@sunbor.or.jp Submitted: 03/06/2015Accepted: 03/14/2015 http://dx.doi.org/10.1080/15592324.2015.1031940 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non- Commercial License (http://creativecommons.org/ licenses/by-nc/3.0/), which permits unrestrictednon-commercial use, distribution, and reproductionin any medium, provided the original work is prop- erly cited.",Non-OADS,/arxiv_data1/oa_pdf/17/d2/kpsb-10-06-1031940.PMC4622428.pdf
Curr Opin Plant Biol 1999; 2:250-53; PMID:10375565; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/17/d2/kpsb-10-06-1031940.PMC4622428.pdf
Mol Plant 2011; 4:464-76; PMID:21447758; http://dx.doi.org/10.1093/mp/ssr015 4.,OADS,/arxiv_data1/oa_pdf/17/d2/kpsb-10-06-1031940.PMC4622428.pdf
Annu Rev Plant Biol 2003; 54:183-206; PMID:14509968; http://dx.doi.org/10.1146/annurev.,OADS,/arxiv_data1/oa_pdf/17/d2/kpsb-10-06-1031940.PMC4622428.pdf
Annu Rev PlantBiol 2012; 63:131-52; PMID:22404471; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/17/d2/kpsb-10-06-1031940.PMC4622428.pdf
Plant Mol Biol 1999; 40:37-44; PMID:10394943; http://dx.doi.org/10.1023/ A:1026438615520 9.,OADS,/arxiv_data1/oa_pdf/17/d2/kpsb-10-06-1031940.PMC4622428.pdf
Plant Physiol 1983; 71:949- 54; PMID:16662934; http://dx.doi.org/10.1104/ pp.71.4.949 10.,Non-OADS,/arxiv_data1/oa_pdf/17/d2/kpsb-10-06-1031940.PMC4622428.pdf
Plant Cell 2002; 14:1223-33; PMID:12084823; http://dx.doi.org/10.1105/tpc.001388 11.,OADS,/arxiv_data1/oa_pdf/17/d2/kpsb-10-06-1031940.PMC4622428.pdf
Ann Bot 2009; 103:1-11; PMID:18977764; http://dx.doi.org/ 10.1093/aob/mcn207 13.,Non-OADS,/arxiv_data1/oa_pdf/17/d2/kpsb-10-06-1031940.PMC4622428.pdf
Nature 2001; 409:346-49; PMID:11201743; http://dx.doi.org/10.1038/35053080 14.,Non-OADS,/arxiv_data1/oa_pdf/17/d2/kpsb-10-06-1031940.PMC4622428.pdf
Soil Sci Plant Nutr 1976:423-33; http://dx.doi.org/10.1080/00380768.1976.10433004 15.,Non-OADS,/arxiv_data1/oa_pdf/17/d2/kpsb-10-06-1031940.PMC4622428.pdf
"Structure of mugineic acid, a newamino acid possessing an iron-chelating activity from roots washings of water-cultured Hordeum vulgare L. Proc Japan Acad 1978; 54:469-73; http://dx.doi.org/10.2183/pjab.54.469 16.",Non-OADS,/arxiv_data1/oa_pdf/17/d2/kpsb-10-06-1031940.PMC4622428.pdf
Nat Biotech 2001; 19:466-69;PMID:11329018; http://dx.doi.org/10.1038/88143 17.,OADS,/arxiv_data1/oa_pdf/17/d2/kpsb-10-06-1031940.PMC4622428.pdf
Soil Sci Plant Nutr 2008; 54:77-85; http://dx.doi.org/10.1111/ j.1747-0765.2007.00205.x 18.,Non-OADS,/arxiv_data1/oa_pdf/17/d2/kpsb-10-06-1031940.PMC4622428.pdf
Plant J 2015; 81:233-46;PMID:25393516; http://dx.doi.org/10.1111/tpj.12722 19.,OADS,/arxiv_data1/oa_pdf/17/d2/kpsb-10-06-1031940.PMC4622428.pdf
AngewChem Int Ed 2007; 46:7060-63; PMID:17691091; http://dx.doi.org/10.1002/anie.200702403 20.,OADS,/arxiv_data1/oa_pdf/17/d2/kpsb-10-06-1031940.PMC4622428.pdf
J Exp Bot 2011; 62:2319-32; PMID:21220781; http://dx.doi.org/10.1093/jxb/erq403 21.,OADS,/arxiv_data1/oa_pdf/17/d2/kpsb-10-06-1031940.PMC4622428.pdf
Plant Sci 2014; 224:36- 43; PMID:24908504; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/17/d2/kpsb-10-06-1031940.PMC4622428.pdf
Trend Plant Sci 2012; 17:478-86; http://dx.doi.org/10.1016/j.tplants.2012.04.001 23.,OADS,/arxiv_data1/oa_pdf/17/d2/kpsb-10-06-1031940.PMC4622428.pdf
Plant Physiol 2003; 132:556-67; PMID:12805587; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/17/d2/kpsb-10-06-1031940.PMC4622428.pdf
"3In ovarian cancer, the aberrant activation of the PI-3 kinase pathway was associated with a poor prognosis.4 Mammalian target of rapamycin (mTOR) is a serine/threo- nine kinase and a component of mTORC1 and mTORC2,which have been shown to be involved in the onset and progres-sion of diabetes, cancer, and aging 5via the downstream targets including hypoxia-inducible factor-1 (HIF-1).6,7 HIF-1, which is composed of 2 subunits, aandb, activates the transcription of various genes that code for proteins involved © Masaaki Takai, Takatoshi Nakagawa, Akiko Tanabe, Yoshito Terai, Masahide Ohmichi, and Michio Asahi *Correspondence to: Michio Asahi; Email: masahi@art.osaka-med.ac.jpSubmitted: 10/09/2014; Revised: 12/15/2014; Accepted: 12/18/2014 http://dx.doi.org/10.1080/15384047.2014.1002362 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/79/3f/kcbt-16-02-1002362.PMC4622433.pdf
"Cancer Sci 2010; 101:2658-63; PMID:21040214; http://dx.doi.org/10.1111/j.1349-7006.2010.01736.x 3 De Luca A, Maiello MR, D’Alessio A, Pergameno M, Normanno N. The RAS/RAF/MEK/ERK and thePI3K/AKT signalling pathways: role in cancer patho- genesis and implications for therapeutic approaches.",Non-OADS,/arxiv_data1/oa_pdf/79/3f/kcbt-16-02-1002362.PMC4622433.pdf
"Expert Opin Ther Targets 2012; 16(Suppl 2):S17-27; PMID:22443084; http://dx.doi.org/10.1517/ 14728222.2011.639361 4 Tanaka Y, Terai Y, Tanabe A, Sasaki H, Sekijima T, Fujiwara S, Yamashita Y, Kanemura M, Ueda M, Sugita M, et al.",OADS,/arxiv_data1/oa_pdf/79/3f/kcbt-16-02-1002362.PMC4622433.pdf
"Cancer Biol Ther 2011; 11:50-7; PMID:21057220; http://dx.doi.org/10.4161/cbt.11.1.13877 5 Zoncu R, Efeyan A, Sabatini DM.",Non-OADS,/arxiv_data1/oa_pdf/79/3f/kcbt-16-02-1002362.PMC4622433.pdf
"Nat Rev Mol Cell Biol 2011; 12:21-35; PMID:21157483; http://dx.doi.org/10.1038/nrm3025 6 Hudson CC, Liu M, Chiang GG, Otterness DM, Loo- mis DC, Kaper F, Giaccia AJ, Abraham RT.",OADS,/arxiv_data1/oa_pdf/79/3f/kcbt-16-02-1002362.PMC4622433.pdf
"Nat Rev Cancer 2003; 3:721-32; PMID:13130303; http://dx.doi.org/10.1038/nrc1187 8 Jaakkola P, Mole DR, Tian YM, Wilson MI, Gielbert J, Gaskell SJ, von Kriegsheim A, Hebestreit HF, MukherjiM, Schoﬁeld CJ, et al.",OADS,/arxiv_data1/oa_pdf/79/3f/kcbt-16-02-1002362.PMC4622433.pdf
Science 2001; 292:468-72; PMID:11292861; http://dx.doi.org/10.1126/science.,OADS,/arxiv_data1/oa_pdf/79/3f/kcbt-16-02-1002362.PMC4622433.pdf
"Cancer Res 2006; 66:2000-11; PMID:16488999; http://dx.doi.org/10.1158/0008-5472.CAN-05-3074 10 Tsunetoh S, Terai Y, Sasaki H, Tanabe A, Tanaka Y, Sekijima T, Fujioka S, Kawaguchi H, Kanemura M, Yamashita Y, et al.",OADS,/arxiv_data1/oa_pdf/79/3f/kcbt-16-02-1002362.PMC4622433.pdf
"Cancer Biol Ther 2010; 10:1137-46; PMID:20935474; http://dx.doi.org/ 10.4161/cbt.10.11.13443 11 Wang X, Yue P, Kim YA, Fu H, Khuri FR, Sun SY.",Non-OADS,/arxiv_data1/oa_pdf/79/3f/kcbt-16-02-1002362.PMC4622433.pdf
"Cancer Res 2008; 68:7409-18;PMID:18794129; http://dx.doi.org/10.1158/0008- 5472.CAN-08-152212 Mendoza MC, Er EE, Blenis J.",Non-OADS,/arxiv_data1/oa_pdf/79/3f/kcbt-16-02-1002362.PMC4622433.pdf
"The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensation.Trends Biochem Sci 2011; 36:320-8; PMID:21531565; http://dx.doi.org/10.1016/j.tibs.2011.03.006 13 Carracedo A, Ma L, Teruya-Feldstein J, Rojo F, Sal- mena L, Alimonti A, Egia A, Sasaki AT, Thomas G, Kozma SC, et al.",OADS,/arxiv_data1/oa_pdf/79/3f/kcbt-16-02-1002362.PMC4622433.pdf
"Ann Oncol 2005; 16:525-37; PMID:15728109; http://dx.doi.org/10.1093/annonc/mdi113 15 Mabuchi S, Kawase C, Altomare DA, Morishige K, Sawada K, Hayashi M, Tsujimoto M, Yamoto M,Klein-Szanto AJ, Schilder RJ, et al.",OADS,/arxiv_data1/oa_pdf/79/3f/kcbt-16-02-1002362.PMC4622433.pdf
"Clin Cancer Res 2009; 15:5404-13; PMID:19690197; http://dx.doi.org/10.1158/1078-0432.CCR-09-0365 16 Fujisue Y, Nakagawa T, Takahara K, Inamoto T, Kiyama S, Azuma H, Asahi M. Induction of erythropoi- etin increases the cell proliferation rate in a hypoxia-inducible factor-1-dependent and -independent manner in renal cell carcinoma cell lines.",Non-OADS,/arxiv_data1/oa_pdf/79/3f/kcbt-16-02-1002362.PMC4622433.pdf
"Biochem Biophys Res Commun 2009; 385:523-7; PMID:19465001; http://dx.doi.org/10.1016/j.bbrc.2009.05.082 19 Li W, Xie L, Chen Z, Zhu Y, Sun Y, Miao Y, Xu Z, Han X. Cantharidin, a potent and selective PP2A inhib-itor, induces an oxidative stress-independent growth inhibition of pancreatic cancer cells through G2/M cell- cycle arrest and apoptosis.",Non-OADS,/arxiv_data1/oa_pdf/79/3f/kcbt-16-02-1002362.PMC4622433.pdf
"Cancer Sci 2010; 101:1226-33; PMID:20331621; http://dx.doi.org/10.1111/ j.1349-7006.2010.01523.x 20 Vivanco I, Sawyers CL.",Non-OADS,/arxiv_data1/oa_pdf/79/3f/kcbt-16-02-1002362.PMC4622433.pdf
Nature reviews Cancer 2002; 2:489-501; PMID:12094235; http://dx.doi.org/10.1038/nrc839 21 Downward J.,Non-OADS,/arxiv_data1/oa_pdf/79/3f/kcbt-16-02-1002362.PMC4622433.pdf
"Nat Rev Cancer 2003; 3:11-22;PMID:12509763; http://dx.doi.org/10.1038/nrc969 22 Campbell IG, Russell SE, Choong DY, Montgomery KG, Ciavarella ML, Hooi CS, Cristiano BE, Pearson RB, Phillips WA.",Non-OADS,/arxiv_data1/oa_pdf/79/3f/kcbt-16-02-1002362.PMC4622433.pdf
"Cancer Res 2004; 64:7678-81; PMID:15520168; http://dx.doi.org/10.1158/0008- 5472.CAN-04-2933 23 Kuo KT, Mao TL, Jones S, Veras E, Ayhan A, Wang TL, Glas R, Slamon D, Velculescu VE, Kuman RJ, et al.",Non-OADS,/arxiv_data1/oa_pdf/79/3f/kcbt-16-02-1002362.PMC4622433.pdf
Am J Pathol 2009; 174:1597- 601; PMID:19349352; http://dx.doi.org/10.2353/ ajpath.2009.08100024 Semenza GL.,Non-OADS,/arxiv_data1/oa_pdf/79/3f/kcbt-16-02-1002362.PMC4622433.pdf
"J Bioenerg Biomembr 2007;39:231-4; PMID:17551816; http://dx.doi.org/ 10.1007/s10863-007-9081-2 25 Agani F, Jiang BH.",OADS,/arxiv_data1/oa_pdf/79/3f/kcbt-16-02-1002362.PMC4622433.pdf
"Curr Cancer Drug Targets 2013; 13:245-51; PMID:23297826; http://dx.doi.org/ 10.2174/1568009611313030003 26 Nickerson ML, Jaeger E, Shi Y, Durocher JA, Mahurkar S, Zaridze D, Matveev V, Janout V, Kollarova H, Bencko V, et al.",Non-OADS,/arxiv_data1/oa_pdf/79/3f/kcbt-16-02-1002362.PMC4622433.pdf
"ClinCancer Res 2008; 14:4726-34; PMID:18676741; http://dx.doi.org/10.1158/1078-0432.CCR-07-4921 27 O’Reilly KE, Rojo F, She QB, Solit D, Mills GB, Smith D, Lane H, Hofmann F, Hicklin DJ, Ludwig DL, et al.",OADS,/arxiv_data1/oa_pdf/79/3f/kcbt-16-02-1002362.PMC4622433.pdf
"Cancer Res 2006; 66:1500-8; PMID:16452206; http://dx.doi.org/ 10.1158/0008-5472.CAN-05-2925 28 Adams DG, Coffee RL Jr., Zhang H, Pelech S, Strack S, Wadzinski BE.",Non-OADS,/arxiv_data1/oa_pdf/79/3f/kcbt-16-02-1002362.PMC4622433.pdf
J Biol Chem 2005; 280:42644- 54; PMID:16239230; http://dx.doi.org/10.1074/jbc.,OADS,/arxiv_data1/oa_pdf/79/3f/kcbt-16-02-1002362.PMC4622433.pdf
Cancer Lett 2005; 226:155-60; PMID:16039954; http://dx.doi.org/10.1016/j.canlet.,OADS,/arxiv_data1/oa_pdf/79/3f/kcbt-16-02-1002362.PMC4622433.pdf
"J Biol Chem 2005; 280:36029- 36; PMID:16129692; http://dx.doi.org/10.1074/jbc.M506986200 31 Huang S, Bjornsti MA, Houghton PJ.",OADS,/arxiv_data1/oa_pdf/79/3f/kcbt-16-02-1002362.PMC4622433.pdf
"Cancer Res 2005; 65:7052-8; PMID:16103051; http://dx.doi.org/10.1158/0008- 5472.CAN-05-0917 33 Um SH, Frigerio F, Watanabe M, Picard F, Joaquin M, Sticker M, Fumagalli S, Allegrini PR, Kozma SC, Auwerx J, et al.",Non-OADS,/arxiv_data1/oa_pdf/79/3f/kcbt-16-02-1002362.PMC4622433.pdf
"Nature 2004; 431:200-5; PMID:15306821; http://dx.doi.org/10.1038/nature02866 34 Hisamatsu T, Mabuchi S, Matsumoto Y, Kawano M, Sasano T, Takahashi R, Sawada K, Ito K, Kurachi H,Schilder RJ, et al.",OADS,/arxiv_data1/oa_pdf/79/3f/kcbt-16-02-1002362.PMC4622433.pdf
"Mol Cancer Ther 2013; 12:1367-77; PMID:23615631;http://dx.doi.org/10.1158/1535-7163.MCT-12-1185 35 Nakagawa T, Asahi M. beta1-adrenergic receptor recycles via a membranous organelle, recycling endo- some, by binding with sorting nexin27.",Non-OADS,/arxiv_data1/oa_pdf/79/3f/kcbt-16-02-1002362.PMC4622433.pdf
J Membr Biol 2013; 246:571-9; PMID:23780416; http://dx.doi.org/10.1007/s00232-013-9571-6 www.taylorandfrancis.com 335 Cancer Biology & Therapy,Non-OADS,/arxiv_data1/oa_pdf/79/3f/kcbt-16-02-1002362.PMC4622433.pdf
"The ﬁrst, by Dorina© James W Larrick, Paul WHI Parren, James S Huston, Andreas Pl €uckthun, Andrew Bradbury, Ian M Tomlinson, Kerry A Chester, Dennis R Burton, Gregory P Adams, Louis M Weiner, Jamie K Scott, Mark R Alfenito, TrudiVeldman, and Janice M Reichert*Correspondence to: Janice M Reichert; Email: reichert.biotechconsulting@ gmail.com Submitted: 09/29/2014; Revised: 09/29/2014; Accepted: 09/29/2014http://dx.doi.org/10.4161/19420862.2014.971627 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/), which permits unrestricted non-commercial use,distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/47/b6/kmab-06-05-971627.PMC4622443.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/36/af/tcrm-11-1627.PMC4622445.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpTherapeutics and Clinical Risk Management 2015:11 1627–1633Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  1627ORiginal ReseaRChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/TCRM.S8982 0Decompressive craniectomy for severe traumatic  brain injury patients with fixed dilated pupils Xiang Mao1,3–5,* guozhuan Miao6,* shuyu hao2–5,* Xiaogang Tao2–5 Zonggang hou2–5 huan li2–5 Runfa Tian2–5 hao Zhang1–6 T e lu2–5 Jun Ma7 Xiaodong Zhang1 hongwei Cheng1 Baiyun liu2–6 1Department of neurosurgery, The  First affiliated hospital of anhui  Medical University, hefei,  anhui,   2Department of n eurosurgery, Beijing  Tian Tan hospital, Capital Medical  University, 3nerve injury and Repair  Center of Beijing institute for Brain  Disorders,  4neurotrauma laboratory,   Beijing neurosurgical institute,   Capital Medical University, 5China  national Clinical Research Center for  neurological Diseases, 6Department  of neurotrauma, general hospital  of armed Police Forces, 7imaging  Center of neuroscience,  Beijing  Tian Tan  hospital, Capital Medical  University, Beijing, People’s Republic  of China *These authors contributed equally  to this workObjective:  The outcome of decompressive craniectomy (DC) for severe traumatic brain injury  (sTBI) patients with fixed dilated pupils (FDPs) is not clear.",Non-OADS,/arxiv_data1/oa_pdf/36/af/tcrm-11-1627.PMC4622445.pdf
"The RESCUE-ICP  trial (ISRCTN66202560) is currently in progress to determine whether craniectomy  improves outcome in the management of TBI (our study is part of the trial).7 Though Correspondence: Baiyun liu Department of neurosurgery,  Beijing Tian Tan hospital, Capital  Medical University, 100050 Beijing,  People’s Republic of China email liubaiyun1212@126.co m Journal name: Therapeutics and Clinical Risk Management Article Designation: Original Research Y ear: 2015 Volume: 11 Running head verso: Mao et al Running head recto: Decompressive craniectomy for traumatic brain injury patients DOI: http://dx.doi.org/10.2147/TCRM.S89820",Non-OADS,/arxiv_data1/oa_pdf/36/af/tcrm-11-1627.PMC4622445.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/36/af/tcrm-11-1627.PMC4622445.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/36/af/tcrm-11-1627.PMC4622445.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/38/33/ott-8-3115.PMC4622446.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 3115–3122OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3115Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9315 2serum dickkopf-1 as a biomarker in screening  gastrointestinal cancers: a systematic review and  meta-analysis Bin liang liansheng Zhong Qun he shaocheng Wang Zhongcheng Pan Tianjiao Wang Yujie Zhao Key laboratory of cell Biology,   Biochip center, Ministry of Public  health, china Medical University,   shenyang, People’s republic of chinaObjective:  Despite advances in the early diagnosis of gastrointestinal (GI) cancers, these  cancers are often being detected rather late in their course.",Non-OADS,/arxiv_data1/oa_pdf/38/33/ott-8-3115.PMC4622446.pdf
"Keywords:  gastrointestinal cancer, dickkopf-1, cancer screening, accuracy Introduction Gastrointestinal (GI) cancers, which refer to the cancers generated from esophagus,  stomach, intestine, gallbladder, liver, and pancreas, collectively rank as the most lethal  cancers worldwide.1 In 2012, the high incidence of GI cancers involves an estimated 284,680  new cases and 142,510 deaths in United States.2 Despite advances in the diagnosis of GI  cancers, these cancers are often being detected rather late in their course, as the detection  relies heavily on symptomatic reporting and on nonspecific screening methods.3 Most of the  patients are diagnosed at the late stage and lose the opportunities of effective medical inter - ventions, and ~20%–45% of those who undergo curative resection subsequently develop  tumor recurrence or distant metastasis due to highly aggressive nature of GI cancers.4  correspondence: Yujie Zhao Key laboratory of cell Biology, Biochip  center, Ministry of Public health, china  Medical University, no 77 Puhe road,  shenbei District, shenyang, liaoning  110122, People’s republic of china email zhaoyjchip@yeah.ne t Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2015 Volume: 8 Running head verso: Liang et al Running head recto: DKK1 in screening gastrointestinal cancers DOI: http://dx.doi.org/10.2147/OTT.S93152",Non-OADS,/arxiv_data1/oa_pdf/38/33/ott-8-3115.PMC4622446.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/38/33/ott-8-3115.PMC4622446.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/38/33/ott-8-3115.PMC4622446.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/3b/ce/sar-6-113.PMC4622447.pdf
"Information on how to request permission may be found at: http://www.dovepress.com/permissions.ph pSubstance Abuse and Rehabilitation 2015:6 113–129Substance Abuse and Rehabilitation Dove press submit your manuscript | www.dovepress.co m Dove press  113Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/SAR.S7358 6emerging drugs of abuse: current perspectives   on synthetic cannabinoids Danièle Debruyne1,2 Reynald Le Boisselier1 1Centre for evaluation and  information on Pharmacodependence -   Addictovigilance (CeiP-A),    2Toxicology and Pharmacology  Laboratory, Department of  Pharmacology, University Hospital  Centre Côte de Nacre, Caen, France Correspondence: Danièle Debruyne   Department of Pharmacology, University  Hospital Centre Côte de Nacre, 14033  Caen cedex 9, France   Tel +33 2 31 06 46 41   Fax +33 2 31 06 46 73   email debruyne-d@chu-caen.f rAbstract:  New psychoactive drugs that have appeared over the last decade are typically  dominated by cathinones and synthetic cannabinoids (SCs).",Non-OADS,/arxiv_data1/oa_pdf/3b/ce/sar-6-113.PMC4622447.pdf
Availableat: http://www.emcdda.europa.,Non-OADS,/arxiv_data1/oa_pdf/3b/ce/sar-6-113.PMC4622447.pdf
"http://www.ofdt.fr/ BDD/publications/docs/eisxfbv4.pd f. Accessed April 15, 2015 French.",Non-OADS,/arxiv_data1/oa_pdf/3b/ce/sar-6-113.PMC4622447.pdf
"Available  from: http://www.bluelight.org/vb/threads/539892-Injection-of- syntheticcannabinoids-like-a-JW H. Accessed May 13, 2015.",Non-OADS,/arxiv_data1/oa_pdf/3b/ce/sar-6-113.PMC4622447.pdf
"Substance Abuse and Rehabilitation Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/substance abuse-and-rehabilitation-journa lSubstance Abuse and Rehabilitation is an international, peer-reviewed,  open access journal publishing original research, case reports, editorials,  reviews and commentaries on all areas of addiction and substance abuse  and options for treatment and rehabilitation.",Non-OADS,/arxiv_data1/oa_pdf/3b/ce/sar-6-113.PMC4622447.pdf
Visit http://www.dovepress.com/testimonials.ph p  to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/3b/ce/sar-6-113.PMC4622447.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/01/16/ott-8-3087.PMC4622451.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 3087–3094OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  3087Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S9253 7concurrent chemoradiotherapy using paclitaxel  plus cisplatin in the treatment of elderly patients  with esophageal cancer Tao song1,* Xuebang Zhang2,* Min Fang1 shixiu Wu1 1Department of radiation Oncology,   hangzhou cancer hospital, hangzhou,   Zhejiang, People’s republic of  china; 2Department of radiation  Oncology, The First affiliated hospital  of Wenzhou Medical University,   Wenzhou, Zhejiang, People’s republic  of china *These authors contributed equally to  this workObjective:  This study aimed at assessing the efficiency and safety of concurrent chemoradiotherapy  (CCRT) using paclitaxel (PTX) plus cisplatin (CDDP) in elderly (age $70 years) esophageal  cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/01/16/ott-8-3087.PMC4622451.pdf
"A series of reports  had revealed that postoperative mortality rates in patients aged $70 years ranged from  4.5% to 23% and may even reach 60%.4–6 Concurrent chemoradiotherapy (CCRT) has also  been considered as the standard treatment option for patients with inoperable or unresect - able diseases, for which elderly patients account for a great proportion as established by  the landmark results of Radiation Therapy Oncology Group (RTOG) 8501.7 A combina - tion of fluorouracil (5-FU) and cisplatin (CDDP) has also been confirmed as a standard correspondence: shixiu Wu Department of radiation Oncology,  hangzhou cancer hospital, number 34,  Yanguan lane, shangcheng District,  hangzhou 310000, People’s republic of  china Tel +86 571 8682 6086 Fax +86 571 8606 2281 email wushixiu@medmail.com.c n Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2015 Volume: 8 Running head verso: Song et al Running head recto: CCRT for elderly esophageal cancer DOI: http://dx.doi.org/10.2147/OTT.S92537",Non-OADS,/arxiv_data1/oa_pdf/01/16/ott-8-3087.PMC4622451.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/01/16/ott-8-3087.PMC4622451.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/01/16/ott-8-3087.PMC4622451.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/20/6a/dddt-9-5749.PMC4622452.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 5749–5754Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  5749ORIGINAL RESEARCHopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S9450 5Antibacterial activity and therapeutic efficacy  of Fl-PRPRPL-5, a cationic amphiphilic polyproline  helix, in a mouse model of staphylococcal skin  infection Shankar Thangamani1 Manish Nepal2 Jean Chmielewski2 Mohamed N Seleem1 1Department of Comparative  Pathobiology, Purdue University  College of Veterinary Medicine, West  Lafayette, IN, USA; 2Department of  Chemistry, Purdue University, West  Lafayette, IN, USAAbstract:  The antibacterial activities and therapeutic efficacy of the cationic, unnatural  proline-rich peptide Fl-PRPRPL-5 were evaluated against multidrug-resistant Staphylococcus  aureus  in a mouse model of skin infection.",Non-OADS,/arxiv_data1/oa_pdf/20/6a/dddt-9-5749.PMC4622452.pdf
"One potential alternative approach is the development  of antimicrobial peptides as novel therapeutic agents.12 Antimicrobial peptides with  anti-inflammatory properties in addition to potent, broad-spectrum antimicrobial  activity might form a promising approach to the treatment of staphylococcal skin  infections.12,13Correspondence: Mohamed N Seleem Department of Comparative  Pathobiology, Purdue University College  of Veterinary Medicine, 625 Harrison St,  West Lafayette, IN, 47907, USA Tel +1 765 494 0763 Fax +1 765 496 2627 Email mseleem@purdue.ed uJournal name: Drug Design, Development and Therapy Article Designation: ORIGINAL RESEARCH Y ear: 2015 Volume: 9 Running head verso: Thangamani et al Running head recto: Antimicrobial peptide for MRSA skin infection DOI: http://dx.doi.org/10.2147/DDDT.S94505",Non-OADS,/arxiv_data1/oa_pdf/20/6a/dddt-9-5749.PMC4622452.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/20/6a/dddt-9-5749.PMC4622452.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/20/6a/dddt-9-5749.PMC4622452.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/fe/74/dddt-9-5719.PMC4622453.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 5719–5725Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  5719Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DDDT .S8147 4Brivaracetam: review of its pharmacology and  potential use as adjunctive therapy in patients  with partial onset seizures Laura Mumoli1 Caterina Palleria2 Sara Gasparini1 Rita Citraro2 Angelo Labate1 edoardo Ferlazzo1 Antonio Gambardella1 Giovambattista De Sarro2 emilio Russo2 1institute of Neurology, 2institute  of Pharmacology, University Magna  Græcia, Catanzaro, italyAbstract:  Brivaracetam (BRV), a high-affinity synaptic vesicle protein 2A ligand, reported  to be 10–30-fold more potent than levetiracetam (LEV), is highly effective in a wide range of  experimental models of focal and generalized seizures.",Non-OADS,/arxiv_data1/oa_pdf/fe/74/dddt-9-5719.PMC4622453.pdf
"Keywords:  brivaracetam, epilepsy, partial seizure, adjunctive therapy, antiepileptic drugs Introduction Although about two-thirds of patients with epilepsy (PWE) treated with antiepileptic  drugs (AEDs) reach seizure-freedom, about one-third remains drug-resistant to the  current therapies.1 Despite the introduction of new AEDs with a better pharmacokinetic  and safety profile compared to old generation AEDs, today, one of the major causes of  failure of antiepileptic treatment is poor adherence often due to occurrence of adverse  drug reactions (ADRs), leading up to 25% of patients to discontinue treatment before the  achievement of effective doses and with a consequent increase of health care costs.2,3 During the last 25 years, many efforts have been directed to the development of  new AEDs with different mechanisms of action able to reduce brain hyperexcitability;   recently considerable interest has been focused on synaptic vesicle protein 2A (SV2A) Correspondence: emilio Russo Department of Science of Health, School  of Medicine, University of Catanzaro,  viale europa Germaneto, 88100  Catanzaro, italy Tel +39 0961 369 4191 Fax +39 0961 369 4192 email erusso@unicz.i t Journal name: Drug Design, Development and Therapy Article Designation: Review Y ear: 2015 Volume: 9 Running head verso: Mumoli et al Running head recto: Brivaracetam: a potential use in partial epilepsy DOI: http://dx.doi.org/10.2147/DDDT.S81474",Non-OADS,/arxiv_data1/oa_pdf/fe/74/dddt-9-5719.PMC4622453.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/fe/74/dddt-9-5719.PMC4622453.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/fe/74/dddt-9-5719.PMC4622453.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/e4/e1/nss-7-139.PMC4622454.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pNature and Science of Sleep 2015:7 139–145Nature and Science of Sleep Dove press submit your manuscript | www.dovepress.co m Dove press  139OrigiNal reSearchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NSS.S8388 2Sleep characteristics of individuals with chronic  stroke: a pilot study Mayis al-Dughmi1 alham al-Sharman2 Suzanne Stevens3 catherine F Siengsukon1 1Department of Physical Therapy and  rehabilitation Science, University  of Kansas Medical center, Kansas  city, KS, USa; 2Department of  rehabilitation Sciences, Jordan  University of Science and T echnology,   irbid, Jordan; 3Department of  Neurology, University of Kansas  Medical center, Kansas city, KS, USa correspondence: catherine F Siengsukon   Department of Physical Therapy and  rehabilitation Science, University of  Kansas Medical center, 3901 rainbow  Boulevard, Mail Stop 2002, Kansas city,  KS 66160, USa   Tel +1 913 588 6913   Fax +1 913 588 4568   email csiengsukon@kumc.ed uAbstract:  Changes in sleep characteristics in individuals with chronic stroke are not well  described, particularly compared with healthy individuals.",Non-OADS,/arxiv_data1/oa_pdf/e4/e1/nss-7-139.PMC4622454.pdf
"Nature and Science of Sleep Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/nature-and-science-of-sleep-journa lNature and Science of Sleep is an international, peer-reviewed, open  access journal covering all aspects of sleep science and sleep medicine,  including the neurophysiology and functions of sleep, the genetics of  sleep, sleep and society, biological rhythms, dreaming, sleep disorders and  therapy, and strategies to optimize healthy sleep.",Non-OADS,/arxiv_data1/oa_pdf/e4/e1/nss-7-139.PMC4622454.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/e4/e1/nss-7-139.PMC4622454.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/18/39/dddt-9-5705.PMC4622455.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 5705–5717Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  5705Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S9226 8evaluation of the cardiovascular effects of  varenicline in rats engin Burak selçuk1 Meltem sungu2 hakan Parlakpinar3 Necip Ermiş4 Elif Taslıdere5 Nigar Vardı5 Murat Yalçınsoy6 Mustafa Sagır3 alaaddin Polat7 Mehmet Karatas8 Burcu Kayhan-T etik1 1Department of Family Medicine,   2inonu University Medical Faculty,   Malatya, T urkey; 3Department of  Pharmacology, 4Department of  cardiology, 5Department of histology  and embryology, 6Department of  Pulmonary Medicine, 7Department of  Physiology, 8Department of Medical  ethics, inonu University Medical  Faculty, Malatya,  T urkeyBackground:  Cardiovascular disease is an important cause of morbidity and mortality among  tobacco users.",Non-OADS,/arxiv_data1/oa_pdf/18/39/dddt-9-5705.PMC4622455.pdf
"Available from: http://www.fda.gov/Drugs/DrugSafety/ ucm259161.htm?source=govdeliver y. Accessed July 15, 2011.",Non-OADS,/arxiv_data1/oa_pdf/18/39/dddt-9-5705.PMC4622455.pdf
Available from: http://havanikoru.org.tr/dosya/ Docs_Tutun_Dumaninin_Zararlari/Tutunle_Mucadele_El_Kitabi.pdf .,Non-OADS,/arxiv_data1/oa_pdf/18/39/dddt-9-5705.PMC4622455.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/18/39/dddt-9-5705.PMC4622455.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/18/39/dddt-9-5705.PMC4622455.pdf
"7In addition, the monoclonal antibodyustekinumab (CNTO-1275), which targets both IL23 and IL12 through their common p40 subunit, has demonstrated efﬁcacy in psoriasis and other inﬂammatory conditions.7 IL23 plays a crucial role in the induction and function of pathogenic effector Th17 cells.8,9While cytokines such as IL6 and TGF- b1 can promote the differentiation of ROR gtCTh17 cells from na €ıve CD4 CT cells, IL23 is required for the full inﬂammatory function of these cells.10,11In addition, the bind- ing of IL23 to its receptor on activated ROR gtCTh17 cells induces further expression of the IL23 receptor (IL23R), thus providing a feed-forward loop for the maintenance and propaga- tion of these cells.11Innate immune cells can also respond to © Sanjaya Singh, Rachel R Kroe-Barrett, Keith A Canada, Xiang Zhu, Eliud Sepulveda, Helen Wu, Yaqin He, Ernest L Raymond, Jennifer Ahlberg, Lee E Frego , Laura M Amodeo, Katrina M Catron, David H Presky, and Jeffrey H Hanke*Correspondence to: Sanjaya Singh; Email: Sanjaya.singh@boehringer-ingelheim.comSubmitted: 01/20/2015; Revised: 03/16/2015; Accepted: 03/18/2015 http://dx.doi.org/10.1080/19420862.2015.1032491 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6f/e2/kmab-07-04-1032491.PMC4622456.pdf
Nat Med 2013; 19:824-5; PMID:23836225; http://dx.doi.org/10.1038/nm.3268 2.,OADS,/arxiv_data1/oa_pdf/6f/e2/kmab-07-04-1032491.PMC4622456.pdf
Nat Rev Immunol 2014; 14:585-600;PMID:25145755; http://dx.doi.org/10.1038/nri3707 3.,Non-OADS,/arxiv_data1/oa_pdf/6f/e2/kmab-07-04-1032491.PMC4622456.pdf
InﬂammAllergy Drug Targets 2012; 11:159-68; PMID:22280236; http://dx.doi.org/10.2174/ 187152812800392805 4.,Non-OADS,/arxiv_data1/oa_pdf/6f/e2/kmab-07-04-1032491.PMC4622456.pdf
Bone Marrow Transplant 2008; 41:821-6; PMID:18209723; http://dx.doi.org/10.1038/sj.bmt.1705980 5.,Non-OADS,/arxiv_data1/oa_pdf/6f/e2/kmab-07-04-1032491.PMC4622456.pdf
Hum Genet 2007; 122:201-6; PMID:17587057; http://dx.doi.org/ 10.1007/s00439-007-0397-0 6.,OADS,/arxiv_data1/oa_pdf/6f/e2/kmab-07-04-1032491.PMC4622456.pdf
Gut 2007; 56:1333-6; PMID:17872562; http://dx.doi.org/10.1136/gut.2006.115402 7.,Non-OADS,/arxiv_data1/oa_pdf/6f/e2/kmab-07-04-1032491.PMC4622456.pdf
Science 1993; 260:547-9;PMID:8097338; http://dx.doi.org/10.1126/ science.8097338 10.,OADS,/arxiv_data1/oa_pdf/6f/e2/kmab-07-04-1032491.PMC4622456.pdf
Semin Immunol 2007; 19:372-6; PMID:18319054; http://dx.doi.org/10.1016/j.smim.2007.10.012 11.,Non-OADS,/arxiv_data1/oa_pdf/6f/e2/kmab-07-04-1032491.PMC4622456.pdf
J Invest Dermatol 2014; 134:2351-60; PMID:24658504; http://dx.doi.org/10.1038/jid.2014.146 13.,Non-OADS,/arxiv_data1/oa_pdf/6f/e2/kmab-07-04-1032491.PMC4622456.pdf
J Invest Dermatol 2014; 134:984-91; PMID:24352038; http://dx.doi.org/ 10.1038/jid.2013.477 14.,Non-OADS,/arxiv_data1/oa_pdf/6f/e2/kmab-07-04-1032491.PMC4622456.pdf
Nat Immunol 2005; 6:1123-32; PMID:16200070; http://dx.doi.org/10.1038/ni1254 15.,Non-OADS,/arxiv_data1/oa_pdf/6f/e2/kmab-07-04-1032491.PMC4622456.pdf
J Exp Med 2005; 201:233-40; PMID:15657292; http://dx.doi.org/10.1084/jem.20041257 16.,Non-OADS,/arxiv_data1/oa_pdf/6f/e2/kmab-07-04-1032491.PMC4622456.pdf
Mol Pharm 2012; 9:791-802; PMID:22352470; http://dx.doi.org/10.1021/mp200566k 32.,Non-OADS,/arxiv_data1/oa_pdf/6f/e2/kmab-07-04-1032491.PMC4622456.pdf
Methods Mol Biol 2014; 1131:427-46;PMID:24515481; http://dx.doi.org/10.1007/978-1- 62703-992-5_26 33.,Non-OADS,/arxiv_data1/oa_pdf/6f/e2/kmab-07-04-1032491.PMC4622456.pdf
J Clin Pharmacol 2009; 49:1382-402;PMID:19837907; http://dx.doi.org/10.1177/ 0091270009337134 34.,Non-OADS,/arxiv_data1/oa_pdf/6f/e2/kmab-07-04-1032491.PMC4622456.pdf
N Engl J Med 2010;362:118-28; PMID:20071701; http://dx.doi.org/ 10.1056/NEJMoa0810652 35.,OADS,/arxiv_data1/oa_pdf/6f/e2/kmab-07-04-1032491.PMC4622456.pdf
Immunity 2008; 28:454-67; PMID:18400188;http://dx.doi.org/10.1016/j.immuni.2008.03.004 36.,OADS,/arxiv_data1/oa_pdf/6f/e2/kmab-07-04-1032491.PMC4622456.pdf
Nat Med 2012; 18:1069-76; PMID:22772566; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/6f/e2/kmab-07-04-1032491.PMC4622456.pdf
Cytokine Growth Factor Rev 2010; 21:365-79; PMID:20870448; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/6f/e2/kmab-07-04-1032491.PMC4622456.pdf
Diabetes Care 1997; 20:1512-7; PMID:9314626; http://dx.doi.org/ 10.2337/diacare.20.10.1512 39.,Non-OADS,/arxiv_data1/oa_pdf/6f/e2/kmab-07-04-1032491.PMC4622456.pdf
Nat Biotechnol 2014; 32:356-63; PMID:24633243; http://dx.doi.org/10.1038/nbt.2825 40.,OADS,/arxiv_data1/oa_pdf/6f/e2/kmab-07-04-1032491.PMC4622456.pdf
MAbs 2014; 6:5-14; PMID:24284914; http://dx.doi.org/10.4161/mabs.27333 41.,OADS,/arxiv_data1/oa_pdf/6f/e2/kmab-07-04-1032491.PMC4622456.pdf
Nature 1996; 381:751-8;PMID:8657279; http://dx.doi.org/10.1038/381751a0 42.,Non-OADS,/arxiv_data1/oa_pdf/6f/e2/kmab-07-04-1032491.PMC4622456.pdf
PMID:24610726; http://dx.doi.org/10.1002/ eji.201343716 43.,OADS,/arxiv_data1/oa_pdf/6f/e2/kmab-07-04-1032491.PMC4622456.pdf
"De Groot AS, Moise L, McMurry JA, Wambre E, Van OL, Moingeon P, Scott DW, Martin W. Activation ofnatural regulatory T cells by IgG Fc-derived peptide “Tregitopes.“ Blood 2008; 112:3303-11; PMID:18660382; http://dx.doi.org/10.1182/blood- 2008-02-138073 44.",Non-OADS,/arxiv_data1/oa_pdf/6f/e2/kmab-07-04-1032491.PMC4622456.pdf
JBiol Chem 1996; 271:22611-8; PMID:8798431; http://dx.doi.org/10.1074/jbc.271.37.22611 45.,OADS,/arxiv_data1/oa_pdf/6f/e2/kmab-07-04-1032491.PMC4622456.pdf
Meth- ods Mol Biol 2014; 1060:1-8; PMID:24037833;http://dx.doi.org/10.1007/978-1-62703-586-6_1 46.,Non-OADS,/arxiv_data1/oa_pdf/6f/e2/kmab-07-04-1032491.PMC4622456.pdf
Biochem Biophys Res Commun 2007; 355:751-7; PMID:17321501; http://dx.doi.org/10.1016/j.bbrc.2007.02.042 48.,OADS,/arxiv_data1/oa_pdf/6f/e2/kmab-07-04-1032491.PMC4622456.pdf
Methods Mol Biol 2014; 1060:123-37; PMID:24037839; http://dx.doi.org/ 10.1007/978-1-62703-586-6_7 49.,Non-OADS,/arxiv_data1/oa_pdf/6f/e2/kmab-07-04-1032491.PMC4622456.pdf
Trends Immunol 2007; 28:482-90;PMID:17964218; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/6f/e2/kmab-07-04-1032491.PMC4622456.pdf
Pharm Res 2010; 27:544-75; PMID:20143256; http://dx.doi.org/10.1007/s11095- 009-0045-6 53.,Non-OADS,/arxiv_data1/oa_pdf/6f/e2/kmab-07-04-1032491.PMC4622456.pdf
J Pharm Sci 2011; 100:1330-40; PMID:24081468; http://dx.doi.org/10.1002/jps.22384 54.,Non-OADS,/arxiv_data1/oa_pdf/6f/e2/kmab-07-04-1032491.PMC4622456.pdf
J Pharm Sci 2004; 93:2645-68; PMID:15389672; http://dx.doi.org/ 10.1002/jps.20178 55.,Non-OADS,/arxiv_data1/oa_pdf/6f/e2/kmab-07-04-1032491.PMC4622456.pdf
J Immunol 2006; 177:4072-9; PMID:16951371; http://dx.doi.org/10.4049/ jimmunol.177.6.4072 56.,Non-OADS,/arxiv_data1/oa_pdf/6f/e2/kmab-07-04-1032491.PMC4622456.pdf
Clin Immunol 2009; 131:189-201; PMID:19269256; http://dx.doi.org/10.1016/j.,Non-OADS,/arxiv_data1/oa_pdf/6f/e2/kmab-07-04-1032491.PMC4622456.pdf
Anal Biochem 1997; 247:102-10; PMID:9126378; http://dx.doi.org/10.1006/abio.1997.2036 62.,Non-OADS,/arxiv_data1/oa_pdf/6f/e2/kmab-07-04-1032491.PMC4622456.pdf
J Biol Chem 2003; 278:1910-4; PMID:12417590; http://dx.doi.org/10.1074/jbc.M207577200 64.,OADS,/arxiv_data1/oa_pdf/6f/e2/kmab-07-04-1032491.PMC4622456.pdf
Biophys J 2000; 78:1606- 19; PMID:10692345; http://dx.doi.org/10.1016/ S0006-3495(00)76713-0 65.,OADS,/arxiv_data1/oa_pdf/6f/e2/kmab-07-04-1032491.PMC4622456.pdf
J Chromatogr B Biomed Sci Appl 1997; 699:133-47; PMID:9392373; http://dx.doi.org/ 10.1016/S0378-4347(97)00202-8 67.,OADS,/arxiv_data1/oa_pdf/6f/e2/kmab-07-04-1032491.PMC4622456.pdf
Biophys J 2006; 90:4651-61; PMID:16565040; http://dx.doi.org/10.1529/ biophysj.106.081372 www.tandfonline.com 791 mAbs,OADS,/arxiv_data1/oa_pdf/6f/e2/kmab-07-04-1032491.PMC4622456.pdf
"27,28 In this study we attempt to investigate the expression of M2 mus- carinic receptors in bladder cancer samples and to explore their bio- logical effects on urothelial cancer cells as we already demonstrated in © Luca Pacini, Elena De Falco, Maria Di Bari, Andrea Coccia, Camilla Siciliano, Donatella Ponti, Antonio Luigi Pastore, Vincenzo Petrozza, Antonio C arbone, Ada Maria Tata, and Antonella Calogero*Correspondence to: Antonella Calogero; Email: antonella.calogero@uniroma1.it; Donatella Ponti; Email: donatella.ponti@uniroma1.itSubmitted: 02/25/2014; Revised: 07/11/2014; Accepted: 08/01/2014 http://dx.doi.org/10.4161/15384047.2014.955740 This is an Open Access article distributed under the terms of the Creative Commons Attribution-Non-Commercial License (http://creativecommons.o rg/licenses/ by-nc/3.0/), which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/22/fe/kcbt-15-11-955740.PMC4622460.pdf
World J Urol 2009; 27:289-93; PMID:19219610; http://dx.doi.org/10.1007/s00345-009-0383-3 3.,Non-OADS,/arxiv_data1/oa_pdf/22/fe/kcbt-15-11-955740.PMC4622460.pdf
Cancer stem cells in bladder cancer: a revisited and evolving concept.Curr Opin Urol 2010; 20:393-97; PMID:20657288; http://dx.doi.org/10.1097/MOU.0b013e32833cc9df4.,Non-OADS,/arxiv_data1/oa_pdf/22/fe/kcbt-15-11-955740.PMC4622460.pdf
Kidney Int 2007; 72:1057-64; PMID:17667988; http://dx.doi.org/ 10.1038/sj.ki.5002439 5.,Non-OADS,/arxiv_data1/oa_pdf/22/fe/kcbt-15-11-955740.PMC4622460.pdf
The J Urol 2010; 184:2578-85; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/22/fe/kcbt-15-11-955740.PMC4622460.pdf
BJU Int 2012; 110:E293-E300; PMID:22551294; http://dx.doi.org/10.1111/j.1464- 410X.2012.011145.x 7.,OADS,/arxiv_data1/oa_pdf/22/fe/kcbt-15-11-955740.PMC4622460.pdf
Neurourol Urodyn 2007; 26:63-70; PMID:17123299; http://dx.doi.org/ 10.1002/nau.20378 9.,Non-OADS,/arxiv_data1/oa_pdf/22/fe/kcbt-15-11-955740.PMC4622460.pdf
PMID:19295256; http://dx.doi.org/10.1159/000209 255 10.,Non-OADS,/arxiv_data1/oa_pdf/22/fe/kcbt-15-11-955740.PMC4622460.pdf
Life Sci 2007; 80:2303-7; PMID:17335853; http://dx.doi.org/10.1016/j.lfs.,OADS,/arxiv_data1/oa_pdf/22/fe/kcbt-15-11-955740.PMC4622460.pdf
Pharmacol Res 2013; 74:1-6; PMID:23628881; http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/22/fe/kcbt-15-11-955740.PMC4622460.pdf
J Neurosci2008; 28:1977-87; PMID:18287514; http://dx.doi.,OADS,/arxiv_data1/oa_pdf/22/fe/kcbt-15-11-955740.PMC4622460.pdf
BJU Int 2007; 99:1433-8; PMID:17428242; http://dx.doi.org/ 10.1111/j.1464-410X.2007.06866.x 15.,OADS,/arxiv_data1/oa_pdf/22/fe/kcbt-15-11-955740.PMC4622460.pdf
J Urol 2006; 176:797-801; PMID:16813950; http://dx.doi.org/10.1016/j.juro.2006.03.074 16.,OADS,/arxiv_data1/oa_pdf/22/fe/kcbt-15-11-955740.PMC4622460.pdf
Life Sci 2007;80:2298-302; PMID:17363007; http://dx.doi.org/ 10.1016/j.lfs.2007.02.010 17.,OADS,/arxiv_data1/oa_pdf/22/fe/kcbt-15-11-955740.PMC4622460.pdf
Curr Bladder Dysf Rep 2009; 4:47-52; http://dx.doi.org/10.1007/s11884-009-0007-1 18.,Non-OADS,/arxiv_data1/oa_pdf/22/fe/kcbt-15-11-955740.PMC4622460.pdf
The prostate 1997; 30:160-66; PMID:9122040; http://dx.doi.org/10.1002/(SICI)1097-0045(19970215)30:3 <160::AID-PROS3>3.0.CO;2-Q 19.,Non-OADS,/arxiv_data1/oa_pdf/22/fe/kcbt-15-11-955740.PMC4622460.pdf
GynecologicOncol 2002; 85:159-64; http://dx.doi.org/10.1006/ gyno.2002.6597 21.,Non-OADS,/arxiv_data1/oa_pdf/22/fe/kcbt-15-11-955740.PMC4622460.pdf
Cancer Res 2007;67:3936-42; PMID:17440109; http://dx.doi.org/ 10.1158/0008-5472.CAN-06-2484 22.,Non-OADS,/arxiv_data1/oa_pdf/22/fe/kcbt-15-11-955740.PMC4622460.pdf
J Cutan Pathol 1997; 24:137-44; PMID:9085148; http://dx.doi.org/10.1111/j.1600- 0560.1997.tb01567.x 23.,Non-OADS,/arxiv_data1/oa_pdf/22/fe/kcbt-15-11-955740.PMC4622460.pdf
Clin Exp Dermatol 2005; 30:557-64; PMID:16045692; http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/22/fe/kcbt-15-11-955740.PMC4622460.pdf
Life Sci 2003; 19:2159-68; http://dx.doi.org/ 10.1016/S0024-3205(03)00078-X 27.,OADS,/arxiv_data1/oa_pdf/22/fe/kcbt-15-11-955740.PMC4622460.pdf
J Cell Mol Med 2013; 17:552-66; PMID:23490231; http://dx.doi.org/10.1111/jcmm.12038 29.,Non-OADS,/arxiv_data1/oa_pdf/22/fe/kcbt-15-11-955740.PMC4622460.pdf
Recent Pat CNS Drug Discov 2013; 8:123-41; PMID:23597304; http://dx.doi.org/10.2174/ 1574889811308020003 30.,Non-OADS,/arxiv_data1/oa_pdf/22/fe/kcbt-15-11-955740.PMC4622460.pdf
J Membr Biol 2000; 176:31-40; PMID:10882426; http://dx.doi.org/10.1007/ s002320001073 32.,Non-OADS,/arxiv_data1/oa_pdf/22/fe/kcbt-15-11-955740.PMC4622460.pdf
